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ABSTRACT 
The initial aims of this PhD project were to investigate the Petasis borono-
Mannich (PBM) reactions of pinacol allenylboronate in the synthesis of anti-β-allenyl-
β-amino alcohols and the application of these products to the synthesis of functionalized 
piperidines via the aza-Prins cyclization reaction. We also planned to develop a 
synthetic strategy for the preparation of the pentacyclic alkaloid 9β-hydroxyvertine.  
In Chapter 2, the first exploration of the Petasis borono-Mannich (PBM) 
reactions of pinacol allenylboronate are described. The reactions of glycoaldehyde and 
chiral α-hydroxyaldehydes with primary and secondary amines gave exclusively anti-β-
allenyl-β-amino alcohol products. These reactions are highly regio- and 
diastereoselective. The anti-stereochemical outcomes of these reactions were 
determined by conversion of representative compounds to their oxazolidinone 
derivatives and then NOESY or ROESY NMR analysis. In contrast, the reactions of 
salicylaldehyde and primary and secondary amines were highly regioselective and gave 
homopropargylamine and α-allenylamine products, respectively. Possible reactive 
intermediates were proposed to explain these different product types. A NMR study of 
the PBM reaction of salicylaldehyde, benzylamine and pinacol allenylboronate 
indicated that a boron “ate” intermediate was readily formed however ESIMS could not 
identify this intermediate. The PBM reactions of the aromatic aldehydes lacking an 
ortho-hydroxy group did not provide PBM products which indicated that the ortho-
hydroxy group was necessary to activate the boron species to allow transfer of the 
allenyl group to the iminium ion intermediate. The PBM reaction of pincaol 
allenylboronate, pyridine 2-carboxaldehyde with primary and secondary amines 
provided exclusively the homopropargyl amine products in poor yields under non-
optimized reaction conditions. 
In Chapter 3, the attempted aza-Prins cyclization reactions of the anti-β-allenyl-
β-amino alcohol 210b or its TBS or TBPDPS ether derivatives with failed to give the 
desired tetrahydropyridine products. The attempted aza-Prins cyclization reactions of 
the N-Ts homopropargyl amine 281 or the N-Ts allenyl amine 282 with resulted only in 
the recovery of unreacted starting materials. The attempted aza-silyl-Prins cyclization 
reactions of (E)-allyl silylated allylic N-Ts amine 290 with failed to provide the desired 
xxviii 
 
product. The attempted aza-Prins cyclization reaction of N-Bn amine 295 with in the 
presence of InCl3 provided mixtures of the aza-Cope rearrangement products. The aza-
silyl-Prins cyclization reaction of (E)-silylated N-Bn allylic amine 303 with the highly 
reactive ethyl glyoxylate in the present of InCl3 or 3Å molecular sieves successfully 
gave the desired trans-2,6-tetrahydropyridine product. Unfortunately, using less reactive 
aldehydes under these reaction conditions failed to provide the desired piperidine 
products. 
In Chapter 4, we described an attempted total synthesis of the alkaloid 9β-
hydroxyvertine using the PBM reaction between a biphenyl substituted chiral amine and 
a chiral α-hydroxy aldehyde as a key step. Several synthetic methods were investigated 
in order to synthesize the biphenyl aldehyde required for the synthesis of the above 
chiral amine. The Ullman coupling reaction of aryl halides failed to provide the desired 
product, while the desired biphenyl aldehyde was successfully prepared under Suzuki 
coupling reaction conditions. The PBM amine coupling partner was obtained in 66% 
overall yield, over five synthetic steps, from the chiral sulfinyl imine derivative of the 
prepared biphenyl aldehyde. The absolute configuration of this molecule was confirmed 
by a single crystal X-ray crystallographic analysis. The PBM aldehyde coupling partner 
was successfully synthesized from commercially available pent-4-en-1-ol. The PBM 
reaction of the chiral amine 378, aldehyde dimer 381 and β-styrylboronic acid 
unexpectedly provided a mixture of two diastereomeric β-amino alcohol products. An 
alternative synthetic strategy using an amine without the biphenyl moiety was not 
further pursued because of the failure of the attempted deprotection of the PMB ether 
group. The quinolizidine 397 was obtained in 9.9% overall yield over three synthetic 
steps from the PMB ether 382. Because of the low yield of the desired quinolizidine 
product 397, the secondary alcohol in the PMB ether 382 was protected as a TBS ether, 
however the attempted deprotection of the PMB protecting group from the  PMB ether 
398 failed. An alternative synthetic strategy was developed by which the primary 
hydroxy group of the aldehyde dimer was protected as a TBS ether. The PBM reaction 
provided a mixture of two diastereomeric β-amino alcohol products 402 and 403. The 
(Z)-α,β-unsaturated methyl ester 417 was obtained in 21.3% overall yield, over six 
synthetic steps, from the desired diastereomer (402) while the undesired diastereomer 
403 was converted to the corresponding methyl ester 416 in 11.4% overall yield. Basic 
xxix 
 
hydrolysis of methyl ester groups of these compounds followed by treatment of the 
resulting acids under bromolactonization reaction conditions unexpectedly gave the 
corresponding (Z)-vinyl bromides and not the desired bromolactones. Due to time 
restraints, alternative methods to prepare the lactone feature of the target alkaloid were 
not investigated. 
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Chapter 1 
Introduction 
1.1 Outline of the thesis 
 This thesis reports on a study to expand the scope of the Petasis Borono-
Mannich (PBM) reaction by using pinacol allenylboronate as the organoboron 
component with the aim of preparing α-allenyl amines or homopropargyl amines. The 
aza-Prins cyclization reactions of the products of these reactions will then be examined 
as a means of preparing highly functionalized piperidines, including the alkaloid target, 
9β-hydroxyvertine. This introductive chapter will provide an overview of the PBM 
reaction, the related metal-catalyzed reactions of pinacol allenylboronate with imines 
and iminium ions and the aza-Prins reaction. 
1.2 The Petasis Borono-Mannich (PBM) reaction  
 The PBM reaction or Petasis reaction is a three component, one-pot reaction 
involving a boronic acid or boronate ester, a carbonyl compound, and a primary or 
secondary amine. The reaction has been developed over more than two decades into a 
potent method in organic chemical synthesis. This reaction has been reviewed in 2010,1 
20142 and 20163 and therefore only a short overview of the PBM reaction will be 
provided with some new recent examples given. 
In 1993, Petasis et al. reported the first use of organoboronic acids                      
in the Mannich reaction to synthesize allylic amines. The reactions between 
paraformaldehyde, secondary amines 1, and (1E)-alkenyl boronic acids 2 provided (E)-
allylic amines 3 in 75-96% yields (Scheme 1.1a).4 The Petasis group then reported the 
synthesis of α-amino acids 5 using glyoxylic acid 4 as the aldehyde component  
(Scheme 1.1b)5 and anti β-amino alcohols 7 from chiral α-hydroxy aldehydes 6 in high 
diastereoselectivities and enantiopurities (Scheme 1.1c).6 In 2001, the same group 
reported the PBM reaction of salicylaldehyde 8 with organoboronic acids and amines to 
give 2-aminoalkylphenols 9 (Scheme 1.1d).7 In 2015, the PBM reaction was extended to 
include α-N-protected amino aldehydes 10 to give anti-1,2-diamines 11 (Scheme 
1.1e).8,9 
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Scheme 1.1 The Petasis borono-Mannich reaction of various types of aldehydes 
 Mechanistic details of these reactions, using the above different types of 
aldehydes will be discussed in later sections of this chapter. One limitation of the PBM 
reaction is that apart from formaldehyde, it only works efficiently for α-hydroxyl 
aldehydes, ortho-hydroxybenzaldehydes, glyoxylic acids and α-N-protected amino 
aldehydes. The PBM reaction works well with aryl, vinyl, allyl, and alkynyl boronic 
acids or boronate esters. In some cases, the potassium trifluoroborate salts have also 
been successfully used.1-3 No examples of allenyl (the subject of this thesis) or alkyl 
boronic acids or esters had been reported prior to the start of this project.                      
The commercial availability of a wide variety of organoboronic acid and their 
derivatives, primarily due to their application in the Suzuki-Miyaura cross-coupling 
reaction,10 is a major advantage of the Petasis reaction. Furthermore, organoboron 
reagents are not only stable in air and water but also non-toxic and environmentally 
friendly. Another benefit of these reagents is that they are tolerant to many functional 
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groups which enables the minimal use of protective group in the synthesis of 
multifunctional molecules.11  
1.2.1 Mechanistic considerations 
 The PBM reaction is categorized as a type II multicomponent reaction which 
involves an undefined number of reversible steps and one irreversible step leading to the 
product.1 Petasis initially proposed that the mechanism begins with the reaction between 
amine 1 and aldehyde 6 to form the hemiaminal 12 followed by elimination of 
hydroxide to produce an iminium intermediate 13 (Scheme 1.2). The boronic acid 
component 7 may catalyse the elimination of water from intermediate 12. Intermediate 
13 can coordinate to the organoboron reagent to produce the boron “ate” complex 14. 
Then an irreversible C-C bond forming reaction occurs through an intramolecular 
transfer of the activated boron substituent to the electrophilic carbon of the iminium ion 
leading to the intermediate 15. Finally, hydrolysis of intermediate 15 then generates the 
final 1,2-amino alcohol product 7 (Scheme 1.2).4,6 
 
Scheme 1.2 The proposed mechanism of the PBM reaction by Petasis4,6 
 An alternative mechanism was proposed by Schlienger and Voisin for the PBM 
reaction using glyoxylic acid 4 as the aldehyde component. Their proposed mechanism 
starts with formation of a boron “ate” complex from the reaction of glyoxylic acid 4 and 
the boronic acid. Subsequently, the carbonyl group of the complex 16 is attacked by the 
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amine to give the hemiaminal 17, which undergoes elimination of hydroxide or water to 
form the iminium intermediate 18. A subsequent intramolecular transfer of the boron 
substituent to the iminium carbon, followed by hydrolysis of the resulting intermediate 
19 gives the observed α-amino acid product 5 (Scheme 1.3).12,13  
Tao and Li reported density functional theory (DFT) calculations of the PBM 
reaction which compared the energies of the transition states for both of the above 
proposed mechanisms. The calculations showed that the initial reaction between the 
amine and aldehyde to form the corresponding hemiaminal intermediates, as suggested 
by Petasis, is more favourable.14 
 
Scheme 1.3 Proposed mechanism of the PBM reaction by Schlienger and Voisin12,13 
 The PBM reaction of α-hydroxy aldehydes, which was first explored by Petasis 
et al., is a highly diastereoselective reaction.6 The exclusive formation of the anti β-
amino alcohol products is observed starting from either racemic or enantiomerically 
pure α-hydroxy aldehydes; a single enantiomer is formed from enantiomerically pure α-
hydroxy aldehydes. Pyne et al. suggested that when a vinylboronic acid is employed; 
the diastereoselectivity is induced by the reactive conformation of the ate-complex 
intermediate 21 in which 1,3-allylic strain between the α-substituent and the N-
substituent on the iminium ion is minimized. This will produce the anti-amino alcohol 
22 (Scheme 1.4).15 
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Scheme 1.4 The proposed mechanism of the diastereocontrol in the PBM reaction via 
an intermediate in which 1,3-allylic strain minimized15 
1.2.2 Synthetic applications 
 The PBM reaction is a useful method for the synthesis of several classes of 
compounds such as α-amino acids, α-amino alcohols, aminophenol derivatives, and 
various heterocycles which can be used for expanding the scope of compound libraries 
in the pharmaceutical industry. Some of the interesting molecules that can be prepared 
using the PBM reaction are described in the following sections. 
1.2.2.1 Synthesis of α-amino acids 
 The PBM reaction of glyoxylic acid 4 or alkyl glyoxylates 23 as aldehyde 
components and amines 1 with organoboronic acids or boronate esters provides the α-
amino acid derivatives 7 and 24, respectively the former are typically isolated and 
purified by filtration and recrystallization. 
 
Scheme 1.5 General PBM reactions for α-amino acid synthesis 
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 The use of primary and secondary amines, as well as the use of organoboron 
compounds such as alkenyl, aryl and heteroaryl boronic acids in these reactions, has 
been reported. Secondary amines are generally more reactive than primary amines, and 
moreover, better yields can be obtained using microwave activation at high temperature 
or by the use of hexafluoroisopropanol (HFIP) as the solvent.5,16-21 For example, 
Jourdan et al. reported a study of the use of HFIP and microwave irradiation in the 
synthesis of α-styryl amino acids 25 from glyoxylic acid 4, β-styrylboronic acid pinacol 
ester and primary or secondary amines. When compared to MeOH as a solvent, HFIP at 
room temperature provided the corresponding α-amino acids 25 in good to excellent 
yields, much higher than those performed in MeOH at room temperature or even MeOH 
with microwave heating (Table 1.1).18  
Table 1.1 Synthesis of α-amino acids 26 by Jourdan et al. 18 
 
        Amines Product   Yielda (%)      Yieldb (%)  
 
 
 
 
 
 
 
a The reaction performed in methanol at rt. b The reaction performed in HFIP at rt. 
c The reaction performed in methanol under microwave irradiation.  
 
67 
60 
67c 
85c 
85 
78 
97 
97 
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 Yuan et al.22 reported the first use of trifluoroacetic acid in the PBM reaction of 
glyoxylic acid 4 with arylboronic acids 26 and 5-nitroindoline 27. These reactions,         
in which only 0.005 mol% of TFA was employed, were performed in CH2Cl2 at room 
temperature and were complete within 1-7 h, to give 2-(nitroindolin-1-yl)-2-arylacetic 
acids 28 in moderate to excellent yields (Scheme 1.6).  
 
Scheme 1.6 TFA-catalyzed PBM reactions of glyoxylic acid 4 
Carboni et al.23 reported the synthesis of γ-boronated unsaturated α-amino esters 
30 via the PBM reaction of (Z)-1-alkene-1,2-diboronic esters 29 with glyoxylic acid 4 
and secondary amines in HFIP at room temperature and subsequent esterification of the 
crude α-amino acid product with CH2N2. These reactions provided (E)-γ-boronated 
unsaturated α-amino esters 30 in moderate yields and high regioselectivities via the 
proposed intermediate 31 (Scheme 1.7). These products could be engaged in Suzuki-
Miyaura cross-coupling reactions with aryl bromides to provide γ-arylated derivatives. 
 
Scheme 1.7 PBM reaction of (Z)-1-alkene-1,2-diboronic esters 29 
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In 2017, Carboni et al.24 reported the PBM reaction of glyoxylic acid 4 with (E)-
alkenyl boronates 32 and secondary amines in HFIP at room temperature. Subsequent 
esterification of the α-amino acid products with CH2N2 gave the (Z)-α,β-unsaturated α-
amino esters  33 in yields ranging from 48-66% (Scheme 1.8). 
 
Scheme 1.8 Synthesis of (Z)-α,β-unsaturated α-amino esters 33 
1.2.2.2 Synthesis of anti-1,2-amino alcohols 
 Anti-1,2-amino alcohols can be prepared from the PBM reactions of α-hydroxy 
aldehydes or their cyclic acetal precursors, amines, and aryl or 1-alkenyl boronic acids. 
Petasis et al. reported the synthesis of 1,2-anti amino alcohols 34 from the reaction of 
boronic acids, primary or secondary amines and chiral -hydroxy aldehydes. These 
reactions provided products with high anti-diastereoselectivities (>99% de) and 
enantiopurities (Table 1.2).6 
Table 1.2 Synthesis of 1,2-anti amino alcohols 34 
Entry 
Aldehyde or 
Precursor 
Amine Boronic acid Product 34 Yield 
(%) 
1 
    
95  
2 
 
  
 
92 
3 
 
 
  
72 
4 
 
  
 
97 
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 Au and Pyne developed a general method for the preparation of anti-1,2-amino 
alcohols. This method involves the preparation of enantiomerically enriched -hydroxy 
aldehydes in situ from the asymmetric dihydroxylation (ADH) reaction of vinyl 
sulfones 35 which under PBM reaction conditions with β-styryl boronic acid gave the 
enantiomerically enriched anti-1,2-amino alcohols 36 and 37 in moderate yields 
(Scheme 1.9).25 
 
Scheme 1.9 Synthesis of enantiomerically pure 1,2-anti amino alcohols 
Schreiber et al.26 reported the PBM reaction of the α-hydroxy aldehyde 
precusors 38, amines and diethyl organoboronate reagents with a catalytic amount of the 
chiral catalyst (S)-3,3′-Br2-BINOL, to give the syn-1,2-amino alcohol products 39 with 
moderate to excellent yields and diastereoselectivities. (Scheme 1.10) 
 
Scheme 1.10 Synthesis of 1,2-syn amino alcohols from the catalytic diastereoselective 
PBM reaction of α-hydroxy aldehydes 
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1.2.2.3 Synthesis of aminoalkylphenols and arylalkylamines 
Functionalized arylalkylamines and aminoalkylphenols are attractive molecules 
for the development of pharmaceutical and agricultural chemicals.7 The PBM reactions 
of salicylaldehyde, amines, and organoboronic acid provide efficient synthetic routes to 
these compounds. 
Petasis et al.7 reported the PBM reactions of substituted salicylaldehydes 40, 
amines and aryl and vinyl boronic acids in the synthesis of aminoalkylphenols 41. The 
products were obtained in poor to excellent yields (Scheme 1.11).  
 
Scheme 1.11 Synthesis of aminoalkylphenols 41 from salicylaldehydes 
Sugiura et al.27 reported the PBM-like reactions of aromatic aldehydes 42, liquid 
ammonia or aqueous ammonia and allyl boronate 43 to provide the α-aryl homoallylic 
amines 44 with excellent yields (Scheme 1.12). This was the first report on using NH3 
in the PBM reaction and also highlighted the enhanced reaction of allyl boronates over 
aryl and vinyl boronates in that no ortho-hydroxy group was required on the aldehyde 
component for a successful reaction. 
 
Scheme 1.12 Synthesis of aryl homoallylic amines 44 from aromatic aldehydes 
Kostakis et al.28 reported the first use of heteronuclear Zn/lanthanide (Ln) 
coordination clusters (CCs) as catalysts for the PBM reaction involving 
salicylaldehydes, arylboronic acids, and secondary amines. Dysprosium was the most 
effective compared to other lanthanide metals. These reactions were performed at room 
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temperature to provide the aminoalkylphenols 45 with yields ranging from 84-98% 
(Scheme 1.13). 
 
Scheme 1.13 Zn/Ln CCs-catalyzed PBM reaction of salicylaldehydes 
 Their proposed mechanism is shown in Scheme 1.14. The coordination of the 
aldehyde to the Ln metal and the secondary amine to the Zn metal provides the Zn-
complex 46 which then reacted with the boronic acid to afford the product 45 and 
regenerated the catalyst. 
 
Scheme 1.14 Proposed mechanism of Zn/Ln CCs-catalysed PBM reaction 
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1.2.2.4 Synthesis of heterocycles 
 Among the several clinical applications, heterocyclic compounds have a 
significant active role as antibacterial, antiviral, antifungal, anti-inflammatory and 
anticancer drugs.29 Of these, the flavonoids, anthocyanins, and tocopherols have a 2H-
chromene (2H-1-benzopyran) based structure.30 The reactions of vinyl or aromatic 
boronic acids, salicylaldehyde derivatives 40, and amines provide product precursors 
which undergo cyclization to 2H-chromenes 48 via loss of the amine upon heating. 
Thus these reactions can occur using sub-stoichiometric amounts of the amine 
component (Scheme 1.15).31  
 
Scheme 1.15 Synthesis of 2H-chromenes 48 using salicylaldehydes 
The mechanism for this reaction was proposed beginning with the formation of 
the iminium ion 49 followed by coordination of the phenolate oxygen to the boronic 
acid to provide the “ate” complex intermediate 50 which undergoes an intramolecular 
transfer of the vinyl group to provide the intermediate 51. Hydrolysis of this 
intermediate gives compound 52 in which the amine component is protonated to 
promote the SN2′-like cyclization step providing the 2H-chromenes 48 and regenerates 
the dibenzylamine catalyst (Scheme 1.16).31 
 
Scheme 1.16 The proposed mechanism for the synthesis of 2H-chromenes 48  
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 Berrée et al. reported the synthesis of 2-hydroxymorpholines which are found as 
common structures in a wide range of bioactive compounds. The PBM reaction of 
glyoxal and its derivatives 53 with boronic acids and 1,2-amino alcohols 54 provides         
2-hydroxymorpholines 55 in yields ranging from 50-80% with poor to high 
diastereoselectivities (Scheme 1.17).32  
 
Scheme 1.17 The synthesis of 2-hydroxymorpholines 55 using glyoxal derivatives 
 Mandai et al.33 reported their studies on the PBM reactions of various pyridine 
2-carboxaldehydes 56 with vinyl, aryl and heteroaryl boronic acids and secondary 
amines. These reactions were performed in MeCN at reflux temperature to provide the 
products 57 in yields ranging from 11-96% (Scheme 1.18). The authors proposed the 
possible reactive intermediate which is shown in Scheme 1.18.  
 
Scheme 1.18 The PBM reaction of pyridine 2-carboxaldehydes 56 
Interestingly, an unexpected product 65 was obtained in >98% yield from the 
reaction of 4-(dimethylamino)-2-pyridinecarboxaldehyde with (S)-(-)-N-methyl-1-
phenylethylamine and 2 equiv. of β-styryboronic acid. The formation of this product 
was proposed to involve the direct alkylation of the aldehyde by the boronic acid, 
followed by anion/enolate tautomerization and a [1,5]-sigmatropic hydrogen shift 
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(Scheme 1.19a).33 An alternative explanation is that since 4-(dimethylamino)-2-pyridine 
moiety is a significantly electron rich molecule then the boronate complex 58b is 
formed more rapidly than the corresponding imine intermediate shown in Scheme 1.18. 
This intermediate can readily form the enol form 61 as shown in Scheme 1.19b which 
then leads to product 65 as shown in Scheme1.19a.  
 
Scheme 1.19 Proposed mechanisms for the formation of product 65 
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1.2.2.5 Synthesis of diamines 
 Beau et al.8,9 reported the diastereoselective synthesis of enantiomerically 
enriched 1,2-trans-diamines 11 from the PBM reaction of N-protected α-amino 
aldehydes 10 with vinyl or arylboronic acids and secondary amines at room temperature 
in PhCF3 (Scheme 1.20). The products 11 were obtained in high enantiopurities from 
sulfonamide protected aldehydes 10 [tosyl (Ts), nosyl (Ns) and mesyl (Ms)], while 
aldehyde having other sulfonamide [4-methoxy-2,3,6-trimethylphenylsulfonamide 
(Mtr), and 2-(trimethylsilyl) ethanesulfonamide (SES)], acetate (Ac), and carbamate 
(Boc) protecting groups provided products 11 in poor yields with low enantiopurities. 
 
Scheme 1.20 PBM reactions of N-protected α-amino aldehydes 10 
 The proposed mechanism was investigated through DFT calculations of the 
possible intermediates. In the first step, nucleophilic addition of dimethylamine to the 
carbonyl compound led to the hemiaminal 66. In the second step, water is eliminated to 
provide the zwitterionic iminium intermediate 67, which is stabilized by a hydrogen 
bond between the amide anion or one oxygen atom of the sulfonamide and a molecule 
of water. This intermediate can coordinate to the boron reagent to give the boron “ate” 
complex 68 which undergoes intramolecular transfer of the vinyl group to provide the 
product 11 (Scheme 1.21).9 
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Scheme 1.21 Proposed mechanism for PBM reactions of N-protected α-amino 
aldehydes 10 based on DFT calculations9 
1.2.2.6 Application to bioactive molecule and natural product synthesis 
 The PBM reaction has been used as a key step in some natural product and drug 
syntheses which often provides an opportunity of obtaining these target molecules in 
fewer synthetic steps, than when using other reactions. 
 Osman and Nazeruddin reported the synthesis of new diclofenac analogues 72 
from the PBM reaction between aromatic aldehydes 42, diclofenac 70 as the amine 
component and phenylboronic acid 71 via the intermediate 73, in which the boron 
reagent is coordinated to the hydroxy group of the carboxylic acid. Some of the 
synthesized products exhibited increased anti-inflammatory activities over the parent 
drug (Scheme 1.22).34 
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Scheme 1.22 The synthesis of diclofenac analogues 72 
 The Pyne group has made successful applications of the PBM reaction to the 
synthesis of bioactive polyhydroxylated indolizidine, pyrrolizidine, and nortropane 
alkaloids.15,35 A recent example is the concise synthesis of (−)-steviamine 77 starting 
with the PBM reaction between the L--ribofuranose derivative 74, (R)-4-penten-2-
amine hydrochloride and β-styrylboronic acid. The 1,2-anti amino alcohol product 76 
was obtained a single diastereomer via the proposed reactive intermediate 75. The diol 
76 then was converted to (−)-steviamine 77 in three synthetic steps (Scheme 1.23).36 
 
Scheme 1.23 A concise synthesis of (−)-steviamine 77. 
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1.3 Synthesis of homopropargyl and α-allenyl amines using allenyl and propargyl 
organoboron reagents 
 This related topic to the PBM reaction was reviewed, along with the synthesis of 
the corresponding alcohol derivatives by our research group in 2017.37 This review is 
included in Appendix 3 of this thesis. Only highlights from this review that are relevant 
to this thesis will be presented. Homopropargyl and α-allenyl amines are valuable 
precursors for the synthesis of heterocyclic compounds and alkaloids.38 A general 
method for synthesis of these precursors involves the nucleophilic addition of 
metallated propargyl 80 or allenyl reagents 81 to imines or iminium ions (Scheme 1.24). 
These organometallic reagents can react with the electrophiles mentioned above to 
provide either allenyl 82 or propargyl products 83 (Scheme 1.24). The regioselectivity 
of these reactions for allenyl versus propargyl products, is dependent upon the nature of 
the metal including magnesium, lithium, zinc, tin, silicon, titanium, aluminium and 
boron, the substituents on both the nucleophilic and electrophilic components as well as 
the reaction temperature and solvent.39-41 
 
Scheme 1.24 Synthesis of homopropargyl and allenyl amines from metal-catalyzed 
reactions of allenyl- and propargylboron reagents. 
 Pinacol esters of allenyl and propargylboronic acid, 78 and 79 respectively, have 
been widely used in the propargylation or allenylation reactions of imines with control 
of regioselectivity. The advantages of these boron reagents are their stability to air and 
protic solvents when compared to other organometallic reagents and their ability to 
undergo transmetalation reactions with other metals, often used in catalytic amounts, 
leading to more simple, tunable and highly regioselective reactions. These organoboron 
reagents have been used for diastereoselective and enantioselective allenylation or 
propargylation reactions.42 
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1.3.1 Direct synthesis of α-allenyl homopropargyl amines 
 Fandrick et al.43 reported that the reactions between dihydroisoquinoline 84, 
including 3,4-dihydro-β-carboline, and pinacol propargylboronates 85 proceeded at 
room temperature in THF to provide the allenyl products 86 with high regioselectivities 
(allene/propargyl >20:1). The proposed cyclic transition state 87 involved coordination 
between the boron and nitrogen atom and then γ-attack by the boronate (Scheme 1.25). 
 
 
Scheme 1.25 The allenylation of dihydroisiquinoline 84 with pinacol propargyl 
boronate 85  
1.3.2 Enantioselective synthesis of homopropargyl and α-allenyl amines without a 
metal catalyst 
 Hoveyda et al.44 reported the enantioselective synthesis of N-Boc protected α-
allenyl amines from N-Boc protected imines 88 using pinacol allenylboronate 89, 
aminophenol catalyst 91, sodium tert-butoxide, and isopropanol in toluene. These 
reactions were proposed to proceed through the intermediate 92 to provide the allenyl 
products 90 in high yields and with high enantioselectivities (Scheme 1.26). 
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Scheme 1.26 Enantioselective synthesis of N-Boc protected α-allenyl amines 90 
 Smith et al.45 recently reported an attempt to develop an enantioselective 
synthesis of homopropargyl amines using 3,4-dihydro-β-carboline 93, chiral Brønsted 
acid catalysts 95-98, and pinacol allenylboronate 89. The carbamate-protected propargyl 
products 94, were obtained, from in situ methyl carbamate protection, in 61-93% yields 
with poor enantioselectivities (0-32% ee) (Scheme 1.27a). The proposed transition state 
is shown in Scheme 1.27b. 
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Scheme 1.27 a) Attempted enantioselective synthesis of homopropargyl amine 94 from 
3,4-dihydro-β-carboline 93 and b) the proposed transition state 
1.3.3 Metal-catalyzed synthesis of homopropargyl and α-allenyl amines 
Kobayashi et al.46 reported the regioselective synthesis of racemic 
homopropargyl and allenyl amines from the reaction of hydrazone ester 99 with pinacol 
allenyl boronate 89 in the presence of a catalytic amount of copper(II) or bismuth(III) 
hydroxide in aqueous DMF. The Cu(OH)2-catalyzed reaction preferentially provided      
a quantitative yield of the propargyl product 100 with high regioselectivity while the 
allenyl product 101 was preferentially obtained in quantitative yield with high 
regioselectivity in the presence of Bi(OH)3 (Scheme 1.28). 
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Scheme 1.28 The regioselective synthesis of racemic homopropargylic and α-allenyl 
amines in the presence of Cu(OH)2 and Bi(OH)3 
A mechanistic study of the reaction of the hydrazone ester 99 using α-deuterated 
pinacol allenyl boronate 89-D (97% D incorporated) in the presence of Cu(OH)2 and 
Bi(OH)3 was undertaken. In the Cu(OH)2-catalyzed reaction, the terminal position of the 
propargyl product 100-D was deuterated while the internal position of the allenyl 
product 101-D was deuterated in the Bi(OH)3-catalyzed reaction (Scheme 1.29a). These 
studies suggested that Cu(OH)2 acted as a Lewis acid catalyst to activate the hydrazone 
ester 99 and allenyl boronate 89-D reacted via γ-addition to afford the propargyl product 
100-D (Scheme 1.29b), whereas, in the Bi(OH)3-catalyzed reaction, a bismuth-
propargyl intermediate was formed via transmetalation from B to Bi followed by 
addition to the hydrazone ester 99 to afford the allenyl product 101-D (Scheme 1.29c). 
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Scheme 1.29 A mechanistic study using pinacol allenyl boronate 89-D 
 Fandrick et al.47 reported the diastereoselective zinc-catalyzed propargylation of 
(R)-N-tert-butylsulfinyl imines 102 with pinacol propargylboronate 85 in the presence 
of catalytic amount of Et2Zn in THF at room temperature to afford homopropargyl 
amines 103 in good yields and with high diastereoselectivities (Scheme 1.30).            
The proposed catalytic cycle started from a B/Zn exchange reaction between Et2Zn and 
propargylboronate 85 to generate the allenylzinc intermediate 104. This was followed 
by addition of 104 to the imine 102 to provide the metallated allenyl intermediate 105. 
Intermediate 105 then underwent reaction via a SE2′-type mechanism to generated the 
propargyl-zinc intermediate 106. This participated in another B/Zn exchange with the 
propargylboronate 85 to produce the propargyl boron complex 107 and the regenerated 
allenylzinc intermediate 104 to complete the catalytic cycle (Scheme 1.30). 
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Scheme 1.30 Zinc-catalyzed propargylation of (R)-N-tert-butylsulfinyl imines 102 and 
proposed mechanism of zinc-catalyzed propargylation of 102 
 Fustero et al.48 reported the zinc-catalyzed propargylation of chiral N-tert-
butylsulfinylimine 108 with pinacol allenyl boronate 89 to afford the homopropargyl 
product 109 in 60% yield and with high diastereoselectivity. This reaction provides a 
higher yield and better diastereoselectivity than the reaction involving addition of 
stoichiometric propargylzinc bromide (33% yield, dr = 5:1) (Scheme 1.31). 
 
Scheme 1.31 Zinc-catalyzed reaction of the chiral N-tert-butylsulfinylimine 108 with 
pinacol allenylboronate 89 
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Jarvo et al.49 reported the development of the silver-catalyzed enantioselective 
propargylation of N-tosyl imines 110 using pinacol allenylboronate 89 in the presence 
of AgF (10 mol%) and bidentate phosphine ligand, (R,R)-Walphos-1, (12 mol%) to 
provide homopropargyl amines 111 in high yields and enantiomeric purities. The more 
hindered aldimines derived from α-methyl cinnamldehyde and 2,2-dimethyl-4-pentenal 
provided the propargyl products in decreased yields (47 and 40%, respectively)  and 
enantioselectivities (89 and 74% ee, respectively) (Scheme 1.32). 
 
Scheme 1.32 Silver-catalyzed enantioselective propargylation of N-tosyl imines 110 
with pinacol allenylboronate 89 and (R,R)-Walphos-1 
Jarvo et al.50 also reported related studies on the reactions of cyclic N-sulfonyl 
ketimines 112 and 114 with pinacol allenylboronate 89, AgF and (R,R)-Walphos-1. 
These reactions provided the homopropargyl amines 113 and 115 in high yields and 
enantioselectivities (Scheme 1.33). 
 
Scheme 1.33 Silver-catalyzed enantioselective propargylation of cyclic N-sulfonyl 
ketimines 112 and 114 
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 To investigate the reaction mechanisms of the reactions of sulfonyl ketamine 
116 with the pinacol propargylboronate 117 and pinacol allenylboronate 89 these 
reactions were studied under identical reaction conditions. The homopropargyl product 
118 was obtained from both reactions in similar yields and enantioselectivities (Scheme 
1.34). The mechanism begins with transmetalation of the silver catalyst with the boron 
reagent to form the allenyl silver intermediate 119 which is equilibrium with the 
propargyl silver intermediate 120. Addition of the thermodynamically more stable 
allenyl-silver intermediate 119 to ketamine 116 via a SE2′ mechanism provides the 
observed propargyl product 118 (Scheme 1.34). 
 
Scheme 1.34 Silver-catalyzed enantioselective propargylation of the ketimine 116 using 
pinacol allenylboronate 89 or pinacol propargylboronate 117 
 Hoveyda et al.51 developed a highly enantioselective synthesis of 
homopropargyl amines from the chiral N-heterocyclic carbene (NHC)-copper catalyzed 
enantioselective propargylation reactions between N-phosphinoyl imines 121 and 
pinacol allenylboronate 89 in the presence of the chiral C1-symmetric imidazolium salt 
122 and CuCl or CuCl2·2H2O. These reactions worked well with a variety of substituent 
groups on the imine such as aryl, heteroaryl, alkyl and vinyl to produce the propargyl 
amines 123 in good to excellent yields with high regioselectivities and excellent 
enantioselectivities (Scheme 1.35). 
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Scheme 1.35 NHC-copper catalyzed enantioselective propargylation of N-phosphinoyl 
imines 121 using allenylboronate 89 and the chiral imidazolium salt 122 
DFT calculations showed that the allenyl-copper complex 124 was more 
energetically favoured than the propargyl-complex 125 (Scheme 1.36a). The 
stereochemical outcomes of the products were defined by the coordination of the 
substrate to the chiral complex. Transition state 126 was preferred over TS 127 due to 
the steric repulsion between the phosphinyl group of the imine and mesityl group of the 
catalyst (Scheme 1.36b). 
 
Scheme 1.36 The energetically favoured complex from DFT calculations and proposed 
model for the stereochemical outcomes 
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Hoveyda et al.52 reported a similar study on the enantioselective synthesis of α-
trimethylsilylallenyl amines using the NHC-copper catalyzed reaction of N-phosphinoyl 
imines 121 with propargylboronate 85 and the chiral imidazolium salt 128. These 
reactions proceeded through the favourable propargyl-Cu complex 130 due to the steric 
repulsion of the TMS group in the allenyl-Cu complex 131 to provide                                
α-trimethylsilylallenyl amines 129 in good yields and enantioselectivities (Scheme 
1.37).  
 
Scheme 1.37 NHC-copper catalyzed enantioselective synthesis of α-trimethylsilyl 
allenyl amines 129 and proposed model for the stereochemical outcomes 
 
 
Chapter 1: Introduction | 29 
 
1.3.4 Applications to natural product synthesis 
 The alkyne and allene moieties of the homopropargyl and α-allenyl amine 
products can be transformed into a number of useful functional groups or undergo 
intramolecular metal-catalyzed cyclization reactions of the amino group onto the 
unsaturated moiety. These compounds have been demonstrated to be versatile 
intermediates in natural product synthesis. 
 Fandrick et al.43 reported that the titanium-catalyzed cyclization reaction of the 
piperidine 135 in the presence of Ti(NMe2)4 and ligand 136 provided (-)-(S)-crispine A 
137 in 75% yield in an excellent enantiopurity (Scheme 1.38). 
 
Scheme 1.38 Synthesis of (-)-(S)-crispine A 137 
 The synthesis of epi-cytoxazone, which has potential as a immunosuppressive 
drug53 was achieved in three synthetic steps from the α-allenyl amine 138. Iodination of 
138 provided the 1:1 E:Z mixture of diiodide 139 which subsequently underwent an 
intramolecular SN2'-like cyclization using AgPF6 to give the oxzolidinone 140. Finally, 
lithium-iodine exchange of 140 with t-BuLi and a subsequent MeOH quench followed 
by ozonoloysis and borohydride reduction gave epi-cytoxazone 141 (Scheme 1.39).44 
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Scheme 1.39 Synthesis of epi-cytoxazone 141 
The synthesis of the amine component of the anticancer agent aza-epothilone A 
started from a catalytic enantioselective propargylation reaction of aldimine 142 to give 
the homopropargyl product 144. The amide 144 was then converted to the iodoalkyne 
and subsequently reduced to give the Z-vinyl iodide 145 in high yield and enantiopurity. 
The vinyl iodide 145 has been used in the synthesis of aza-epothilone A 146 
(Scheme1.40).51 
 
Scheme 1.40 Synthesis of aza-epothilone A 146 
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1.4 The Prins cyclization reaction 
 The Prins cyclization reaction is a powerful method for the synthesis of various 
heterocyclic compounds which are found to be important moieties of many classes of 
bioactive compounds and natural products.54 In 1919, Prins reported the first study of 
the acid-catalyzed reaction between formaldehyde and alkenes in the presence of 
sulfuric acid as a catalyst to produce the 1,3-diols 147 (Scheme 1.41).55  
 
Scheme 1.41 Synthesis of 1,3-butanediol derivatives 147 
 The products were generally formed as mixtures of 1,3-dioxanes, 1,3-diols, 
allylic alcohols and 3-substituted alcohols, depending on the reaction conditions. The 3-
substituted alcohols 149 can obtain from addition of nucleophiles to the carbocation 
148.  In the presence of water, the carbocation intermediate 148 leads to the formation 
of 1,3-diols 150 which can undergo dehydration to give allylic alcohols 151. The 1,3-
diols 150 can also react with another molecule of the aldehyde to produce 1,3-dioxanes 
152 (Scheme 1.42).54 
 
Scheme 1.42 Products formed from the Prins reaction 
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Hanschke et al.56 reported the successful Prins cyclization reactions of 
homoallylic alcohol 153, and aldehydes using sulfuric acid as a catalyst to give 2-alkyl-
tetrahydropyranols 154 in 35-72% yields, while 4-halo-tetrahydro-2H-pyrans 155 were 
obtained when hydrohalic acids were employed (Scheme 1.43). 
 
Scheme 1.43 Synthesis of 3-alkyl-4-halotetrahydropyrans via the Prins cyclization 
reaction 
 A general mechanism for these reactions is shown in Scheme 1.44. In the initial 
step, the hemiacetal intermediate 156 is generated from the nucleophilic addition of the 
homoallylic alcohol to the Lewis acid activated aldehyde. Loss of the Lewis acid 
fragment from the hemiacetal produces the key oxocarbenium ion intermediate 157 
which subsequently undergoes a 6-endo cyclization, via a cyclic transition state in 
which R1 and R2 are pseudo-equatorial, to provide the secondary tetrahydropyranyl 
carbocation 158, which is trapped by the nucleophile (X¯) to give the 2,4,6,-
trisubstituted tetrahydropyran 159.54,57 
 
Scheme 1.44 General mechanism of the Prins cyclization reaction 
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Loh et al.58 developed the Prins cyclization reactions of silicon-substituted 
allenyl alcohol 160 with aldehydes in the presence of a catalytic amount of In(OTf)3 and 
TMSBr as a nucleophilic bromide source to provide 2,6-trans-dihydropyrans 161 in 
good to excellent yields and excellent diastereoselectivities (Scheme 1.45).  
 
Scheme 1.45 Prins cyclization reactions of allenyl alcohol 160 with aldehydes  
A plausible mechanism for the diastereoselectivity of these products was 
proposed. The trans-isomer 162 is obtained from the electronically favoured 
intermediate A, in which the oxygen lone pair of the carboxylate group stabilizes the 
oxocarbenium ion, while the intermediate B, which has no lone pair stabilization form 
the carboxylate group to the oxocarbenium ion, leads to the less favoured cis-isomer 
163 (Scheme 1.46).58 
 
Scheme 1.46 Proposed cyclization pathway for Prins cyclization of allenyl alcohol 
 Martin et al.59,60 reported the Prins cyclization reactions of homopropargyl 
alcohol 164 with aldehydes. These reactions were conducted in halogenated solvents in 
the presence of TMSX (1.2 equiv) as a halide anion source and 7 mol% of the iron 
catalyst FeX3 to give 4-halo-2-alkyl-5,6-dihydro-2H-pyrans 165 in various yields 
ranging from 30-90% yields (Scheme 1.47). 
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Scheme 1.47 Iron-catalyzed Prins cyclization reactions of homopropargyl alcohol 164 
1.4.1 Aza-Prins cyclization reaction 
 The aza-Prins cyclization reaction is the nitrogen version of the Prins 
cyclization, which is a powerful tool for synthesis of nitrogen-containing heterocycles. 
Piperidine is generally found as a subunit or core structure in many bioactive 
compounds including alkaloids and is an important scaffold for drug discovery.61,62 
Martin et al.63 reported the iron-catalyzed aza-Prins cyclization reactions of the N-tosyl 
homoallylamine 166 with aldehydes in the presence of FeCl3 or FeBr3 to provide 
racemic trans-2-alkyl-4-halo-1-tosylpiperidines 167 with high diastereoselectivities, 
while the analogous reactions of the N-tosyl homopropargylamine 168 provided 2-
alkyl-4-halo-1-tosyl-1,2,5,6-tetrahydropyridines 169. Both FeCl3 and FeBr3 produced 
good yields of products, but FeBr3 provided higher yields in most cases (Scheme 1.48). 
 
Scheme 1.48 Aza-Prins cyclization reactions of N-tosyl homoallyl amine 166 and 
homopropargyl amine 168 in the presence of iron(III) halide catalysts 
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The stereochemical outcome of the piperidines 167 was studied by ab initio 
DFT calculations of the intermediate iminium ion. These calculations indicated that in 
the case of aliphatic aldehydes, the E-iminium ion 170, which leads to the trans-isomer 
171, was more stable than the corresponding Z-iminium ion 172 leading to the cis-
isomer 173. In the case of an aromatic aldehyde, the Z-iminium ion was more stable 
(Scheme 1.49).63 
 
Scheme 1.49 Proposed intermediate in aza-Prins cyclization of homoallylamine 166 
  Reddy et al.64 developed a new method for the synthesis of 4-fluoropiperidines 
via the aza-Prins cyclization reactions of the N-tosyl homoallylamine 174 and aromatic 
aldehydes using a solution of tetrafluoroboric acid-diethyl ether complex (HBF4.OEt) as 
a catalyst. The reactions of aromatic aldehydes provided cis-4-fluoropiperidines 
derivatives 175 in good yields and high diastereoselectivities whereas aliphatic 
aldehydes and trans-cinnamaldehyde provide cyclic products with moderate                 
cis-selectivities (7:3 to 8:2) (Scheme 1.50). Based on DFT calculations of Martin’s 
work,63 the cis-selectivity was induced due to the Z-iminium ion being more stable 
when an aromatic aldehyde was employed leading to equatorial attack by the 
nucleophlie to give the cis-isomer 175 (Scheme 1.50). 
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Scheme 1.50 Aza-Prins cyclizations of N-tosyl homoallylamine 174 and aldehydes 
1.4.2 Aza-silyl-Prins cyclization reaction 
 Dobbs and co-worker65 developed the aza-silyl-Prins cyclization reactions of N-
substituted (Z)-4-trimethylsiyl-3-buten-1-ylamine 176 and aliphatic or aromatic 
aldehydes in the presence of indium trichloride in refluxing acetonitrile to give trans-
tetrahydropyridines 177 as single diastereomers in yields ranging from 22-95% 
(Scheme 1.51). The trans-selectivity is believed to proceeds through the Z-iminium ion 
intermediate 178. Further cyclization gives the carbocation 179 which is stabilized by  
the adjacent β-TMS group. The subsequent elimination of the silyl group provides the 
less sterically encountered trans-product (Scheme 1.51). 
 
Scheme 1.51 Aza-Prins cyclization reactions of N-substituted (Z)-4-trimethylsiyl-3-
buten-1-ylamine 176 and the proposed iminium ion intermediate 
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 Barbero et al.66 reported the first synthesis of 7-membered azacycles, azepanes, 
by the aza-silyl-Prins cyclization reactions of the allylsilyl amine 180 with aryl and 
vinyl aldehydes in the presence of InCl3. These reactions provided trans-2,7-azepanes 
181 in high yields and with good to excellent diastereoselectivities. The mechanism for 
this cyclization involes the formation of preferred E-iminium ion intermediate 182 in 
which the R and the N-Bn substituents of the imine are in a trans relationship. Further 
7-endo cyclization provided the azepanyl carbocation 183 and subsequent elimination 
of the silyl group provides the azepane derivatives 181 (Scheme 1.52). 
 
Scheme 1.52 Synthesis of azepanes by the aza-silyl-Prins cyclization reaction of 
allylsilyl amine 180 
 Martin et al.67 developed this reaction further for the synthesis of quinolizidine 
and indolizidine derivatives. The aza-silyl-Prins cyclization reactions of allylsilyl 
amines 184 and 185 with monoacetal aldehyde 186 in the presence of trifluoroacetic 
acid was performed in acetonitrile at -40 °C followed by addition of triethylsilane to 
give the indolizidine 187 and quinolizidine derivatives 188 in moderate and good yields, 
respectively, and as single diastereomers (Scheme 1.53). The proposed mechanism 
involved the condensation of the allylsilyl amine and the monoprotected dialdehyde to 
form the imine intermediate 189, followed by acid-catalyzed expulsion of methanol to 
form the oxocabenium ion intermediate 190 which then undergoes an aza-silyl-Prins 
cyclization reaction to give the azacycle 191. The N,O-acetal moiety of 191 was ionized 
to generate another iminium ion which was trapped with the nucleophilic silane 
reducing agent to provide the products 187 and 188 (Scheme 1.53). 
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Scheme 1.53 Synthesis of quinolizidine and indolizidine derivatives though the aza-
silyl-Prins cyclization of allylsilyl amines 184 and 185 
1.4.3 Application to natural product synthesis 
 Loh and Lee68 reported the synthesis of (-)-centrolobine 195 from the 
enantiomerically enriched homoallylic alcohol 192. The InCl3-catalyzed Prins 
cyclization reaction of 192 with p-anisaldehyde in CH2Cl2 gave the 4-chloro-
tetrahydropyran 193 in 70% yield and with high enantioselectivity (90% ee). Further 
dechlorination of 193 with Bu3SiH provided the tetrahydropyran 194 in 94% yield 
which subsequently underwent O-benzyl deprotection over Pd/C and H2 in MeOH to 
give (-)-centrolobine 195 in 86% yield (Scheme 1.54). 
 
Scheme 1.54 Synthesis of (-)-centrolobine 195 
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Dobbs et al.69 reported the synthesis of racemic pipecolic acid derivatives from 
the racemic vinylsilane-containing homoallyl amine 196. The aza-Prins cyclization 
reaction of 196 and ethyl glyoxylate in acetonitrile in the presence of InCl3 provided     
2-ethoxycarbonyl tetrahydropyridine 197 in 75% yield with high diastereoselectivity 
(87:13).  Hydrogenation/hydrogenolysis of 197 over Pd(OH)2/C and H2 provided the 
corresponding piperidine 198 in 87% yield, which was hydrolysed with aqueous 
hydrochloric acid to give trans-6-methyl pipecolic acid 199 in 83% yield and 53% 
overall yield from 196 (Scheme 1.55). 
 
Scheme 1.55 Synthesis of trans-6-methylpipecolic acid 199 
Thomassigny et al.70 reported a short synthesis of the anabasine 202, a minor 
alkaloid from the tobacco plant. The aza-Prins cyclization reaction of pyridine-3-
carbaldehyde 200 and the homoallyl amine 166 in the presence of In(OTf)3 provided a 
mixture of the two alkene isomers of pyridylpiperidine 201 in 44% yield. 
Hydrogenation of 201 over Pt2O and H2 gave racemic anabasine 202 in 93% yield 
(Scheme 1.56). 
 
Scheme 1.56 Synthesis of racemic anabasine 202 
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1.5 Aims of this project 
 The initial aims of this PhD project are summarised as follows: 
 1) To investigate the Petasis borono-Mannich (PBM) reaction of α-hydroxy 
aldehydes 203 with primary or secondary amines and pinacol allenylboronate 89 to 
prepare 2-allenyl 1,2-amino alcohols 204 or 2-alkynyl 1,2-amino alcohols 205. An 
examination of the regiochemistry (α or γ attack), stereochemistry (syn or anti isomer) 
and diastereoselectivity of these reactions will be also be undertaken (Scheme 1.57). 
The results of this study are discussed in Chapter 2. 
 2) To study the aza-Prins cyclization reactions of the prepared 1,2-amino 
alcohols 204 or 205 to synthesize functionalized piperidines 206 or 207 (Scheme 1.57). 
The results of this study are discussed in Chapter 3. 
 
Scheme 1.57 The borono-Mannich reaction of pinacol allenylboronate 89 and the      
aza-Prins cyclization of the prepared products 204 and 205 
 3) To develop a synthetic strategy for the preparation of 9β-hydroxyvertine 208, 
starting with compound 206 or 207 and submit the synthesized alkaloid for bioassay 
studies. Our retrosynthetic analysis of 208 is shown in Scheme 1.58, this involves, as a 
key step, an intramolecular lactonization reaction to prepare the 12-membered ring 
lactone moiety of 208. An introduction to 9β-hydroxyvertine 208 and related alkaloids 
and a more detailed retrosynthetic analysis will be presented in Chapter 4, along with 
the results towards its total synthesis. 
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Scheme 1.58 Proposed retrosynthetic analysis of 9-hydroxyvertine 208 
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 Chapter 2  
Petasis Borono-Mannich (PBM) Reactions                               
of Pinacol Allenylboronate 
In this chapter, we report our study on the pioneering use of pinacol 
allenylboronate in the Petasis borono-Mannich (PBM) reaction of various aldehydes 
with primary or secondary amines to provide 2-allenyl 1,2-amino alcohols or 2-alkynyl 
1,2-amino alcohols. These products were viewed as potential substrates for the 
construction of the heterocyclic core structures of bioactive alkaloids using the              
aza-Prins cyclization reaction (Project aims 1 and 2, page 40). Some sections of this 
chapter were published in Organic Letters in February 2015.71 This article is included in 
Appendix 1 of this thesis. Shortly after this article was published Petasis reported a 
related study.72 This will be discussed in more detail in the conclusion section of this 
chapter. 
2.1 Petasis borono-Mannich (PBM) reactions of α-hydroxy aldehydes 
2.1.1 PBM reactions of glycolaldehyde 209 
 The PBM reaction of glycolaldehyde dimer 209 with allenyl boronate 89 and 
morpholine was first studied using 1 equiv. of each of the three components in MeOH at 
room temperature. The reaction was monitored by TLC analysis which indicated 
complete consumption of the boronate after 2 days. The 1H NMR spectrum of the crude 
reaction mixture indicated that the reaction provided exclusively the allenyl product. 
After purification by column chromatography the 2-allenyl-1,2-amino alcohol 210a was 
isolated in 42% yield (Table 2.1, Entry 1). In order to increase the rate of reaction and 
the yield of the desired product, the reaction was repeated in MeOH under conventional 
heating at 50 °C. The reaction was complete in 8 h (by TLC monitoring) and               
the isolated yield of the product 210a increased to 70 % (Table 2.1, Entry 2). 
Performing the reaction in MeOH in a microwave reactor at 120 °C for 10 min provided 
the allenyl product 210a in a higher yield of 76% (Table 2.1, Entry 3). Increasing the 
reaction temperature to 140 °C provided a decreased yield of 58% (Table 2.1, Entry 4). 
The use of EtOH or MeOH/H2O (9:1) as solvents in reactions at room temperature and 
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microwave heating gave lower yields (Table 2.1, Entries 5-7). A reaction in 
hexafluoroisopropanol (HFIP) at room temperature gave none of the desired product 
and only unreacted allenyl boronate 89 was evident from the 1H NMR analysis of the 
crude reaction mixture (Table 2.1, Entry 8). The product 210a, however, was obtained 
in 26% yield when the reaction in HFIP was performed under microwave heating at 120 
°C for 10 min (Table 2.1, Entry 9). 
Table 2.1 Optimization of the PBM reactions of glycolaldehyde dimer 209 
 
Entry Solvent T (°C) Time Yield (%) 
1 MeOH rt 2 days 42 
2 MeOH 50 8 h 70 
3 MeOH MW, 120 10 min 76 
4 MeOH MW, 140 10 min 58 
5 EtOH MW, 120 10 min 57 
6 MeOH/H2O (9:1) rt 8 h 65 
7 MeOH/H2O (9:1) MW, 120 10 min 59 
8 HFIP rt 4 h - 
9 HFIP MW, 120 10 min 26 
 
The IR spectrum of the allenyl product 210a showed characteristic absorption 
bands for a hydroxy group and an allenyl group at νmax 3399 and 1950 cm-1, 
respectively. The 1H NMR spectrum (Figure 2.1) showed resonances for two geminal 
allenyl protons (H-5) at δH 4.77 (app. d, J = 6.8, 2H) and an apparent quartet resonance 
for the α-allenyl proton (H-3) at δH 5.07 with J = 7.0 Hz, a typical value for 4J for 
allenic protons (6-7 Hz).73 The 13C NMR spectrum (Figure 2.2) showed resonances for 
three allenyl carbons at δC 75.6, 84.0 and 209.2, the latter, highly deshielded resonance 
is characteristic of the internal carbon of an allene.74 LRESIMS analysis of compound 
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210a showed a protonated molecular ion peak at m/z 170 (100%) [M + H]+ in 
accordance with the molecular formula C9H16NO2 which was confirmed by HRESIMS 
analysis (calculated for C9H16NO2 [M + H]+: 170.1181, found: 170.1181). 
 
Figure 2.1 1H NMR spectrum (CDCl3, 500 MHz) of 210a 
 
Figure 2.2 13C NMR spectrum (CDCl3, 125 MHz) of 210a 
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Under the optimized reaction conditions, the 2-allenyl-1,2-amino alcohols 210b-e 
were obtained from the reactions of the primary and secondary amines depicted in Table 
2.2. In all cases, 1H NMR spectroscopic analysis of the crude reaction mixtures 
indicated the exclusive formation of the allenyl products. For the reaction with 
benzylamine, the yield of 201b was only 46%. When the amount of glycolaldehyde was 
increased from 1.0 to 1.25 equiv. then the desired product 210b was obtained in a lower 
yield (41%), perhaps due to its further reaction with the excess amount of 
glycolaldehyde. The best yield of 210b was 55% when the molar ratio of 
glycolaldehyde, benzylamine and allenyl boronate 89 was 1:1.5:1.5, respectively. The 
reaction of piperidine provided only a poor yield (26%). The IR, 1H NMR and 13C NMR 
spectra of the allenyl products 210b-e were similar to those of compound 210a, apart 
from the expected variations due to the different amine components. 
Table 2.2 PBM reactions of glycolaldehyde dimer 209 with primary and secondary 
amines 
 
Entry Amine Product Yield (%) 
1  
 
46 (41)a (55)b  
2 
 
 
55 
3  
 
54 
4 
 
 
26 
a 1.25 equiv. of 209 was used. b 1.5 equiv. of BnNH2 and  89 were used. 
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Glycolaldehyde is known to exist in a crystalline dimeric form as 2,5-dihydroxy-
1,4-dioxane.75 However, in solution this dimer undergoes dedimerisation into different 
dimeric and monomeric forms and the rate of depolymerization depends on the solvent 
and the presence of acid or base catalyst.76 Moreover, monomeric glycolaldehyde can 
undergo autoxidation into glycolic acid during heating in solution.77 Furthermore, the 
Amadori rearrangement of glycolaldehyde and primary amines is another competitive 
side reaction which can produce an amino acetaldehyde 211 (Scheme 2.1).78 Therefore, 
unavoidable side reactions of glycolaldehyde could be the cause of the relatively low 
yields of the products in Table 2.2. Such products, however, were not observed in the 
1H NMR spectra of the crude reaction mixtures. 
 
Scheme 2.1 Amadori rearrangement of glycolaldehyde 209 and primary amines 
2.1.2 PBM reactions of racemic 2-hydroxy-4-phenylbutanal dimer 214 
 We also investigated the PBM reactions of racemic 2-hydroxy-4-phenylbutanal 
dimer 214. The synthesis of this compound had not been previously reported however 
we used a method reported for the synthesis of a related dimer.79 The synthesis of 214 
started with a dihydroxylation reaction of commercially available 4-phenyl-1-butene 
212 with K2OsO4 and N-methylmorpholine N-oxide (NMO) in acetone/H2O (3:1) to 
give the racemic 4-phenylbutane-1,2-diol 213 in 99% yield. The selective oxidation of 
the primary alcohol in diol 213 with (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) 
and commercial sodium hypochlorite in CH2Cl2 at 0 °C for 1 h80 provided the racemic 
aldehyde dimer 214 in 20% yield after recrystallization from chloroform (Scheme 2.2). 
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Scheme 2.2 Synthesis of racemic 2-hydroxy-4-phenylbutanal dimer 214 
The IR spectrum of the aldehyde dimer 214 showed a characteristic absorption 
band for a hydroxy group at νmax 3336 cm-1. The 1H NMR spectrum of 214 (Figure 2.3) 
showed two 1H doublet resonances at at δH 4.33 (J = 4.6 Hz) and δH 4.31 (J = 5.6 Hz).    
These resonances correlated with two acetal 13C NMR resonances at δC 101.1 and 101.3 
in the HSQC spectrum. The 13C NMR spectrum showed the doubling up of all 
resonances. This indicated that 214 was a single diastereomer and was not symmetrical. 
The above mentioned coupling constants would indicate 1,2-axial-equatorial coupling 
between the acetal methines (H-2 and H-5) and their vicinal partners (H-3 and H-6). 
This data is consistent with the structure of 214 shown in Scheme 2.2. Fortunately the 
stereochemistry of this compound is not relevant to the outcomes of its PBM reactions.  
LRESIMS analysis of compound 214 showed a sodiated molecular ion peak at m/z 315 
(100%) [M + Na]+ in accordance with the molecular formula C20H24O4Na which was 
confirmed by HRESIMS analysis (calculated for C20H24O4Na [M + Na]+: 351.1572, 
found: 351.1571).  
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Figure 2.3 1H NMR spectrum (MeOH-d4, 500 MHz) of 214 
 
Figure 2.4 13C NMR spectrum (MeOH-d4, 125 MHz) of 214 
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The PBM reactions of racemic 2-hydroxy-4-phenylbutanal dimer 214 and 
allenyl boronate 89 with primary and secondary amines were performed with 1 equiv. 
of each of the three components (that is 0.5 equiv. of 214) in MeOH at room 
temperature for 18 h. The racemic 2-allenyl-1,2-anti amino alcohols 215a-d were 
obtained in low yields after purification of the crude reaction mixtures by flash column 
chromatography (Table 2.3). Analysis of the 1H NMR spectra of the crude reaction 
mixtures indicated that the products 215a-d were obtained as a single regioisomer and a 
single diastereomer. Importantly, it was found that pre-treating the aldehyde dimer 214 
with the amine component first for 2 h at room temperature prior to addition of the 
allenyl boronate 89 provided better yields of the products 215a-d (Table 2.3).  
Table 2.3 PBM reactions of racemic 2-hydroxy-4-phenylbutanal dimer 214 
 
Entry Amine Product Yield (%)a Yield (%)b 
1  
 
48 62 
2 
 
 
47 55 
3  
 
38 76 
4 
 
 
33 60 
 
a
 Aldehyde dimer 214, amine and allenyl boronate 89 was mixed at the same time. 
b
 Aldehyde dimer 214 and amine was mixed first for 2 h prior to addition of allenyl boronate 89. 
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The IR spectrum of the allenyl product 215a showed a characteristic absorption 
band for an allenyl group at νmax 1954 cm-1 and stretching bands for a N-H (3271 cm-1) 
and an O-H (3136 cm-1). The 1H NMR spectrum (Figure 2.5) showed a resonance for 
the two geminal allenyl protons (H-7) at δH 4.81 (dd, J5,7 = 6.7 and J4,7 = 1.9 Hz, 1H). A 
resonance for the α-allenyl proton (H-5) was observed at δH 5.12 (app. q, Jca 7.0 Hz, 
1H). A resonance at δH 3.67 (td, J2,3 = 6.5 and J3,4 = 3.6 Hz, 1H) was assigned to the α-
hydroxy methine proton (H-3). A resonance for the α-amino methine proton (H-4) was 
observed at δH 3.23 (ddt, J4,5 = 7.5 Hz, J4,3 = 3.6 Hz and J4,7 = 1.9 Hz, 1H). The 13C 
NMR spectrum (Figure 2.6) showed characteristic resonances for the three allenyl 
carbons at δC 76.4, 88.7 and 208.9.  LRESIMS analysis of compound 215a showed a 
protonated molecular ion peak at m/z 294 (100%) [M + H]+ in accordance with the 
molecular formula C20H24NO which was confirmed by HRESIMS analysis (calculated 
for C20H24NO [M + H]+: 294.1858, found: 294.1864). The IR, 1H NMR and 13C NMR 
spectra of the allenyl products 215b-d were similar to those of compound 215a, apart 
from the expected variations due to the different amine components. The vicinal 
coupling constants between H-3 and H-4 (J3,4) for the products 215b-d were similar to 
that of compound 215a, ranging from 4.0 to 4.3 Hz, which indicated that they had the 
same relative configurations. 
 
Figure 2.5 1H NMR spectrum (CDCl3, 500 MHz) of 215a 
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Figure 2.6 13C NMR spectrum (CDCl3, 125 MHz) of 215a 
 To confirm the expected relative anti configuration of the products 215a-d, 
product 215a was converted in 65% yield to the oxazolidinone 216 by treatment with 
triphosgene and triethylamine (Scheme 2.3).  
 
Scheme 2.3 Synthesis of oxazolidinone 216 
The IR spectrum of the oxazolidinone 216 showed a characteristic absorption 
band for a carbonyl group at νmax 1732 cm-1 and the absence of bands in the O-H and    
N-H stretching region. The 1H NMR spectrum of 216 (Figure 2.7) showed overlapped 
resonances for the two geminal allenyl protons (H-3′) and one of the two diastereotopic 
benzylic protons as a 3H multiplet at δH 4.93-4.79. The α-allenyl proton (H-1′) was 
observed at δH 4.98 (dt, J1′,4 = 9.1 Hz and J1′,3′ = 6.5 Hz, 1H). A resonance at δH 4.44 
(dd, J1′′A,5 = 9.0 Hz, J4,5 = 8.0 Hz and J1′′B,5 = 4.0 Hz, 1H) was assigned to the α-hydroxy 
methine proton (H-5). Overlapped resonances for the α-amino methine proton (H-4) and 
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the other diastereotopic benzylic proton were observed at δH 4.06-3.97 as a 2H 
multiplet. The 13C NMR spectrum (Figure 2.8) showed resonances for the three allenyl 
carbons at δC 77.4, 85.3 and 210.0 and a carbonyl quaternary carbon (C-2) at δC 157.5. 
LRESIMS analysis of compound 216 showed a sodiated molecular ion peak at m/z 342 
(100%) [M + Na]+ in accordance with the molecular formula C21H21NO2Na which was 
confirmed by HRESIMS analysis (calculated for C21H21NO2Na [M + Na]+: 342.1470, 
found: 342.1472).  
 
Figure 2.7 1H NMR spectrum (CDCl3, 500 MHz) of 216 
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Figure 2.8 13C NMR spectrum (CDCl3, 125 MHz) of 216 
The NOESY spectrum (Figure 2.9) of 216 showed a correlation between the 
resonances for H-4 and H-5 which indicated the relative syn stereochemical relationship 
of these protons in the oxazolidinone 216. Their vicinal coupling constant (J4,5) was 8.0 
Hz which was consistent with the 4,5-cis relative configuration of the oxazolidinone 
ring as reported by Au,25 thus confirming the anti-relative configuration of 215a. 
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Figure 2.9 2D NOESY spectrum (CDCl3, 500 MHz) of 216 
The anti-relative configuration of product 215a was consistent with the 
stereochemical outcome of the products from the PBM reactions of α-hydroxyaldehydes 
and aryl and vinyl boronic acids1,2 which further supported the proposed mechanism 
being depicted in Scheme 2.4. The anti-diastereoselectivity and regioselectivity of the 
product 215a is consistent with the reactive intermediate 217 in which A1,3-allylic strain 
is minimized with intramolecular transfer of the allenyl group to the iminium carbon 
through α-attack. 
 
Scheme 2.4 Proposed mechanism of the PBM reaction of α-hydroxy aldehydes towards 
the 1,2-anti amino alcohols 
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2.1.3 PBM reactions of enantiomerically pure α-hydroxy aldehydes 
 In order to further explore the degree of diastereoselectivity in these reactions, 
enantiomerically enriched α-hydroxy aldehydes were employed in the PBM reaction. 
The synthesis of chiral α-hydroxy aldehyde precursor 220 started from commercial 
available (S)-(-)-3-phenyllactic acid 218 (>99% ee) which was treated with 2,2-
dimethoxypropane in the presence of a catalytic amount of p-TsOH to provide the 
known 4-oxo-5-benzyl-2,2-dimethyl-1,3-dioxolane 219 in 92% yield. Subsequent 
reduction of 219 with diisobutylaluminium hydride (DIBAL-H) provided the known 4-
hydroxy-5-benzyl-2,2-dimethyl-1,3-dioxolane 220 in 93% yield (dr = 2:1) (Scheme 
2.5).81 
 
Scheme 2.5 Synthesis of 4-hydroxy-5-benzyl-2,2-dimethyl-1,3-dioxolane 220 
  The PBM reactions of the α-hydroxy aldehyde precusor 220 with primary and 
secondary amines and allenyl boronate 89 with 1 equiv. of aldehyde precursor and 
amine and 1.25 equiv. of 89 in MeOH at room temperature for 6 h provided exclusively 
the 2-allenyl-1,2-anti amino alcohols 221a-f (Table 2.4). In the case of the reaction with 
dibenzylamine, the allenyl product 221e was obtained in 61% yield (Table 2.4, Entry 5) 
along with ketone 222 in 17% yield. Ketone 222 most likely arose from the prototropic 
rearrangement of the initially formed iminium ion 223 (Scheme 2.6). This reaction was 
repeated using 2 equiv. of amine and the allenyl boronate 89 and provided the product 
232e in an improve yield of 84% yield with no evidence for ketone 222 being formed 
(Table 2.4, Entry 5). Under the same modified reaction conditions, the reaction of 
morpholine provided a significantly improved yield from 52-92% (Table 2.4, Entry 6). 
 
Scheme 2.6 The formation of ketone 222 
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Table 2.4 PBM reactions of α-hydroxy aldehydes 220 
 
Entry Amine Product Time Yield (%)a 
1  
 
6 h 67 
2 
 
 
6 h 67 
3 
 
 
6 h 66 
4  
 
6 h 44 
5  
 
6 h  64 (84)a 
6 
 
 
24 h 52 (92)a 
 
a 2 equiv. of amine and allenyl boronate 89 were employed. 
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The IR spectrum of the allenyl product 221a showed a characteristic absorption 
band for an allenyl group at νmax 1958 cm-1 and stretching bands for a N-H (3244 cm-1) 
and an O-H (3350 cm-1). The 1H NMR spectrum (Figure 2.10) showed a 2H resonance 
for the two geminal allenyl protons (H-6) as a multiplet at δH 4.92-4.78 and a resonance 
for the α-allenyl proton (H-4) was observed at δH 5.23 (app. q, Jca= 7.0 Hz, 1H). A 1H 
multiplet resonance for the α-amino methine proton (H-3) was observed at δH 3.29-3.22 
while that for the α-hydroxy methine proton (H-2) was observed at δH 3.94 (dt, J1,2 = 8.5 
Hz and J2,3 = 4.3 Hz, 1H). The 13C NMR spectrum (Figure 2.11) showed resonances for 
the three allenyl carbons at δC 76.3, 88.7 and 209.2. LRESIMS analysis of compound 
221a showed a protonated molecular ion peak at m/z 280 (100%) [M + H]+ in 
accordance with the molecular formula C19H22NO which was confirmed by HRESIMS 
analysis (calculated for C19H22NO [M + H]+: 280.1701, found: 280.1706). 
Characteristic signals for the allenyl products 221b-f were also evidence in their IR, 1H 
NMR and 13C NMR spectra. The vicinal coupling constants between H-2 and H-3 (J2,3) 
for the products 221b-f were similar to that of compound 221a, ranging from 3.9 to 4.3 
Hz, which indicated their same relative configurations. 
 
Figure 2.10 1H NMR spectrum (CDCl3, 500 MHz) of 221a 
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Figure 2.11 13C NMR spectrum (CDCl3, 125 MHz) of 221a 
To determine the enantiomeric purities of the 1,2-anti amino alcohols 221e and 
221f, they were treated with (R)- and (S)-Mosher’s acid chlorides to provide the 
corresponding (S)- and (R)-Mosher ester derivatives 224 and 225, respectively (Scheme 
2.7 and 2.8). Interestingly, the yields of the (S)-Mosher esters, (S)-224 and (S)-225 were 
very high (98% and 93%, respectively), while the yields of the (R)-Mosher esters, (R)-
224 and (R)-225 were significantly lower (61% and 41%, respectively). Thus suggesting 
that (S)-Mosher chloride was reacting at a much reduced rate over its (R) counterpart. 
Analysis of the 1H and 19F NMR spectra of these esters showed that the enantiomeric 
purities of 1,2-anti amino alcohols were >96% which was consistent with that of the 
chiral α-hydroxy acid precursor of 220 (ee >99%). The 1H and 19F NMR analysis with 
each diastereomeric pair showed distinctly different resonances which indicated that the 
diastereomeric purities of these derivatives were >98:2 (Scheme 2.7 and 2.8). 
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Scheme 2.7 Synthesis of (R)- and (S)-Mosher ester 224 and their 19F NMR spectra 
(CDCl3, 470 MHz)  
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Scheme 2.8 Synthesis of (R)- and (S)-Mosher ester 225 and their 19F NMR spectra 
(CDCl3, 470 MHz)  
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In order to study a more complex chiral α-hydroxy aldehyde in the PBM 
reaction the D-β-ribofuranose derivative 230 [(3R,4S,5R)-4-(benzyloxy)-5-(benzyloxy 
methyl)tetrahydrofuran-2,3-diol], a ring closed α-hydroxy aldehyde, was synthesized 
following the literature procedures (Scheme 2.9).36 
 
 
Scheme 2.9 Synthesis of the D-β-ribofuranose derivative 23036 
 The PBM reaction of the sugar derivative 230, allenyl boronate 89 and 
benzylamine was investigated. The results are shown in Table 2.5.  
Table 2.5 PBM reactions of the D-β-ribofuranose derivative 230 
 
Entry Solvent T (°C) Time Yield (%) 
1 EtOH 30 72 h 15a 
2 EtOH 30 120 h 17 
3 MeOH 25 120 h 14b 
4 HFIP 30 120 h 15 
5 HFIP/CH2Cl2 (1:9) 30 120 h 10 
6 MeOH-d4 25 72 h 29 
 
a 1 equiv. of benzylamine and allenyl boronate 89 were used. 
b 1.5 equiv. of benzylamine and allenyl boronate 89 were used. 
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The yields of 2-allenyl-1,2-anti amino alcohol 231 were low under all the 
conditions tried, however, the reaction provided exclusively the allenyl product with 
high regioselectivity which was observed from the analysis of the 1H NMR spectra of 
the crude reaction mixtures. The best yield was 29% when the reaction was run in 
MeOH-d4 (Table 2.5, Entry 6) and monitored by 1H NMR spectroscopy. 
The IR spectrum of the allenyl product 231 showed a characteristic absorption 
band for an allenyl group at νmax 1955 cm-1 and a board band for the O-H stretch    
(3356 cm-1) The 1H NMR spectrum (Figure 2.12) showed two resonances for the two 
geminal allenyl protons (H-8) at δH 4.83 (dd, J6,8 = 6.7 Hz and J8A,8B = 11.0 Hz, 1H) and 
at δH 4.77 (dd, J6,8 = 6.7 Hz and J8A,8B = 11.0 Hz, 1H) and a resonance for the α-allenyl 
proton (H-6) was observed at δH 5.25 (dt, J5,6 = 8.7 Hz and J6,8 = 6.7 Hz, 1H). The 
resonance at δH 3.63 (dd, J5,6 = 8.7 Hz and J4,5 = 4.4 Hz, 1H) was assigned to the α-
amino methine proton (H-5). Overlapped resonances for the α-hydroxy methine proton 
(H-4) and one of the diastereotopic benzylic protons at δH 3.97-3.87 showed as a 
multiplet. The 13C NMR spectrum (Figure 2.13) showed resonances for the three allenyl 
carbons at δC 76.4, 88.6 and 209.3. LRESIMS analysis of compound 231 showed a 
protonated molecular ion peak at m/z 460 (100%) [M + H]+ in accordance with the 
molecular formula C29H34NO4 which was confirmed by HRESIMS analysis (calculated 
for C29H34NO4 [M + H]+: 460.2488, Found: 460.2500). 
 
Figure 2.12 1H NMR spectrum (CDCl3, 500 MHz) of 231 
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Figure 2.13 13C NMR spectrum (CDCl3, 125 MHz) of 231 
 The PBM reaction of the sugar derivative 230, allenyl boronate 89 and the 
secondary amine, dibenzylamine, provided the 2-allenyl-1,2-anti amino alcohol 232 in 
25% yield (based on the moles of 230) with high regioselectivity (Scheme 2.10). The 
IR, 1H NMR and 13C NMR spectra of allenyl product 232 were similar to those of 
compound 231, apart from those resonances due to the different amine component. 
 
Scheme 2.10 PBM reaction of the sugar derivative 230, allenyl boronate 89 and 
dibenzylamine 
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The relative anti configuration of the product 231 was determined by formation 
of the cis-oxazolidinone 233 in 29% yield (Scheme 2.11). The NOESY spectrum of 233 
showed a correlation between H-4 and H-5 which indicated the relative syn 
stereochemical relationship of these protons in the oxazolidinone 233. Their vicinal 
coupling constant (J4,5) of 7.4 Hz was also consistent with the 4,5-cis relative 
configuration of the oxazolidinone ring.25 
 
Scheme 2.11 Synthesis of oxazolidinone 233 
 The aldehyde dimer 235 was also investigated as a component of the PBM 
reaction of allenyl boronate 89. The diol precursor 234, which was prepared by our 
group member,82 underwent regioselective oxidation of the primary hydroxy group with 
TEMPO to provide the aldehyde dimer 235 (Scheme 2.12). The PBM reactions of the 
crude aldehyde dimer product 235, allenyl boronate 89 and benzylamine or 
dibenzylamine were performed at room temperature in MeOH for 24 h. These reactions 
provided exclusively the 2-allenyl-1,2-anti amino alcohols 236 and 237 in 60% and 
69% yields, respectively (Scheme 2.12). The NMR spectra of these products indicated a 
single diastereomeric product, even though 234 was a 9:1 mixture of diastereomers. 
This would indicate that the PBM reaction products from the minor diastereomer of 235 
were either not formed or were separated and not isolated on purification of the crude 
reaction mixture by column chromatography. 
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Scheme 2.12 PBM reaction of the aldehyde dimer 235, allenyl boronate 89 and 
benzylamine or dibenzylamine 
The IR spectrum of the allenyl product 236 showed a characteristic absorption 
band for an allenyl group at νmax 1952 cm-1 and a board band for an O-H stretch          
(3447 cm-1). The 1H NMR spectrum (Figure 2.14) showed a resonance for two geminal 
allenyl protons (H-8) at δH 4.80 (dd, J6,8 = 6.8 Hz and J5,8 = 1.8 Hz, 2H) and the 
resonance for the α-allenyl proton (H-6) at δH 5.13 (app. q,  J6,8 = 6.8 Hz, 1H). The 
multiplet resonance at δH 3.19-3.12 was assigned to the α-amino methine proton (H-5). 
The resonance at δH 3.97 (dt, J3,4 = 9.7 Hz and J4,5 = 3.2 Hz, 1H) was assigned to the α-
hydroxy methine proton (H-4). The 13C NMR spectrum (Figure 2.15) showed 
resonances for the three allenyl carbons at δC 76.2, 89.2 and 208.9. LRESIMS analysis 
of compound 236 showed a protonated molecular ion peak at m/z 368 (100%) [M + H]+ 
in accordance with the molecular formula C22H30NO3 which was confirmed by 
HRESIMS analysis (C22H30NO3 [M + H]+: 368.2226, found: 368.2233). The 
characteristic signals for the allenyl product 237, as shown in their corresponding IR, 1H 
NMR and 13C NMR spectra, were similar to those of the allenyl product 236. 
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Figure 2.14 1H NMR spectrum (CDCl3, 500 MHz) of 236 
 
Figure 2.15 13C NMR spectrum (CDCl3, 125 MHz) of 236  
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2.2 PBM reactions of salicylaldehyde 8  
The PBM reactions of salicylaldehyde 8, morpholine and allenyl boronate 89 
were also investigated. Performing the reaction with 1 equiv. of each substrate in MeOH 
under microwave heating at 120 °C for 10 min did not provide the desired product 
(Table 2.6, Entry 1). However, decreasing the temperature to 50 °C and using 
conventional heating provided the allenyl product 238a in 30% yield as a single 
regioisomer (Table 2.6, Entry 2). The reactions were also performed in MeOH-d4 and 
CDCl3 in an NMR tube at room temperature and monitored by 1H NMR spectroscopy. 
The reaction in MeOH-d4 was complete in 1 h, while the reaction in CDCl3 was 
complete in 20 h. After purification by column chromatography, the product 239a was 
obtained in 52% and 65% yields, respectively (Table 2.6, Entries 3 and 4). Further 
optimization studies were in MeOH because of the more favourable rate of reaction. 
The optimization of the ratio of the reagents was investigated by systematically 
increasing the number of equivalents (1.0, 1.25, 1.5 equiv.) of morpholine and/or the 
boronate components 89 and using salicylaldehyde as the limiting reagent as shown in 
Table 2.7. The product 238a was obtained in the highest yield in 88% when 1.5 equiv. 
of morpholine and 1.25 equiv. of allenylboronate 89 were employed (Table 2.7, Entry 
5). The yield did not improve upon increasing the amounts of amine and boronate 
components to 1.5 equiv. (Table 2.7, Entry 6). 
Table 2.6 The optimization of the PBM reactions of salicylaldehyde 8 
 
Entry Solvent T (°C) Time Yield (%) 
1 MeOH MW, 120 10 min - 
2 MeOH 50 8 h 30 
3 MeOH-d4 rt 1 h 52 
4 CDCl3 rt 20 h 65 
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Table 2.7 The optimization of the PBM reactions of salicylaldehyde 8 
 
Entry 
Molar equiv. of 
aldehyde 8 
Molar equiv. of 
morpholine  
Molar equiv. of 
Boronate 89 Yield (%) 
1 1.0 1.0 1.25 61 
2 1.0 1.25 1.0 71 
3 1.0 1.25 1.25 79 
4 1.0 1.5 1.0 79 
5 1.0 1.5 1.25 88 
6 1.0 1.5 1.5 88 
 
The IR spectrum of allenyl product 238a showed a characteristic absorption 
band for an allenyl group at νmax 1954 cm-1. The 1H NMR spectrum (Figure 2.16) 
showed a multiplet resonances for the two geminal allenyl protons (H-4′) at δH 4.90-
4.74 and a resonance for the α-allenyl proton (H-2′) at δH 5.33 (dt, J1′,2′ = 9.8 Hz and 
J2′,4′ = 6.6 Hz, 1H). The resonance at δH 4.09 (d, J1′,2′ = 9.8 Hz was assigned to the α-
amino methine proton (H-1′). The 13C NMR spectrum (Figure 2.17) showed resonances 
for the three allenyl carbons at δC 76.1, 87.5 and 209.7. LRESIMS analysis of 
compound 238a showed a protonated molecular ion peak at m/z 232 (100%) [M + H]+ 
in accordance with the molecular formula C14H18NO2 which was confirmed by 
HRESIMS analysis (calculated for C14H18NO2 [M + H]+: 232.1338, found: 232.1339).  
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Figure 2.16 1H NMR spectrum (CDCl3, 500 MHz) of 238a 
 
Figure 2.17 13C NMR spectrum (CDCl3, 125 MHz) of 238a 
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Next the PBM reaction of salicylaldehyde 8 and allenyl boronate 89 was 
performed with seven different amines under the optimized conditions (Table 2.8 and 
2.9). In the case of the secondary amine piperidine, the corresponding allenyl product 
238b was obtained in 87% yield (Table 2.8, Entry 1). In contrast, the reaction of 
dibenzylamine provided a moderate yield of product 238c in 56% yield even through 
the reaction time was increased to 20 h (Table 2.8, Entry 3). However, the reaction of 
N-benzylcyclopropanamine gave the product 238d in 35% yield (Table 2.8, Entry 4). 
The characteristic signals for the allenyl products 238b-d, as shown in their 
corresponding IR, 1H NMR and 13C NMR spectra, were similar to those of the allenyl 
product 238a, apart from variations due to the different amine components. 
Table 2.8 The PBM reactions of salicylaldehyde 8 with secondary amines 
 
Entry Amine Time Product Yield (%) 
1 
 
3 h 
 
87 
2  1 h 
 
46 
3  20 h 
 
56 
4 
 
3 h 
 
35 
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In contrast, the PBM reactions of salicylaldehyde 8 with primary amines and 
pinacol allenylboronate 89 provided the homopropargyl amine products 239a-c as 
single regioisomers (Table 2.9). The reaction of benzylamine, cyclopropylamine, and 
allylamine gave the products 239a-c, respectively in good yields (Table 2.9). 
Table 2.9 The PBM reactions of salicylaldehyde 8 with primary amines 
 
Entry Amine Time Product Yield (%) 
1  1 h 
 
75 
2  3 h 
 
74 
3  3 h 
 
70 
 
However, the reaction of diphenylmethylamine with 8 and 89 in MeOH required 
6 days to provide the product 239d in 55% yield (Table 2.10, Entry 2) due to the poor 
solubility of the intermediate imine in MeOH, which immediately precipitated upon 
mixing. Performing this reaction in MeOH/CH2Cl2 (1:1) resulted in an increased yield 
of 62% (Table 2.10, Entry 3), while the highest yield of 65% for the product 239d was 
obtained in MeOH-d4/CDCl3 (1:4). Monitoring the reaction by 1H NMR spectroscopy 
indicated rapid formation of the imine intermediate (δH 8.41, s) (Table 2.10, Entry 4). 
This resonance slowly decreased in intensity over time, requiring 9 days for a complete 
reaction. 
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Table 2.10 The PBM reactions of salicylaldehyde 8 with diphenylmethylamine  
 
Entry Solvent Time Yield (%) 
1 MeOH 1 h - 
2 MeOH 6 days 55 
3 MeOH/CH2Cl2 (1:1) 6 days 62 
4 MeOH-d4/CDCl3 (1:4) 9 days 65 
 
The IR spectrum of the alkynyl product 239a showed characteristic absorption 
bands for a terminal alkyne group at νmax 3291 and 2119 cm-1. An O-H stretch vibration 
did not appear due to strong intramolecular hydrogen-bonding.83 The 1H NMR spectrum 
(Figure 2.18) showed resonances for the terminal alkyne proton (H-4′) of 239a at δH 
2.09 (t, J2′,4′ = 2.0 Hz, 1H) and two set of resonances for the two diastereotopic 
propargylic protons (H-2′). One was observed at δH 2.72 (ddt, J2′A,2′B = 17.1 Hz, J1′,2′A = 
10.5 Hz and J2′A,4′ = 2.0 Hz, 1H). The other was observed at δH 2.55 (ddt, J2′A,2′B = 17.1 
Hz, J1′,2′B = 4.2 Hz and J2′A,4′ = 2.0 Hz, 1H). The resonance for the α-amino methine 
proton (H-1′) was observed at δH 4.09 (dd, J1′,2′A = 10.5 Hz and J1′,2′B = 4.2 Hz, 1H). The 
13C NMR spectrum (Figure 2.19) showed resonances for the two alkyne carbons at δC 
71.5 and 80.8. LRESIMS analysis of compound 239a showed a protonated molecular 
ion peak at m/z 252 (100%) [M + H]+ in accordance with the molecular formula 
C17H18NO which was confirmed by HRESIMS analysis (calculated for C17H18NO [M + 
H]+: 252.1388, found: 252.1382). Characteristic resonances for the alkynyl products 
239b-d were also observed in their IR, 1H NMR and 13C NMR spectra and were similar 
to those of the alkynyl product 239a, apart from the expected variation due to the 
different amine component. 
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Figure 2.18 1H NMR spectrum (CDCl3, 500 MHz) of 239a 
 
Figure 2.19 13C NMR spectrum (CDCl3, 125 MHz) of 239a 
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Based on these results, our proposed mechanisms of the PBM reactions of 
salicylaldehyde 8 with secondary and primary amines are shown in Scheme 2.1. In the 
case of secondary amines, the zwitterionic intermediate 240 was initially formed from 
the condensation reaction of salicylaldehyde and the amine. The intermediate 240 then 
reacted with the pinacol allenylboronate 89 to provide the boronate intermediate 241. 
Intramolecular transfer of the allenyl substituent in 241 to the iminium carbon through 
α-attack, via a six-membered transition state, then lead to the allenyl product 238 
(Scheme 2.13a). In the case of the primary amines, two possible intermediates were 
proposed: (1) the cyclic transition state intermediate 242 in which the ortho-hydroxy 
substituent enhances the electrophilicity of imine carbon, by H-bonding, to γ-attack by 
the allenyl boronate 89; and (2) the zwitterion boronate intermediate 243 which can 
undergo intramolecular transfer of the allenyl substituent to the imine carbon through γ-
attack to provide the alkynyl product 239 (Scheme 2.13b). 
 
Scheme 2.13 Proposed intermediates for the PBM reactions of salicylaldehyde 8 with 
secondary and primary amines 
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 Comparison of the rate of reactions of salicylaldehyde 8, benzylamine and 89 
(reaction (a)) and the preformed salicylaldehyde imine 244 with benzylamine and 89 
(reaction (b)) were made by monitoring these reactions by 1H NMR spectroscopy in 
MeOH-d4. This analysis indicated no difference between the rates of these reactions 
(Scheme 2.14a, b). However, the reaction of the preformed aldimine 244 provided the 
alkynyl product 239a in a higher yield (87%) compared to the reaction of 
salicylaldehyde 8 which gave a 78% yield of the product 239a. After 0.5 h, 1H NMR 
analysis of reaction (a) indicated that the salicylaldehyde 8 was converted to a 1:1.4 
mixture of imine 244 and a second imine labelled A in Figure 2.20. The most likely 
structure of this imine is shown as A in Scheme2.14c. This structure was based on a 2D 
NMR analysis of this reaction mixture. The imine species A showed an imine resonance 
at δH 8.17 (s) and a resonance at δH 4.17 (dd, J = 7.0 and 11.0 Hz) integrating to 2H 
relative to the imine proton resonance. These proton resonances correlated to those of 
an imine carbon (δC 164.2) and a terminal methylene carbon (δC 67.0), respectively. 
Intermediate A was also evident in reaction (b) (Figure 2.21) and had completely 
reacted after 3 h. The 1H NMR spectra of these studies are shown in Figures 2.20 and 
2.21. 
 
Scheme 2.14 Reactions of salicylaldehyde 8 and preformed aldimine 244 in          
MeOH-d4 and proposed boronate intermediate A 
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Figure 2.20 The 1H NMR monitoring of the PBM reaction of salicylaldehyde 8 in      
MeOH-d4 
 
Figure 2.21 The 1H NMR monitoring of the PBM reaction of preformed aldimine 244 
in MeOH-d4 
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Figure 2.22 shows further 1H NMR experiments of the PBM reaction of 
salicylaldehyde 8, allenyl boronate 89 and BnNH2. In this study, the reaction was 
monitored every 10 min for the first 60 min then every 0.5 h until 4 h. The first 
spectrum (t = 0) was of the mixture of salicylaldehyde 8 and BnNH2 only which 
indicated about 75% conversion to the imine 244 (δH 8.33) during the acquisition time 
of the NMR experiment (ca 1 min). After addition of 89, the second spectrum (t = 10 
min) indicated that the imine 244 was converted to the imine intermediate A (δH 8.16, 
(s) and δH 4.16, (dd J = 7.0 and 11.0 Hz)). Then two resonances of A decreased in 
intensity over time however their relative integrations remained constant at 1:2, 
respectively, supporting their assignment to the same intermediated A and nearly 
disappeared at 4 h. Attempts to observe intermediate A by negative ion ESIMS were 
unsuccessful. 
 
Figure 2.22 The 1H NMR monitoring of the PBM reaction of salicylaldehyde 8 in      
MeOH-d4 
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2.3 PMB reactions of aromatic aldehydes lacking an ortho-hydroxy group 
The PBM reactions of two aromatic aldehydes lacking an ortho-hydroxy group 
were investigated. The reactions of 2-methoxybenzaldehyde 245 or benzaldehyde 246 
with morpholine or benzylamine and allenyl boronate 89 were performed in MeOH-d4 
and were monitored by 1H NMR spectroscopy. This analysis indicated that the 
corresponding imine (δH 8.81) rapidly formed in nearly quantitative yield after 10 min 
in the PBM reaction of 245, 89 and benzylamine. However, these reactions provided 
only low yields of a mixture of regioisomers of the corresponding aldehyde addition 
products 247 and 248 even though the reaction time was 48 h (Table 2.11). The reaction 
of the aldimine 249, derived from 2-methoxybenzaldehyde, gave only a 4% isolated 
yield of a mixture of products 247a/248a (1.6:1) (Table 2.11, Entry 4). We speculate 
that 247a/248a are formed from 2-methoxybenzaldehyde that is generated in situ from 
the slow hydrolysis of aldimine 249 via adventitious water in the MeOH-d4. 
Table 2.11 The PBM reactions of 2-methoxybenzaldehyde 245 or benzaldehyde 246 
with allenyl boronate 89 and amines 
 
Entry 
Aldehyde or 
aldimine 
Time Product Yield (%) 
1a 245 8 h 
247a/248a 
(11.5:1) 
29 
2a 246 8 h 
247b/248b 
(11.5:1) 
15 
3b 245 48 h 
247a/248a 
(1.6:1) 
24 
4 249 48 h 
247a/248a 
(1.6:1) 4 
a Morpholine was used as an amine component. 
b Benzylamine was used as an amine component. 
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 The reactions of salicylaldehyde 8 or 2-methoxybenzaldehyde 245 with allenyl 
boronate 89, in the absence of the amine component, provided the homopropargyl 
alcohols 249 and 247a in 79% and 85% yields, respectively, with high regioselectivity 
(>99:1) (Scheme 2.15). Monitoring these reactions by 1H NMR spectroscopy (MeOH-
d4) indicated that the reactions occurred at nearly the same rates, with no evidence for 
rate acceleration by the 2-hydroxy group of salicylaldehyde (Figure 2.23 and 2.24). 
Both of these reactions showed 100% conversion of the allenyl boronte 89 after 6 h, 
however these rates were considerably slower than the rates of the PBM reactions of 
salicylaldehyde 8 with allenyl boronate 89 and benzylamine which showed 100% 
conversion after 4 h (Figure 2.20). The difference in rates may indicate the iminium ion 
in the boron “ate” complex 241 and 243 in Scheme 2.13, would be more electrophilic 
than an aldehyde and the reaction rate would also be enhanced by their intramolecular 
nature. Furthermore, there was no evidence from the 1H NMR analysis for the formation 
of a boron “ate” intermediate in the reaction of 8 and 89, which would require the 
presence of a base to form. 
 
Scheme 2.15 Reactions of salicylaldehyde 8 and 2-methoxybenzaldehyde 245 with 
allenyl boronate 89 in MeOH-d4 
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Figure 2.23 The 1H NMR monitoring of the reaction of salicylaldehyde 8 with allenyl 
boronate 89 in MeOH-d4 
 
Figure 2.24 The 1H NMR monitoring of the reaction of 2-methoxybenzaldehyde 245 
with allenyl boronate 89 in MeOH-d4 
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2.4 PBM reactions of pyridine 2-carboxaldehyde 250 
The PBM reactions of pyridine 2-carboxaldehydes 250 with vinyl, aryl and 
heteroaryl boronic acids and secondary amines were studied by Mandai et al.33 These 
reactions were performed in MeCN at reflux temperature to provide the products 57 
(Scheme 1.17). To further explore the scope of allenyl boronate 89 in the PBM reaction, 
the reaction of pyridine 2-carboxaldehyde 250 was studied. The reactions of 250, 89 and 
benzylamine or dibenzylamine were performed in MeOH at room temperature for 72- 
96 h to provide the propargyl products 251 and 252 in 17% and 8% yields, respectively 
with high regioselectivities (Scheme 2.16). The homopropargyl alcohol 253 from 
addition of allenyl boronate 89 to aldehyde 250 was formed in both reactions. The 
analysis of the 1H NMR spectrum of the crude reaction mixture of benzylamine 
indicated that the imine of 250 quantitatively formed, while that of dibenzylamine 
indicated mostly unreacted substrates. However, under these non-optimized conditions, 
the imine intermediate of benzylamine was not reactive enough, probably due to the 
lack of a hydroxy group to activate allenyl boronate 89 as the boron “ate” intermediate.  
 
Scheme 2.16 PBM reaction of pyridine 2-carboxaldehyde 250 
A proposed mechanism for the formation of the propargyl product is shown in 
Scheme 2.17. For the primary amine, the intramolecular transfer of the allenyl moiety 
via the B-N coordinated intermediate 254 leads to the propargyl product 251 (Scheme 
2.17a), while in the case of the secondary amine intermolecular transfer of the allenyl 
moiety via the ion-pair intermediate 255 will provide the product 252 (Scheme 2.17b). 
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Scheme 2.17 A proposed mechanism for the formation of alkynyl products  
The IR spectrum of the homopropargyl amine product 251 showed characteristic 
absorption bands of the terminal alkyne group at νmax 3294 and 2116 cm-1 An N-H 
stretch vibration did not appear due to intramolecular hydrogen-bonding. The 1H NMR 
spectrum (Figure 2.25) showed a resonance for the terminal alkyne proton (H-4) of 251 
at δH 1.96 (t, J2,4 = 2.6 Hz, 1H) and resonances for the two diastereotopic propargylic 
protons (H-2) as a 2H multiplet at δH 2.75-2.62. The resonance for the α-amino methine 
proton (H-1) was observed at δH 3.97 (t, J1,2 = 6.6 Hz , 1H). The 13C NMR spectrum 
(Figure 2.26) showed resonances for the two alkyne carbons at δC 70.5 and 81.5. 
LRESIMS analysis of compound 251 showed a protonated molecular ion peak at m/z 
237 [M + H]+ in accordance with the molecular formula C16H17N2 which was confirmed 
by HRESIMS analysis (calculated for C16H17N2 [M + H]+: 237.1392, found: 237.1381). 
The IR, 1H NMR and 13C NMR spectra of the alkynyl product 252 were similar to those 
of compound 251, apart from the expected differences due to the different amine 
component. 
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Figure 2.25 1H NMR spectrum (CDCl3, 500 MHz) of 251 
 
Figure 2.26 13C NMR spectrum (CDCl3, 125 MHz) of 251 
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 In summary, the PBM reactions of pinacol allenylboronate 89 with different 
types of aldehydes and primary and secondary amines were explored. The reactions of 
the α-hydroxy aldehydes, glycolaldehyde 209 and (rac)-2-hydroxy-4-phenylbutanal 
214, with primary and secondary amines gave exclusively 2-allenyl-anti-1,2-amino 
alcohol products. In case of the enantiomerically enriched α-hydroxyaldehyde precursor 
220 and the aldehyde dimer 235, the reactions were highly regio- and diastereoselective 
giving products in high enantiomeric purities. While the reactions of the D-β-
ribofuranose derivative 230 were highly regio- and diastereoselective for the 1,2-anti 
amino alcohol products but proceeded in low yields. The PBM reactions of pinacol 
allenylboronate 89 with salicylaldehyde 8 and primary and secondary amines were also 
highly regioselective. The reactions with primary amines provided exclusively the 
homopropargyl amine products, while those of secondary amines provided the α-allenyl 
amine products. The PBM reactions of the aromatic aldehydes lacking an ortho-
hydroxy group, 2-methoxybenzaldehyde 245 and benzaldehyde 246, did not provide 
PBM products which indicated that the ortho-hydroxy group was necessary to activate 
the allenyl boronate 89 via formation of its more nucleophilic “ate” complex. The PBM 
reaction of pyridine 2-carboxaldehyde 250 with primary and secondary amines provided 
exclusively the homopropargyl amine products but the yields were poor under non-
optimized conditions. Homopropargyl alcohol products were also produced in similar 
yields. 
Soon after this work was published, Petasis et al.72 reported a similar study on 
the PBM reaction of glyoxylic acid 4 with allenyl boronic acid 256 with primary and 
secondary amines. They found that primary amines provided α-propargyl amino acid 
derivatives 257 while secondary amines provided α-allenyl amino acid derivatives 258 
(Scheme 2.18). 
 
Scheme 2.18 PBM reactions of glyoxylic acid 4 with allenyl boronic acid 256 
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Petasis proposed mechanisms for the regiochemical outcomes of these reactions. 
In the case of primary amines, B-N coordination leads to the reactive intermediate 259 
giving the propargyl product 257 via intramolecular γ-addition of the allenyl moiety to 
the iminium ion (Scheme 2.19a), while the formation of the α-allenyl product 258 was 
explain by the intramolecular α-addition of allenyl moiety via B-O coordination in the 
reactive intermediate 260 (Scheme 2.19b).72 
 
Scheme 2.19 Proposed mechanism of the PBM reactions of glyoxylic acid 4 with 
allenyl boronic acid 256 
Just prior to the above Petasis’ publication, a BSc (Hons) student (Rachel 
Chambers) started an investigation of the PBM reaction of allenyl boronate 89 and 
glyoxylic acid 4.84 She found that the primary amine (diphenylmethyl)amine gave a 
mixture of the α-propargyl and α-allenyl amino acid derivatives (257a/258a = 73:27, 
Petasis et al. obtained a 68:32 mixture of 257a/258a using allenyl boronic acid 256) 
while the secondary amine dibenzylamine gave exclusively the α-allenyl amino acid 
derivative 258b in 79% yield (Scheme 2.20). This later reaction was not reported in the 
Petasis publication. 
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Scheme 2.20 PBM reactions of glyoxylic acid 4 with allenyl boronate 89 
After the Petasis’ paper was published Chambers’ project focused on the PBM 
reaction of allenyl boronate 89 and ethyl glyoxylate 261. The reactions were performed 
in CH2Cl2 at room temperature for 72 h. In the cases of primary amines these reactions 
provided exclusively ethyl α-propargylglycinates 262. While the reactions of secondary 
amines failed to give the desired ethyl glycinate products with allenyl boronate 89, the 
reactions using the more nucleophilic potassium allenyltrifluroborate 263 successfully 
provided the ethyl α-propargylglycinates 264 (Scheme 2.21).84 
 
Scheme 2.21 PBM reactions of ethyl glyoxylate 259 with allenyl boronate 89 or 
potassium allenyltrifluroborate 261 
 The regiochemical outcomes of the PBM reaction of allenyl boronate 89 and 
ethyl glyoxylate 259 with primary amines, which gave the α-allenyl products, were 
consistent with the reactive intermediate 265, similar to the B-N coordinated 
intermediate 259 proposed by Petasis (Scheme 2.22a). Since ethyl glyoxylate 259 
cannot form a boron intermediate through B-O coordination, the regiochemical 
outcomes for the ethyl glyoxylate 259 with secondary amines can be explained by the 
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ion-pair intermediate 266 which underwent the intermolecular γ-addition to provide the 
propargyl product 264 (Scheme 2.22b). 
 
Scheme 2.22 Proposed mechanisms of the PBM reactions of ethyl glyoxylate 259 with 
allenyl boronate 89 or potassium allenyltrifluroborate 261 
The Pyne group84 reported the indium-catalyzed reaction of ethyl glyoxylate (S)-
N-tert-butylsulfinyl imines 267 with potassium allenyltrifluoroborate 263 in the 
presence of indium(III) chloride in DMF. The reaction provided a mixture of 
homopropargyl product 268 and α-allenyl product 269 with high regioselectivity. Ethyl 
(S)-α-propargylglycinate was obtained in highly enantiomeric excess (97% ee) after 
deprotection of the (S)-N-tert-butylsulfinyl group of 267 (Scheme 2.23). The 
stereochemical outcome of 268 was explained by formation of the chelated 
allenylindium intermediate 270 and propargylation anti to the t-Bu group leading to the 
propargyl product 268 (Scheme 2.23) 
 
Scheme 2.23 Indium-catalyzed reaction of the (S)-N-tert-butylsulfinyl imines 267 with 
potassium allenyltrifluoroborate 263 
 
 
Chapter 3 
Aza-Prins Cyclization Reactions 
In this chapter, we report our study on the attempted aza-Prins cyclization 
reactions of the allenyl amino alcohol 210b, its TBS and TBDPS ether derivatives, and 
related homopropargyl amines to prepare functionalized piperidines as heterocyclic 
scaffolds for bioactive alkaloid synthesis (Project aim 2, page 40). Some sections of this 
chapter were published in the European Journal of Organic Chemistry in July 2016.84 
This article is included in Appendix 2 of this thesis.  
3.1 Attempted aza-Prins cyclization reactions of β-amino alcohol 210b and               
its O-TBS and O-TBDPS ethers  
 We first tried the aza-Prins cyclization reaction of the 2-allenyl-1,2-amino 
alcohol 210b with benzaldehyde in toluene using MgSO4 as a desiccant at 70 °C,            
a modified condition according to Liu’s procedure.85 After 24 h, 1H NMR analysis of 
the crude reaction mixture indicated 100% conversion to the oxazolidine derivative 271 
as a 2.6:1 mixture of diastereomers (Scheme 3.1). The IR spectrum of 271 showed an 
absence of a characteristic absorption band in the N-H and O-H stretching regions. The 
1H NMR spectrum of 271 showed resonances for H-2 at δH 5.03 (s) for the major 
diastereomer and at δH 5.25 (s) for the minor diastereomer. The 13C NMR spectrum 
showed resonances for C-2 at δC 96.6 (major) and 94.2 (minor). 
 
Scheme 3.1 Attempted aza-Prins cyclization reaction of 210b 
A proposed mechanism for the formation of the oxazolidine derivative 271 is 
shown in Scheme 3.1. The alcohol 210b underwent a condensation reaction with 
benzaldehyde to form the iminium ion 272a/b followed by cyclization through the 
hydroxy group of 272 to produce the oxazolidine product 271, after a basic work up. 
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Scheme 3.2 A proposed mechanism for the formation of the oxazolidine derivative 271 
Due to formation of the undesired reaction product 271, we decided to protect 
the hydroxy group of 210b to prevent this undesired side reaction. Treatment of the      
2-allenyl-1,2-amino alcohol 210b with tert-butyldimethylsilyl chloride (TBSCl) and 
imidazole in DMF at room temperature for 1 h provided the O-TBS 2-allenyl-1,2-amino 
alcohol product 273 in 93% yield (Scheme 3.3). 
 
Scheme 3.3 TBS protection of 2-allenyl-1,2-amino alcohol 210b 
The IR spectrum of 273 showed a characteristic absorption band for an allenyl 
group at νmax 1955 cm-1 and the absence of a characteristic absorption band in the O-H 
stretching region. The 1H NMR spectrum of 273 showed resonances for the tert-butyl 
and the two methyl substituents of the TBS group as singlets at δH 0.88, 0.04 and 0.03, 
respectively. The 13C NMR spectrum showed resonances for the three allenyl carbons at 
δC 76.0, 90.5 and 208.9 and resonances for the TBS group at δC 26.0 (Cq) and 18.4 (3 x  
CH3), -5.2 (CH3) and -5.3 (CH3). LRESIMS analysis of compound 273 showed a 
protonated molecular ion peak at m/z 304 (100%) [M + H]+ in accordance with the 
molecular formula C18H30NOSi which was confirmed by HRESIMS analysis 
(calculated for C18H30NOSi [M + H]+: 304.2097, found: 304.2097).  
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 We next examined the aza-Prins cyclization reaction of the OTBS-protected β-
amino alcohol 273 with the simple aromatic aldehyde, benzaldehyde. Treatment of 273 
with benzaldehyde (1.2 equiv.) and TMSCl (1.5 equiv.) in CH2Cl2 at room temperature 
for 24h, according to Martin’s procedure,86 resulted in the recovery of unreacted starting 
material 273 (Table 3.1, Entry 1). Using FeCl3 (0.45 equiv.) according to Martin’s other 
procedure63 resulted in the recovery of unreacted starting material 273 (Table 3.1, Entry 
2). Performing the reaction with TMSCl (1.5 equiv.)  in DCE at 60 °C for 24 h again 
provided an undesired oxazolidine derivative 271 in 13% isolated yield along with 
recovered unreacted starting material 273 (45%) (Table 3.1, Entry 3). Treatment of 273 
without the Lewis acid catalyst FeCl3 in DCE using microwave heating at 100 °C 
provided a 3% isolated yield of the chlorinated product 274 which most likely arises 
from a SN2 reaction of dichloroethane with the amine moiety of 273 (Table 3.1, Entry 
4). Performing the reaction in toluene at 120 °C gave the cycloisomerization reaction87 
product 275 in 21% yield (Table 3.1, Entry 5). The use of In(OTf)3 (0.45 equiv.) as a 
Lewis acid catalyst according to Loh’s procedure58 gave a trace amount of the 
oxazolidine 271 as observed from 1H NMR analysis of the crude reaction mixture 
(Table 3.1, Entry 6). 
Due to the formation of oxazolidine 271 in the above reactions, we decided to 
use a more acid tolerant silyl ether protecting group. Treatment of 210b with tert-
butyldiphenylchlorosilane (TBDPSCl) and imidazole in DMF at room temperature for 2 
h provided the silyl ether product 276 in 41% isolated yield. The aza-Prins cyclization 
reaction of 276 and benzaldehyde with FeCl3 (0.45 equiv.) and TMSCl (1.5 equiv.) in 
CH2Cl2 was initially performed at room temperature, but no progress was observed after 
24 h by TLC analysis. The reaction was then warmed to 50 °C and stirred for another 24 
h. 1H NMR analysis of the crude reaction mixture showed a complex mixture had 
formed with no resonances observed for the desired product (Scheme 3.4). These initial 
results suggested that iminium ion formation occurred but the cyclization of the allenyl 
moiety onto the iminium ion may not be favourable. 
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Table 3.1 Attempted aza-Prins cyclization reactions of silyl ether 273 
 
Entry Lewis acid Solvent T (°C) Time Product 
1 TMSCl CH2Cl2 rt 24 h 
No reaction, 
Recovered SM 
2 
TMSCl 
FeCl3 
CH2Cl2 rt 24 h 
No reaction, 
Recovered SM 
3 TMSCl DCE 60 24 h 
   
4 - DCE MW, 100 0.5 h 
 
5 - toluene 120 18 h 
 
6 In(OTf)3 toluene 100 72 
   
 
 
Scheme 3.4 The aza-Prins cyclization reaction of silyl ether 276 
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3.2 Synthesis of N-tosylated amine 
Based on Martin’s work63 (Scheme 1.47), we postulated that the N-Ts analogue 
of 210b or related homopropargyl amines, rather than the N-Bn versions, may be more 
productive substrates. Thus we first examined the PBM reaction of salicylaldehyde 8 
with aqueous ammonia solution and allenyl boronate 89 in MeOH at room temperature. 
We had expected to obtain the primary amine 277 which could be N-tosylated to give 
the desired substrate. Unfortunately, this reaction did not give the desired primary 
amine 277 but the imine 278 and the boron zwitterion complex 279 were obtained in 
20% and 8% isolated yields, respectively (Scheme 3.4). Imine 278 was likely produced 
from the condensation reaction of the desired primary amine 277 with another molecule 
of salicylaldehyde 8 due to the reactive free primary amine group (Scheme 3.5).  
 
Scheme 3.5 PBM reaction of salicylaldehyde 8 with allenyl boronate 89 and             
ammonia solution 
The IR spectrum of the imine 278 showed characteristic absorption bands for a 
terminal alkyne group at νmax 3295 and 2152 cm-1 and a band for the O-H stretch at νmax 
3316 cm-1. The 1H NMR spectrum of 278 (Figure 3.1) was consistent with that of the 
imine 278 and also indicated resonances for a minor terminal alkyne product (δH 2.17, 
2.65, 2.77 and 3.80) which could be the (Z)-imine isomer (Figure 3.1). However a 
resonance for the imine proton for this proposed isomer was not evident. Resonances 
for the terminal alkyne proton (H-4′) at δH 2.02 (dt, J4′,2′ = 2.6 Hz, 1H) and the two 
diastereotopic propargylic protons (H-2′) as a 2H multiplet at δH 2.92-2.87 were 
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observed for 278. The resonance for the α-amino methine proton (H-1′) was observed at 
δH 4.83 (dd, J1′,2′A = 8.5 Hz and J1′,2′B = 5.4 Hz, 1H), while that for the imine proton was 
observed at δH 8.47 (s, 1H). The 13C NMR spectrum (Figure 3.2) showed resonances for 
the two alkyne carbons at δC 71.5 and 80.8 and the resonance for imine carbon at δC 
165.6. LRESIMS analysis of compound 278 showed a protonated molecular ion peak at 
m/z 266 (100%) [M + H]+ in accordance with the molecular formula C17H16NO2 which 
was confirmed by HRESIMS analysis (calculated for C17H16NO2 [M + H]+: 266.1181, 
found: 266.1188). 
 
 
Figure 3.1 1H NMR spectrum (CDCl3, 500 MHz) of 278 
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Figure 3.2 13C NMR spectrum (CDCl3, 125 MHz) of 278 
The IR spectrum of the boron zwitterion complex 279 showed characteristic 
absorption bands for a terminal alkyne group at νmax 3286 and 2161 cm-1 and an absence 
of a band in the O-H stretching region. The 1H NMR spectrum of 279 (Figure 3.3) 
showed resonances for the terminal alkyne proton (H-3′) at δH 2.25 (s, 1H), two set of 
resonances for the two diastereotopic propargylic protons (H-1′), at δH 3.43 (dd, J1′A,1′B 
= 17.4 Hz and J1′A,12 = 11.3 Hz, 1H) and δH 2.88 (dt, J1′B,1′A = 17.4 Hz and J1′B,12 = 3.4 
Hz, 1H). The resonance for the α-amino methine proton (H-12) was observed at δH 4.73 
(dd, J12,1′A = 11.3 Hz and J12,1′B = 3.4 Hz, 1H) and a resonance for the methoxy group 
was observed at δH 3.25 (s, 3H). The resonance for the iminium ion proton (H-14) was 
observed at δH 8.45 (s, 1H). The 13C NMR spectrum (Figure 3.4) showed resonances for 
two alkyne carbons at δC 73.2 and 80.9 and the resonance for iminium ion carbon at δC 
163.0. LRESIMS analysis of compound 278 showed a positive ion at m/z 274 (100%) 
[M−OMe]+ in accordance with the molecular formula C17H13BNO2 which was 
confirmed by HRESIMS analysis (calculated for C17H13BNO2 [M−OMe]+: 274.1039, 
found: 274.1049). Compound 279 was obtained as colourless crystals with a melting 
point 184-185 °C. A single crystal X-ray diffraction analysis confirmed the structure of 
compound 279 (Figure 3.5). 
Chapter 3: Aza-Prins Cyclization Reactions | 96 
 
 
 
Figure 3.3 1H NMR spectrum (CDCl3, 500 MHz) of 279 
 
Figure 3.4 13C NMR spectrum (CDCl3, 125 MHz) of 279 
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Figure 3.5 X-ray crystal structure of the boron zwitterion complex 279 
 When bis(trimethylsilyl)amine was used as an ammonia surrogate in the PBM 
reaction of salicylaldehyde 8 and allenyl boronate 89, the imine 278 was again obtained 
but in a poorer yield of 18% (Scheme 3.6). This low yield may be due to imine 
hydrolysis occurring during the column chromatographic process, however, none of the 
desired and more polar primary amine 277 could be isolated. Analysis of the 1H NMR 
spectrum of the crude reaction mixture indicated no resonances for the boron zwitterion 
complex 279. 
 
Scheme 3.6 PBM reaction of salicylaldehyde 8 with bis(trimethylsilyl)amine 
 We next decided to prepare related N-Ts substituted amines as analogous 
compounds to these were found to successfully give the aza-Prins cyclized products as 
discussed in Chapter 1 (Schemes 1.4763, 4964, 5065, 5267 and 5570). Aldimine 280 was 
prepared following the literature method.88 The condensation of benzaldehyde and p-
toluenesulfonamide in the presence of catalytic amount of pyrrolidine (10 mol%) in 
CH2Cl2 at reflux temperature gave the aldimine 280 in 88% yield (Scheme 3.7). 
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Scheme 3.7 Synthesis of aldimine 280 
 To extend the use of allenyl boronate 89, the PBM reaction of the aldimine 280 
with 89 was examined in MeOH-d4 with monitoring the reaction progress by 1H NMR 
spectroscopy. After 24 h at room temperature, 1H NMR spectroscopic analysis showed 
around 40 % conversion to the N-Ts homopropargyl amine product 281. The reaction 
was heated at 60 °C for another 48 h but the conversion did not significantly change. 
After solvent evaporation and purification by FCC the known N-Ts homopropargyl 
amine 28189 was obtained in 24% isolated yield (Table 3.2, Entry 1). The aldimine 280 
was treated with allenyl boronate 89 in the presence of a catalytic amount of Et2Zn (10 
mol%) to provide N-Ts homopropargyl amine 281 and  N-Ts allenyl amine 28249 in 
30% and 20 % isolated yields respectively after separation by column chromatography 
(Table 3.2, Entry 2). The regiochemical outcome of this reaction can be explained by B 
to Zn transmetalltion and isomerization between the propargylzinc and allenylzinc 
intermediates as discussed in Chapter 1 (Scheme 1.29). The propargylation of aldimine 
280 with propargyl bromide in the presence of zinc metal gave the propargylated 
product 281 in excellent yield (91% yield) (Table 3.2, Entry 3).89 
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Table 3.2 Propargylation of aldimine 280 
 
Entry Reagent Additive Solvent T (°C) Time 
Product 
Yield (%) 
1 
 
- MeOH-d4 60 72 h 
281 
24 
2 
 
 Et2Zn     
(10 mol%) 
toluene 0 24 h 281/282 
30 and 20 
3  Zn metal THF rt 1 h 
281 
91 
 
3.3 Aza-Prins cyclization reactions of the N-Ts homoprogargyl amine 281 
Before examining the aza-Prins cyclization reactions of compounds 281 and 282 
with aldehydes, the following literature reports were consulted. Miranda86 reported the 
aza-Prins cyclization reactions of the N-Ts homoprogargyl amine 283, a simpler 
analogue of 281, with isovaleraldehyde using FeCl3 and TMSCl in CH2Cl2 to give 
tetrahydropyridine 284 in 80% yield (Scheme 3.8). Figueiredo90 reported the iodine-
catalyzed aza-Prins cyclization reaction of the homoallylic amine 285 with aliphatic or 
aromatic aldehydes in CH2Cl2. These reactions provided the products 286 in 28-76% 
yields (Scheme 3.9). Dobbs65 reported the use of InCl3 in in the reaction of the silylated 
homoallylic N-Bn amine as discussed in Chapter 1 (Scheme 1.50). Liu85 reported aza-
Prins cyclizations of 2-allylpyrrolidines 287 with glyoxylic acid in MeCN in the 
presence of 4Å molecular sieves to afford indolizidine lactone products 288 in 83-97% 
yields (Scheme 3.10). 
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Scheme 3.8 Miranda’s86 aza-Prins cyclization reactions of N-Ts homoprogargyl
amine 283 
Scheme 3.9 Figueiredo’s90 iodine-catalyzed aza-Prins cyclization reaction of the
homoallylic amine 285 
Scheme 3.10 Liu’s85 aza-Prins cyclizations of 2-allylpyrrolidines 287
Our search for the best conditions for the aza-Prins cyclization reactions of the 
N-Ts homoprogargyl amine 281 involved screening the Lewis acids, solvents and
reaction temperatures described in Schemes 1.5065, 3.885, 3.990 and 3.1085 as
summarized in Table 3.3. After work up and 1H NMR analysis of the crude reaction
mixtures, only unreacted N-Ts amine staring material was recovered in quantitative 
yield, in each case. 
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Table 3.3 Attempted aza-Prins cyclization reactions of N-Ts progargyl amine 281 
 
Entry Aldehyde 
Additive 
(lit. method) 
Solvent T (°C) Time Yield (%) 
1  
(1.4 equiv.) 
FeCl3 
(10 mol%)  
TMSCl  
(1.5 equiv.)86  
CH2Cl2 60 96 h 
No reaction, 
Recovered 
SM 
2  
(1.2 equiv.) 
I2  
(20 mol%)90  
CH2Cl2 rt 16 h 
No reaction, 
Recovered 
SM 
3  
(1.2 equiv.) 
InCl3 
 (1.0 equiv.)65  
MeCN reflux 24 h 
No reaction, 
Recovered 
SM 
4 
 
(1.5 equiv.) 
InCl3 
(1.2 equiv.)65 
MeCN reflux 24 h 
No reaction, 
Recovered 
SM 
5 
 
(1.5 equiv.) 
4Å MS85 toluene 80 96 h 
No reaction, 
Recovered 
SM 
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A similar unsuccessful result was obtained for the attmepted aza-Prins 
cyclization reaction of the N-tosyl allenyl amine 282 with ethyl glyoxylate 261 in the 
presence of InCl3 in MeCN at reflux temperature for 72 h. Only unreacted staring 
material was recovered (Scheme 3.11). 
 
Scheme 3.11 Attempted aza-Prins cyclization reaction of the N-Ts allenyl amine 282 
 Yu et. al.91 reported that the reaction of the allenyl amine 282 with n-butanal in 
the presence of InCl3 in CH2Cl2 gave an aldol type product (Scheme 3.12). In our case, 
only unreacted staring material was recovered after work up the reaction. 
 
Scheme 3.12 Coupling reaction of allenyl amine 282 with n-butanal 
3.4 Attempted aza-silyl-Prins cyclization reaction of silylated N-Ts allylic amine 290 
 Due to these unsuccessful results, we decided to try the aza-silyl-Prins 
cyclization reaction as discussed in Chapter 1 (Scheme 1.50). Takeuchi et. al.92 reported 
the hydrosilylation of alkyne 289 with Et3SiH using Wilkinson's rhodium catalyst in 
benzene. This reaction gave a mixture of β-(Z)-, β-(E)-  and α-vinylsilane in 86%, 12% 
and 2% yields, respectively (Scheme 3.13). 
 
Scheme 3.13 Takeuchi’s92 hydrosilylation of alkyne 289 
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 The desired starting silylated N-Ts allylic amine 290 for the aza-silyl-Prins 
cyclization reaction was prepared following Takeuchi’s procedure.92 Hydrosilylation of 
the N-Ts propargyl amine 281 using Wilkinson's catalyst gave the silylated amine 
product 290 in 23% yield along with recovered starting material (29%) (Scheme 3.14).  
 
Scheme 3.14 Synthesis of silylated N-Ts allylic amine 290 
A proposed mechanism of hydrosilylation of N-Ts propargyl amine 281 is 
shown in Scheme 3.15. Oxidative addition of Et3SiH to rhodium catalyst forms the 
rhodium complex A. Further cis-hydrometallation of the coordinated alkyne produces 
rhodium complex B and subsequent reductive elimination of the alkenyl silane provides 
the trans-product 290. 
 
Scheme 3.15 Proposed mechanism of hydrosilylation of N-Ts propargyl amine 281 
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The IR spectrum of the silylated N-Ts allylic amine 290 showed the absence of 
bands in the terminal alkyne stretching region. The 1H NMR spectrum of 290 (Figure 
3.6) showed a resonance for the alkene methine proton (H-4) at δH 5.58 (d, J4,3 = 18.6 
Hz, 1H), indicating the expected (E)-isomer. The other alkene methine proton (H-3) was 
observed at δH 5.71 (dt, J3,4 = 18.6 Hz and J3,2 = 6.6 Hz, 1H). The 2H multiplet 
resonance at δH 2.58-2.44 was assigned to the methylene protons (H-2), while the 
resonance for α-amino methine proton (H-1) was observed at δH 4.37 (q, J1,2 = 6.6 Hz, 
1H). The two resonances for the ethyl substituents of the triethylsilyl group was 
observed at δH 0.86 (t, J = 8.0 Hz, 3 x 3H) and δH 0.47 (q, J = 8.0 Hz, 3 x 2H). The 13C 
NMR spectrum (Figure 3.7) showed resonances for the two alkene carbons at δC 142.1 
and 132.6 and the ethyl carbons of the triethylsilyl group at δC 7.5 and 3.5. LRESIMS 
analysis of compound 290 showed a sodiated molecular ion peak at m/z 438 (100%)    
[M + Na]+ in accordance with the molecular formula C23H33NO2NaSiS which was 
confirmed by HRESIMS analysis (calculated for C23H33NO2NaSiS [M + Na]+: 
438.1899, found: 438.1911). 
 
Figure 3.6 1H NMR spectrum (CDCl3, 500 MHz) of 290 
Chapter 3: Aza-Prins Cyclization Reactions | 105 
 
 
Figure 3.7 13C NMR spectrum (CDCl3, 125 MHz) of 290 
The aza-silyl-Prins cyclization reaction of 290 with hexanal in the presence of 
InCl3 in MeCN at reflux temperature for 24 h provided the known desilylated product 
29193 in 21% yield along with recovered starting material (29%) (Table 3.4, Entry 1). 
The reaction of 290 with ethyl glyoxylate did not proceed to the desired product and 
only starting material was recovered (Table 3.4, Entry 2).  
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Table 3.4 Attempted aza-silyl-Prins cyclization reactions of 290 
 
Entry Aldehyde Additive Solvent 
T 
(°C) 
Time Product 
1  
(1.5 equiv.) 
InCl3 
(1.2 equiv.)  
MeCN reflux 24 h 
 
2 
 
(2.0 equiv.) 
3Å MS xylene 80 24 h 
No reaction, 
Recovered SM 
 
3.5 Attempted aza-Prins cyclization reactions of the N-Bn homoprogargyl amine 
281 
 We next decided to use a N-benzyl substituent instead of the N-Ts substituent, 
which was found to be successful in the aza-silyl-Prins cyclization reaction in the 
Dobbs’ publication.65 The preparation of the N-benzyl propargyl amine 295 started with 
the condensation reaction of benzaldehyde and benzylamine in CH2Cl2 at reflux 
temperature using MgSO4 as a desiccant which gave imine 294 in 76% yield (Scheme 
3.16).94 A subsequent propargylation reaction with propargyl bromide in the presence of 
Zn metal provided the known amine 29595 in 59% yield (Scheme 3.16). 
 
Scheme 3.16 The preparation of N-benzyl propargyl amine 295 
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 Before treating amine 295 under the hydrosilylation reaction conditions, we 
decided to subject it to the aza-Prins cyclization reaction. The reaction of 295 with ethyl 
glyoxylate 261 using 3Å molecular sieves as a desiccant was performed in toluene at 80 
°C for 96 h. After work up, 1H NMR analysis of the crude reaction mixture indicated no 
desired product was formed (Scheme 3.17a). However, the reaction using InCl3 in 
MeCN at reflux temperature for 24 h provided an inseparable 8.5:1 mixture of ethyl α-
allenylglycinate 296 and ethyl α-propargylglycinate 297 in 17% yield (Scheme 3.17b).  
 
Scheme 3.17 Aza-Prins cyclization reaction of N-benzyl propargyl amine 295 and           
ethyl glyoxylate 261 
The IR spectrum of this mixture showed a characteristic absorption band for an 
allenyl group at νmax 1957 cm-1 and for an ester carbonyl group at νmax 1732 cm-1. The 
1H NMR spectrum of this mixture (Figure 3.8) showed a resonance for the two geminal 
allenyl protons (H-5) at δH 4.90 (app. d, J3,5 = 6.4 Hz, 2H). The resonance for the α-
allenyl proton (H-3) was observed at δH 5.26 (app. q, Jca = 6.7 Hz, 1H). The resonance 
for the α-amino methine proton (H-2) was observed at δH 3.88 (dd, J2,3 = 6.7 Hz and J2,5 
= 3.2 Hz, 1H). The resonances for the ethyl ester group were observed at δH 4.20 (q, J = 
7.0 Hz, 2H) and δH 1.28 (t, J = 7.0 Hz, 3H). Resonances for alkyne 290 were observed 
at δH 3.44 (t, J2,3 = 5.9 Hz, 1H, H-2′), 2.62 (dd, J2,3 = 5.9 and  J3,5 = 2.7 Hz, 2H, H-3′) 
and 2.04 (t, J3,5 = 2.7 Hz, 1H, H-5′). The 13C NMR spectrum of this mixture (Figure 3.9) 
showed resonances for three allenyl carbons at δC 78.9, 89.6 and 208.6 and the ethyl 
ester carbons at δC 173.3, 61.3 and 14.4. Resonances for the terminal alkyne carbon of 
compound 297 were observed at δC 79.7 and 71.2. LRESIMS analysis of this mixture 
showed a protonated molecular ion peak at m/z 232 [M + H]+ in accordance with the 
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molecular formula C14H18NO2 which was confirmed by HRESIMS analysis (calculated 
for C14H18NO2 [M + H]+: 232.1338; found: 232.1345). 
 
Figure 3.8 1H NMR spectrum (CDCl3, 500 MHz) of a 8.5:1 mixture of 296 and 297 
 
Figure 3.9 13C NMR spectrum (CDCl3, 125 MHz) of a 8.5:1 mixture of 296 and 297 
Chapter 3: Aza-Prins Cyclization Reactions | 109 
 
Compounds 296 and 297 were most likely products of an aza-Cope 
rearrangement from the iminium ion 298, which subsequently underwent a [3,3]-
sigmatropic rearrangement to the iminium ion 299. Hydrolysis of 299 provided the ethyl 
α-allenylglycinate 296. Some of this compound underwent an aza-Cope rearrangement 
to give ethyl α-propargylglycinate 297 (Scheme 3.18). 
 
 
Scheme 3.18 Aza-Cope rearrangement of N-Bn propargyl amine 295 and ethyl             
α-allenylglycinates 296 
 A similar result was obtained using N-Bn allenyl amine 273 under the same 
conditions. The reaction provided 4.6:1 mixture of the rearrangement products 297 and 
296 in 17% yield (Scheme 3.19). The alkyne product 297 was favoured over the allenyl 
product 296 in this case due to [3,3]-sigmatropic rearrangement of iminium ion 302 to 
compound 297, some of this compound underwent a further aza-Cope rearrangement to 
give compound 296 (Scheme 3.20). 
 
Scheme 3.19 Aza-Cope rearrangement of N-Bn allenyl amine 273 
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Scheme 3.20 Proposed mechanism for the aza-Cope rearrangement of N-Bn allenyl 
amine 273 
3.6 Aza-silyl-Prins cyclization reactions of silylated N-Bn allylic amine 303 
 The hydrosilylation of amine 295 with Wilkinson's catalyst92 gave the silylated 
N-Bn allylic amine 303 in 23% yield along with unreacted starting material (20%) 
(Table 3.5, Entry 1). In order to increase the yield of the desired product, the reaction 
was repeated using other catalysts. The use of [Rh(COD)2]BF496 provided the product in 
only 12 % yield (Table 3.5, Entry 2), while using RhCl2(p-cymene)297 only unreacted 
staring material was observed (Table 3.5, Entry 3). However, the reaction using 
chloroplatinic acid (H2PtCl6)98 gave the product 303 in 50% yield (Table 3.5, Entry 4). 
Table 3.5 The hydrosilylation of N-Bn allenyl amine 295 
 
Entry Catalyst Solvent T (°C) Time Yield (%) 
1 
(PPh3)3RhCl 
 (10 mol%) 
toluene 40 24 h 23 
2 
[Rh(COD)2]BF4/PPh3  
(0.2 mol%)  
DCE rt 96 h 12 
3 
RhCl2(p-cymene)2 
(5 mol%)  
CH2Cl2 45 24 h 
Recovered 
SM 
4 
10% wt H2PtCl6 
(8.5 mol%) 
- 60 20 h 50 
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The IR spectrum of the silylated N-benzyl allylic amine 303 showed an absence 
of bands in the alkyne stretching region. The 1H NMR spectrum of 303 (Figure 3.10) 
showed a resonance for the alkene methine proton (H-4) at δH 5.62 (d, J3,4 = 18.7 Hz, 
1H), indicating the (E)-isomer formed predominantly. The other alkene methine proton 
(H-3) was observed at δH 5.92 (ddd, J3,4 = 18.4 Hz, J2A,3 = 7.7 Hz  and J2B,3 = 5.6 Hz, 
1H). The 2H multiplet resonance at δH 2.52-2.39 was assigned to the two diastereotopic 
methylene protons (H-2). The resonance for the α-amino methine proton (H-1) was 
overlapped with that for one of the diastereotopic benzylic protons at δH 3.74-3.65 as a 
2H multiplet. The two resonances for ethyl substituents of the triethylsilyl group were 
observed at δH 0.89 (t, J = 8.0 Hz, 9H) and at δH 0.51 (q, J = 8.0 Hz, 6H). Smaller 
intensity resonances for a minor product, which could be the (Z)-isomer, were also 
observed. The 13C NMR spectrum (Figure 3.11) showed resonances for the two alkene 
carbons at δC 145.0 and 130.2 and the triethylsilyl group carbons resonances at δC 7.5 
and 3.6. LRESIMS analysis of compound 295 showed a protonated molecular ion peak 
at m/z 352 (100%) [M + H]+ in accordance with the molecular formula C23H34NSi 
which was confirmed by HRESIMS analysis (calculated for C23H34NSi [M + H]+: 
352.2461, found: 352.2477). 
 
Figure 3.10 1H NMR spectrum (CDCl3, 500 MHz) of 303 
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Figure 3.11 13C NMR spectrum (CDCl3, 125 MHz) of 303 
 An attempted aza-silyl-Prins cyclization reaction of the silylated N-Bn allylic 
amine 303 with the highly reactive aldehyde ethyl glyoxylate 261 in the absence of a 
Lewis acid in MeCN at reflux temperature or in toluene at 80 °C did not provide any of 
the desired product after work up and 1H NMR analysis of the crude reaction mixtures 
(Table 3.6, Entries 1-2). The use of 3Å molecular sieves as a desiccant in xylene at 80 
°C for 36 h provided the racemic trans-2,6-tetrahydropyridine product 304 in 50% 
isolated yield (Table 3.6, Entry 3). Xylene was used in this particular reaction as it 
would allow the reaction mixture to be heated to a higher temperature (bp = 138 °C) if 
no reaction was observed at 80 °C. While the reaction using InCl3 (1.2 equiv.) as a 
Lewis acid in MeCN at reflux temperature also gave the desired product 304 as a single 
diastereomer in 50% isolated yield in a shorter reaction time (20 h) (Table 3.6, Entry 4). 
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Table 3.6 Aza-silyl-Prins cyclization reaction of silylated N-Bn allylic amine 303 
 
Entry Additive Solvent T (°C) Time Yield (%) 
1 - MeCN reflux 20 h 
No reaction, 
Recovered 
SM 
2 - toluene 80 72 h 
No reaction, 
Recovered 
SM 
3 3 Å MS xylene 80 36 h 50 
4 
InCl3 
 (1.2 equiv.) 
MeCN reflux 20 h 50 
The IR spectrum of 304 showed a characteristic absorption band for the ester 
carbonyl group at νmax 1732 cm-1. The 1H NMR spectrum of 304 (Figure 3.12) showed 
resonances for the two alkene methine protons at δH 6.09-6.03 (m, 1H, H-4) and δH 
5.85-5.77 (m, 1H, H-3). The resonance for the methine proton (H-6) was observed at δH 
4.53 (dd, J5A,6 = 10.0 Hz and J5B,6 = 4.7 Hz, 1H), while the α-amino methine proton (H-
2) was observed at δH 3.88 as a singlet. A two set of resonances for the two 
diastereotopic methylene protons (H-5) were observed at δH 2.49 (ddd, J5A,5B = 17.8 Hz, 
J5A,6 = 10.0 Hz and 3J4,5A= 2.6 Hz, 1H) and at δH 2.37 (dt, J5A,5B = 17.8 Hz and J5B,6 = 
4.7 Hz, 1H). The resonances for the ethoxy group were observed at δH 4.18 (q, J = 7.2 
Hz, 2H) and at δH 1.28 (t, J = 7.2 Hz, 3H). The 13C NMR spectrum of 304 
(Figure 3.13) showed resonances for the carbonyl carbon at δC 172.3, the two alkene 
carbons at δC 128.2 and 123.4 and the ethyl ester carbons at δC 60.6 and 14.5. LRESIMS 
analysis of compound 304 showed a protonated molecular ion peak at m/z 322 (100%) 
[M + H]+ in accordance with the molecular formula C21H24NO2 which was confirmed 
by HRESIMS analysis (calculated for C21H24NO2 [M + H]+: 322.1807, found: 
322.1805). 
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Figure 3.12 1H NMR spectrum (CDCl3, 500 MHz) of 304 
 
Figure 3.13 13C NMR spectrum (CDCl3, 125 MHz) of 304 
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The 2D NOESY spectrum (Figure 3.14) of 304 showed no correlation between 
the resonances for H-2 and H-6 which indicated that these protons were located on 
opposite faces of the tetrahydropyridine ring indicating their trans-relative 
configuration.  
 
Figure 3.14 2D NOESY spectrum (CDCl3, 500 MHz) of 304 
 A proposed mechanism for this cyclization reaction involves the formation of 
the iminium ion intermediate 305 in which steric hindrance between the ester and             
N-iminium substituents were minimized. Subsequent elimination of the triethylsilyl 
group then provided the trans-2,6-tetrahydropyridine 304. (Scheme 3.21) 
 
Scheme 3.21 A proposed mechanism for the aza-silyl-Prins cyclization reaction of 303 
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 Comparison of the results of the aza-silyl-Prins reaction of silylated N-Ts allylic 
amine 290 and silylated N-Bn allylic amine 303, we have proposed the two possible 
transition states (307 and 310) that proceed to the trans-products (Scheme 3.22). 
Transition state 307 would be expected to be favoured over 310 since the Ph substituent 
is pseudo-equatorial in the former and pseudo-axial in the latter. These transition states 
are destabilized when R is a larger group (Ts group) due to more severe 1,3-diaxial 
interactions with the axial hydrogens at C-2 and C-4. Furthermore, the nitrogen atom of 
the N-Ts amine is less nucleophilic therefore iminium ion formation is slower. While 
when R is a smaller Bn group, these 1,3-diaxial interactions are less severe and product 
formation is more favourable. 
 
Scheme 3.22 A proposed mechanism for the aza-silyl-Prins cyclization reaction 
 The trans-relative configuration of 304 was further was confirmed by reduction 
of an ester group of 304 to the corresponding alcohol 313 in 38% yield using LiBH4 in 
10% MeOH/Et2O (Scheme 3.23). The IR spectrum of 313 showed a characteristic 
absorption band for an alcohol group at νmax 3447 cm-1 and an absence of the band in the 
carbonyl stretching region. The 2D NOESY spectrum (Figure 3.15) of 313 showed a 
correlation between H-2 and H-1′ which indicated the cis-relative configuration of these 
protons in the tetrahydropyridine ring. 
 
Scheme 3.23 Reduction of trans-2,6-tetrahydropyridine 304 
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Figure 3.15 2D NOESY spectrum (CDCl3, 500 MHz) of 313  
 Under the successful reaction conditions described in Table 3.6, the aza-silyl-
Prins cyclization reactions of the silylated N-Bn allylic amine 303 with benzaldehyde, 
glycolaldehyde and isobutyraldehyde were then investigated. All reactions resulted in 
only recovered starting material 303 after work up and 1H NMR analysis of the crude 
reaction mixtures (Table 3.7). The failure of the silylated N-Bn allylic amine 303 in 
reactions of these less reactive aldehydes greatly limits the scope of this and related 
substrates in the use of the aza-silyl-Prins cyclization reaction in preparation of the 
heterocyclic core structures required for natural product synthesis. 
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Table 3.7 The attempted aza-silyl-Prins cyclization reactions of amine 303 
 
Entry Aldehyde Yield (%) 
1 
 
No reaction, Recovered SM 
2 
 
No reaction, Recovered SM 
3 
 
No reaction, Recovered SM 
 
In summary, the aza-Prins cyclization reactions of the β-amino alcohol 210b     
or its O-TBS or O-TBPDPS ethers 273 and 276 failed to give the desired 
tetrahydropyridine products. Only recovered starting material or undesired reaction 
products, including the oxazolidine 271, the chloride 274 and the 2,5-dihydropyrrole 
275 were obtained. In an attempt to prepare a N-Ts substrate, the PBM reaction of 
salicylaldehyde 8, allenyl boronate 89 and ammonia or (TMS)2NH were attempted. 
These reactions resulted in the undesired imine 278. The reaction with ammonia also 
gave the novel boron zwitterion complex 279 which provided single crystals for X-ray 
structural analysis. An alternative method of synthesis starting from N-Ts imine 280 
gave the N-Ts homopropargyl amine 281. The attempted aza-Prins cyclization reaction 
of this compound gave only the recovered unreacted starting N-Ts amine 281. The 
reaction of N-Ts allenyl amine 282 also failed to provide the desired product. 
Hydrosilylation of compound 281 using Wilkinson's catalyst and Et3SiH provided (E)-
allyl silylated allylic N-Ts amine 290. The attempted aza-silyl-Prins cyclization reaction 
of compound 290 give only recovered starting material or undesired desilylated product 
291.  In an attempt to prepare a N-Bn substrate, the propargylation of prepared imine 
294 with propargyl bromide and Zn metal successfully provided the desired N-Bn 
amine 295. The attempted aza-Prins cyclization reaction of compound 295 or 273 with 
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ethyl glyoxylate 261 in the presence of InCl3 provided mixtures of the aza-Cope 
rearrangement products 296 and 297. Hydrosilylation of compound 295 using H2PtCl6 
gave (E)-silylated N-Bn allylic amine 303.  The aza-silyl-Prins cyclization reactions of 
this amine and the highly reactive ethyl glyoxylate 261 in the present of InCl3 as a 
Lewis acid or 3Å molecular sieve as a desiccant successfully gave the trans-2,6-
tetrahydropyridine product 304. Unfortunately, using less reactive aldehydes under 
these conditions resulted in only unreacted starting material. 
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Chapter 4 
Progress Toward the Total Synthesis of 9β-Hydroxyvertine 
 In this chapter, we report our attempts to prepare 9β-hydroxyvertine. 
4.1 Alkaloids from Heimia salicifolia 
Heimia salicifolia; or commonly called, sinicuichi, sun opener or willow-leaf 
heimia is a wild flowering plant in the Lythraceae family distributed over the Americas 
ranging from Western Texas through Mexico and Central America to South America.99 
In Central and South America, H. salicifolia has been used in traditional medicine as an 
antipyretic, an emetic, a laxative, a diuretic and as an anti-inflammatory agent.100 Over 
the past two decades, many alkaloids have been isolated from H. salicifolia. These 
include, vertine (cryogenine) 314, lyfoline 315, epi-lyfoline 316, lythrine 317, 
dehydrodecodine 318, sinicuichine 319, 9β-hydroxyvertine 208, lythridine (sinine) 320, 
heimidine 321 and (2S,4S,10R)-4-(3-hydroxy-4-methoxyphenyl)-quinolizidin-2-acetate 
322 (Table 4.1).99-101 Except for 322, these are pentacyclic alkaloids with an octahydro-
2H-quinolizin-2-one base structure with a biphenyl substituent at C-4 which forms part 
of a 12-membered ring lactone system. The major Heimia alkaloid vertine 314, is a 
prostaglandin synthetase inhibitor,102 which accounts for the anti-inflammatory activity 
of extracts from this plant species, and has moderate antimalarial activity.100 However, 
many of these alkaloids, including 9β-hydroxyvertine 208, the subject of this chapter, 
have not been synthesized (except for vertine 314 and lythrine 317) or screened for any 
biological activities. 
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Table 4.1 Isolated alkaloids from Heimia salicifolia 
 
Alkaloid 10-H R1 R2 R3 R4 
Vertine 314 β H H OMe OMe 
Lyfoline 315 α H H OMe OH 
epi-Lyfoline 316 β H H OMe OH 
Lythrine 317 α H H OMe OMe 
Dehydrodecodine 318 α H OH OMe H 
Sinicuichine 319 β H OMe OMe H 
9β-Hydroxyvertine 208 β OH H OMe OMe 
 
4.1.1 The total synthesis of (+)-vertine 314 and (+)-lythrine 317 
Chausset-Boissarie et. al.103 reported the asymmetric synthesis of (+)-vertine 
314 and (+)-lythrine 317. Their synthesis of (+)-vertine 314 started from the resolution 
of commercially available racemic 2-piperidineethanol (rac)-323 using (S)-10-
camphorsulfonic acid to obtain the salt of (R)-324. This was then N-protected as a 
carbamate with (Boc)2O, followed by Swern oxidation to give the aldehyde 325 in 91% 
yield. The reaction of 325 with MeMgBr gave the corresponding secondary alcohol 
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which was directly oxidized with Dess-Martin periodinane (DMP) to give pelletierine 
326 in 90% yield over the two steps. Treatment of methyl ketone 326 with                     
6-iodoveratraldehyde under basic (aldol) conditions provided the α,β-unsaturated ketone 
327 in 91% yield. N-Boc deprotection of 327 with TFA, followed by cyclisation under 
basic conditions via an aza-Michael reaction provided a mixture of the 
diastereoisomeric quinolizin-2-ones 328 and 329 in an 8 : 1 ratio. A Suzuki cross-
coupling reaction of 328 with aryl boronate 330 gave the biphenyl dicarbonyl 
compound 331 which was reduced with L-selectride to the corresponding diol and then 
the benzylic alcohol was selectively reoxidized with MnO2 to give corresponding 
aldehyde 332 in 98% yield. Esterification of 332 with acryloyl chloride gave the ester 
333. Deprotection of the MOM protecting group and then protection of the free phenol 
group as the TBS ether yielded compound 334. Treatment of 334 with Nysted’s reagent 
provided alkene 335 in 60% yield. The RCM reaction of 335 using Hoveyda-Grubbs II 
catalyst at 110 °C in toluene followed by removal of the TBS ether protecting group 
with TBAF afforded (+)-vertine 314 in 37% yield (Scheme 4.1). The overall yield of 
314 was 4.4% over 16 linear synthetic steps. 
Their synthesis of (+)-lythrine 317 started from epimerizition of the cis-
quinolizidin-2-one ent-328 by treatment with NaOH in MeOH at room temperature for 
72 h which provided the trans-quinolizidinone ent-329 in 98% yield (96% ee). Using 
the same reaction conditions and sequences as described previously for (+)-vertine 314, 
compound ent-329 was converted to (+)-lythrine 317 in 2.2% overall yield over 17 
linear synthetic steps (Scheme 4.2). 
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Scheme 4.1 Synthesis of (+)-vertine 314 by Chausset-Boissarie et. al.103 
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Scheme 4.2 Synthesis of (+)-lythrine 317 by Chausset-Boissarie et. al.103 
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4.1.2 Retrosynthetic analysis of 9β-hydroxyvertine 208 
The X-ray crystallographic analysis of (+)-vertine 314 indicated that the C-2 
oxygen substituent of the lactone ring was in an axial position on the quinolizidine ring 
while the C-4 biphenyl substituent of this lactone ring was equatorial (Figure 4.1).  In 
our proposed synthesis of 9β-hydroxyvertine 208, we assume it has a similar 3D 
structure to (+)-vertine 314. 
 
Figure 4.1 OPTEP X-ray crystal structure of vertine 314100 
 
Figure 4.2 Structure of vertine 314, 9β-hydroxyvertine 208 and a proposed bromomium 
ion intermediate A 
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Because of the problems encountered using the aza-Prins cyclization which 
limited its application to the synthesis of the target alkaloid 9β-hydroxyvertine 208, we 
proposed a different synthetic strategy using the PBM reaction as a key step. Our 
retrosynthetic analysis (Scheme 4.3) indicated that 9β-hydroxyvertine 208 could be 
obtained from the acid 351 via an intramolecular bromolactonization reaction (Figure 
4.2) followed by reductive removal of the bromine substituent. The acid 351 (Scheme 
4.3) could be prepared from aldehyde 350 via a Still–Gennari modified Horner-
Wadsworth-Emmons (HWE) reaction followed by hydrolysis of the methyl ester 
moiety. The aldehyde 350 can be obtained from benzonitrile 349 via a ring-closing 
metathesis (RCM) reaction of the diene 349, followed by reduction of the cyano 
substituent to an aldehyde. The piperidine 349 could be prepared from the 1,2-amino 
alcohol 348 via a tandem O-mesylation-cyclization reaction. The 1,2-amino alcohol 348 
could be prepared from the PBM reaction of the α-hydroxyaldehyde 347, amine 345 and 
trans-phenylvinyl boronic acid. The chiral α-hydroxyaldehyde 347 could in turn be 
obtained from the vinyl sulfone 346 via a Sharpless asymmetric dihydroxylation 
reaction.104 The sulfone 346 could be prepared from commercially available pent-4-en-
1-ol via a cross-coupling metathesis reaction with phenyl vinyl sulfone. The chiral 
primary amine 345 could be obtained from an allylation reaction of the chiral 
sulfinamide 344 using allylmagnesium bromide followed by acid hydrolysis of the 
sulfinamide protecting group. The sulfinamide 344 could be prepared from the 
condensation reaction of aldehyde 343 with (R)-2-methyl-2-propanesulfinamide. The 
aldehyde 343 could be obtained from the cross-coupling reaction of aryl halide 342 (X 
= Br, I), which could be prepared from commercially available 4-hydroxybenzonitrile, 
and aldehyde 341 (Y = Br, I or Bpin). The latter compounds could be prepared from 
commercially available 3,4-dimethoxy benzaldehyde. 
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Scheme 4.3 Retrosynthesis of 9β-hydroxyvertine 208 
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4.2 Preparation of a suitable biphenyl aldehyde analogous to 343 
For the synthesis of the biphenyl aldehyde 343 suitable protecting groups (PG) 
that seemed appropriate were MOM and Bn. The literature indicated a number of 
possible biphenyl coupling procedures to obtain analogous or related biphenyl 
aldehydes. 
For example, Loev et. al.105 reported a synthesis of the biphenyl aldehyde 353 
via an Ullmann coupling reaction of 6-bromoveratraldehyde 352 and methyl 3-(3-iodo-
4-methoxyphenyl)propanoate using copper powder in the absence of a solvent. The 
reaction gave the biphenyl aldehyde 353 in 30% yield (Scheme 4.4). Seitz and Quick106 
reported the Ullman coupling reaction of 6-bromoveratraldehyde and 3-iodo-4-
methoxybenzonitrile provided the biphenyl aldehyde 354 in 30% yield (Scheme 4.5). 
 
Scheme 4.4 Loev’s synthesis of biphenyl aldehyde 353105 
 
Scheme 4.5 Seitz and Quick's synthesis of biphenyl aldehyde 354106 
In order to use this methodology in our study, we first prepared 6-
bromoveratraldehyde 352 following the procedure of Chandrasekhar.107 Treatment of 
commercially available veratraldehyde 355 with Br2 in MeOH at room temperature 
gave the desired product 352 in 91% yield (Scheme 4.6). Iodination of 355 with iodine 
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and silver trifluoroacetate in CH2Cl2, following the procedure of Whiting.108 provided 
product 356 in 56% yield (Scheme 4.6). 
 
Scheme 4.6 Synthesis of 6-haloveratraldehydes 352 and 356 
 We next prepared benzonitrile derivatives from iodination of commercially 
available 4-hydroxybenzonitrile with iodine in the presence of KI and NH4OH at room 
temperature which gave 4-hydroxy-3-iodobenzonitrile 357 in 91% yield (Scheme 
4.7).109 Initially, the MOM group was chosen to protect the free hydroxy group of 357 
due to its ease of formation and cleavage. Treatment of benzonitrile 357 with MOMCl 
in the presence of (i-Pr)2EtN in CH2Cl2 at room temperature gave the MOM ether 358 
in 90% yield (Scheme 4.7).110 Treatment of commercially available 4-hydroxy-3-
bromobenzonitrile with MOMCl in the presence of NaH in THF at room temperature 
provided MOM ether 359 in 93% yield (Scheme 4.7).111 
 
Scheme 4.7 Synthesis of MOM ethers 358 and 359 
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 We first examined the Ullmann coupling reaction of 6-bromoveratraldehyde 352 
and MOM ether 358 using Cu-bronze without solvent at 220 °C for 2 h according to 
Loev’s procedure.105 1H NMR analysis of the crude reaction mixture indicated that 
veratraldehyde 355, the debromo product of 352, and the de-iodo product of 358 was 
formed (Table 4.2, Entry 1). Using Pd2(dba)3 as a catalyst according to Banwell’s 
procedure112 resulted in the isolation of unreacted starting materials (Table 4.2, Entry 2). 
Table 4.2 Attempted Ullmann coupling reaction of 6-bromoveratraldehyde 352 and 
MOM ether 358 
 
Entry Catalyst Solvent T (°C) Time Producta 
1 Cu-bronze105 - 220 2 h 355/de-iodo-358 
2 
5% Pd2(dba)3 
Cu powder112 
- 220 2 h Recovered SMs 
a The product was identified by 1H NMR analysis of the crude reaction mixture 
 Due to the formation of undesired product 355 in the above reaction, we decided 
to use the Suzuki coupling reaction to prepare the biphenyl aldehyde. We attempted to 
prepare the boronate ester component using Castle’s procedure.113 Treatment of MOM 
ethers 358 or 359 with bis(pinacolato)diboron, KOAc and Pd(OAc)2 in DMF at 90 °C 
provided only the dehalo product as observed from 1H NMR analysis of the crude 
reaction mixtures (Table 4.3). 
 
 
Chapter 4: Progress Toward the Total Synthesis of 9β-Hydroxyvertine | 132 
 
 
Table 4.3 Attempted borylation of MOM ethers 358 and 359 
 
Entry X Catalyst Solvent T (°C) Time Producta 
1 I 
3% Pd(OAc)2 
KOAc 
DMF 90 24 h de-iodo-358 
2 Br 
3% Pd(OAc)2 
KOAc 
DMF 90 18 h de-bromo-359 
a The product was identified by 1H NMR analysis of the crude reaction mixture 
We also tried to prepare the boronic acid derivative using Wenger’s method.111 
Treatment of MOM ether 358 with n-BuLi in THF at -78 °C for 2 h and then B(OMe)3 
(-78 °C to rt) follwed by acid hydrolysis, did not provide the desired product and only a 
complex reaction mixture was obtained. While in the case of the bromo MOM ether 
359, the known boronic acid 360111 was obtained in only 17 % yield (Scheme 4.8). 
 
Scheme 4.8 Preparation of boronic acid 360 
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 We next tried a Suzuki coupling reaction of aldehyde 352 and the boronic acid 
360 with Pd(PPh3)4 and K3PO4 in DME/H2O at reflux temperature for 16 h. The 
reaction provided the desired biphenyl aldehyde 361 in 40% yield (Scheme 4.9). 
 
Scheme 4.9 Suzuki coupling reaction of aldehyde 352 and boronic acid 360 
The IR spectrum of aldehyde 361 showed a characteristic absorption band for a 
cyano group at νmax 2225 cm-1 and for an aryl aldehyde carbonyl group at νmax 1672    
cm-1. The 1H NMR spectrum (Figure 4.3) of 361 showed a resonance for the aldehyde 
proton at δH 9.64 (s, 1H). The assignments made to the aromatic proton resonances 
(Figure 4.3) were based on gCOSY correlations, chemical shifts, multiplicities and 
coupling constants. The resonances for the MOM group were observed at δH 5.16 (d, J 
= 11.8 Hz, 1H), 5.15 (d, J = 11.8 Hz, 1H) and 3.37 (s, 3H). The 13C NMR spectrum 
(Figure 4.4) of 361 showed a resonance for the aldehyde carbonyl carbon at δC 190.3 
and one for the nitrile carbon at δC 118.6. The other 13C NMR resonances were assigned 
based on HSQC and HMBC experiments. LRESIMS analysis of compound 361 showed 
a sodiated molecular ion peak at m/z 350 (100%) [M + Na]+ in accordance with the 
molecular formula C18H17NO5Na which was confirmed by HRESIMS analysis 
(calculated for C18H17NO5Na [M + Na]+: 350.1004, found: 350.1017).  
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Figure 4.3 1H NMR spectrum (CDCl3, 500 MHz) of biphenyl aldehyde 361 
 
Figure 4.4 13C NMR spectrum (CDCl3, 125 MHz) of biphenyl aldehyde 361 
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 Because the MOM ether protecting group could be cleaved under the acidic 
conditions which might be used in subsequent reactions, we decided to use the more 
acid tolerant benzyl ether protecting group. Following Kohn’s procedure,114 treatment 
of benzonitrile 357 with BnBr and Na2CO3 in acetone at reflux temperature provided 
benzyl ether 362 in 94% yield (Scheme 4.10). The analogous benzylation reaction of 4-
hydroxy-3-bromobenzonitrile with BnBr and K2CO3 provided the coressponding benzyl 
ether 363 in 95% yield (Scheme 4.10).115 
 
Scheme 4.10 Synthesis of benzyl ethers 362 and 363 
We tried to couple the aryl iodide 362 with the 6-bromoverataldehyde 352 under 
Ullman reaction conditions following the literature methods105, 106, 112 but 1H NMR 
analysis of the crude reaction mixtures indicated no desired product was formed; only 
unreacted starting aryl iodide or the debromoaldehyde product 355 and the de-iodo 
product of 362 was formed, in each case. The results were summarized in Table 4.4. 
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Table 4.4 Attempted Ullmann coupling reactions of 6-bromoveratraldehyde 352 and 
benzyl ether 362 
 
Entry Catalyst Solvent T (°C) Time Producta 
1 
5% Pd2(dba)3 
Cu powder112 
- 220 2 h Recovered SM 
2 Cu-bronze105 - 220 2 h 355/de-iodo-362 
3 Cu-bronze106 naphthalene 220 2 h 355/de-iodo-362 
a The product 355 was identified by 1H NMR analysis of the crude reaction mixture 
Following Wenger’s method for the preparation of boronic acids,111 treatment of 
benzyl ether 362 with n-BuLi in THF at -78 °C for 2 h and then B(OMe)3, followed by 
acid hydrolysis, provided a complex reaction mixture (Scheme 4.11). 
 
Scheme 4.11 Attempted preparation of the corresponding boronic acid derivative 
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 We also did additional literature searches for other methods for the synthesis of 
arylboronic esters. Miyaura et. al.116 reported the borylation reaction of aryl halides with 
bis(pinacolato)diboron, KOAc and Pd(dppf)Cl2 in DMSO at 80 °C to give arylboronates 
in 23-98% yields (Scheme 4.12). Ma117 reported the CuI-catalyzed coupling reaction of 
pinacolborane with aryl iodides in THF at room temperature to provide arylboronates in 
61-80% yields (Scheme 4.13). Uchiyama et. al.118 reported the use of Et2Zn in the 
borylation reaction of aryl halides to provided arylboronates in 60-99% yields (Scheme 
4.14). 
 
Scheme 4.12 Miyaura’s116 Pd-catalyzed borylation reaction of aryl halides 
 
Scheme 4.13 Ma’s117 Cu-catalyzed borylation reaction of aryl iodides 
 
Scheme 4.14 Uchiyama’s118 Zn-catalyzed borylation reaction of aryl halides 
 The results of our attempts to prepare the corresponding arylboronate of aryl 
iodide 362 using the above described literature methods are summarized in Table 4.5. 
After work up and 1H NMR analysis of the crude reaction mixtures, only unreacted 
starting material or deiodobenzonitrile product 364 was observed, in each case. 
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Table 4.5 Attempted borylation reactions of aryl iodide 362 
 
Entry Catalyst Solvent T (°C) Time Producta 
1 
3% Pd(OAc)2  
KOAc113 
DMF 100 20 h 
 
2 
5% Pd2(dba)3, PCy3 
KOAc115 
1,4-dioxane 100 24 h 
No reaction, 
Recovered SM 
3 
3% Pd(dppf)Cl2·CH2Cl2 
KOAc116 
1,4-dioxane 95 24 h 
No reaction, 
Recovered SM 
4 10% CuI, NaH117 THF Rt 48 h 
362:364 
(4:6) 
5 10% Et2Zn, t-BuOK118 THF 75 24 h 364 
a The product was identified by 1H NMR analysis of the crude reaction mixture 
 Due to these unsuccessful results, we decided to prepare an arylboronate starting 
from 6-haloveratraldehyde. Following Castle’s procedure,113 aldehyde 356 was treated 
with 360, KOAc and a catalytic amount of Pd(OAc)2 to provide a 2.5:4.2:1 mixture of 
veratraldehyde 355, aldehyde dimer 365 and arylboronate 366, respectively as 
determined by 1H NMR analysis of the crude reaction mixture (Table 4.6, Entry 1). 
While using aldehyde 352 as the starting material provided a 3.3:1.2:1 mixture of 355, 
365 and 366 (Table 4.6, Entry 2). Treatment of aldehyde 356 with 
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bis(pinacolato)diboron, KOAc and a catalytic amount of Pd(dppf)Cl2·CH2Cl2 in 1,4-
dioxane following Miyaura’s reaction conditions116 resulted in only recovery of 
unreacted starting material (Table 4.6, Entry 3). Using aldehyde 352 under Miyaura’s 
conditions provided a 2.5:1.5:1 mixture of 355, 365 and 366 (Table 4.6, Entry 4). 
Performing the reaction in THF successfully provided the known arylboronate 366119 in 
93% yield. During the purification process by column chromatography, the product had 
to be eluted as rapidly as possible due to its sensitivity to boronate hydrolysis by SiO2 
(Table 4.6, Entry 5). 
Table 4.6 Borylation reactions of 6-haloveratraldehydes 352 and 356 
 
Entry X Catalyst Solvent T (°C) Time Product 
1 I 
3% Pd(OAc)2  
KOAc113 
DMF 80 18 h 
355:365:366 
(2.5:4.2:1)a 
2 Br 
3% Pd(OAc)2  
KOAc113 
DMF 80 24 h 
355:365:366 
(3.3:1.2:1)a 
3 I 
3% Pd(dppf)Cl2·CH2Cl2 
KOAc116 
dioxane 60 18 h Recovered 356 
4 Br 
3% Pd(dppf)Cl2·CH2Cl2 
KOAc116 
dioxane 60 18 h 
355:365:366 
(2.5:1.5:1)a 
5 Br 
3% Pd(dppf)Cl2·CH2Cl2 
KOAc116 
THF 60 18 h 366 
93 % 
a These products were identified by 1H NMR analysis of the crude reaction mixture 
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Follow Chausset-Boissarie’s reaction conditions,103 the Suzuki coupling reaction 
of aryl iodide 362 and arylboronate 366 with 10% Pd(PPh3)4 and CsF in DME at 95 °C 
was carried out for 48 h. After purification by column chromatography, the desired 
biphenyl aldehyde 367 was obtained in 24% yield (Table 4.7, Entry 1). The product 367 
was obtained at a much higher yield of 88% when 15% of Pd(PPh3)4 was employed as 
well as increasing the reaction time to 94 h (Table 4.7, Entry 2). A shorter reaction time 
(48 h) was observed when the aryl bromide 363 was used as the starting material which 
provided the product 367 in 94 % yield (Table 4.7, Entry 3). 
Table 4.7 Suzuki coupling reactions of aryl halide 362 or 363 and arylboronate 366 
 
Entry X Catalyst Solvent T (°C) Time 
Product  
Yield (%) 
1 I 
10% Pd(PPh3)4, 
CsF 
DME 95 48 h 24 
2 I 
15% Pd(PPh3)4, 
CsF 
DME 95 94 h 88 
3 Br 
15% Pd(PPh3)4, 
CsF 
DME 95 48 h 94 
 
The IR spectrum of biphenyl 367 showed a characteristic absorption band for a 
cyano group at νmax 2225 cm-1 and one for an aryl aldehyde carbonyl group at νmax 
1677cm-1. The 1H NMR spectrum (Figure 4.5) of 367 showed a resonance for the 
aldehyde proton at δH 9.66 (s, 1H). The assignments made to the aromatic proton 
resonances (Figure 4.3) were based on gCOSY correlations, chemical shifts, 
multiplicities and coupling constants. The 13C NMR spectrum (Figure 4.6) of 367 
showed a resonance for the aldehyde carbonyl carbon at δC 190.4 and one for the nitrile 
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carbon at δC 118.7. The other 13C NMR resonances were assigned based on HSQC and 
HMBC experiments. LRESIMS analysis of compound 367 showed a sodiated molecular 
ion peak at m/z 396 (100%) [M + Na]+ in accordance with the molecular formula 
C23H19NO4Na which was confirmed by HRESIMS analysis (calculated for 
C23H19NO4Na [M + Na]+: 396.1212, found: 396.1197). Compound 367 was obtained as 
colourless crystals with a melting point 132-134 °C. A single crystal X-ray diffraction 
analysis confirmed the structure of compound 367 (Figure 4.7.). 
 
Figure 4.5 1H NMR spectrum (CDCl3, 500 MHz) of biphenyl aldehyde 367 
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Figure 4.6 13C NMR spectrum (CDCl3, 125 MHz) of biphenyl aldehyde 367 
 
Figure 4.7 OPTEP X-ray crystal structure of biphenyl aldehyde 367 
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4.3 Preparation of (R)-N-tert-butanesulfinamide 370 
 Xu and Li120 reported condensation reactions of biphenyl aldehydes 368 with 
(R)-N-tert-butanesulfinamide in CH2Cl2 at room temperature using KHSO4 as an acid 
catalyst and as a desiccant. These reactions gave the corresponding N-sulfinyl imines 
369 in yields of 60-89% (Scheme 4.15). 
 
Scheme 4.15 Xu’s120 preparation of (R)-N-tert-butanesulfinamide 
 Following this procedure, we obtained the desired N-sulfinyl imine 370 in 89% 
yield (Table 4.8, Entry 1). A lower yield (73%) of 367 was obtained using Cid’s 
procedure88 which used pyrrolidine as an organocatalyst (Table 4.8, Entry 2).  
Table 4.8 Synthesis of (R)-N-sulfinyl imine 370 
 
Entry Reagent Solvent T (°C) Time 
Product  
Yield (%) 
1 KHSO4 CH2Cl2 rt 24 h 89 
2 10% pyrrolidine CH2Cl2 60 24 h 73 
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The IR spectrum of 370 showed characteristic absorption bands for a sulfinyl 
and an imine group at νmax 1075 and 1581 cm-1, respectively and the absence of an 
aldehyde carbonyl stretch. The 1H NMR spectrum (Figure 4.8) of 370 revealed 
resonances for the presence of two biphenyl axis rotamers in a 52:48 ratio. Two 
resonances for the tert-butyl group was observed at δH 1.21 (s, 4.68H) (major) and 1.11 
(s, 4.32H) (minor). Likewise, two sets of methoxy and benzyloxy group resonances 
were also observed. The 13C NMR spectrum (Figure 4.9) of 370 showed resonances for 
the imine carbon at δC 161.0 and the nitrile carbon at δC 118.9. The resonances for the 
tert-butyl group were observed at δC 57.8 (major Cq), 57.5 (minor Cq), 22.7 (major 
(CH3)3) and 22.5 (minor (CH3)3). LRESIMS analysis of compound 370 showed a 
sodiated molecular ion peak at m/z 499 (100%) [M + Na]+ in accordance with the 
molecular formula C27H28N2O4NaS which was confirmed by HRESIMS analysis 
(calculated for C27H28N2O4NaS [M + Na]+: 499.1667, found: 499.1674.). 
 
Figure 4.8 1H NMR spectrum (CDCl3, 500 MHz) of (R)-N-sulfinyl imine 370 
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Figure 4.9 13C NMR spectrum (CDCl3, 125 MHz) of (R)-N-sulfinyl imine 370 
4.4 The allylation of (R)-N-tert-butanesulfinamide 370 
 We next examined the allylation reaction of (R)-N-sulfinyl imine 370 using 
allylmagnesium bromide in THF at -78 °C for 4 h following a literature procedure.121 
After work up and purification by column chromatography, the desired product 371 was 
obtained in 10% yield as a single diastereomer (Scheme 4.16). The stereochemistry of 
the product was assumed to have the (S)-configuration based on the literature; this 
configurational assignment, based on a single crystal X-ray analysis, will be further 
discussed later. 
 
Scheme 4.16 Allylation reaction of 370 using allylmagnesium bromide 
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Due to the unsatisfactory yield of the product 371 when using a Grignard 
reagent, we performed further literature reviews before further examining the allylation 
reaction of imine 370. Sun et. al.122 reported that the allylation reaction of N-tert-
butanesulfinyl imine 372 with allyl bromide and Zn powder in THF at room 
temperature for 0.5 h provided the homoallylic N-tert-butanesulfinyl amine 373 in 93% 
yield, with good diastereoselectivity (89:11 dr) (Scheme 4.17). Lin et. al.123 reported 
that the Zn-mediated allylation reactions of N-sulfinyl aldimines 374 with allyl bromide, 
Zn powder and In(OTf)3 as a Lewis acid gave the corresponding products 375 in yields 
ranging from 81-99% and with high diastereoselectivities (Scheme 4.18). They also 
developed an In-mediated allylation of N-sulfinyl aldimines 374 in saturated aqueous 
NaBr to provide the products 375 in good to excellent yields with a significant 
improvement in diastereoselectivities (Scheme 4.19).124 Kuznetsov et. al.125 reported the 
Zn-mediated allylation of the substituted pyrazol-4-yl derived (R)-N-tert-butanesulfinyl 
ketimine 376 using Zn(OTf)2 as a Lewis acid to provide the corresponding product 377 
in 95% yield with excellent diastereoselectivity (98.5:1.5 dr) (Scheme 4.20). 
 
Scheme 4.17 Allylation of N-tert-butanesulfinyl imine 372122 
 
Scheme 4.18 Zn-mediated allylations of N-sulfinyl aldimines 373 using In(OTf)3123 
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Scheme 4.19 In-mediated allylations of N-sulfinyl aldimines 373 in aqueous NaBr124 
 
Scheme 4.20 Zn-mediated allylation of ketimine 376 using Zn(OTf)2125 
 The allylation of imine 370 with allyl bromide and Zn powder in THF was 
initially performed at room temperature, but no progress was observed after 2 h by TLC 
analysis. The reaction was then warm to 50 °C and stirred for another 16 h. 1H NMR 
analysis of the crude reaction mixture showed only unreacted starting material 370 
(Table 4.9, Entry 1). Using In powder in sat. aq. NaBr according to Lin’s procedure124 
resulted in the desired homoallylic amine 371 in 10% yield but increasing the 
temperature of the reaction mixture to 50 °C gave the product 371 in a lower yield (5%) 
(Table 4.9, Entries 2 and 3). Changing the aqueous media to sat. aq. NaI failed to give 
the desired product, only unreacted starting material was recovered (Table 4.9, Entry 4). 
Following Lin’s other procedure,123 the product 371 was obtained in only 7% yield upon 
treatment of 370 with allyl bromide, Zn powder and In(OTf)3 in THF at 60 °C (Table 
4.9, Entry 5). The use of Zn(OTf)2 as a Lewis acid catalyst according to Kuznetsov’s 
procedure125 gave the desired product 371 in 87% yield (Table 4.9, Entry 6). An attempt 
involving the transfer of preformed allylzinc reagent to the flask containing the imine 
370 did shorten the reaction time to 20 min but the yield of 371 was lower (74%) (Table 
4.9, Entry 7). Preformed allylzinc reagent in conjunction with Zn(OTf)2 provided the 
product 371 in 82% yield (Table 4.9, Entry 8). 
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Table 4.9 Allylation reactions of (R)-N-sulfinyl imine 370 
 
Entry Reagent Solvent T (°C) Time 
Product  
Yield (%) 
1 Zn122 THF rt to 50 18 h Recovered SM 
2 In124 sat. aq. NaBr rt 20 h 10 
3 In124 sat. aq. NaBr 50 20 h 5 
4 In124 sat. aq. NaI Rt 20 h Recovered SM 
5 Zn, In(OTf)3123 THF 60 20 h 7 
6 Zn, Zn(OTf)2 THF rt 8 h 87 
7 
pre-formed  
allyl Zn 
THF rt 20 min 74 
8 Zn, Zn(OTf)2 THF rt 20 min 82 
 
The IR spectrum of 371 showed characteristic absorption bands for a secondary 
amine and a sulfinyl and group at νmax 3270 and 1067 cm-1, respectively and the absence 
of an imine stretching band. The 1H NMR spectrum (Figure 4.10) of 371 revealed 
resonances the presence of two biphenyl axis rotamers in a 62:38 ratio. The 2.7H 
multiplet resonance at δH 5.15-4.96 was assigned to the terminal alkene protons (H-4′′) 
and two diastereotopic benzylic protons (PhCH2O (minor)). The 1H NMR multiplet 
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resonance at δH 5.61-5.45 was assigned to the alkene proton H-3′′. The two 
diastereotopic allylic protons (H-2′′) were observed as a 2H multiplet resonance at δH 
2.49-2.20. The α-amino methine proton (H-1′′) resonances was observed at δH 4.23 (dd, 
J = 8.6, 5.3 Hz, 0.62H) (major) and δH 4.21-4.17 (m, 0.38H (minor)). The resonances 
for the tert-butyl group was observed at δH 1.17 (s, 3.42H) (minor) and 1.07 (s, 5.58H) 
(major). The 13C NMR spectrum (Figure 4.11) of 371 showed resonances for the nitrile 
carbon at δC 119.2 (major) and 119.0 (minor), the terminal alkene carbon (C-4′′) at δC 
119.5 (major) and 118.8 (minor), and the alkene methine carbon (C-3′′) at δC 134.7 
(minor) and 134.2 (major). LRESIMS analysis of compound 371 showed a sodiated 
molecular ion peak at m/z 541 (100%) [M + Na]+ in accordance with the molecular 
formula C30H34N2O4NaS which was confirmed by HRESIMS analysis (calculated for 
C30H34N2O4NaS [M + Na]+: 541.21374, found: 341.2135). Compound 371 was obtained 
as colourless crystals with a melting point 156-158 °C. A single crystal X-ray 
diffraction analysis confirmed the structure (and (1′′S)-configuration) of compound 371 
(Figure 4.12.), which crystallized as a single atropisomer. A 1H NMR spectrum of this 
crystal gave the same spectrum as shown in Figure 4.10. 
 
Figure 4.10 1H NMR spectrum (CDCl3, 500 MHz) of 371 
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Figure 4.11 13C NMR spectrum (CDCl3, 125 MHz) of 371  
 
Figure 4.11 13C NMR spectrum (CDCl3, 125 MHz) of 371 (enlarged) 
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Figure 4.12 OPTEP X-ray crystal structure of homoallylic N-sulfinyl amine 371 
 Our proposed transition state structures for the formation of compound 371 are 
shown in Scheme 4.21. The six-membered ring chair-like transition state TS-1 shows 
that the allylzinc is coordinated to the sulfinyl oxygen atom which makes the t-Bu group 
occupy the Re-face of the imine. Direct allyl attack to the Si-face is more favourable 
leading to the (S)-amine.123 When a Lewis acid was employed, an acyclic transition 
state TS-2 has been proposed. The chelation of the Lewis acid (Zn(OTf)2) with both 
nitrogen and sulfinyl oxygen atoms would direct allyl attack from the less sterically 
demanding Si-face of the imine to also give the (S)-amine. 123 
 
Scheme 4.21 Proposed transition state structures for the formation of the amine 371 
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4.5 The hydrolysis of homoallylic N-butanesulfinyl amine 371 
 Acid hydrolysis of amine 371 using TMSCl in MeOH at room temperature for    
1 h, followed by a basic work up with saturated aqueous NaHCO3, afforded the primary 
amine 378 in 95% yield (Scheme 4.22). 
 
Scheme 4.22 Hydrolysis of homoallylic N-butanesulfinyl amine 371 
The IR spectrum of 378 showed characteristic absorption bands for a primary 
amine group at νmax 3420 and 3365 cm-1 and the absence of a sulfinyl stretching band. 
The 1H NMR spectrum of 378 indicated the absence of resonances for the N-tert-
butanesulfinyl group and that the α-amino methine proton (H-1′′) now resonated further 
upfield at δH 3.74 (m, 1H). LRESIMS analysis of compound 378 showed a protonated 
molecular ion peak at m/z 415 (100%) [M + H]+ in accordance with the molecular 
formula C26H27N2O3 which was confirmed by HRESIMS analysis (calculated for 
C26H27N2O3 [M + H]+: 415.2012, found: 415.2019). 
4.6 The synthesis of aldehyde dimer 381 
 The aldehyde dimer 381 was prepared from commercially available pent-4-en-1-
ol in three steps. PMB ether 379 was prepared in 96% yield from pent-4-en-1-ol by 
treatment with PMBCl and DIPEA at 150 °C for 2 h (Scheme 4.23).126 The cross-
metathesis reaction of 379 with phenyl vinyl sulfone and Grubbs’ second generation 
catalyst in CH2Cl2 at reflux for 18 h provided the (E)-vinyl sulfone 380 (1H NMR: δH 
6.30 (d, J1,2 = 15.0 Hz, 1H, H-1) ) in 76% yield (Scheme 4.23).127 Sharpless asymmetric 
dihydroxylation (ADH) of 380 with AD-mix-β and MeSO2NH2 in t-BuOH/H2O (1:1) 
according to Evan’s procedure104 provided aldehyde dimer 381 which was used without 
further purification. MS analysis of the crude reaction mixture indicated 100% 
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consumption of 380 (Scheme 4.20) and 1H NMR analysis showed resonances consistent 
with structure 381 as a mixture diastereomers. LRESIMS analysis of compound 381 
showed a protonated molecular ion peak at m/z 239 (100%) [M+H]+ in accordance with 
the molecular formula C13H19O4 (monomer) which was confirmed by HRESIMS 
analysis (calculated for C13H19O4 [M + H]+: 239.1283, found: 239.1286). 
 
Scheme 4.23 Synthesis of aldehyde dimer 375 
4.7 The synthesis of anti-1,2-amino alcohols 
The PBM reaction of amine 378, aldehyde dimer 381 and β-styrylboronic acid 
was performed in EtOH at room temperature for 72 h. After work up and purification, 
two diastereomers were isolated which were the desired anti-1,2-amino alcohol 382 
(37% yield) and the undesired syn-1,2-amino alcohol 383 (35% yield) (Scheme 4.24). 
This was a highly unexpected result since the PBM reaction is normally highly anti-
diastereoselective. Our initial thoughts were that the ADH reaction of 380 had produced 
381 as a racemic mixture. However this suggestion proved to be incorrect (see later). 
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Scheme 4.24 PBM reaction of amine 378, aldehyde dimer 381 and β-styrylboronic acid 
The IR spectrum of amino alcohol 382 showed characteristic absorption bands 
for a hydroxy and a cyano group at νmax 3427 and 2224 cm-1, respectively. An analysis 
of the 1H NMR spectrum (Figure 4.13) of 382 revealed resonances for the presence of 
two biphenyl axis rotamers in a 60:40 ratio. The resonances for the styryl protons were 
observed at δH 6.26 (d, J = 16.0 Hz, 0.4H, H-1′′′) (minor), 6.03 (d, J = 16.0 Hz, 0.6H, H-
1′′′) (major), 5.93-5.81 (m, 1H, H-2′′′) (Figure 4.13). Resonances for the α-amino 
methine proton (H-3′′′) were observed at δH 3.01 (dd, J = 8.8, 3.0 Hz, 0.4H) (minor) and 
2.96 (dd, J = 9.4, 3.1 Hz, 0.6H) (major). The 13C NMR spectrum (Figure 4.14) of 382 
showed resonances for the nitrile carbon at δC 119.0 (major) and 118.9 (minor), the 
styryl carbons at δC 132.7 (C-1′′′, major), 133.0 (C-1′′′, minor), 127.7 (C-2′′′, major) and 
127.69 (C-2′′′, minor), the α-amino methine carbon (C-3′′′) at δC 63.2 (major) and 62.0 
(minor), and the α-hydroxy methine carbon (C-4′′′) at δC 71.7 (minor) and 71.1 (major). 
LRESIMS analysis of compound 382 showed a protonated molecular ion peak at m/z 
739 (100%) [M + H]+ in accordance with the molecular formula C47H51N2O6 which was 
confirmed by HRESIMS analysis (calculated for C47H51N2O6 [M + H]+: 739.3747; 
found: 739.3749). 
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Figure 4.13 1H NMR spectrum (CDCl3, 500 MHz) of 1,2-amino alcohol 382 
 
Figure 4.14 13C NMR spectrum (CDCl3, 125 MHz) of 1,2-amino alcohol 382 
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Figure 4.14 13C NMR spectrum (CDCl3, 125 MHz) of 1,2-amino alcohol 382 
(expanded) 
The IR spectrum of 383 showed characteristic absorption bands for hydroxy and 
cyano groups at νmax 3409 and 2225 cm-1, respectively. The 1H NMR spectrum (Figure 
4.15) of 383 revealed resonances for the presence of two biphenyl axis rotamers in a 
60:40 ratio. Resonances for the styryl protons were observed at δH 5.88 (d, J = 16.0 Hz, 
0.4H, H-1′′′) (minor), 5.84 (d, J = 16.0 Hz, 0.6H, H-1′′′) (major), 5.67 (dd, J = 16.0, 8.7 
Hz, 0.6H, H-2′′′) (major) and 5.64 – 5.55 (m, 0.4H, H-2′′′) (minor). The α-amino 
methine proton (H-3′′′) resonances were observed at δH 2.60 (t, J = 8.0 Hz, 0.4H) 
(minor) and 2.51 (t, J = 8.6 Hz, 0.6H). The 13C NMR spectrum (Figure 4.16) of 383 
showed resonances for, the nitrile carbon at δC 119.0; the styryl carbons at δC 132.7 (C-
1′′′, major), 131.6 (C-1′′′, minor), 129.4 (C-2′′′, major) and 128.57 (C-2′′′, minor), the α-
amino methine carbon (C-3′′′) at δC 63.3 (major) and 62.4 (minor), and the α-hydroxy 
methine carbon (C-4′′′) at δC 73.2 (minor) and 73.15 (major). LRESIMS analysis of 
compound 383 showed a protonated molecular ion peak at m/z 739 (100%) [M + H]+ in 
accordance with the molecular formula C47H51N2O6 which was confirmed by 
HRESIMS analysis (calculated for C47H51N2O6 [M + H]+: 739.3747; found: 739.3741). 
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Figure 4.15 1H NMR spectrum (CDCl3, 500 MHz) of 1,2-amino alcohol 383 
 
Figure 4.16 13C NMR spectrum (CDCl3, 125 MHz) of 1,2-amino alcohol 383 
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Figure 4.16 13C NMR spectrum (CDCl3, 125 MHz) of 383 (expanded) 
To confirm the stereochemistries of the products 382 and 383, both 
diastereomers were treated with triphosgene to give their respective oxazolidinone 
derivatives 384 and 385 in yields of 40% and 33%, respectively (Scheme 4.25). The IR 
spectra of these products showed a characteristic absorption band for a carbonyl group 
at νmax 1740 and 1738 cm-1, respectively and the absence of N-H and O-H stretching 
bands. 
 
Scheme 4.25 Synthesis of oxazolidinone 384 and 385 
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The NOESY spectrum (Figure 4.17) of 384 showed a correlation between the 
resonances for H-4′′′ and H-5′′′ which indicated the relative syn stereochemical 
relationship of these protons in the oxazolidinone 384. Their vicinal coupling constant 
(J4′′′,5′′′) was 8.9 Hz which was consistent with the 4,5-cis relative configuration of the 
oxazolidinone ring as reported by Au,25 thus confirming the anti-relative configuration 
of 382. 
 
 
Figure 4.17 2D NOESY spectrum (CDCl3, 500 MHz) of 384 
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In contrast, the NOESY spectrum (Figure 4.18) of 385 showed no correlation 
between the resonances for H-4′′′ and H-5′′′ which indicated that these protons were 
located on opposite faces of the oxazolidinone ring indicating their trans-relative 
configuration, thus confirming the syn-relative configuration of 383. Their vicinal 
coupling constant (J4′′′,5′′′) was 8.2 Hz, which was similar to that found in 384, indicating 
that J4′′′,5′′′ is not indicative of oxazolidinone syn or anti 4,5-configuration. 
 
 
Figure 4.18 2D NOESY spectrum (CDCl3, 500 MHz) of 385 
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The unexpected formation of two diastereomers in the PBM reaction may be due 
to the bulky and atropisometric biphenyl substituent on the amine component which 
could affect the diastereoselectivity of this reaction as attack to either face of the imine 
may be equally blocked by this large group.  
 To further confirm the identity of compound 382 and 383, we investigated the 
PBM reaction of 378 with the enantiomer of α-hydroxy aldehyde 381. Aldehyde dimer 
386 was prepared by an ADH of vinyl sulfone 374 with AD-mix-α. The crude product 
was directly treated with amine 378 and β-styrylboronic acid under the PBM reaction 
conditions to give the anti-1,2-amino alcohol 387 in 68% yield as a single diastereomer 
(Scheme 4.26). The 1H NMR spectrum of 387 showed clear differences in chemical 
shifts and splitting patterns when compared to the 1H NMR spectra of 382 and 383.  
 
Scheme 4.26 PBM reaction of amine 378, aldehyde dimer 386 and β-styrylboronic acid 
The relative anti configuration of the product 387 was determined by formation 
of the cis-oxazolidinone 388 in 37% yield (Scheme 4.27). The 1H NMR spectrum of 
this compound differed to that of 384 and 385. The 1D NOESY spectra of 388 showed a 
NOE correlation between H-4′′′ and H-5′′′ which indicated the relative syn 
stereochemical relationship of these protons in the oxazolidinone 388. This experiment 
helped confirm our structural assignments to 384 and 385 and ruled out the possibility 
that 381 was racemic. 
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Scheme 4.27 Synthesis of oxazolidinone 388 
Our proposed mechanisms for the formation of the products 382, 383 and 387 
are shown in Scheme 4.28. When R1 is large then we would expect to observe poor 
diastereoselectivity. That is when R1 is biphenyl and the (R)-aldehyde 308 is used. In 
this case, the R3 group (β-styryl) is delivered syn to the bulky R1 group, in the expected 
reactive conformation A in which 1,3-allylic strain is minimized (Scheme 4.28). Thus 
reaction via the alternative conformation B is equally likely leading to a mixture of 
diastereomeric products. When the (S)-aldehyde 386 is use then high anti-
diastereoselectivity was observed. In this case the R3 group is delivered anti to the bulky 
R1 group via the expected reactive conformation C to give exclusively anti-387. 
 
Scheme 4.28 Proposed mechanisms for the formation of products 382, 383 and 387 
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4.8 An alternative synthetic pathway, via the anti-1,2-amino alcohol 392 
Due to a mixture of diastereomers being formed in the PBM reaction of 378 and 
381, we examined a second alternative synthetic pathway in which a less bulky amine 
component was used (Scheme 4.29). Treatment of 6-bromoveratraldehyde 352 with N-
tert-butanesufinamide and KHSO4 in CH2Cl2 at room temperature for 24 h gave the 
corresponding imine 389 in 82% yield. In this case the allylation of the sterically less 
hindered  389 with allylmagnesium bromide in THF at -78 °C was successful in the 
absence of a Lewis acid and provided the homoallylic amine 390 in 82% yield. 
Subsequent hydrolysis of the N-sulfinyl group with TMSCl in MeOH gave the desired 
amine 391 in 86% yield. Treatment of aldehyde dimer 381 with amine 391 and β-
styrylboronic acid in EtOH at room temperature gave the anti-1,2-amino alcohol 392 in 
44% yield as a single diastereomer. Unfortunately, the attempted deprotection of the 
PMB group of 392 with DDQ in CH2Cl2/H2O (8:1)128 gave a complex mixture of 
products as was indicated from 1H NMR analysis of the crude reaction mixture. We 
speculated that the dimethoxybromo-substituted aromatic ring may have undergone 
oxidation to a reactive para-quinone intermediated resulting in undesired products 
being formed. 
 
Scheme 4.29 Synthesis of anti-1,2-amino alcohol 392 and our attempted removal of    
the PMB protecting group 
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4.9 The PMB deprotection of PMB ether 382 
Due to this unsuccessful result from our second pathway, we went back to the 
original pathway. The deprotection of the PMB group of the desired compound 382 
with ceric ammonium nitrate (CAN)129 in MeCN/H2O (4:1) at 0 °C for 10 min gave a 
complex mixture of products from 1H NMR analysis of the crude reaction mixture 
(Table 4.10, Entry 1). Treatment of the PMB ether 382 with DDQ130 in CH2Cl2/H2O 
(20:1) at room temperature for 24 h provided the corresponding diol 393 in 37% yield 
(Table 4.10, Entry 2). The yield of 393 slightly increased to 47% when the reaction time 
was reduced to 6 h (Table 4.10, Entry 3). 
Table 4.10 PMB deprotection reactions of PMB ether 382 
 
Entry Reagent Solvent T (°C) Time 
Product  
Yield (%) 
1 CAN129 
MeCN:H2O 
(4:1) 
0 10 min 
Complex 
mixture 
2 DDQ130 
CH2Cl2:H2O 
(20:1) 
rt 24 h 37 
3 DDQ130 
CH2Cl2:H2O 
(20:1) 
rt 6 h 46 
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4.10 The mesylation-cyclization of diol 393 
 The mesylation-cyclization of diol 393 using methanesulfonyl chloride (1.0 
equiv.) and triethylamine (1.0 equiv.) was performed in CH2Cl2 at 0 °C for 5 min then 
the O-mesylated intermediate was heated at 45 °C to give the desired product 394 in 
54% yield and recovered 393 in 31% yield (Scheme 4.30). 
 
Scheme 4.30 Mesylation-cyclization of diol 393 
4.11 The ring-closing metathesis reaction of 394 
 Yu et. al.131 reported the successful ring-closing metathesis (RCM) reactions of 
chiral diallylamines using Grubbs’ second generation catalyst and Ti(i-PrO)4 as a Lewis 
acid, which helped prevent deactivation of the Ru catalyst by coordination to the          
N-atom, to provide pyrrolidine derivatives in 79-93% yields (Scheme 4.31). 
Jiangseubchatveera et. al.36 reported that the RCM reaction of the diene 395 using 18 
mol% Grubbs’ second generation catalyst, in the presence of Ti(i-PrO)4 (0.2 equiv.) 
gave the indolizidine 396 in 76% yield (Scheme 4.32). 
 
Scheme 4.31 Ti(i-PrO)4-assisted RCM reaction of chiral diallylamines131 
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Scheme 4.32 Ti(i-PrO)4-assisted RCM reaction of diene 39536 
 We attempted the RCM reaction of compound 394 with Grubbs’ second 
generation catalyst (18 mol%) and Ti(i-PrO)4 (0.2 equiv.) but no desired product was 
obtained. When we increased the amount of Ti(i-PrO)4 to 1.0 equiv., the reaction 
provided the desired product 397 in 40% yield (Scheme 4.33) 
 
Scheme 4.33 Ti(i-PrO)4-assisted RCM reaction of compound 394 
The IR spectrum of 397 showed a characteristic absorption band for a hydroxy 
group at νmax 3351 cm-1 and one for a cyano group at νmax 2224 cm-1. The 1H NMR 
spectrum (Figure 4.19) of 397 revealed resonances that indicated the presence of two 
biphenyl axis rotamers in a 75:25 ratio. The resonances for the alkene protons were 
observed at δH 6.20 – 6.11 (m, 1H, H-9′′), 6.02 (d, J = 9.1 Hz, 0.25H, H-8′′) (minor) and 
5.92 (d, J = 10.1 Hz, 0.75H, H-8′′) (major) (Figure 4.19). The 2H multiplet resonance at 
δH 2.76 – 2.58 was assigned to the methylene protons H-7′′A (major) and H-7′′A (minor) 
and the α-amino methine proton (H-9a′′). The resonance for α-hydroxy methine proton 
(H-1′′) was observed at 3.29 (br s, 1H). The 13C NMR spectrum (Figure 4.20) of 397 
showed resonances for, the nitrile carbon at δC 119.0, the alkene carbons at δC 126.4 (C-
9′′), 126.2 (C-8′′, minor), 125.8 (C-8′′, major), the α-amino methine carbon (C-9a′′) at δC 
61.2, and the α-hydroxy methine carbon (C-1′′) at δC 71.2 (minor) and 71.7 (major). 
LRESIMS analysis of compound 397 showed a sodiated molecular ion peak at m/z 497 
(100%) [M + H]+ in accordance with the molecular formula C31H33N2O4 which was 
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confirmed by HRESIMS analysis (calculated for C31H33N2O4 [M + H]+: 497.2440; 
found: 497.2454). 
 
Figure 4.19 1H NMR spectrum (CDCl3, 500 MHz) of 397 
 
Figure 4.20 13C NMR spectrum (CDCl3, 125 MHz) of 397 
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 Due to the low yield of quinolizidine 397 and the incomplete mesylation-
cyclization of diol 393, we decided to modify the original route from alcohol 382. The 
secondary hydroxy group in compound 382 was protected as a TBS ether which 
allowed us to increase the amount of Et3N and MsCl, and hence the yield, in the 
cyclization reaction to complete the reaction.  
 Treatment of 382 with TBSOTf and 2,6-lutidine132 in CH2Cl2 at 0 °C for 6 h 
gave only 34 % yield of the desired TBS ether 398 (Table 4.11, Entry 1). Performing the 
reaction using TBSCl, DMAP (10 mol%) and Et3N133 in DMF at room temperature for 
48 h provided the product 398 in 42% yield (Table 4.11, Entry 2). Treatment of 382 
with TBSCl and imidazole134 in CH2Cl2 at 50 °C for 24 h increased the yield of 398 to 
65% (Table 4.11, Entry 3). 
Table 4.11 TBS protection of 1,2-amino alcohol 382 
 
Entry Reagent Base Solvent T (°C) Time 
Product  
Yield (%) 
1 TBSOTf132 2,6-lutidine CH2Cl2 0 6 h 34 
2 TBSCl133 DMAP/Et3N DMF rt 48 h 42 
3 TBSCl134 imidazole CH2Cl2 50 24 h 65 
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The attempted PMB deprotection of 398 with DDQ in CH2Cl2/H2O (20:1) gave 
a complex reaction mixture from 1H NMR analysis of the crude reaction mixture. While 
the use of CAN in MeCN/H2O (4:1) unexpectedly provided the amine 378 in 98% yield 
(Scheme 4.34), resulting from oxidative cleavage of the styrenyl side chain. 
 
Scheme 4.34 The attempted PMB deprotection of 398 
4.12 The preparation of aldehyde dimer 401 
Due to the failure of deprotection of the PMB protecting group from the PMB 
ether 398, we decided to modify the original route from the preparation of the α-
hydroxy aldehyde by protecting the primary hydroxy group as its TBS ether. 
 Treatment of commercially available pent-4-en-1-ol with TBSCl and imidazole 
at room temperature for 12 h gave the desired TBS ether 399 in 98% yield (Scheme 
4.32).135 A cross-metathesis reaction of 399 with phenyl vinyl sulfone and Grubbs’ 
second generation catalyst in CH2Cl2 at reflux for 18 h provided the (E)-vinyl sulfone 
400 in 63% yield (Scheme 4.32).127 The ADH of 400 with AD-mix-β and MeSO2NH2 in 
t-BuOH/H2O (1:1) provided aldehyde dimer 401 which was directly used in the 
subsequent PBM reaction without further purification (Scheme 4.35).104 In contrast to 
381, LRESIMS analysis of compound 401 showed a sodiated molecular ion peak for the 
dimeric form at m/z 487 (100%) [M + Na]+ in accordance with the molecular formula 
C22H48O6Si2Na which was confirmed by HRESIMS analysis (calculated for 
C22H48O6Si2Na [M + Na]+: 487.2887; found: 487.2906). 
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Scheme 4.35 Synthesis of aldehyde dimer 401 
4.13 The PBM reaction of aldehyde dimer 401 
The PBM reaction of amine 378, aldehyde dimer 401 and β-styrylboronic acid 
was performed in EtOH at room temperature for 72 h. After work up and purification, 
two diastereomers were isolated which were the desired anti-1,2-amino alcohol 402 
(43% yield) and the undesired syn-1,2-amino alcohol 403 (35% yield) (Scheme 4.36). 
The IR, 1H NMR and 13C NMR spectra of the alcohol products 402 and 403 were 
similar to those of compound 382 and 383, respectively, apart from the expected 
variations due to the different protecting group. The molecular formula of 402 and 403 
was confirmed by the HRESIMS analysis (calculated for C45H57N2O5Si [M + H]+: 
733.4037; found: 733.4058 and 733.4042, respectively). 
 
Scheme 4.36 PBM reaction of amine 378, aldehyde dimer 401 and β-styrylboronic acid 
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4.14 The selective deprotection of the primary TBS ether 
 The cyclization of 402 to its piperidine derivative required us to protect the 
secondary hydroxy group and then selectively deprotect the primary hydroxy group. 
To this end we next prepared the bis-silyl ethers of alcohols 402 and 403 by 
treatment with TBSCl and imidazole in CH2Cl2 at 60°C for 18 h. This provided the 
desired products 404 and 405 in 88% and 85% yield, respectively (Scheme 4.37). The 
IR spectra of 404 and 405 showed the absence of an O-H stretch. The molecular 
formula of 404 and 405 was confirmed by the HRESIMS analysis (calculated for 
C51H71N2O5Si2 [M + H]+: 847.4902; found: 847.4904 and 847.4935, respectively). 
 
Scheme 4.37 TBS protection of alcohols 402 and 403 
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Evans et. al.136 reported the selective deprotection of a primary TBS ether in the 
presence of three secondary TBS ethers with HF·pyridine in THF to provide the 
corresponding primary alcohol product in 76% yield (Scheme 4.38). 
 
Scheme 4.38 Evans’ selective deprotection of a primary TBS ether 
 We decided to use the undesired diastereoisomer 405 for optimization of the 
subsequent reactions due to the limited amount of the desired starting material. 
Following Evans’ procedure,136 treatment of the TBS ether 405 with HF·pyridine in 
THF at room temperature for 8 h gave the corresponding alcohol product 406 in 41% 
yield along with the diol 407 in 26% yield (Table 4.12, Entry 1). Increasing the molar 
equivalents of HF∙pyridine and performing the reaction at 0 °C improved the yield of 
406 with less double-deprotection to diol 407 (Table 4.12, Entries 2-4). The highest 
yield (77%) of 406 obtained when using 15.0 equiv. of HF∙pyridine at 0 °C (Table 4.12, 
Entry 4). 
We then applied the optimized reaction conditions to the desired compound 404. 
Treatment of 404 with 15.0 equiv. of HF∙Py in THF at 0 °C for 2 h gave the 
corresponding alcohol 408 in 79% yield along with the diol 393 in 12% yield (Scheme 
4.39). 
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Table 4.12 The selective deprotection of primary TBS ether 405 
 
Entry Equiv. of HF∙Py T (°C) Time 
Yield (%) 
406 393 
1 5 rt 8 h 41 26 
2 6 0 6 h 51 22 
3 7 0 8 h 66 16 
4 15 0 6 h 77 10 
 
 
Scheme 4.39 The selective deprotection of primary TBS ether 404 
The IR spectra of 406 and 408 showed a characteristic absorption band for a 
hydroxy group at νmax 3519 cm-1, for each compound. The molecular formula of 406 
and 408 was confirmed by HRESIMS analysis (calculated for C45H57N2O5Si [M + H]+: 
733.4037; found: 733.4037 and 733.4057, respectively). 
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4.15 The mesylation-cyclization of alcohol 406 
Compound 406 was treated with 1.1 equiv. of Et3N and MsCl in CH2Cl2 at 0 °C 
for 5 min then the O-mesylated intermediate was treated with another 1.1 equiv. of Et3N 
and the reaction mixture was heated to 50 °C for 16 h to provide the piperidine product 
409 in 56% yield along with recovered 406 in 30% yield (Table 4.13, Entry 1). 
Increasing the molar equivalents of Et3N (2.0 equiv.) and MsCl (1.5 equiv.) slightly 
improved the yield of 409 (68%) along with recovered 406 in 16% yield (Table 4.13, 
Entry 2). While performing the reaction with 2.0 equiv. of Et3N and 1.7 equiv. of MsCl 
gave the desired piperidine 409 in 86% yield as the sole product (Table 4.13, Entry 3). 
Table 4.13 The mesylation-cyclization of alcohol 406 
 
Entry 
Equiv. of Et3N 
(Step 1) 
Equiv. of 
MsCl 
Equiv. of Et3N 
(Step 2) 
Yield (%) 
409 406 
1 1.1 1.1 1.1 56 30 
2 2 1.5 2 68 16 
3 2 1.7 2 86 - 
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We then applied these optimized reaction conditions to the desired compound 
408. Treatment of 408 with 2.0 equiv. of Et3N and 1.7 equiv. of MsCl gave the 
corresponding piperidine 410 in 88% yield (Scheme 4.40). The IR spectra of 409 and 
410 showed the absence of a hydroxy stretching band. The molecular formula of 409 
and 410 was confirmed by the HRESIMS analysis (calculated for C45H55N2O4Si [M + 
H]+: 715.3931; found: 715.3940 and 715.3958, respectively). 
 
Scheme 4.40 The mesylation-cyclization of alcohol 408 
4.16 The ring-closing metathesis reaction of diene 409 
Following the literature method,36 the RCM of 409 using Grubbs’ second 
generation catalyst and Ti(i-PrO)4 as a Lewis acid in CH2Cl2 at 50 °C provided the 
desired quinolizidine 411 only in poor yield (Table 4.14, Entries 1-3). While, changing 
a solvent to DCE in the absence of Ti(i-PrO)4 at 80 °C significantly improved the yield 
of 411 to 67% (Table 4.14, Entry 4). 
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Table 4.14 The ring-closing metathesis reaction of diene 409 
 
Entry 
Equiv. of  
Ti(i-PrO)4 
Mol% of 
Grubbs’II cat. 
Solvent T (°C) Time Yield (%) 
1 0.2 18 CH2Cl2 50 6 h 26 
2 0.4 18 CH2Cl2 50 2 h 33 
3 1.1 18 CH2Cl2 50 3 h 26 
4 - 15 DCE 80 8 h 67 
 
We then applied these optimized RCM reaction conditions to the desired 
compound 410 by treatment with 10 mol% of Grubbs’ second generation catalyst. This 
resulted in the corresponding piperidine 412 in 70% yield (Scheme 4.41). The IR 
spectra of 411 and 412 showed the absence of a hydroxy stretching band. The 2D 
NOESY spectrum of 411 showed a correlation between the resonance for H-1′′ and H-
9a′′ which confirmed the relative syn stereochemical relationship of these protons in the 
quinolizidine ring. While the 2D NOESY spectrum of 412 showed no correlation 
between the resonance for H-1′′ and H-9a′′, consistent with their anti-relative 
configuration. The molecular formula of 411 and 412 was confirmed by the HRESIMS 
analysis (calculated for C37H47N2O4Si [M + H]+: 611.3305; found: 611.3311 and 
611.3324, respectively). 
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Scheme 4.41 The ring-closing metathesis reaction of diene 410 
4.17 The nitrile reduction reaction of compound 411 and 412 with DIBAL-H 
 The cyano groups of compound 411 and 412 were reduced by treatment with 
DIBAL-H in toluene at -78 °C for 1 h followed by an aqueous work up with aqueous 
Rochelle salt solution to give their corresponding aldehydes 413 and 414 in 54% and 
83% yields, respectively (Scheme 4.42).  
The IR spectra of 413 and 414 showed characteristic absorption bands for an 
aryl aldehyde carbonyl group at νmax 1690 and 1692 cm-1, respectively and the absence 
of a nitrile stretching band. The 1H NMR spectrum of 413 revealed resonances for the 
presence of two biphenyl axis rotamers in a 53:47 ratio. The resonances for the 
aldehyde proton were observed at δH 9.94 (s, 0.53H) (major) and 9.93 (s, 0.47H) 
(minor). While the 1H NMR spectrum of 414 showed resonances for the presence of 
two biphenyl axis rotamers in a 77:23 ratio. Resonances for the aldehyde proton of 414 
were observed at δH 9.93 (s, 0.77H) (major) and 9.90 (s, 0.23H) (minor). The 13C NMR 
spectrum of 413 showed resonances for the aldehyde carbonyl carbon at δC 191.05 
(major) and 191.0 (minor), while those of 414 resonated at δC 191.0 (major) and 190.8 
(minor). The molecular formula of 413 and 414 was confirmed by HRESIMS analysis 
(calculated for C37H48NO5Si [M + H]+: 614.3302; found: 614.3306 and 614.3313, 
respectively). 
Chapter 4: Progress Toward the Total Synthesis of 9β-Hydroxyvertine | 178 
 
 
 
Scheme 4.42 The nitrile reduction reactions of compounds 411 and 412 
4.18 The Still–Gennari modified Horner-Wadsworth-Emmons (HWE) reaction of 
aldehyde 413 and 414 
 Still and Gennari137 reported a modification of the HWE reaction of aliphatic 
and aromatic aldehydes using bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl) 
phosphonate under  strongly dissociated basic condition (KHMDS and 18-crown-6) in 
THF at -78 °C to provide the Z-alkene with excellent stereoselectivities (Scheme 4.43).  
 
Scheme 4.43 The Still–Gennari modified HWE reaction 
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 A proposed mechanism is shown in Scheme 4.44. Initially, deprotonation of the 
phosphonate gives the phosphonate carbanion A. Nucleophilic addition of the carbanion 
onto the aldehyde gives the erythro intermediate B or the threo intermediate D. The 
intermediate B is kinetically more favoured than the intermediate D as the transition 
state leading to B is the less sterically hindered as it minimizes steric interactions 
between the R and the CO2Me substituents.137,138 The bis(trifluoroethyl) substituents on 
P ensures rapid conversion of B, via C, to the Z-alkene, minimizing the chance of the 
reverse reaction giving rise to the E-alkene. 
 
Scheme 4.44 A proposed mechanism for Still–Gennari modified HWE reaction 
 Following the literature method,103,137 aldehyde 413 was treated with 18-crown-
6 and 1.3 equiv. of KHMDS and bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl) 
phosphonate and  in THF at -78 °C for 2 h to give the corresponding methyl ester 415  
in 22% yield (Table 4.15, Entry 1). The product 415 was obtained in the highest yield of 
56% when 1.4 equiv. of KHMDS and phosphonate were employed (Table 4.15, Entry 
2). The yield did not improve upon increasing the amount of KHMDS and phosphonate 
components to 1.6 equiv. (Table 4.15, Entry 3). 
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Table 4.15 The Still–Gennari modified HWE reaction of aldehyde 413 
 
Entry Equiv. of  KHMDS Equiv. of phosphonate esters Yield (%) 
1 1.3 1.3 22 
2 1.4 1.4 56 
3 1.6 1.6 56 
 
 The IR spectrum of 415 showed a characteristic absorption band for an ester 
carbonyl group at νmax 1721 cm-1 and the absence of an aldehyde stretching band. The 
1H NMR spectrum (Figure 4.21) of 415 revealed resonances for the presence of two 
biphenyl axis rotamers in a 48:52 ratio. The resonances for the (Z)-alkene protons were 
observed at δH 6.84 (d, J = 12.8 Hz, 0.48H, H-3) (minor), 6.83 (d, J = 12.8 Hz, 0.52H, 
H-3) (major), 5.84 (d, J = 12.8 Hz, 0.48H, H-2) (minor) and 5.84 (d, J = 12.8 Hz, 
0.52H, H-2) (major). The magnitude of J2,3 (12.8 Hz) was consistent with the expected 
(Z)-alkene being produced. The 13C NMR spectrum (Figure 4.22) of 415 showed a 
resonance for the ester carbonyl carbon at δC 166.7. The resonances for the alkene 
carbons were observed at δC 143.5 (C-3, major), 143.46 (C-3, minor), 116.9 (C-2, 
major) and 116.8 (C-2, minor). LRESIMS analysis of compound 415 showed a 
protonated molecular ion peak at m/z 670 (100%) [M + H]+ in accordance with the 
molecular formula C40H52NO6Si which was confirmed by HRESIMS analysis 
(calculated for C40H52NO6Si [M + H]+: 670.3564; found: 670.3595). 
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Figure 4.21 1H NMR spectrum (CDCl3, 500 MHz) of 415 
 
Figure 4.22 13C NMR spectrum (CDCl3, 125 MHz) of 415 
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 Treatment of aldehyde 414 with 1.5 equiv. of KHMDS and bis(2,2,2-
trifluoroethyl) (methoxycarbonylmethyl) phosphonate gave the desired methyl ester 416 
in 60% yield (Scheme 4.45). 
 
Scheme 4.45 The Still–Gennari modified HWE reaction of aldehyde 414 
The IR spectrum of 416 showed a characteristic absorption band for an ester 
carbonyl group at νmax 1723 cm-1 and the absence of an aldehyde stretching band. The 
1H NMR spectrum (Figure 4.23) of 416 revealed resonances for the presence of two 
biphenyl axis rotamers in a 71:29 ratio. The resonances for the Z-alkene protons were 
observed at δH 6.93 – 6.81 (m, 1H, H-3) and 5.86 (d, J = 12.6 Hz, 1H, H-2). The 13C 
NMR spectrum (Figure 4.24) of 416 showed resonances for the carbonyl carbon at δC 
166.7 (major), 166.6 (minor). The resonances for the alkene carbons were observed at 
δC 143.5 (C-3, minor), 143.4 (C-3, major) and 117.3 (C-2). LRESIMS analysis of 
compound 416 showed a protonated molecular ion peak at m/z 670 (100%) [M + H]+ in 
accordance with the molecular formula C40H52NO6Si which was confirmed by 
HRESIMS analysis (calculated for C40H52NO6Si [M + H]+: 670.3564; found: 670.3595). 
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Figure 4.23 1H NMR spectrum (CDCl3, 500 MHz) of 416 
 
Figure 4.24 13C NMR spectrum (CDCl3, 125 MHz) of 416 
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4.19 The hydrolysis of methyl ester 415 and 416 
 Treatment of the methyl ester 415 with 1M aq. NaOH in MeOH at 0 °C 
according to Dau’s procedure139 provided the corresponding carboxylic acid 417 in 26% 
conversion which was observed by LRESIMS analysis of the crude reaction mixture 
(Table 4.16, Entry 1). Increasing the reaction temperature to room temperature slightly 
improved the conversion of 415 to 33% (Table 4.16, Entry 2). While performing the 
reaction in dioxane:MeOH (14:5) at room temperature or THF:MeOH (4:1) at 50 °C did 
not improve the conversion of 415 (Table 4.16, Entries 3-4). Following Paterson’s 
procedure,140 the use of Ba(OH)2·8H2O as a base in MeOH at 50 °C improved the 
conversion of 415 to 49% (Table 4.16, Entry 5). A >99% conversion to 417 was 
obtained when the methyl ester 415 was treated with LiOH·H2O141 in THF:MeOH:H2O 
(4:1:1) at 50 °C for 16 h (Table 4.16, Entry 6). Importantly, the secondary TBS ether 
was stable under these basic conditions. 
Table 4.16 The hydrolysis of methyl ester 415  
 
Entry Base 
Equiv. of 
base 
Solvent 
T 
(°C) 
Time % Conversion 
1 1M aq. NaOH 12 MeOH 0 5 h 26 
2 1M aq. NaOH 12 MeOH rt 5 h 33 
3 1M aq. NaOH 12 
dioxane:MeOH 
(14:5) 
rt 16 h 26 
4 1M aq. NaOH 12 
THF:MeOH 
(4:1) 
50 16 h 31 
5 Ba(OH)2·8H2O 400 MeOH 50 16 h 49 
6 LiOH·H2O 20 
THF:MeOH:H2O 
(4:1:1) 
50 16 h >99 
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 These optimized reaction conditions were applied to methyl ester 416. 
Treatment of 416 with LiOH·H2O in THF:MeOH:H2O (4:1:1) at 50 °C for 16 h 
provided the desired crude carboxylic acid 418 in >99% conversion (Scheme 4.46). The 
molecular formula of 417 and 418 was confirmed by the HRESIMS analysis (calculated 
for C39H50NO6Si [M + H]+: 656.3407; found: 656.3402 and 656.3437, respectively). 
These crude acids were directly subjected to halolactonization experiments without 
purification. 
 
Scheme 4.46 The hydrolysis of methyl ester 416 
4.20 The attempted halolactonization reaction of compound 417 and 418 
 Tunge et. al.142 reported the selenium-catalyzed bromolactonization of β,γ-
unsaturated carboxylic acid using NBS in the presence of a catalytic amount of (PhSe)2 
in MeCN at -30 °C to provide γ-lactones in 41-90% yield with moderate to excellent 
regioselectivities (Scheme 4.47). 
 
Scheme 4.47 Tunge’s bromolactonization of β,γ-unsaturated carboxylic acid142 
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 The proposed mechanism of this reaction is shown in Scheme 4.48. Initially, the 
ionic intermediate A was generated from nucleophilic attack of (PhSe)2 on NBS The 
addition of this intermediate to the alkene forms the selenium-coordinated bromonium 
ion B, which subsequently undergoes an intramolecular SN2 reaction resulting in the 
anti-γ-lactone product.142 
 
Scheme 4.48 Proposed mechanism of selenium-catalyzed bromolactonization 
 Following this procedure, the crude acid 417 was treated with NBS and (PhSe)2 
in MeCN at -30 °C for 5 h. Purification of the crude reaction mixture by column 
chromatography gave the unexpected decarboxylated product 419 in 14% yield 
(Scheme 4.45). This result was unexpected since we had speculated that the                
α,β-unsaturated alkene would be more electron deficient then the unconjugated cyclic 
alkene which would ensure selective reaction of the bromonium ion with the more 
electron rich alkene. While this may be the case the lactone forming reaction may be 
kinetically slow resulting in formation of the vinyl bromide by an irreversible final step. 
Our attempted iodolactonization reactions of 417 with I2 and NaHCO3 in MeCN143 at 
room temperature and 60 °C were also not successful and only unreacted starting 
material was recovered. We also tried bromolactonization of compound 418 under 
Tunge’s reaction conditions but unfortunately this reaction also produced the (Z)-
bromoalkene 420 in 18% yield (Scheme 4.49). 
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 The IR spectra of 419 and 420 showed the absence of a carbonyl stretch. The 1H 
NMR spectrum of 419 revealed resonances for the presence of two biphenyl axis 
rotamers in a 48:52 ratio. The resonances for the Z-alkene protons were observed at δH 
7.00 (d, J = 8.1 Hz, 0.48H, H-1′′′) (minor), 6.99 (d, J = 8.1 Hz, 0.52H, H-1′′′) (major) 
and 6.31 (d, J = 8.1 Hz, 1H, H-2′′′). The magnitude of J1′′′,2′′′ (8.1 Hz) indicated that the 
(Z)-bromoalkene had formed. The 1H NMR spectrum of 420 revealed the presence of 
two biphenyl axis rotamers in a 39:61 ratio. The resonances for the Z-alkene protons 
were observed at δH 7.02 (d, J = 8.0 Hz, 0.69H, H-1′′′) (major), 6.99 (d, J = 8.0 Hz, 
0.31H, H-1′′′) (minor), 6.34 (d, J = 8.0 Hz, 0.69H, H-2′′′) (major) and 6.32 (d, J = 8.0 
Hz, 0.31H, H-2′′′) (minor). The 13C NMR spectra of 419 and 420 showed the absence of 
a carbonyl carbon resonance. The molecular formula of 419 and 420 was confirmed by 
the HRESIMS analysis (calculated for C38H49NO4Si79Br [M + H]+: 690.2614; found: 
690.2642 and 690.2648, respectively). 
 
Scheme 4.49 Attempted bromolactonization reactions of compound 417 and 418 
 A proposed mechanism of the formation of 419 and 420 is shown in Scheme 
4.50. Initially, the ionic intermediate A reacts with the α,β-unsaturated carboxylic acid 
to form the bromonium intermediate B. Subsequent elimination of CO2 and ring-
opening of the bromonium ion gives the (Z)-bromoalkene product. Unfortunately, time 
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restrictions did not allow further or althernative methods to be explored to make the key 
lactone ring of the target alkaloid. 
 
Scheme 4.50 Proposed mechanism for the formation of compound 419 and 420 
In summary, we have achieved the successful synthesis of four of the five rings 
of the target alkaloid, 9β-hydroxyvertine 208. We have examined several synthetic 
methods to synthesize the biphenyl aldehyde 367. The Ullman coupling reaction failed 
to provide the desired product. Using the Suzuki coupling reaction, we successfully 
prepared the desired biphenyl aldehyde 367 which was then converted to the (R)-N-
sulfinyl imine 370. Allylation of imine 370 gave the N-sulfinyl amine 371. The absolute 
configuration of this molecule was established by a single crystal X-ray crystallographic 
analysis. Hydrolysis of N-sulfinyl group of 371 gave the corresponding amine 378 in 
65.7% overall yield over five synthetic steps (Scheme 4.51).  
 
Scheme 4.51 Synthesis of chiral amine 378 
Aldehyde dimer 381 was successfully synthesized from commercially available 
pent-4-en-1-ol. The PBM reaction of the chiral amine 378, aldehyde dimer 381 and β-
styrylboronic acid unexpectly provided a mixture of  two diastereomeric 1,2-amino 
alcohols 382 and 383. An alternative synthetic strategy failed because the attempted 
deprotection of the PMB ether group of 392 gave a complex mixture of products. PMB 
ether 382 was converted to quinolizidine 397 in 9.9% overall yield over three synthetic 
steps (Scheme 4.52). 
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Scheme 4.52 Synthesis of quinolizidine 397 
 Because of the low yield of the desired product, the secondary alcohol in the 
PMB ether 382 was protected as a TBS ether, however the attempted deprotection of the 
PMB protecting group from PMB ether 398 resulted in the amine 378 from the 
oxidative cleavage of the styrenyl side chain. An alternative synthetic strategy was 
developed in which the primary hydroxy group of the aldehyde dimer 401 was protected 
as a TBS ether. The PBM reaction of chiral amine 378, aldehyde dimer 401 and β-
styrylboronic acid provided a mixture of  two diastereomeric 1,2-amino alcohols 402 
and 403. The desired isomer 402 was converted to the methyl ester 416 in 21.3% overall 
yield over six synthetic steps while the undesired isomer 403 was converted to the 
methyl ester 415 in 11.4% overall yield (Scheme 4.53).  
 
Scheme 4.53 Synthesis of methyl esters 415 and 416 
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Hydrolysis of 415 and 416 provided the corresponding carboxylic acids 417 and 
418. The attempted bromlactonization reactions of 418 and 419 unexpectedly gave the 
(Z)-bromoalkene 419 and 420 in 14% and 18% yields, respectively. 
A different method for preparing the key lactone ring of the alkaloid target will 
be required to successfully achieve the total synthesis of 208 in the future. Such an 
approach could involve regioselective hydroboration of the alkene group of 416 and 
then cyclization of the corresponding carboxylic acids via a Yamaguchi lactonization144 
of 421 or a Mitsunobu reaction145 of the alcohol isomer 422 resulting in inversion of 
stereochemistry (Scheme 4.54). Subsequent removal of the O-Bn and O-TBS protecting 
groups should then afford the alkaloid target 208. 
 
Scheme 4.54 Possible alternative syntheses of the lactone ring 
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 An alternative synthesis could involve the O-TBS ether analogue 423 of the 
compound 392 as shown in Scheme 4.55. 
 
Scheme 4.55 Possible alternative synthesis of 416 
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Chapter 5 
Conclusions and future directions 
5.1 Conclusions 
 The initial aims of this PhD project were to investigate the Petasis borono-
Mannich (PBM) reactions of pincacol allenylboronate in the synthesis of anti-β-allenyl-
β-amino alcohols. These compounds were then to be employed in the synthesis of 
functionalized piperidines, via the aza-Prins cyclization reaction. We also aimed to 
develop a synthetic strategy for the total synthesis of the pentacyclic alkaloid 9β-
hydroxyvertine 208. 
 We successfully investigated the PBM reaction of pincacol allenylboronate with 
different types of aldehydes and primary and secondary amines. The reactions of 
racemic α-hydroxy aldehydes gave exclusively anti-β-allenyl-β-amino alcohol products, 
while the PBM reactions of enantiomerically enriched α-hydroxyaldehydes were highly 
regio- and diastereoselective giving products in high enantiomeric purities. The anti-
stereochemical outcomes of these reactions were determined by conversion of 
representative compounds to their oxazolidinone derivatives and then NOESY or 
ROESY NMR analysis. The PBM reactions of pinacol allenylboronate with 
salicylaldehyde with primary amines provided exclusively the homopropargyl amine 
products, while those of secondary amines provided the α-allenyl amine products. A 
NMR study of the PBM reaction of this aldehyde with benzylamine and pinacol 
allenylboronate indicated that a boron “ate” intermediate was readily formed however 
ESIMS could not identify this intermediate. The PBM reactions of aromatic aldehydes 
lacking an ortho-hydroxy group, 2-methoxybenzaldehyde 245 and benzaldehyde 246, 
did not provide PBM products which indicated that the ortho-hydroxy group was 
necessary to activate the boron species to allow transfer of the allenyl group to the 
iminium ion intermediate. The first exploration of the PBM reaction of pinacol 
allenylboronate, pyridine 2-carboxaldehyde with primary and secondary amines 
provided exclusively the homopropargyl amine products in poor yields under non-
optimized reaction conditions. 
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 An examination of the aza-Prins cyclization reactions of the anti-β-allenyl-β-
amino alcohol 210b or its O-TBS or O-TBPDPS ether derivatives, 273 and 276 with 
failed to give the desired tetrahydropyridine products. The attempted aza-Prins 
cyclization reactions of the N-Ts homopropargyl amine 281 or the N-Ts allenyl amine 
282 with resulted only in the recovery of unreacted starting materials. The attempted 
aza-silyl-Prins cyclization reactions of (E)-allyl silylated allylic N-Ts amine 290 with 
failed to provide the desired product. The attempted aza-Prins cyclization reaction of N-
Bn amine 295 with in the presence of InCl3 provided mixtures of the aza-Cope 
rearrangement products 296 and 297. The aza-silyl-Prins cyclization reaction of (E)-
silylated N-Bn allylic amine 303 with highly reactive ethyl glyoxylate 261, in the 
present of InCl3 as a Lewis acid or 3Å molecular sieves as a desiccant, successfully 
gave the trans-2,6-tetrahydropyridine product 304. Unfortunately, using less reactive 
aldehydes under these reaction conditions failed to provide the desired 
tetrahydropyridine products. 
 Progress towards the total synthesis of the alkaloid 9β-hydroxyvertine 208 has 
been made. We achieved the successful synthesis of four of the five rings of the target 
alkaloid. Several synthetic methods to synthesize the biphenyl aldehyde 367 were 
examined. The Ullman coupling reaction of aryl halides failed to provide the desired 
product. The desired biphenyl aldehyde 367 was successfully prepared using the Suzuki 
coupling reactions of aryl halide 362 or 363 and arylboronate 366. The aldehyde 367 
was then converted to the N-sulfinyl imine 370 which underwent allylation with allyl 
bromide and Zn/Zn(OTf)2 to give the allylic N-sulfinyl amine 371. The absolute 
configuration of this molecule was confirmed by a single crystal X-ray crystallographic 
analysis. Hydrolysis of the N-sulfinyl group of 371 gave the corresponding amine 378, 
the PBM amine coupling partner, in 65.7% overall yield over five synthetic steps. 
Aldehyde dimer 381, the PBM aldehyde coupling partner, was successfully synthesized 
from commercially available pent-4-en-1-ol. The PBM reaction of the chiral amine 378, 
aldehyde dimer 381 and β-styrylboronic acid unexpectly provided a mixture of two 
diastereomeric 1,2-amino alcohol products, 382 and 383. An alternative synthetic 
strategy using an amine without the biphenyl moiety was not productive because of the 
failure of the attempted deprotection of the PMB ether group of 392. PMB ether 382 
was converted to quinolizidine 397 in 9.9% overall yield over three synthetic steps. 
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Because of the low yield of the desired quinolizidine product 397, the secondary alcohol 
in the PMB ether 382 was protected as a TBS ether, however the attempted deprotection 
of the PMB protecting group from PMB ether 398 failed. An alternative synthetic 
strategy was developed in which the primary hydroxy group of the aldehyde dimer 401 
was protected as a TBS ether. The PBM reaction of chiral amine 378, aldehyde dimer 
401 and β-styrylboronic acid provided a mixture of two diastereomeric 1,2-amino 
alcohol products, 402 and 403. The desired isomer 402 was converted to the (Z)-α,β-
unsaturated methyl ester 416 in 21.3% overall yield over six synthetic steps, while the 
undesired isomer 403 was converted to the corresponding methyl ester 415 in 11.4% 
overall yield. Subsequent hydrolysis of 416 and 417 provided the corresponding 
carboxylic acids 417 and 418. Attempted bromolactonization reactions of 417 and 418 
unexpectedly gave the (Z)-bromoalkene 419 and 420 in 14% and 18% yield, 
respectively. 
5.2 Future directions 
 In future studies, a different method for preparing the key lactone ring of the 
alkaloid target will be required to successfully achieve the total synthesis of 208. Such 
an approach could involve regioselective hydroboration of the alkene group of 416 and 
then cyclization via a Yamaguchi lactonization reaction of 421 or by an intramolecular 
Mitsunobu reaction of 422 as discussed in Chapter 4 (Scheme 4.54). 
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Chapter 6 
Experimental Section 
6.1 General Experimental  
6.1.1 General reaction conditions 
In general, all reactions were performed under anhydrous conditions under a 
nitrogen atmosphere in a single necked round bottom flask sealed with a suba-seal 
septum and connected to a nitrogen manifold with a gas bubbler. Reactions were 
monitored by thin-layer chromatography (TLC). The solvents were purchased as 
Analytical Reagent (AR) grade. Anhydrous diethyl ether, dichloromethane, 
tetrahydrofuran and toluene were taken from a Johnson Morris anhydrous solvent 
dispenser. Anhydrous acetonitrile, methanol, 1,2-dichloroethane and 1,2-
dimethoxyethane were purchased from Sigma Aldrich in sure/sealedTM bottles. Water 
was purified and deionized on a Millipore RiOsTM 5 Century water purification system. 
Petroleum spirit (PS) refers to the hydrocarbon fraction of b.p. 40-60 C. 
Where ‘dried’ is specified, this refers to the drying of the organic extract over 
anhydrous magnesium sulfate or anhydrous sodium sulfate followed by filtration.  
Where ‘in vacuo’ is specified, this refers to the evaporation of the organic 
solvent under reduced pressure using a rotary evaporator. The pure compounds were 
then dried under the high vacuum for at least 1 h before the calculation of their yields. 
6.1.2 Chromatography 
Aluminium backed Merck F254 sorbent silica gel was used for thin-layer 
chromatography (TLC) analysis. Compounds were detected at 254 nm under an 
ultraviolet lamp, for UV active compounds, and ceric ammonium molybdate dipping 
solution followed by development with 1400 Watt heat gun. The ceric ammonium 
molybdate stain solution was prepared by the slow addition of concentrated sulfuric 
acid  (50 mL) to a solution of 50 g ammonium molybdate ((NH4)6MoO24) and 2 g 
cesium(IV) sulfate (Ce(SO4)2) in 950 mL of distilled water. Flash column 
chromatography was performed using Merck Kieselgel 60 PF254 packed by the slurry 
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method. The crude product was applied by pipette as a solution in the eluent to the top 
of the silica gel bed or absorbed on silica gel prior to loading on the column bed. 
6.1.3 Polarimetry 
Optical rotations were measured at 25 oC in a 10 mm length cell (2.0 mL), on a 
JASCO 2000 series polarimeter. An average of ten measurements was used to calculate 
the specific rotation. 
6.1.4 Mass spectrometry 
 A Micromass Waters Platform LCZ (single quadrupole, MeOH as solvent) was 
used to obtain low resolution mass spectra (LRESIMS). A Micromass Waters Q-ToF 
Ultima (quadrupole time-of-flight) or a Waters XEVO (quadrupole time-of-flight) mass 
spectrometer were used for acquiring high resolution mass spectra (HRESIMS and 
HRASAPMS, respectively). 
6.1.5 Nuclear magnetic resonance spectroscopy 
 A 500 MHz Varian Unity Inova, 500 MHz Varian Premium Shield (VNMRS PS 
54), Bruker AVANCE 500 MHz, and 300 MHz Varian Mercury spectrometer were 
used for obtaining the NMR spectral data. 1H NMR (500 or 300 MHz) and 13C NMR 
(125 or 75 MHz) spectra were recorded in deuterochloroform (CDCl3) or deuterated 
methanol (CD3OD) solution. 19F NMR spectra were recorded on a 500 MHz Varian 
Unity Inova (470 MHz) spectrometer using CF3C6H5 as an external standard. All signals 
which were recorded in CDCl3 were relative to the tetramethylsilane (TMS) signal for 
1H NMR and the CDCl3 signal for 13C NMR, referenced at 0.00 ppm and 77.16 ppm, 
respectively. All signals which were recorded in CD3OD were relative to the CD2HOD 
signal for 1H NMR and the CD3OD for 13C NMR, referenced at 3.31 ppm and 49.00 
ppm, respectively. The 1H NMR data were listed in order of the number of protons, 
multiplicity [singlet (s), broad singlet (brs), doublet (d), doublet of doublets (dd), 
doublet of doublet of doublets (ddd), doublet of doublet of doublet of doublets (dddd), 
doublet of triplets (dt), doublet of doublet of triplets (ddt), doublet of triplet of doublets 
(dtd), triplet (t), triplet of doublets (td), quartet (q), multiplet (m), and apparent (app.)], 
coupling constants (J) in Hz and assignment of nuclei concerned. NMR assignments 
were based upon gCOSY, APT, gHSQC, gHMBC, NOESY and ROESY experiments. 
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In some cases, 13C NMR signals were absent in the standard 13C NMR spectrum and 
only observed in the HSQC or HMBC spectra. 
6.1.6 Infrared spectroscopy 
 A SHIMADZU MIRacle 10 IRAffinity 1 was used for obtaining IR spectral data 
on neat samples. 
6.1.7 Melting points 
Melting points were obtained using a Gallenkamp MF-370 capillary tube 
melting point apparatus and are uncorrected. 
6.1.8 Microwave Reactions 
Microwave reactions were conducted using a CEM Discover Microwave 
Synthesis System with Explorer (24 positions) Automated Reactor. All reactions were 
conducted at 300 W in a 10 mL pressure vessel with a 30 bar pressure cap and strict 
control of the internal temperature. 
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6.2 Experimental for Chapter 2 
6.2.1 General method 1 for PBM reactions with glycolaldehyde 
2-Morpholinopenta-3,4-dien-1-ol (210a) 
 
 Glycolaldehyde dimer (30 mg, 0.25 mmol) was dissolved in methanol (0.5 mL) 
in a 10 mL microwave tube and morpholine (43.5 mg, 43.7 µL, 0.5 mmol, 1 equiv.) was 
then added with stirring. Pinacol allenylboronate (83.1 mg, 90 µL, 0.5 mmol, 1 equiv.) 
was added at room temperature and the tube sealed with a pressure cap. The reaction 
was irradiated in a CEM Discover system microwave reactor for 10 min at 120 °C (300 
W). After cooling to room temperature, the solvent was evaporated. The crude product 
was dissolved in CH2Cl2 (4 mL) and then washed with sat. aqueous NaHCO3 solution 
(2 x 4 mL). The combined organic layer was dried (MgSO4), filtered and concentrated 
in vacuo. The crude product was purified by column chromatography on silica gel 
eluting with 70:30 EtOAc/PS to afford the title compound 210a as a light brown oil 
(48.2 mg, 76%). 
Rf = 0.2 (EtOAc:PS = 70:30). 
IR (neat): νmax 3399, 2920, 2853, 1950, 1452, 1280, 1111, 849 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.07 (app. q, J = 7.0 Hz, 1H, H-3), 4.77 (app. d, J = 6.8, 
2H, H-5), 3.80 – 3.66 (m, 4H, H-2′), 3.60 – 3.48 (m, 2H, H-1), 3.33 – 3.19 (m, 1H, H-
2), 2.74 – 2.64 (m, 2H, H-1′A), 2.55 – 2.41 (m, 2H, H-1′B). 
13C NMR (125 MHz, CDCl3): δ 209.2 (C-4), 84.0 (C-3), 75.6 (C-5), 67.3 (2 x C-2′), 
64.7 (C-2), 60.4 (C-1), 48.9 (2 x C-1′′). 
ESIMS m/z 170 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C9H16NO2 [M + H]+: 170.1181, found: 170.1181. 
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2-(Benzylamino)penta-3,4-dien-1-ol (210b) 
 
 The title compound was prepared by Method 1 using benzylamine (80.4 mg, 
81.9 µL 0.75 mmol, 1.5 equiv.) instead of morpholine and pinacol allenylboronate 
(124.6 mg, 134.4 µL, 0.75 mmol, 1.5 equiv.). Purification by column chromatography 
on silica gel eluting with 70:30 EtOAc/PS gave 210b as a white solid (52.0 mg, 55%). 
Rf = 0.2 (EtOAc:PS = 70:30). 
Mp.: 60-61 °C. 
IR (neat): νmax 3271, 3069, 3026, 2922, 2857, 1956, 1493, 1452, 1105, 1047, 893 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.37 – 7.22 (m, 5H, ArH), 5.11 (app. q, J = 6.6 Hz, 1H, 
H-3), 4.86 (dt, J = 6.5, 1.7 Hz, 2H, H-5), 3.95 (d, J = 12.9 Hz, 1H, PhCHAHBN), 3.74 
(d, J = 12.9 Hz, 1H,  PhCHAHBN), 3.65 (dd, J = 10.5, 4.2 Hz, 1H, H-1A), 3.37 (dd, J = 
10.5, 8.1 Hz, 1H,  H-1B), 3.33 – 3.25 (m, 1H, H-2). 
13C NMR (125 MHz, CDCl3): δ 208.3 (C-4), 140.2 (ArC), 128.6 (2 x ArCH), 128.4 (2 x 
ArCH), 127.3 (ArCH), 90.3 (C-3), 77.1 (C-5), 65.0 (C-1), 57.8 (C-2), 51.3 (C-6). 
ESIMS m/z 190 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C12H16NO [M + H]+: 190.1232, found: 190.1227. 
2-(Benzhydrylamino)penta-3,4-dien-1-ol (210c) 
 
 The title compound was prepared by General method 1 using benzhydrylamine 
(91.6 mg, 86.2 µL 0.5 mmol) instead of morpholine. Purification by column 
Chapter 6: Experimental Section | 202 
 
 
chromatography on silica gel eluting with 5:95 EtOAc/CH2Cl2 gave 210c as a white 
solid (73.4 mg, 55%) 
Rf = 0.2 (EtOAc:CH2Cl2 = 5:95). 
Mp.: 56-58 °C. 
IR (neat): νmax 3291, 3161, 3057, 3026, 2935, 2845, 1954, 167, 1599, 1493, 1449, 1435, 
1072, 1045, 840, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.41 (d, J = 7.6 Hz, 2H, ArH), 7.38 (d, J = 7.6 Hz, 2H, 
ArH) , 7.29 (app. q, J = 7.9 Hz, 4H, ArH), 7.26 – 7.15 (m, 2H, H-3 and (Ph)2CH), 4.88 
– 4.79 (m, 2H, H-5), 3.62 (dd, J = 10.8, 4.4 Hz, 1H, H-1A), 3.40 (dd, J = 10.8, 8.0 Hz, 
1H, H-1B), 3.26 – 3.18 (m, 1H, H-2). 
13C NMR (125 MHz, CDCl3): δ 208.3 (C-4), 144.4 (ArC), 142.9 (ArC), 128.74 (2 x 
ArCH), 128.72 (2 x ArCH), 127.8 (2 x ArCH), 127.36 (ArCH), 127.34 (ArCH), 127.3 
(2 x ArCH), 90.1 (C-3), 77.3 (C-5), 65.6 (C-1), 64.1 ((Ph)2CH), 55.8 (C-2). 
ESIMS m/z 266 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C18H20NO [M + H]+: 266.1545, found: 266.1544. 
2-(Dibenzylamino)penta-3,4-dien-1-ol (210d) 
 
 The title compound was prepared by General method 1 using dibenzylamine 
(98.6 mg, 96.1 µL 0.5 mmol) instead of morpholine. Purification by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS gave 210d as a brown oil 
(75.4 mg, 54%). 
Rf = 0.3 (EtOAc:PS = 10:90). 
IR (neat): νmax 3439, 3016, 2930, 2837, 1948, 1602, 1495, 1452, 1072, 1028, 839 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.39 – 7.19 (m, 10H, ArH), 5.14 (app. q, J = 6.9 Hz, 1H, 
H-3), 4.87 – 4.74 (m, 2H, H-5), 3.85 (d, J = 13.4 Hz, 2H, PhCHAHBN), 3.66 – 3.56 (m, 
1H, H-1A), 3.53 – 3.45 (m, 2H, H-1B and H-2), 3.42 (d, J = 13.4 Hz, 2H, PhCHAHBN), 
2.90 (s, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 209.6 (C-4), 139.0 (2 x ArC), 129.2 (4 x ArCH), 128.6 
(4 x ArCH), 127.4 (2 x ArCH), 83.8 (C-3), 75.5 (C-5), 61.1 (C-1), 58.4 (C-2), 53.8 (2 x 
PhCH2). 
ESIMS m/z 280 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C19H22NO [M + H]+: 280.1701, found: 280.1698. 
2-(Piperidin-1-yl)penta-3,4-dien-1-ol (210e) 
 
The title compound was prepared by General method 1 using piperidine (42.6 
mg, 90.0 µL 0.5 mmol) instead of morpholine. Purification by column chromatography 
on silica gel eluting with 10:90 MeOH/CH2Cl2 gave 210e as a brown oil (21.4 mg, 
26%). 
Rf = 0.2 (MeOH:CH2Cl2 = 10:90). 
IR (neat): νmax 3412, 2932, 2853, 2806, 1950, 1423, 1325, 1157, 1099, 1036, 835 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.07 (app. q, J = 7.1 Hz, 1H, H-3), 4.74 (d, J = 6.4 Hz, 
2H, H-5), 3.57 – 3.47 (m, 2H, H-1), 3.29 (q, J = 7.9 Hz, 1H, H-2), 2.74 – 2.58 (m, 2H, 
H-1′A), 2.49 – 2.35 (m, 3H, H-1′B and OH), 1.71 – 1.52 (m, 4H, H-2′), 1.52 – 1.41 (m, 
2H, H-3′). 
13C NMR (125 MHz, CDCl3): δ 209.0 (C-4), 84.2 (C-3), 75.2 (C-5), 64.8 (C-2), 60.4 
(C-1), 49.7 (C-1′), 26.5 (C-2′), 24.7 (C-3′). 
ESIMS m/z 168 (100%) [M + H]+.  
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HRMS (ESI): m/z calculated for C10H18NO [M + H]+: 168.1388, found: 168.1377. 
4-Phenylbutane-1,2-diol (213) 
 
To a solution of 4-phenyl-1-butene (0.6610 g, 5.0 mmol) in 3:1 acetone/water 
(24 mL) was added N-methylmorpholine-N-oxide (1.1715 g, 10.0 mmol, 2 equiv.) and 
potassium osmate dihydrate (18.4 mg, 0.05 mmol, 0.01 equiv.) and stirred vigorously at 
room temperature for 2 days. The reaction mixture was added sat. aqueous Na2SO3 
solution (10 mL) and extracted with EtOAc (2 x 40 mL). The combined organic layer 
was washed with brine, dried (MgSO4), filtered and concentrated in vacuo. The crude 
product was purified by column chromatography on silica gel eluting with 50:50 
EtOAc/PS to afford the title compound 213 as a colorless oil (0.8250 mg, 99%).  The 
spectroscopic data of this compound matched with those in the literature.146 
Rf = 0.2 (EtOAc:PS = 50:50). 
IR (neat): νmax 3335, 3026, 2916, 2849, 1603, 1495, 1454, 1067, 1030, 870, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.51 – 6.99 (m, 5H, ArH), 3.77 – 3.70 (m, 1H, H-2), 
3.69 – 3.61 (m, 1H, H-1A), 3.54 – 3.41 (m, 1H, H-1B), 2.88 – 2.75 (m, 1H, H-4A), 2.75 – 
2.64 (m, 1H, H-4B), 2.24 (d, J = 4.2 Hz, 1H, OH), 2.01 (s, 1H, OH), 1.86 – 1.69 (m, 2H, 
H-3). 
13C NMR (125 MHz, CDCl3): δ 141.8 (ArC), 128.6 (2 x ArCH), 128.5 (2 x ArCH), 
126.1 (ArCH), 71.7 (C-2), 66.9 (C-1), 34.8 (C-3), 31.9 (C-4). 
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6.2.2 General method 2 for the selective oxidation of primary alcohol using 
TEMPO80 
3,6-Diphenethyl-1,4-dioxane-2,5-diol or (rac)-2-hydroxy-4-phenylbutanal dimer 
(214) 
 
To a solution of 4-phenylbutane-1,2-diol (213) (0.8311 g, 5.0 mmol), TEMPO 
(15.6 mg, 0.1 mmol, 0.02 equiv.), potassium bromide (0.6545 g, 5.5 mmol, 1.1 equiv.) 
in anhydrous CH2Cl2 (50 mL) and sat. aqueous NaHCO3 solution (20.0 mL) was cooled 
to 0 °C and added slowly dropwise commercial 0.7 M sodium hypochlorite solution (10 
mL, 7.0 mmol) and stirred at 0 °C for 30 min. The reaction mixture was quenched by 
addition of sat. aqueous Na2S2O3 (45 mL) at 0 °C and extracted with EtOAc (3 x 100 
mL). The combined organic layer was dried (MgSO4) and concentrated in vacuo. The 
crude product was purified by recrystallization from chloroform to afford the title 
compound 214 as colorless crystals (0.3350 g, 40%) and as a single diastereomer. 
Rf = 0.3 (MeOH:CH2Cl2 = 5:95). 
IR (neat): νmax 3336, 3026, 2917, 2862, 1616, 1494, 1139, 992, 856, 747, 698 cm-1. 
1H NMR (500 MHz, CD3OD): δ 7.27 – 7.17 (m, 8H, ArH), 7.14 (t, J = 7.2 Hz, 2H, 
ArH), 4.33 (d, J = 4.6 Hz, 1H, H-2),  4.31 (d, J = 5.6 Hz, 1H, H-5), 3.44 – 3.35 (m, 2H, 
H-3 and H-6), 2.87 – 2.76 (m, 2H, H-1′A), 2.69 – 2.59 (m, 2H, H-1′B), 1.96 – 1.82 (m, 
2H, H-2′A), 1.74 – 1.63 (m, 2H, H-2′A). 
13C NMR (125 MHz, CD3OD): δ 143.7 (ArC), 141.8 (ArC), 129.5 (4 x ArCH), 129.3 (4 
x ArCH), 126.7 (2 x ArCH), 101.3 (C-2), 101.1 (C-5), 73.9 (C-3), 73.8 (C-6), 34.9 (C-
2′), 34.6 (C-2′), 32.8 (C-1′), 32.78 (C-1′). 
ESIMS m/z 351 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C20H24O4Na [M + Na]+: 351.1572, found: 351.1571. 
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6.2.3 General method 3 for PBM reactions with (rac)-2-hydroxy-4-phenylbutanal 
(214) 
(rac)-(3R,4S)-4-(Benzylamino)-1-phenylhepta-5,6-dien-3-ol (rac)-(215a) 
 
To a solution of (rac)-2-hydroxy-4-phenylbutanal dimer (214) (16.4 mg, 0.05 
mmol, 1 equiv.) in methanol (0.2 mL) was added benzylamine (10.7 mg, 11.0 µL 0.1 
mmol, 1 equiv.) and the mixture was stirred at room temperature for 1 h followed by the 
addition of pinacol allenylboronate (16.6 mg, 18.0 µL, 1 mmol, 1 equiv.) and the 
mixture was stirred at room temperature. After the reaction had completed (18 h), the 
mixture was then evaporated. The crude product was dissolved in CH2Cl2 (2 mL) and 
then washed with sat. aqueous NaHCO3 solution (2 x 2 mL). The combined organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel eluting with 50:50 EtOAc/PS to afford 
the title compound 215a as a white solid (18.1 mg, 62%). 
Rf = 0.2 (EtOAc:PS = 50:50). 
Mp.: 70-71 °C. 
IR (neat): νmax 3271, 3136, 3061, 3024, 2947, 2843, 1954, 1601, 1493, 1454, 1443, 
1074, 1013, 988, 983, 851, 745, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.37 – 7.22 (m, 7H, ArH), 7.22 – 7.15 (m, 3H, ArH), 
5.12 (app. q, J = 7.0 Hz, 1H, H-5), 4.81 (dd, J = 6.7, 1.9 Hz, 2H, H-7), 3.88 (d, J = 13.0 
Hz, 1H, PhCHAHBN), 3.73 (d, J = 13.0 Hz, 1H, PhCHAHBN), 3.67 (td, J = 6.5, 3.6 Hz, 
1H, H-3), 3.23 (ddt, J = 7.5, 3.6, 1.9 Hz, 1H, H-4), 2.84 (dt, J = 14.3, 7.7 Hz, 1H, H-1A), 
2.65 (dt, J = 14.3, 8.2 Hz, 1H, H-1B), 1.79 – 1.69 (m, 2H, H-2). 
13C NMR (125 MHz, CDCl3): δ 208.9 (C-6), 142.3 (ArC), 140.1 (ArC), 128.6 (3 x 
ArCH), 128.5 (3 x ArCH), 128.4 (2 x ArCH), 127.3 (ArCH), 125.9 (ArCH), 88.7 (C-5), 
76.4 (C-7), 71.8 (C-3), 61.3 (C-4), 51.6 (PhCH2N), 34.9 (C-2), 32.5 (C-1). 
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ESIMS m/z 294 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C20H24NO [M + H]+: 294.1858, found: 294.1864. 
(rac)-(3R,4S)-4-(Benzhydrylamino)-1-phenylhepta-5,6-dien-3-ol (rac)-(215b) 
 
The title compound was prepared by General method 3 using benzhydrylamine 
(18.3 mg, 18.0 µL 0.1 mmol) instead of benzylamine. Purification by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS gave 215b as a light brown 
solid (20.4 mg, 55%). 
Rf = 0.2 (EtOAc:PS = 10:90) 
Mp.: 88-90 °C 
IR (neat): νmax 3294, 3198, 2947, 2853, 1950, 1601, 1493, 1451, 1431, 1069, 1017, 887, 
843, 760, 745, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.43 – 7.32 (m, 4H, ArH), 7.32 – 7.23 (m, 6H, ArH), 
7.23 – 7.13 (m, 5H, ArH), 5.08 (app. q, J = 7.0 Hz, 1H, H-5), 5.00 (s, 1H, (Ph)2CH), 
4.79 (dd, J = 6.7, 1.8 Hz, 2H, H-7),  3.65 (dt, J = 8.4, 4.0 Hz, 1H, H-3), 3.19 – 3.10 (m, 
1H, H-4), 2.85 – 2.74 (m, 1H, H-1A), 2.68 – 2.58 (m, 1H, 1H, H-1B), 1.82 – 1.67 (m, 
2H, H-2). 
13C NMR (125 MHz, CDCl3): δ 208.9 (C-6), 144.3 (ArC), 143.2 (ArC), 142.2 (ArC), 
128.7 (4 x ArCH), 128.6 (2 x ArCH), 128.5 (2 x ArCH), 127.8 (2 x ArCH), 127.4 (2 x 
ArCH), 127.3 (ArCH), 127.28 (ArCH), 125.9 (ArCH), 88.6 (C-5), 76.5 (C-7), 72.8 (C-
3), 64.2 ((Ph)2CH), 59.4 (C-4), 35.0 (C-2), 32.4 (C-1). 
ESIMS m/z 370 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C26H28NO [M + H]+: 370.2171, found: 370.2178. 
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(rac)-(3R,4S)-4-(Dibenzylamino)-1-phenylhepta-5,6-dien-3-ol (rac)-(215c) 
 
The title compound was prepared by General method 3 using dibenzylamine 
(19.7 mg, 20.0 µL 0.1 mmol) instead of benzylamine. Purification by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS gave 215c as a pale yellow 
oil (29.1 mg, 76%). 
Rf = 0.3 (EtOAc:PS = 10:90). 
IR (neat): νmax 3393, 3061, 3026, 2924, 2835, 1948, 1603, 1495, 1452, 1242, 1029, 
1028, 837, 745, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.19 (m, 12H, ArH), 7.19 – 7.11 (m, 3H, ArH), 
5.19 (dt, J = 8.9, 6.6 Hz, 1H, H-5), 4.84 (ddd, J = 11.0, 6.7, 1.1 Hz, 1H, H-7A), 4.77 
(ddd, J = 11.0, 6.7, 1.1 Hz, 1H, H-7B), 3.82 – 3.69 (m, 3H, H-3 and PhCHAHBN), 3.41 
(d, J = 13.5 Hz, 2H, PhCHAHBN), 3.19 (t, J = 8.9 Hz, 1H, H-4), 2.68 (ddd, J = 14.3, 9.9, 
5.2 Hz, 1H, H-1A), 2.57 (ddd, J = 14.3, 9.2, 7.0 Hz, 1H, H-1B), 2.18 (dddd, J = 13.7, 9.9, 
7.0, 3.0 Hz, 1H, H-2A), 1.79 (s, 1H, OH), 1.64 (dtd, J = 13.7, 9.2, 5.2 Hz, 1H, H-2B). 
13C NMR (125 MHz, CDCl3): δ 210.2 (C-6), 142.5 (ArC), 139.5 (2 x ArC), 129.1 (4 x 
ArCH), 128.7 (3 x ArCH), 128.4 (4 x ArCH), 127.2 (3 x ArCH), 125.8 (ArCH), 84.5 
(C-5), 74.8 (C-7), 71.5 (C-3), 64.0 (C-4), 55.2 (2 x PhCH2N), 35.5 (C-2), 31.6 (C-1). 
ESIMS m/z 384 (100%) [M + H]+. 
HRMS (ESI): m/z calculated for C27H30NO [M + H]+: 384.2327, found: 384.2326. 
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(rac)-(3R,4S)-4-Morpholino-1-phenylhepta-5,6-dien-3-ol (rac)-(215d) 
 
The title compound was prepared by General method 3 using morpholine (8.7 
mg, 9.0 µL, 0.1 mmol) instead of benzylamine. Purification by column chromatography 
on silica gel eluting with 40:60 EtOAc/PS gave 215d as a pale yellow solid (16.5 mg, 
60%). 
Rf = 0.3 (EtOAc:PS = 40:60). 
Mp.: 66-67 °C. 
IR (neat): νmax 3553, 3360, 3024, 2955, 2916, 2814, 1954, 1641, 1632, 1601, 1489, 
1451, 1123, 1109, 993, 872, 748, 700 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.24 (m, 2H, ArH), 7.24 – 7.15 (m, 2H, ArH) 
5.08 (dt, J = 9.9, 6.6 Hz, 1H, H-5), 4.73 (d, J = 6.6 Hz, 2H, H-7), 3.87 (dt, J = 8.4, 4.3 
Hz, 1H, H-3), 3.74 – 3.64 (m, 4H, H-2′), 2.87 – 2.74 (m, 2H, H-4 and H-1A), 2.67 (ddd, 
J = 13.7, 9.7, 6.7 Hz, 1H, H-1B), 2.56 (dt, J = 6.0, 2.8 Hz, 4H, H-1′), 1.91 – 1.73 (m, 2H, 
H-2). 
13C NMR (125 MHz, CDCl3): δ 209.9 (C-6), 142.2 (ArC), 128.6 (2 x ArCH), 128.5 (2 x 
ArCH), 125.9 (ArCH), 85.3 (C-5), 74.9 (C-7), 70.1 (C-4), 68.7 (C-3), 67.3 (2 x C-2′), 
51.4 (2 x C-1′), 35.5 (C-2), 32.2 (C-1). 
ESIMS m/z 274 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C17H24NO2 [M + H]+: 274.1807, found: 274.1814. 
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6.2.4 General method 4 for synthesis of oxazolidinones 
(4S*,5R*)-3-Benzyl-5-phenethyl-4-(propa-1,2-dienyl)oxazolidin-2-one (216) 
 
 To a solution of 215a (44.9 mg, 0.15 mmol) and triethylamine (61.9 μL, 0.61 
mmol, 4.0 equiv.) in anhydrous CH2Cl2 (5 mL) was added triphosgene (22.9 mg, 0.08 
mmol, 0.53 equiv.) at 0 °C under a nitrogen atmosphere. After being stirred for 15 min, 
the reaction mixture was allowed to warm to room temperature and stirred for 18 h, and 
then concentrated in vacuo to give the crude product. Purification by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS gave 216 as a light brown 
solid (33.4 mg, 68%). 
Rf = 0.2 (EtOAc:PS = 8:92). 
Mp.: 62-64 °C. 
IR (neat): νmax 3065, 3028, 2918, 2849, 1952, 1732, 1497, 1418, 1225, 864, 694 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.23 (m, 7H, ArH), 7.23 – 7.15 (m, 3H, ArH), 
4.98 (dt, J = 9.1, 6.5 Hz, 1H, H-1′), 4.93 – 4.79 (m, 3H, H-3′and PhCHAHBN), 4.44 
(ddd, J = 9.0, 8.0, 4.0 Hz, 1H, H-5), 4.06 – 3.97 (m, 2H,  PhCHAHBN and H-4), 2.86 
(ddd, J = 13.9, 9.5, 5.0 Hz, 1H, H-2′′A), 2.68 (ddd, J = 13.9, 9.3, 7.4 Hz, 1H, H-2′′B), 
2.06 (dtd, J = 14.0, 9.5, 5.0 Hz, 1H, H-1′′A), 1.84 (dddd, J = 14.0, 9.3, 7.4, 4.0 Hz, 1H, 
H-1′′B). 
13C NMR (125 MHz, CDCl3): δ 210.0 (C-2′), 157.5 (C-2), 140.7 (ArC), 136.1 (ArC), 
128.8 (2 x ArCH), 128.7 (2 x ArCH), 128.6 (2 x ArCH), 128.5 (2 x ArCH), 128.0 
(ArCH), 126.4 (ArCH), 85.3 (C-1′), 77.4 (C-3′), 76.4 (C-5), 58.6 (C-4), 46.1 (PhCH2N), 
32.7 (C-1′′), 31.8 (C-2′′). 
ESIMS m/z 342 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C21H21NO2Na [M + Na]+: 342.1470, found: 342.1472. 
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(S)-5-Benzyl-2,2-dimethyl-1,3-dioxolan-4-one (219) 
 
To a solution of (S)-2-hydroxy-3-phenylpropionic acid (0.4985 g, 3.0 mmol) in 
acetone (5 mL) was added 2,2-dimethoxypropane (1.2654 g, 1.5 mL, 12.15 mmol, 4.05 
equiv.) and p-toluenesulfonic acid monohydrate (25.9 mg, 0.13 mmol, 0.044 equiv.) and 
the reaction mixture was stirred at room temperature for 24 h. The solvent was 
evaporated and added EtOAc (7.5 mL), washed with sat. aqueous NaHCO3 solution (2 x 
5 mL). The combined organic layer was washed with brine, dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel eluting with 20:80 EtOAc/PS to afford the title compound 219 as a colorless 
oil (0.5693 g, 92%). The spectroscopic data of this compound matched with those in the 
literature.81 
Rf = 0.6 (EtOAc:PS = 20:80). 
IR (neat): νmax 2990, 1778, 1746, 1391, 1381, 1294, 1244, 850, 754, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.33 – 7.28 (m, 2H, ArH), 7.28 – 7.22 (m, 3H, ArH), 
4.65 (dd, J = 6.5, 4.1 Hz, 1H, H-5), 3.19 (dd, J = 14.5, 4.1 Hz, 1H, PhCHAHB), 3.05 (dd, 
J = 14.5, 6.5 Hz, 1H, PhCHAHB), 1.50 (s, 3H, CH3), 1.36 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 172.6 (C-4), 135.9 (ArC), 130.0 (2 x ArCH), 128.5 (2 x 
ArCH), 127.2 (ArCH), 111.0 (C-2), 75.2 (C-5), 37.8 (PhCH2), 27.1 (CH3), 26.3 (CH3). 
(5S)-5-Benzyl-2,2-dimethyl-1,3-dioxolan-4-ol (220) 
 
To a solution of 219 (1.1289 g, 5.43 mmol) in toluene (21.8 mL) at -78 °C was 
added DIBAL-H (8.70 mL, 8.70 mmol, 1 M in toluene, 1.6 equiv.). After stirring for 30 
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min, the reaction was quenched at -78 °C with aqueous 1 M HCl (10.9 mL) at -78 °C 
and allowed to reach room temperature and stirred for another 30 min. The reaction 
mixture was diluted with water (100 mL) and extracted with CH2Cl2 (3 x 100 mL). The 
combined organic layers were dried over MgSO4, filtered and the solvent was 
concentrated in vacuo to afford the title compound 220 as a colorless oil (1.6:1 
diastereomeric mixture, 1.0463 g, 93 %), which was used without further purification. 
The spectroscopic data of this compound matched with those in the literature.81 
Rf = 0.3 (EtOAc:PS = 20:80). 
IR (neat): νmax 3381, 3028, 2916, 1703, 1605, 1497, 1454, 1144, 1042, 741, 698 cm-1. 
1H NMR (500 MHz, CDCl3) (major diastereomer): δ 7.32 – 7.27 (m, 3H, ArH), 7.26 – 
7.20 (m, 2H, ArH), 5.24 (app. t, J = 3.4 Hz, 1H, H-4), 4.27 (td, J = 6.6, 3.4 Hz, 1H, H-
5), 3.08 (d, J = 4.0 Hz, 1H, OH), 2.95 (dd, J = 14.0, 7.0 Hz, 1H, PhCHAHB), 2.88 (dd, J 
= 14.0, 6.6 Hz, 1H, PhCHAHB), 1.51 (s, 3H, CH3), 1.45 (s, 3H, CH3). 
1H NMR (500 MHz, CDCl3) (minor diastereomer): δ 7.33 – 7.27 (m, 3H, ArH), 7.27 – 
7.20 (m, 2H, ArH), 5.22 (dd, J = 6.0, 3.5 Hz, 1H, H-4), 4.21 (td, J = 6.9, 3.5 Hz, 1H, H-
5), 3.03 (d, J = 6.9 Hz, 2H, PhCH2), 2.76 (d, J = 6.0 Hz, 1H, OH), 1.56 (s, 3H, CH3), 
1.34 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) (major diastereomer): δ 137.3 (ArC), 129.4 (2 x ArCH), 
128.6 (2 x ArCH), 126.7 (ArCH), 110.9 (C-2), 99.6 (C-4), 83.7 (C-5), 39.3 (PhCH2), 
28.2 (CH3), 27.3 (CH3) 
13C NMR (125 MHz, CDCl3) (minor diastereomer): δ 137.8 (ArC), 129.4 (2 x ArCH), 
128.6 (2 x ArCH), 126.6 (ArCH), 109.8 (C-2), 95.2 (C-4), 80.7 (C-5), 35.0 (PhCH2), 
29.1 (CH3), 26.0 (CH3). 
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6.2.5 General method 5 for PBM reactions with (S)-5-benzyl-2,2-dimethyl-1,3-
dioxolan-4-ol (220) 
(2S,3R)-3-(Benzylamino)-1-phenylhexa-4,5-dien-2-ol (221a) 
 
To a solution of (S)-5-benzyl-2,2-dimethyl-1,3-dioxolan-4-ol (220) (52.1 mg, 
0.25 mmol) ) in methanol (0.4 mL) was added benzylamine (26.9 mg, 27.3 µL 0.25 
mmol, 1 equiv.) followed by pinacol allenylboronate (83.1 mg, 90 µL, 0.5 mmol, 2 
equiv.) and the mixture was stirred at room temperature for 24 h. After the reaction had 
completed, the mixture was then evaporated. The crude product was dissolved in 
CH2Cl2 (4 mL) and then washed with sat. aqueous NaHCO3 solution (2 x 4 mL). The 
combined organic layer was dried (MgSO4), filtered and concentrated in vacuo. The 
crude product was purified by column chromatography on silica gel eluting with 40:60 
EtOAc/PS to afford the title compound 221a as a white solid (46.8 mg, 67%). 
Rf = 0.2 (EtOAc:PS = 40:60). 
    
    + 16.1 (c 0.91, CHCl3). 
Mp.: 72-74 °C. 
IR (neat): νmax 3350, 3244, 3061, 2924, 2832, 1958, 1597, 1493, 1452, 1350, 1217, 
1071, 1053, 981, 747, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 – 7.15 (m, 10H, ArH), 5.23 (app. q, J = 7.0 Hz, 1H, 
H-4), 4.92 – 4.78 (m, 2H, H-6), 3.94 (dt, J = 8.5, 4.3 Hz, 1H, H-2), 3.88 (d, J = 13.0 Hz, 
1H, PhCHAHBN), 3.73 (d, J = 13.0 Hz, 1H, PhCHAHBN), 3.29 – 3.22 (m, 1H, H-3), 2.85 
– 2.73 (m, 2H, H-6). 
13C NMR (125 MHz, CDCl3): δ 209.2 (C-5), 140.2 (ArC), 138.8 (ArC), 129.5 (3 x 
ArCH), 128.6 (3 x ArCH), 128.4 (2 x ArCH), 127.2 (ArCH), 126.5 (ArCH), 88.7 (C-4), 
76.3 (C-6), 74.0 (C-2), 61.0 (C-3), 51.5 (PhCH2N), 39.7 (C-1). 
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ESIMS m/z 280 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C19H22NO [M + H]+: 280.1701, found: 280.1706. 
(2S,3R)-3-(Benzhydrylamino)-1-phenylhexa-4,5-dien-2-ol (221b) 
 
 The title compound was prepared by General method 5 using benzhydrylamine 
(45.8 mg, 43.1 µL 0.25 mmol, 1 equiv.) instead of benzylamine and pinacol 
allenylboronate (51.9 mg, 56.0 µL, 0.31 mmol, 1.25 equiv.). The mixture was stirred at 
room temperature for 6 h. Purification by column chromatography on silica gel eluting 
with 10:90 EtOAc/PS gave 221b as a light brown oil (59.3 mg, 67%). 
Rf = 0.2 (EtOAc:PS = 10:90). 
    
    + 14.2 (c 1.34, CHCl3). 
IR (neat): νmax 3551, 3059, 3026, 1950, 1659, 1599, 1493, 1452, 1028, 850, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.41 – 7.37 (m, 2H, ArH), 7.34 (d, J = 7.1 Hz, 2H, 
ArH), 7.32 – 7.24 (m, 7H, ArH), 7.24 – 7.17 (m, 4H, ArH), 5.19 (dt, J = 7.8, 6.6 Hz, 
1H, H-4), 5.02 (s, 1H, (Ph)2CH), 4.82 (dd, J = 6.6, 1.7 Hz, 2H, H-6), 3.91 (dt, J = 9.2, 
3.9 Hz, 1H, H-2), 3.18 (ddt, J = 7.8, 3.9, 1.7 Hz, 1H, H-3), 2.84 (dd, J = 14.0, 3.9 Hz, 
1H, H-1A), 2.70 (dd, J = 14.0, 9.2 Hz, 1H, H-1B). 
13C NMR (125 MHz, CDCl3): δ 209.1 (C-5), 144.4 (ArC), 143.2 (ArC), 138.9 (ArC), 
129.4 (2 x ArCH), 128.63 (2 x ArCH), 128.6 (2 x ArCH), 128.57 (2 x ArCH), 127.8 (2 
x ArCH), 127.4 (2 x ArCH), 127.2 (2 x ArCH), 126.4 (ArCH), 88.7 (C-4), 76.3 (C-6), 
74.8 (C-2), 64.2 ((Ph)2CH), 59.4 (C-3), 40.1 (C-1). 
ESIMS m/z 356 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C25H26NO [M + H]+: 356.2014, found: 356.1999. 
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(2S,3R)-3-(4-Methoxybenzylamino)-1-phenylhexa-4,5-dien-2-ol (221c) 
 
 The title compound was prepared by General method 5 using 4-methoxy 
benzylamine (34.3 mg, 32.5 µL 0.25 mmol, 1 equiv.) instead of benzylamine and 
pinacol allenylboronate (41.5 mg, 44.8 µL, 0.25 mmol, 1 equiv.). The mixture was 
stirred at room temperature for 6 h. Purification by column chromatography on silica 
gel eluting with 2.5:97.5 MeOH/CH2Cl2 gave 221c as a light brown oil (51.3 mg, 66%). 
Rf = 0.2 (EtOAc:PS = 50:50). 
    
    + 13.8 (c 0.64, CHCl3). 
IR (neat): νmax 3296, 3061, 3026, 2932, 2911, 2833, 1952, 1611,1512, 1454, 1300, 
1175, 1032, 831, 731, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.32 – 7.24 (m, 2H, ArH), 7.20 (t, J = 8.2 Hz, 5H, ArH), 
6.83 (d, J = 8.7 Hz, 2H, ArH), 5.21 (dt, J = 8.1, 6.6 Hz, 1H, H-4), 4.89 – 4.80 (m, 2H, 
H-6), 3.94 – 3.87 (m, 1H, H-2), 3.83 – 3.74 (m, 4H, OCHAHBPMP and OCH3), 3.64 (d, 
J = 12.7 Hz, 1H, OCHAHBPMP), 3.25 – 3.18 (m, 1H,  H-3), 2.83 – 2.70 (m, 2H, H-1), 
2.31 (brs, 2H, OH and NH). 
13C NMR (125 MHz, CDCl3): δ 209.2 (C-5), 158.8 (ArC), 138.8 (ArC), 132.1 (ArC), 
129.6 (2 x ArCH), 129.4 (2 x ArCH), 128.5 (2 x ArCH), 126.4 (ArCH), 113.9 (2 x 
ArCH), 88.6 (C-4), 76.2 (C-6), 73.9 (C-2), 60.8 (C-3), 55.4 (OCH3), 50.8 (OCH2PMP), 
39.7 (C-1). 
ESIMS m/z 310 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C20H24NO2 [M + H]+: 310.1807, found: 310.1805. 
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(2S,3R)-3-(Allylamino)-1-phenylhexa-4,5-dien-2-ol (221d) 
 
The title compound was prepared by General method 5 using allylamine (14.3 
mg, 18.8 µL 0.25 mmol, 1 equiv.) instead of benzylamine and pinacol allenylboronate 
(41.3 mg, 46.2 µL, 0.31 mmol, 1.25 equiv.). The mixture was stirred at room 
temperature for 6 h. Purification by column chromatography on silica gel eluting with 
5:95 MeOH/CH2Cl2 gave 221d as a light brown oil (25.3 mg, 44%). 
Rf = 0.2 (MeOH:CH2Cl2 = 5:95). 
    
    + 22.6 (c 0.35, CHCl3). 
IR (neat): νmax 3300, 3080, 3026, 2918, 2847, 1951, 1643, 1603, 1495, 1454, 1358, 
1080, 1028, 839, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.33 – 7.17 (m, 5H, ArH), 5.85 (ddt, J = 16.5, 10.1, 6.0 
Hz, 1H, H-2′), 5.24 – 5.11 (m, 2H, H-4 and H-3′A), 5.08 (d, J = 10.2 Hz, 1H, H-3′B), 
4.89 – 4.77 (m, 2H, H-6), 3.99 – 3.87 (m, 1H, H-2), 3.33 (dd, J = 14.0, 6.0 Hz, 1H, H-
1′A), 3.26 – 3.14 (m, 2H, H-1′B and H-3), 2.78 (d, J = 6.2 Hz, 2H, H-1), 2.44 (s, 2H, OH 
and NH). 
13C NMR (125 MHz, CDCl3): δ 209.3 (C-5), 138.7 (ArC), 136.3 (C-2′), 129.4 (2 x 
ArCH), 128.6 (2 x ArCH), 126.4 (ArCH), 116.6 (C-3′), 88.2 (C-4), 76.1 (C-6), 73.9 (C-
2), 60.9 (C-3), 49.8 (C-1′), 39.9 (C-1). 
ESIMS m/z 230 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C15H20NO [M + H]+: 230.1545, found: 230.1535. 
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(2S,3R)-3-(Dibenzylamino)-1-phenylhexa-4,5-dien-2-ol (221e) 
 
 The title compound was prepared by General method 5 using dibenzylamine 
(98.6 mg, 96.1 µL, 0.5 mmol, 2 equiv.) instead of benzylamine and pinacol 
allenylboronate (51.9 mg, 56.0 µL, 0.31 mmol, 1.25 equiv.). The mixture was stirred at 
room temperature for 6 h. Purification by column chromatography on silica gel eluting 
with 40:60 EtOAc/PS gave 221e as a pale yellow oil (77.4 mg, 84%). 
Rf = 0.3 (EtOAc:PS = 10:90). 
    
    - 42.8 (c 0.53, CHCl3). 
IR (neat): νmax 3449, 3061, 3026, 2924, 2833, 2805, 1948, 1603, 1495, 1452, 1364, 
1067, 1028, 837, 743, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 (d, J = 7.5 Hz, 4H, ArH), 7.31 (t, J = 7.4 Hz, 4H, 
ArH), 7.29–7.21 (m, 4H, ArH), 7.22–7.15 (m, 1H, ArH), 7.12 (d, J = 6.8 Hz, 2H, ArH), 
5.26 (dt, J = 8.7, 6.6 Hz, 1H, H-4), 4.86 (dd, J = 10.9, 6.6 Hz, 1H, H-6A), 4.80 (dd, J = 
10.9, 6.6 Hz, 1H, H-6B), 4.01 – 3.92 (m, 1H, H-2), 3.88 (d, J = 13.6 Hz, 2H, 
PhCHAHBN), 3.50 (d, J = 13.6 Hz, 2H, PhCHAHBN), 3.33 (dd, J = 14.0, 3.1 Hz, 1H, H-
1A),  3.26 (t, J = 8.7 Hz, 1H, H-3), 2.40 (dd, J = 14.0, 9.5 Hz, 1H, H-1B), 1.72 (brs, 1H, 
OH). 
13C NMR (125 MHz, CDCl3): δ 210.2 (C-5), 139.6 (2 x ArC), 139.2 (ArC), 129.5 (2 x 
ArCH), 129.1 (4 x ArCH), 128.6 (2 x ArCH), 128.5 (4 x ArCH), 127.2 (2 x ArCH), 
126.4 (ArCH), 84.4 (C-4), 74.9 (C-6), 73.7 (C-2), 63.6 (C-3), 55.3 (2 x PhCH2N), 41.1 
(C-1). 
ESIMS m/z 370 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C26H28NO [M + H]+: 370.2171, found: 370.2172. 
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(2S,3R)-3-Morpholino-1-phenylhexa-4,5-dien-2-ol (221f) 
 
 The title compound was prepared by General method 5 using morpholine (43.6 
mg, 43.7 µL 0.5 mmol) instead of benzylamine. Purification by column 
chromatography on silica gel eluting with 40:60 EtOAc/PS gave 221f as a pale yellow 
oil (59.9 mg, 92%). 
Rf = 0.2 (EtOAc:PS = 40:60). 
    
    - 21.2 (c 0.29, CHCl3). 
IR (neat): νmax 3433, 3061, 3026, 2955, 2853, 1950, 1495, 1452, 1115, 862, 841 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.33 – 7.19 (m, 5H, ArH), 5.17 (dt, J = 9.7, 6.7 Hz, 1H, 
H-4), 4.83 – 4.72 (m, 2H, H-6),  4.10 (q, J = 6.4 Hz, 1H, H-2),  3.76 – 3.65 (m, 4H, H-
2′), 2.84 (d, J = 6.4 Hz, 2H, H-1), 2.80 (dd, J = 9.7, 4.3 Hz, 1H, H-3), 2.65 – 2.53 (m, 
4H, H-1′). 
13C NMR (125 MHz, CDCl3): δ 210.1 (C-5), 138.7 (ArC), 129.5 (2 x ArCH), 128.5 (2 x 
ArCH), 128.5 (ArCH), 126.5 (ArCH), 85.2 (C-4), 75.0 (C-6), 71.0 (C-2), 69.5 (C-3), 
67.3 (2 x C-2′), 51.2 (2 x C-1′), 40.3 (C-1). 
ESIMS m/z 260 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C12H22NO2 [M + H]+: 260.1651, found: 260.1643. 
1-(Dibenzylamino)-3-phenylpropan-2-one (222) 
 
 Ketone 222 was obtained as a by-product from the above Petasis reaction of 
220, dibenzylamine and pinacol allenylboronate as a brown oil before optimizing the 
reaction condition. 
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Rf = 0.4 (EtOAc:PS = 10:90). 
IR (neat): νmax 3061, 3028, 2920, 1713, 1672, 1495, 1452, 1074, 976, 738, 969 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 – 7.18 (m, 13H, ArH), 7.04 (d, J = 7.0 Hz, 2H, 
ArH), 3.67 (s, 6H, H-3 and PhCH2N), 3.27 (s, 2H, H-1). 
13C NMR (125 MHz, CDCl3): δ 208.0 (C-2), 138.7 (2 x ArC), 134.1 (ArC), 129.5 (2 x 
ArCH), 129.2 (4 x ArCH), 128.7 (2 x ArCH), 128.5 (4 x ArCH), 127.4 (2 x ArCH), 
127.0 (ArCH), 62.0 (C-1), 58.7 (PhCH2), 47.2 (C-3). 
ESIMS m/z 330 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C23H24NO [M + H]+: 330.1858, found: 330.1844. 
6.2.6 General method 6 for synthesis of Mosher ester derivatives 
(R)-((2S,3R)-3-(Dibenzylamino)-1-phenylhexa-4,5-dien-2-yl)3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (224) 
 
 To a solution of 221e (14.7 mg, 0.04 mmol) in anhydrous CH2Cl2 (0.5mL) under 
nitrogen atmosphere was added triethylamine (23 µL, 0.16 mmol), DMAP (12.2 mg, 0.1 
mmol), and (S)-(+)-α-methoxy-α-trifluoromethylphenylacetyl chloride (20 mg, 0.08 
mmol). The reaction mixture was stirred at room temperature for 18 h and then 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel eluting with 4:96 EtOAc/PS to afford the title compound (R)-224 as a pale 
yellow oil (22.9 mg, 98%). 
Rf = 0.5 (EtOAc:PS = 8:92). 
IR (neat): νmax 3064, 3031, 2847, 1951, 1744, 1495, 1454, 1246, 1168, 731, 696 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.35 – 7.18 (m, 14H, ArH), 7.15 (t, J = 7.7 Hz, 2H, 
ArH), 7.11 (d, J = 7.9 Hz, 2H, ArH), 7.06 (dd, J = 6.8, 2.8 Hz, 2H, ArH), 5.65 (td, J = 
9.3, 3.9 Hz, 1H, H-2), 5.17 (dt, J = 9.9, 6.5 Hz, 1H, H-4), 4.78 (dd, J = 10.9, 6.5 Hz, 1H, 
H-6A), 4.55 (dd, J = 10.9, 6.5 Hz, 1H, H-6B), 3.85 (d, J = 13.6 Hz, 2H, PhCHAHBN), 
3.53 (dd, J = 14.7, 3.9 Hz, 1H, H-1A), 3.44 (d, J = 13.6 Hz, 2H, PhCHAHBN), 3.37 (t, J 
= 9.3 Hz, 1H, H-3), 3.29 (s, 3H, OCH3), 2.57 (dd, J = 14.7, 9.3 Hz, 1H, H-1B). 
13C NMR (125 MHz, CDCl3): δ 210.9 (C-5), 166.5 (C=O), 139.2 (2 x ArC), 137.4 
(ArC), 132.2 (ArC), 129.4 (3 x ArCH), 129.3 (ArCH), 129.1 (4 x ArCH), 128.7 (2 x 
ArCH), 128.5 (4 x ArCH), 128.3 (2 x ArCH), 127.5 (ArCH), 127.3 (2 x ArCH), 126.7 
(ArCH), 83.2 (C-4), 78.0 (C-2), 74.5 (C-6), 62.3 (C-3), 55.0 (OCH3), 38.6 (C-1). 
19F NMR (470 MHz, CDCl3): δ -72.64. Trifluorotoluene (C6H5CF3) referenced at δ -
63.72. 
ESIMS m/z 586 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C36H34F3NO3 [M + H]+: 586.2569, found: 586.2593. 
(S)-((2S,3R)-3-(Dibenzylamino)-1-phenylhexa-4,5-dien-2-yl)3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (224) 
 
 The title compound was prepared by General method 6 using (R)-(+)-α-
methoxy-α-trifluoromethylphenylacetyl chloride (20 mg, 0.08 mmol) instead of the (S)-
acid chloride. Purification by column chromatography on silica gel eluting with 4:96 
EtOAc/PS gave (S)-224 as a pale yellow oil (14.4 mg, 61%). 
Rf = 0.5 (EtOAc:PS = 8:92). 
IR (neat): νmax 3065, 3028, 284, 1951, 1743, 1495, 1454, 1255, 1168, 733, 696 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.38 – 7.22 (m, 11H, ArH), 7.22 – 7.15 (m, 4H, ArH), 
7.15 – 7.06 (m, 3H, ArH), 6.99 – 6.93 (m, 2H, ArH), 5.62 (td, J = 9.1, 3.6 Hz, 1H, H-2), 
5.21 (dt, J = 9.8, 6.6 Hz, 1H, H-4), 4.85 (dd, J = 11.1, 6.6 Hz, 1H, H-6A), 4.73 (dd, J = 
11.1, 6.6 Hz, 1H, H-6B), 3.88 (d, J = 13.6 Hz, 2H, PhCHAHBN), 3.53 – 3.39 (m, 4H, 
PhCHAHBN, H-1A and H-3), 3.45 (s, 3H, OCH3), 2.52 (dd, J = 14.6, 9.4 Hz, 1H, H-1B). 
13C NMR (125 MHz, CDCl3): δ 210.8 (C-5), 166.5 (C=O), 139.2 (2 x ArC), 137.3 
(ArC), 131.9 (ArC), 129.3 (3 x ArCH), 129.1 (4 x ArCH), 128.54 (4 x ArCH), 128.52 
(3 x ArCH), 128.3 (2 x ArCH), 127.6 (ArCH), 127.3 (2 x ArCH), 126.5 (ArCH), 83.7 
(C-4), 78.0 (C-2), 74.7 (C-6), 62.1 (C-3), 55.0 (OCH3), 38.5 (C-1). 
19F NMR (470 MHz, CDCl3): δ -72.87. Trifluorotoluene (C6H5CF3) referenced at δ -
63.72. 
ESIMS m/z 586 (100%) [M + H]+. 
HRMS (ESI): m/z calculated for C36H34F3NO3 [M + H]+: 586.2569, found: 586.2574. 
(R)-((2S,3R)-3-Morpholino-1-phenylhexa-4,5-dien-2-yl)3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate (225) 
 
 The title compound was prepared by General method 6 using 221f (10.4 mg, 
0.04 mmol) instead of 221e. Purification by column chromatography on silica gel 
eluting with 8:92 EtOAc/PS gave (R)-225 as a colorless oil (17.7 mg, 93%). 
Rf = 0.2 (EtOAc:PS = 8:92). 
IR (neat): νmax 2990, 2969, 2845, 1947, 1751, 1452, 1273, 1244, 1117, 1018, 700 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.41 – 7.18 (m, 10H, ArH), 5.70 (dt, J = 7.8, 5.32Hz, 
1H, H-2), 4.97 (dt, J = 9.8, 6.6 Hz, 1H, H-4), 4.71 (dd, J = 11.1, 6.6 Hz, 1H, H-6A), 4.64 
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(dd, J = 11.1, 6.6 Hz, 1H, H-6B), 3.64 (m, 4H, H-2′), 3.40 (s, 3H, OCH3), 3.14 (dd, J = 
14.4, 5.2 Hz, 1H, H-1A), 3.07 – 2.92 (m, 2H, H-1B and H-3), 2.50 (t, J = 4.7 Hz, 4H, H-
1′). 
13C NMR (125 MHz, CDCl3): δ 210.2 (C-5), 166.2 (C=O), 136.8 (ArC), 132.3 (ArC), 
129.6 (2 x ArCH), 129.5 (ArCH), 128.7 (2 x ArCH), 128.3 (2 x ArCH), 127.7 (2 x 
ArCH), 126.9 (ArCH), 84.6 (C-6), 76.1 (C-2), 74.9 (C-4), 68.0 (C-3), 67.2 (C-2′), 55.5 
(OCH3), 50.8 (C-1′), 38.2 (C-1). 
19F NMR (470 MHz, CDCl3): δ -72.77. Trifluorotoluene (C6H5CF3) referenced at δ -
63.72. 
ESIMS m/z 476 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C26H28F3NO4 [M + H]+: 476.2049, found: 476.2032. 
(S)-((2S,3R)-3-Morpholino-1-phenylhexa-4,5-dien-2-yl)3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (225) 
 
 The title compound was prepared by General method 6 using 221f (10.4 mg, 
0.04 mmol) instead of 221e and (R)-(+)-α-methoxy-α-trifluoromethylphenylacetyl 
chloride (20 mg, 0.08 mmol) instead of the (S)-acid chloride. Purification by column 
chromatography on silica gel eluting with 8:92 EtOAc/PS gave (S)-225 as a white solid 
(7.8 mg, 41%). 
Rf = 0.2 (EtOAc:PS = 8:92). 
Mp.: 82-84 °C. 
IR (neat): νmax 3031, 2958, 2853, 1953, 1744, 1453, 1249, 1168, 1019, 697 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.51 (d, J = 7.6 Hz, 2H, ArH), 7.44 – 7.30 (m, 3H, 
ArH), 7.28 – 7.15 (m, 3H, ArH), 7.11 (d, J = 7.8 Hz, 2H, ArH), 5.73 (dt, J = 7.5, 5.2 
Hz, 1H, H-2), 5.09 (dt, J = 9.9, 6.6 Hz, 1H, H-4), 4.76 (d, J = 6.6 Hz, 2H, H-6), 3.74 – 
3.59 (m, 4H, H-2′), 3.40 (s, 3H, OCH3), 3.03 (dd, J = 14.3, 5.2 Hz, 1H, H-1A), 2.99 – 
2.90 (m, 2H, H-1B and H-3), 2.56 (t, J = 4.6 Hz, 4H, H-1′). 
13C NMR (125 MHz, CDCl3): δ 210.3 (C-5), 166.1 (C=O), 136.7 (ArC), 132.5 (ArC), 
129.7 (2 x ArCH), 129.6 (ArCH), 128.5 (2 x ArCH), 128.4 (2 x ArCH), 127.7 (2 x 
ArCH), 126.8 (ArCH), 85.2 (C-6), 75.5 (C-2), 75.2 (C-4), 67.9 (C-3), 67.2 (C-2′), 55.5 
(OCH3), 51.0 (C-1′), 38.2 (C-1). 
19F NMR (470 MHz, CDCl3): δ -72.46. Trifluorotoluene (C6H5CF3) referenced at δ -
63.72. 
ESIMS m/z 476 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C26H28F3NO4 [M + H]+: 476.2049, found: 476.2063. 
(2R,3S,4S,5S)-5-(Benzylamino)-1,3-bis(benzyloxy)octa-6,7-diene-2,4-diol (231) 
 
To a solution of 3,5-di-O-benzyl-,-L-xylofuranose (230) (100.0 mg, 0.3 
mmol) in methanol-d4 (0.5 mL) in a NMR tube was added benzylamine (40.2 mg, 40.0 
µL, 0.375 mmol, 1.25 equiv.) followed by pinacol allenylboronate (62.3 mg, 69.5 µL, 
0.375 mmol, 1.25 equiv.). The reaction mixture was left at room temperature and 
monitored by 1H NMR spectroscopy at 0.5 h, 2 h, 52 h and 72 h. The mixture was then 
evaporated and redissolved in CH2Cl2 (2 mL) and then washed with sat. aqueous 
NaHCO3 solution (2 x 2 mL). The combined organic layer was dried (MgSO4), filtered 
and concentrated in vacuo. The crude product was purified by column chromatography 
on silica gel eluting with 4:96 MeOH/CH2Cl2 to afford the title compound 231 as a pale 
yellow oil (39.4 mg, 29%). 
Rf = 0.3 (EtOAc:PS = 70:30). 
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    - 14.7 (c 0.14, CHCl3). 
IR (neat): νmax 3356, 3064, 3031, 2924, 2855, 1955, 1560, 1507, 1073, 735, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 – 7.22 (m, 13H, ArH), 7.19 (d, J = 7.5 Hz, 2H, 
ArH), 5.25 (dt, J = 8.7, 6.7 Hz, 1H, H-6), 4.83 (dd, J = 11.0, 6.7 Hz, 1H, H-8A), 4.77 
(dd, J = 11.0, 6.7 Hz, 1H, H-8B), 4.65 – 4.54 (m, 3H, PhCH2O and PhCHAHBO), 4.52 
(d, J = 11.4 Hz, 1H, PhCHAHBO), 4.05 – 4.00 (m, 1H, H-2), 3.97 – 3.87 (m, 2H, H-4 
and PhCHAHBN), 3.75 – 3.66 (m, 4H, H-1, H-3 and PhCHAHBN), 3.63 (dd, J = 8.7, 4.4 
Hz, 1H, H-5). 
13C NMR (125 MHz, CDCl3): δ 209.3 (C-7), 139.2 (ArC), 138.3 (ArC), 138.1 (ArC), 
128.7 (2 x ArCH), 128.6 (2 x ArCH), 128.6 (2 x ArCH), 128.5 (2 x ArCH), 128.1 (2 x 
ArCH), 128.1 (2 x ArCH), 128.0 (ArCH), 127.8 (ArCH), 127.4 (ArCH), 88.6 (C-6), 
79.6 (C-3), 76.4 (C-8), 73.8 (PhCH2O), 73.7 (C-4), 73.3 (PhCH2O), 71.5 (C-1), 69.9 (C-
2), 58.8 (C-5), 51.3 (PhCH2N). 
ESIMS m/z 460 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C29H34NO4 [M + H]+: 460.2488, found: 460.2500. 
(2R,3S,4S)-1,3-Bis(benzyloxy)-5-(dibenzylamino)octa-6,7-diene-2,4-diol (232) 
 
To a solution of 3,5-di-O-benzyl-,-L-xylofuranose (230) (100.0 mg, 0.3 
mmol) in methanol-d4 (0.5 mL) in a NMR tube was added benzylamine (40.2 mg, 40.0 
µL, 0.375 mmol, 1.25 equiv.) followed by pinacol allenylboronate (62.3 mg, 69.5 µL, 
0.375 mmol, 1.25 equiv.). The reaction mixture was left at room temperature and 
monitored by 1H NMR spectroscopy at 0.5 h, 2 h, 52 h and 72 h. The mixture was then 
evaporated and redissolved in CH2Cl2 (2 mL) and then washed with sat. aqueous 
NaHCO3 solution (2 x 2 mL). The combined organic layer was dried (MgSO4), filtered 
and concentrated in vacuo. The crude product was purified by column chromatography 
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on silica gel eluting with 4:96 MeOH/CH2Cl2 to afford the title compound 232 as a pale 
yellow oil (41.2 mg, 25%). 
Rf = 0.1 (EtOAc:PS = 15:85). 
    
    + 16.9 (c 0.10, CHCl3). 
IR (neat): νmax 3420, 3028, 2916, 2849, 1948, 1495, 1452, 1071, 733, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.40 – 7.16 (m, 18H, ArH), 7.05 – 6.98 (m, 2H, ArH), 
5.30 (dt, J = 9.5, 6.6 Hz, 1H, H-6), 4.84 (dd, J = 10.9, 6.6 Hz, 1H, H-8A), 4.74 (dd, J = 
10.9, 6.5 Hz, 1H, H-8B), 4.48 (d, J = 11.8 Hz, 1H, PhCHAHBO), 4.44 – 4.35 (m, 3H, 
PhCHAHBO and PhCH2O), 4.09 (t, J = 5.6 Hz, 1H, H-4), 3.87 (d, J = 13.6 Hz, 2H, 
PhCHAHBN), 3.77 (t, J = 5.5 Hz, 1H, H-3), 3.72 (q, J = 5.2 Hz, 1H, H-2), 3.64 (dd, J = 
9.5, 6.1 Hz, 1H, H-5), 3.55 (dd, J = 9.8, 3.9 Hz, 1H, H-1A), 3.50 (dd, J = 9.8, 5.2 Hz, 
1H, H-1B), 3.46 (d, J = 13.6 Hz, 2H, PhCHAHBN). 
13C NMR (125 MHz, CDCl3): δ 210.4 (C-7), 139.6 (2 x ArC), 138.1 (ArC), 138.0 
(ArC), 129.2 (3 x ArCH), 128.5 (2 x ArCH), 128.42 (4 x ArCH), 128.40 (4 x ArCH), 
127.94 (3 x ArCH), 127.92 (ArCH), 127.7 (ArCH), 127.1 (2 x ArCH), 84.3 (C-6), 79.2 
(C-3), 74.6 (C-8), 74.3 (C-4), 73.4 (PhCH2O), 73.3 (PhCH2O), 70.9 (C-1), 70.9 (C-2), 
60.3 (C-5), 55.0 (PhCH2N). 
ESIMS m/z 550 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C36H40NO4 [M + H]+: 550.2957, found: 550.2961. 
(4S,5S)-3-Benzyl-5-((1R,2R)-1,3-bis(benzyloxy)-2-hydroxypropyl)-4-(propa-1,2-
dien-1-yl)oxazolidin-2-one (233) 
 
The title compound was prepared following General method 4 for the synthesis 
of oxazolidinones using 1,2-amino alcohol 231 (55.2 mg, 0.12 mmol), triethylamine 
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(48.6 mg, 67.0 µL, 0.48 mmol, 4.0 equiv.), and triphosgene (18.0 mg, 0.06 mmol, 0.5 
equiv.). Purification by column chromatography on silica gel eluting with 20:80 
EtOAc/PS gave compound 233 as a colorless oil (17.0 mg, 29%). 
Rf = 0.1 (EtOAc:PS = 20:80). 
    
    + 7.6 (c 0.91, CHCl3). 
IR (neat): νmax 3436, 3031, 2920, 2869, 1955, 1737, 1497, 1454, 1028, 736, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.39 – 7.16 (m, 15H, ArH), 5.21 (dt, J = 8.8, 6.5 Hz, 
1H, H-1′), 4.89 – 4.79 (m, 2H, H-3′A and PhCHAHBN), 4.77 (dd, J = 11.7, 6.5 Hz, 1H, 
H-3′B), 4.72 (d, J = 11.1 Hz, 1H, PhCHAHBO), 4.66 (t, J = 7.4 Hz, 1H, H-5), 4.62 (d, J = 
11.1 Hz, 1H, PhCHAHBO), 4.58 – 4.50 (m, 2H, PhCH2O), 4.22 – 4.14 (m, 2H, H-4 and 
H-2′′), 4.02 (d, J = 15.0 Hz, 1H, PhCHAHBN), 3.97 (dd, J = 7.0, 5.0 Hz, 1H, H-3′′), 3.64 
(d, J = 5.1 Hz, 2H, H-1′′), 2.52 (d, J = 4.2 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 210.0 (C-2′), 157.0 (C-2), 137.9 (ArC), 137.8 (ArC), 
136.1 (ArC), 128.8 (2 x ArCH), 128.6 (2 x ArCH), 128.5 (2 x ArCH), 128.4 (2 x 
ArCH), 128.03 (ArCH), 128.02 (2 x ArCH), 127.94 (ArCH), 127.91 (ArCH), 127.8 (2 x 
ArCH), 86.0 (C-1′), 78.2 (C-3′′), 77.6 (C-3′), 75.7 (C-5), 74.3 (PhCH2O), 73.6 
(PhCH2O), 70.6 (C-2′′), 70.4 (C-1′′), 57.8 (C-4), 45.9 (PhCH2N). 
ESIMS m/z 508 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C30H31NO5Na [M + Na]+: 508.2100, found: 580.2103. 
(3R,6R)-3,6-Bis((S)-2-((4-methoxybenzyl)oxy)propyl)-1,4-dioxane-2,5-diol (235) 
 
The title compound was prepare following General method 2 for selective 
oxidation of primary alcohol using (2R,4S)-4-((4-methoxybenzyl)oxy)pentane-1,2-diol 
(49.1 mg, 0.205 mmol), TEMPO (0.6 mg, 0.004 mmol, 0.02 equiv.), potassium bromide 
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(26.9 mg, 0.226 mmol, 1.1 equiv.), sat. aqueous NaHCO3 solution (0.82 mL) and 
commercial 0.7 M sodium hypochlorite solution (0.41 mL, 0.287 mmol, 1.4 equiv.). 
After quenching and extraction protocol, crude product was obtained as a white powder 
which was used without further purification.82 
 (2S,4R,5S)-5-(Benzylamino)-2-((4-methoxybenzyl)oxy)octa-6,7-dien-4-ol (236) 
 
To a solution of the crude diol 235 in methanol (0.2 mL) was added 
benzylamine (16.1 mg, 17.0 µL, 0.15 mmol) followed by pinacol allenylboronate (24.9 
mg, 28.0 µL, 0.15 mmol, 1 equiv.) and the mixture was stirred at room temperature for 
24 h. After the reaction had completed, the mixture was then evaporated. The crude 
product was redissolved in CH2Cl2 (2 mL) and then washed with sat. aqueous NaHCO3 
solution (2 x 2 mL). The combined organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel eluting with 4:44:52 MeOH/EtOAc/PS to afford the title compound 236 as a 
pale yellow oil (22.5 mg, 41%). 
Rf = 0.2 (EtOAc:PS = 70:30). 
    
    + 3.7 (c 0.35, CHCl3). 
IR (neat): νmax 3447, 3031, 2967, 2909, 1952, 1613, 1512, 1454, 1246, 1033, 699 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.34 – 7.28 (m, 4H, ArH), 7.27 – 7.22 (m, 3H, ArH), 
6.86 (d, J = 8.6 Hz, 2H, ArH), 5.13 (app. q, J = 6.8 Hz, 1H, H-6), 4.80 (dd, J = 6.8, 1.8 
Hz, 2H, H-8), 4.53 (d, J = 11.2 Hz, 1H, PMPCHAHBO), 4.37 (d, J = 11.2 Hz, 1H, 
PMPCHAHBO), 3.97 (dt, J = 9.7, 3.2 Hz, 1H, H-4), 3.90 (d, J = 13.0 Hz, 1H, 
PhCHAHB), 3.85 – 3.80 (m, 1H, H-2), 3.79 (s, 3H, OCH3), 3.72 (d, J = 13.0 Hz, 1H, 
PhCHAHB), 3.19 – 3.12 (m, 1H, H-5), 1.69 – 1.53 (m, 2H, H-3), 1.23 (d, J = 6.2 Hz, 3H, 
H-1). 
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13C NMR (125 MHz, CDCl3): δ 208.9 (C-7), 159.3 (ArC), 140.4 (ArC), 131.0 (ArC), 
129.5 (2 x ArCH), 128.5 (2 x ArCH), 128.4 (2 x ArCH), 127.2 (ArCH), 114.0 (2 x 
ArCH), 89.2 (C-6), 76.2 (C-8), 72.4 (C-2), 70.6 (PMPCH2O), 69.7 (C-4), 61.5 (C-5), 
55.4 (OCH3), 51.5 (PhCH2N), 39.7 (C-3), 19.9 (C-1). 
ESIMS m/z 368 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C22H30NO3 [M + H]+: 368.2226, found: 368.2233. 
(2S,4R,5S)-5-(Dibenzylamino)-2-((4-methoxybenzyl)oxy)octa-6,7-dien-4-ol (237) 
 
To a solution of the above crude diol 235 in methanol (0.2 mL) was added 
dibenzylamine (29.6 mg, 30.0 µL, 0.15 mmol) followed by pinacol allenylboronate 
(24.9 mg, 28.0 µL, 0.15 mmol, 1 equiv.) and the mixture was stirred at room 
temperature for 24 h. After the reaction had completed, the mixture was then 
evaporated. The crude product was redissolved in CH2Cl2 (2 mL) and then washed with 
sat. aqueous NaHCO3 solution (2 x 2 mL). The combined organic layer was dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS to afford the title compound 
237 as a pale yellow oil (32.5 mg, 47%). 
Rf = 0.3 (EtOAc:PS = 15:85). 
    
    + 6.5 (c 0.36, CHCl3). 
IR (neat): νmax 3483, 3026, 2967, 2836, 1950, 1613, 1513, 1247, 1028, 748, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.27 (m, 8H, ArH), 7.26 – 7.20 (m, 2H, ArH), 
7.13 (d, J = 8.6 Hz, 1H, ArH), 6.81 (d, J = 8.6 Hz, 1H, ArH), 5.24 (dt, J = 9.2, 6.6 Hz, 
1H, H-6), 4.86 (dd, J = 10.5, 6.6 Hz, 1H, H-8A), 4.81 (dd, J = 10.5, 6.6 Hz, 1H, H-8B), 
4.34 (d, J = 11.1 Hz, 1H, PMPCHAHBO), 4.00 (d, J = 11.1 Hz, 1H, PMPCHAHBO), 4.02 
– 3.95 (m, 1H, H-4), 3.77 (s, 3H, OCH3), 3.77 (d, J = 13.4 Hz, 2H, PhCHAHBN) , 3.58 – 
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3.49 (m, 1H, H-2), 3.42 (d, J = 13.4 Hz, 2H, PhCHAHBN), 3.18 (app. t, J = 8.9 Hz, 1H, 
H-5), 1.97 (ddd, J = 14.7, 8.4, 2.5 Hz, 1H, H-3A), 1.66 (ddd, J = 14.7, 7.7, 3.2 Hz, 1H, 
H-3B), 1.15 (d, J = 6.1 Hz, 3H, H-1). 
13C NMR (125 MHz, CDCl3): δ 210.4 (C-7), 159.3 (ArC), 139.8 (ArC), 130.7 (ArC), 
129.4 (2 x ArCH), 129.3 (4 x ArCH), 128.4 (4 x ArCH), 127.1 (2 x ArCH), 113.9 (2 x 
ArCH), 85.1 (C-6), 74.4 (C-8), 73.1 (C-2), 70.2 (PMPCH2O), 69.9 (C-4), 62.9 (C-5), 
55.4 (OCH3), 54.8 (PhCH2N), 39.7 (C-3), 19.6 (C-1). 
ESIMS m/z 458 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C30H36NO3 [M + H]+: 458.2695, found: 458.2713. 
6.2.7 General method 7 for PBM reactions with salicylaldehyde 
2-(1-Morpholinobuta-2,3-dienyl)phenol (238a) 
 
 To a solution of salicylaldehyde (61.1 mg, 53 µL, 0.5 mmol) in methanol (0.5 
mL) was added morpholine (65.3 mg, 65.6 µL, 0.75 mmol, 1.5 equiv.) followed by 
pinacol allenylboronate (103.8 mg, 112 µL, 0.625 mmol, 1.25 equiv.) and the mixture 
was stirred at room temperature. After the reaction had completed (1 h) the MeOH was 
then evaporated. The crude product was purified by column chromatography on silica 
gel eluting with 15:85 EtOAc/PS to afford the title compound 238a as a yellow oil 
(101.8 mg, 88%). 
Rf = 0.3 (EtOAc:PS = 15 : 85). 
IR (neat): νmax 3046, 2961, 2849, 1954, 1609, 1586, 1487, 1452, 1248, 1115 cm-1. 
1H NMR (500 MHz, CDCl3): δ 10.90 (s, 1H, OH), 7.19 (t, J = 7.7 Hz, 1H, H-5), 7.06 
(dd, J = 7.8, 1.7 Hz, 1H, H-3), 6.88 – 6.77 (m, 2H, H-4 and H-6), 5.33 (dt, J = 9.8, 6.6 
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Hz, 1H, H-2′), 4.90 – 4.74 (m, 2H, H-4′), 4.09 (d, J = 9.8 Hz, 1H, H-1′), 3.76 (brs, 4H, 2 
x H-2′′), 2.72 (brs, 2H, H-1′′A), 2.57 (brs, 2H, H-1′′B). 
13C NMR (125 MHz, CDCl3): δ 209.7 (C-3′) 156.7 (C-1), 129.3 (C-3), 128.6 (C-5), 
124.1 (C-2), 119.7 (C-4), 116.7 (C-6), 87.5 (C-2′), 76.1 (C-4′), 70.5 (C-1′), 67.0 (2 x C-
2′′), 50.6 (2 x C-1′′). 
ESIMS m/z 232 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C14H18NO2 [M + H]+: 232.1338, found: 232.1339. 
2-(1-(Piperidin-1-yl)buta-2,3-dienyl)phenol (238b) 
 
The title compound was prepared by General method 7 using piperidine (63.9 
mg, 74.1 µL, 0.75 mmol) instead of morpholine. Purification by column 
chromatography on silica gel eluting with 2:98 EtOAc/PS gave 238b as a light brown 
oil (100.2 mg, 87%). 
Rf = 0.2 (EtOAc:PS = 2:98). 
IR (neat): νmax 3030, 2934, 2851, 1954, 1601, 1586, 1464, 1454, 1621, 1088 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.16 (td, J = 7.7, 1.7 Hz, 1H, H-5), 7.06 (dd, J = 7.6, 1.7 
Hz, 1H, H-3), 6.86 – 6.72 (m, 2H, H-4 and H-6), 5.33 (dt, J = 9.9, 6.5 Hz, 1H, H-2'), 
4.87 – 4.72 (m, 2H, H-4'), 4.21 (d, J = 9.9 Hz, 1H, H-1'), 2.64 (brs, 2H, H-1''A), 2.54 
(brs, 2H, H-1''B), 1.71 – 1.57 (m, 4H, H-2''), 1.49 (brs, 2H, H-3''). 
13C NMR (125 MHz, CDCl3): δ 209.7 (C-3'), 157.7 (C-1), 128.9 (C-5), 128.2 (C-3), 
124.8 (C-2), 119.1 (C-4), 116.6 (C-6), 86.9 (C-2'), 75.6 (C-4'), 70.0 (C-1'), 50.7 (2 x C-
1''), 26.2 (2 x C-2''), 24.3(C-3''). 
ESIMS m/z 230 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C15H20NO2 [M + H]+: 230.1545, found: 230.1541. 
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2-(1-(Dibenzylamino)buta-2,3-dienyl)phenol (238c) 
 
The title compound was prepared by General method 7 using dibenzylamine 
(63.9 mg, 74.1 µL, 0.75 mmol) instead of morpholine. Purification by column 
chromatography on silica gel eluting with 2:98 EtOAc/PS gave 238c as a light brown 
solid (96.1 mg, 56%). 
Rf = 0.4 (EtOAc:PS = 2:98). 
Mp.: 94-96 °C. 
IR (neat): νmax 3030, 2922, 2847, 1945, 1603, 1584, 1487, 1454, 1621, 1229, 1069 cm-1. 
1H NMR (500 MHz, CDCl3): δ 11.14 (s, 1H, OH), 7.37 – 7.24 (m, 10H, ArH), 7.21 (d, J 
= 7.7 Hz, 1H, H-3), 7.17 (t, J = 7.8 Hz, 1H, H-5), 6.85 (d, J = 8.0 Hz, 1H, H-6), 6.81 (t, 
J = 7.5 Hz, 1H, H-4), 5.48 (dt, J = 10.2, 6.5 Hz, 1H, H-2'), 5.01 (dd, J = 11.3, 6.5 Hz, 
1H, H-4'A), 4.90 (dd, J = 11.3, 6.5 Hz, 1H, H-4'B), 4.72 (d, J = 10.2 Hz, 1H, H-1'), 3.86 
(d, J = 12.9 Hz, 2H, PhCHAHBN), 3.48 (d, J = 12.9 Hz, 2H, PhCHAHBN). 
13C NMR (125 MHz, CDCl3): δ 210.7 (C-3'), 157.3 (C-1), 137.3 (ArC), 130.0 (4 x 
ArCH), 129.2 (C-5), 128.8 (4 x ArCH), 128.3 (C-3), 127.1 (2 x ArCH), 124.6 (C-2), 
119.3 (C-4), 116.6 (C-6), 83.6 (C-2'), 75.7 (C-4'), 61.6 (C-1'), 53.7 (2 x PhCH2N). 
ESIMS m/z 342 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C24H24NO [M + H]+: 342.1858, found: 342.1873. 
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2-(1-(Benzyl(cyclopropyl)amino)buta-2,3-dien-1-yl)phenol (238d) 
 
The title compound was prepared by General method 7 using N-benzyl 
cyclopropylamine (110.4 mg, 0.75 mmol) instead of morpholine. Purification by 
column chromatography on silica gel eluting with 2.5:97.5 EtOAc/PS gave 238d as a 
pale yellow oil (96.1 mg, 56%). 
Rf = 0.3 (EtOAc:PS = 2.5:97.5). 
IR (neat): νmax 3029, 2945, 2847, 1951, 1584, 1488, 1454, 1255, 1023, 752, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 10.74 (s, 1H, OH), 7.35 – 7.22 (m, 5H, ArH), 7.22 – 
7.16 (m, 2H, H-3 and H-5), 6.89 – 6.80 (m, 2H, H-4 and H-6), 5.54 (dt, J = 10.0, 6.6 
Hz, 1H, H-2′), 4.90 – 4.79 (m, 2H, H-4′), 4.74 (d, J = 10.0 Hz, 1H, H-1′), 3.82 (d, J = 
12.7 Hz, 1H, PhCHAHBN), 3.67 (d, J = 12.7 Hz, 1H, PhCHAHBN), 2.07 – 1.99 (m, 1H, 
H-1′′), 0.52 – 0.34 (m, 4H, H-2′′). 
13C NMR (125 MHz, CDCl3): δ 210.1 (C-3'), 157.5 (C-1), 137.1 (ArC), 130.4 (4 x 
ArCH), 129.1 (C-5), 128.4 (4 x ArCH), 128.0 (C-3), 127.6 (2 x ArCH), 125.1 (C-2), 
119.4 (C-4), 116.6 (C-6), 85.3 (C-2'), 75.4 (C-4'), 66.1 (C-1'), 56.1 (PhCH2N), 34.2 (C-
1′′), 9.2 (C-2′′), 4.9 (C-2′′). 
ESIMS m/z 292 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C20H22NO [M + H]+:, 292.1701,  found: 292.1711. 
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2-(1-(Benzylamino)but-3-ynyl)phenol (239a) 
 
The title compound was prepared by General method 7 using benzylamine (80.4 
mg, 81.8 µL 0.75 mmol) instead of morpholine. Purification by column chromatography 
on silica gel eluting with 5:95 EtOAc/PS gave 239a as a pale yellow oil (94.8 mg, 75%). 
Rf = 0.2 (EtOAc:PS = 5:95). 
IR (neat): νmax 3464, 3375, 3359, 3290, 2950, 2852, 2119, 1628, 1590, 1477, 1454, 
1255, 1151, 1090 cm-1. 
1H NMR (500 MHz, CDCl3): δ 11.44 (s, 1H, OH), 7.38 – 7.22 (m, 5H, ArH), 7.19 (t, J 
= 7.7 Hz, 1H, H-5), 6.97 (d, J = 7.4 Hz, 1H, H-3), 6.86 (d, J = 8.1 Hz, 1H, H-6), 6.81 (t, 
J = 7.4 Hz, 1H, H-4), 3.96 (dd, J = 10.5, 4.2 Hz, 1H, H-1'), 3.88 (d, J = 13.1 Hz, 1H, 
PhCHAHBN), 3.64 (d, J = 13.1 Hz, 1H, PhCHAHBN), 2.72 (ddt, J = 17.1, 10.5, 2.0 Hz, 
1H, H-2'A), 2.55 (ddt, J = 17.1, 4.2, 2.0 Hz, 1H, H-2'B), 2.09 (t, J = 2.0 Hz, 1H, H-4'). 
13C NMR (125 MHz, CDCl3): δ 157.5 (C-1), 138.3 (ArC), 129.3 (C-5), 129.0 (C-3), 
128.9 (2 x ArCH), 128.6 (2 x ArCH), 127.8 (ArCH), 123.7 (C-2), 119.5 (C-4), 117.2 
(C-6), 80.8 (C-3'), 71.5 (C-4'), 61.7 (C-1'), 51.6 (PhCH2N), 26.0 (C-2'). 
ESIMS m/z 252 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C17H18NO [M + H]+: 252.1388, found: 252.1382. 
2-(1-(Cyclopropylamino)but-3-yn-1-yl)phenol (239b) 
 
The title compound was prepared by General method 7 using cyclopropylamine 
(42.8 mg, 53.0 µL 0.75 mmol) instead of morpholine. Purification by column 
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chromatography on silica gel eluting with 10:90 Et2O/PS gave 239b as a pale yellow oil 
(74.1 mg, 74%). 
Rf = 0.2 (diethyl ether:PS = 10:90). 
IR (neat): νmax 3289, 3006, 2956, 2858, 2118, 1589, 1489, 1477, 1254, 752, 633 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.16 (td, J = 7.8, 1.7 Hz, 1H, H-5), 7.03 (dd, J = 7.7, 1.7 
Hz, 1H, H-3), 6.84 – 6.65 (m, 2H, H-4 and H-6), 4.01 (dd, J = 10.0, 4.6 Hz, 1H, H-1'), 
2.69 (ddd, J = 17.1, 10.0, 2.7 Hz, 1H, H-2'A), 2.56 (ddd, J = 17.1, 4.6, 2.7 Hz, 1H, H-
2'B), 2.20 (tt, J = 6.7, 4.0 Hz, 1H, H-1''), 2.11 (t, J = 2.7 Hz, 1H, H-4''), 0.55 – 0.33 (m, 
4H, H-2''). 
13C NMR (125 MHz, CDCl3): δ 157.3 (C-1), 129.1 (C-5), 128.5 (C-3), 125.1 (C-2), 
119.4 (C-4), 117.1 (C-6), 80.9 (C-3′), 71.4 (C-4′), 62.8 (C-1′), 30.1 (C-1′′), 25.6 (C-2′), 
5.9 (C-2′′), 5.3 (C-2′′). 
ESIMS m/z 201 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C13H16NO [M + H]+: 201.1154, found: 201.1145. 
2-(1-(Allylamino)but-3-ynyl)phenol (239c) 
 
The title compound was prepared by General method 7 using allylamine (42.8 
mg, 56.3 µL 0.75 mmol) instead of morpholine. Purification by column chromatography 
on silica gel eluting with 5:95 EtOAc/PS gave 239c as a pale yellow oil (71.0 mg, 70%). 
Rf = 0.2 (EtOAc:PS = 5:95). 
IR (neat): νmax 3295, 3046, 2914, 2849, 2116, 1613, 1587, 1489, 1476, 1254, 1094 cm-1. 
1H NMR (500 MHz, CDCl3): δ 11.40 (s, 1H, OH), 7.16 (td, J = 7.7, 1.7 Hz, 1H, H-5), 
6.96 (dd, J = 7.5, 1.7 Hz, 1H, H-3), 6.84 – 6.75 (m, 2H, H-4 and H-6), 5.89 (dddd, J = 
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17.2, 10.3, 7.0, 4.8 Hz, 1H, H-2''), 5.28 – 5.12 (m, 2H, 2 x H-3''), 3.98 (dd, J = 10.5, 4.3 
Hz, 1H, H-1'), 3.33 (dd, J = 14.3, 4.8 Hz, 1H, H-1''A), 3.17 (dd, J = 14.3, 7.0 Hz, 1H, H-
1''B), 2.71 (ddd, J = 17.1, 10.5, 2.6 Hz, 1H, H-2'A), 2.57 (ddd, J = 17.1, 4.3, 2.6 Hz, 1H, 
H-2'B), 2.37 (s, 1H, NH), 2.12 (t, J = 2.6 Hz, 1H, H-4'). 
13C NMR (125 MHz, CDCl3): δ 157.6 (C-1), 134.8 (C-2''), 129.2 (C-5), 128.8 (C-3), 
123.7 (C-2), 119.4 (C-4), 117.4 (C-3''), 117.2 (C-6), 80.9 (C-3'), 71.5 (C-4'), 61.6 (C-1'), 
49.5 (C-1''), 26.0 (C-2'). 
ESIMS m/z 202 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C13H16NO [M + H]+: 202.1232, found: 202.1232. 
2-(1-(Benzhydrylamino)but-3-ynyl)phenol (239d) 
 
The title compound was prepared by General method 7 using benzhydrylamine 
(137.4 mg, 129.3 µL 0.75 mmol) instead of morpholine. Purification by column 
chromatography on silica gel eluting with 3:97 EtOAc/PS gave 239d as a pale yellow 
solid (109.3 mg, 67%). 
Rf = 0.2 (EtOAc:PS = 3:97). 
Mp.: 96-98 °C. 
IR (neat): νmax 3293, 3059, 2916, 2849, 2117, 1609, 1586, 1475, 1464, 1254, 1030 cm-1. 
1H NMR (500 MHz, CDCl3): δ 11.11 (s, 1H, OH), 7.38 (t, J = 7.4 Hz, 2H, ArH), 7.35 – 
7.15 (m, 8H, ArH and H-5), 6.87 (d, J = 8.1 Hz, 1H, H-6), 6.82 – 6.74 (m, 2H, H-3 and 
H-4), 4.85 (d, J = 8.8 Hz, 1H, (Ph)2CH), 3.83 (dd, J = 10.8, 4.1 Hz, 1H, H-1'), 3.15 (d, J 
= 11.4 Hz, 1H, NH), 2.79 (ddd, J = 17.1, 10.8, 2.7 Hz, 2H, H-2'A), 2.50 (ddd, J = 17.1, 
4.1, 2.7 Hz, 1H, H-2'B), 2.14 (t, J = 2.7 Hz, 1H, H-4'). 
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13C NMR (125 MHz, CDCl3): δ 157.5 (C-1), 142.3 (ArC), 140.6 (ArC), 129.3 (C-5), 
129.1 (C-3), 129.0 (2 x ArCH), 128.7 (2 x ArCH), 128.0 (2 x ArCH), 127.8 (ArCH), 
127.5 (2 x ArCH), 127.4 (ArCH), 123.6 (C-2), 119.7 (C-4), 117.3 (C-6), 80.9 (C-2'), 
71.7 (C-4'), 62.8 ((Ph)2CH), 59.1 (C-1'), 25.6 (C-2'). 
ESIMS m/z 328 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C23H22NO [M + H]+: 328.1701, found: 328.1699. 
6.2.8 NMR Study experiments of the PBM reactions 
1-(2-Methoxyphenyl)but-3-yn-1-ol (247a)147 and 1-(2-methoxyphenyl)buta-2,3-
dien-1-ol (248a)148 
       
Procedure A: To a solution of 2-methoxybenzaldehyde (68.1 mg, 0.5 mmol) in 
methanol-d4 (0.5 mL) in a NMR tube was added benzylamine (56.2 mg, 55.0 µL, 0.5 
mmol, 1.0 equiv.) and pinacol allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 
equiv.). The reaction mixture was left at room temperature and monitored by NMR 
spectroscopy at 1, 4, 24, 28, 30 and 48 h. The mixture was concentrated in vacuo. The 
crude product was purified by column chromatography on silica gel eluting with 10:90 
EtOAc/PS to afford a mixture (1.6:1) of compounds 247a and 248a, respectively, as a 
yellow oil (20.7 mg, 24%).  
Procedure B: To a solution of N-benzyl-1-(2-methoxyphenyl)methanimine149 
(249) (112.7 mg, 0.5 mmol) in methanol-d4 (0.5 mL) in a NMR tube was added pinacol 
allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 equiv). The reaction mixture was left 
at room temperature and monitored by NMR spectroscopy at 1, 4, 24, 28, 30 and 48 h. 
The mixture was concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 10:90 EtOAc/PS to afford a mixture (1.6:1) 
of compound 247a and 248a, respectively, as a yellow oil (3.5 mg, 4%). The 
spectroscopic data of these compounds matched with those in the literature.148 
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248a: Rf = 0.3 (EtOAc:PS = 15:85). 
1H NMR (500 MHz, CDCl3): δ 7.35 (d, J = 7.4 Hz, 1H, H-6′), 7.28 (t, J = 7.9 Hz, 1H, 
H-4′), 6.97 (t, J = 7.6 Hz, 1H, H-5′), 6.89 (d, J = 8.3 Hz, 1H, H-3′), 5.56 (app. q, J = 6.4 
Hz, 1H, H-2), 5.45 (d, J = 6.7 Hz, 1H, H-1), 4.95 – 4.81 (m, 2H, H-4), 3.88 (s, 3H, 
OCH3), 2.80 (m, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 207.3 (C-3), 156.8 (C-2′), 130.9 (C-1′), 129.0 (C-4′), 
127.3 (C-6′), 121.0 (C-5′), 110.8 (C-3′), 94.2 (C-2), 77.9 (C-4), 69.2 (C-1), 55.5 
(OCH3). 
1-Phenylbut-3-yn-1-ol (247b)150 and 1-phenylbuta-2,3-dien-1-ol (248b)151  
                    
 To a solution of benzaldehyde (53.1 mg, 62.0 µL 0.5 mmol) in methanol-d4 (0.5 
mL) in a NMR tube was added morpholine (43.7 mg, 44.0 µL, 0.5 mmol, 1.0 equiv.) 
and pinacol allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 equiv.). The reaction 
mixture was left at room temperature and monitored by NMR spectroscopy at 1, 2, 4 
and 22 h. The mixture was concentrated in vacuo. The crude product was purified by 
column chromatography on silica gel eluting with 15:85 EtOAc/PS to afford a mixture 
(10:1) of compounds 247a and 247b, respectively, as a yellow oil (10.8 mg, 15%). The 
spectroscopic data of these compounds matched with those in the literature.150,151 
Rf = 0.3 (EtOAc:PS = 15:85). 
IR (neat): νmax 3387, 3291, 3063, 2911, 2118, 1956, 1603, 1495, 1454, 1045, 698 cm-1. 
247a: 1H NMR (500 MHz, CDCl3): δ 7.42 – 7.33 (m, 4H, ArH), 7.32 – 7.28 (m, 1H, 
ArH), 4.88 (td, J = 6.4, 3.4 Hz, 1H, H-1), 2.65 (dd, J = 6.4, 2.6 Hz, 2H, H-2), 2.39 (d, J 
= 3.4 Hz, 1H, OH), 2.07 (t, J = 2.6 Hz, 1H, H-4). 
13C NMR (125 MHz, CDCl3): δ 142.6 (ArC), 128.6 (2 x ArCH), 128.1 (ArCH), 125.9 
(2 x ArCH), 80.8 (C-3), 72.5 (C-1), 71.1 (C-4), 29.6 (C-2). 
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247b: 1H NMR (500 MHz, CDCl3): δ 7.42 – 7.33 (m, 4H, ArH), 7.33 – 7.28 (m, 1H, 
ArH), 5.45 (app. q, J = 6.5 Hz, 1H, H-2), 5.30 – 5.25 (m, 1H, H-1), 4.93 (dt, J = 6.2, 2.9 
Hz, 2H, H-4), 2.14 (d, J = 4.2 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 207.2 (C-3), 143.0 (ArC), 128.6 (2 x ArCH), 128.0 
(ArCH), 126.2 (2 x ArCH), 95.3 (C-2), 78.4 (C-4), 72.1 (C-1). 
6.2.9 General method 8 for synthesis of homopropargylic alcohols  
2-(1-Hydroxybut-3-ynyl)phenol (249)152 
 
 To a solution of salicylaldehyde (61.1 mg, 53 µL, 0.5 mmol) in methanol-d4 (0.5 
mL) was added pinacol allenylboronate (83.1 mg, 90 µL, 0.5 mmol, 1 equiv.) and the 
mixture was stirred at room temperature for 6 h and then evaporated. The crude product 
was purified by column chromatography on silica gel eluting with 15:85 EtOAc/PS to 
afford the title compound 249 as a pale pink oil (64.4 mg, 79%). The spectroscopic data 
of this compound matched with those in the literature.152 
Rf = 0.2 (EtOAc:PS = 15:85). 
IR (neat): νmax 3349, 3291, 2981, 1589, 1492, 1456, 1382, 1144, 754, 622 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.73 (s, 1H, OH), 7.19 (td, J = 7.8, 1.7 Hz, 1H, H-5), 
7.03 (dd, J = 7.6, 1.7 Hz, 1H, H-3), 6.93 – 6.80 (m, 2H, H-4 and H-6), 5.02 (ddd, J = 
9.2, 4.5, 2.1 Hz, 1H, H-1′), 3.17 (s, 1H, OH), 2.81 (ddd, J = 16.9, 9.2, 2.6 Hz, 1H, H-
2′A), 2.68 (ddd, J = 16.9, 4.5, 2.6 Hz, 1H, H-2′B), 2.14 (t, J = 2.6 Hz, 1H, H-4′). 
13C NMR (125 MHz, CDCl3): δ 155.5 (C-1), 129.6 (C-5), 127.3 (C-3), 125.4 (C-2), 
120.2 (C-4), 117.6 (C-6), 80.4 (C-3′), 73.8 (C-1′), 71.8 (C-4′), 28.2 (C-2′). 
ESIMS m/z 161 (100%) [M − H]−. 
 
Chapter 6: Experimental Section | 239 
 
 
1-(2-Methoxyphenyl)but-3-yn-1-ol (247a)147 
 
 The title compound was prepared by Method 8 using 2-methoxybenzaldehyde 
(68.1 mg, 0.04 mmol) instead of salicylaldehyde. Purification by column 
chromatography on silica gel eluting with 15:85 EtOAc/PS gave 247a as a colorless oil 
(74.6 mg, 85%). The spectroscopic data of this compound matched with those in the 
literature.147 
Rf = 0.2 (EtOAc:PS = 15:85). 
IR (neat): νmax 3290, 2916, 2849, 2118, 1601, 1489, 1464, 1238, 1047, 1026, 752 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.40 (dd, J = 7.5, 1.8 Hz, 1H, H-6′), 7.34 – 7.20 (m, 1H, 
H-4′), 6.98 (td, J = 7.5, 1.1 Hz, 1H, H-5′), 6.92 – 6.82 (m, 1H, H-3′), 5.08 (dt, J = 7.6, 
5.3 Hz, 1H, H-1), 3.85 (s, 3H, OCH3), 2.87 (d, J = 6.0 Hz, 1H, OH), 2.76 (ddd, J = 16.8, 
5.3, 2.6 Hz, 1H, H-2A), 2.63 (ddd, J = 16.8, 7.6, 2.6 Hz, 1H, H-2B), 2.04 (t, J = 2.6 Hz, 
1H, H-4). 
13C NMR (125 MHz, CDCl3): δ 156.4 (C-2′), 130.4 (C-1′), 128.9 (C-4′), 127.0 (C-6′), 
120.8 (C-5′), 110.5 (C-3′), 81.5 (C-3), 70.6 (C-4), 69.1 (C-1), 55.4 (OCH3), 27.4 (C-2). 
ESIMS m/z 175 (100%) [M − H]−. 
N-Benzyl-1-(pyridin-2-yl)but-3-yn-1-amine (251) 
 
To a solution of 2-pyridinecarboxaldehyde (53.6 mg, 47.6 µL, 0.5 mmol) in 
methanol (0.5 mL) was added benzylamine (53.6 mg, 55.0 µL, 0.5 mmol, 1.0 equiv.) 
and pinacol allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 equiv.) and stirred at 
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room temperature for 4 days. The reaction mixture was evaporated and redissolved in 
CH2Cl2 (2 mL) and then washed with sat. aqueous NaHCO3 solution (2 x 2 mL). The 
combined organic layer was dried (MgSO4), filtered and concentrated in vacuo. The 
crude product was purified by column chromatography on silica gel eluting with 20:80 
EtOAc/PS to afford the title compound 251 as a dark green oil (20.3 mg, 17%). 
Rf = 0.3 (EtOAc:PS = 40:60). 
IR (neat): νmax 3294, 3026, 2916, 2116, 1589, 1570, 1545, 1433, 734, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.60 (d, J = 4.8 Hz, 1H, H-6′), 7.67 (t, J = 7.7 Hz, 1H, 
H-4′), 7.40 (d, J = 7.7 Hz, 1H, H-3′), 7.35 – 7.27 (m, 3H, ArH), 7.27 – 7.22 (m, 2H, 
ArH), 7.20 (dd, J = 7.5, 5.0 Hz, 1H, H-5′), 3.97 (t, J = 6.6 Hz, 1H, H-1), 3.73 (d, J = 
13.3 Hz, 1H, PhCHAHBN), 3.65 (d, J = 13.3 Hz, 1H, PhCHAHBN), 2.75 – 2.62 (m, 2H, 
H-2), 2.19 (brs, 1H, NH), 1.96 (t, J = 2.6 Hz, 1H, H-4). 
13C NMR (125 MHz, CDCl3): δ 161.7 (C-2′), 149.7 (C-6′), 140.2 (ArC), 136.4 (C-4′), 
128.5 (2 x ArCH), 128.3 (2 x ArCH), 127.1 (ArCH), 122.5 (C-5′), 122.4 (C-3′), 81.5 
(C-3), 70.5 (C-4), 61.9 (C-1), 51.7 (PhCH2N), 26.5 (C-2). 
ESIMS m/z 237 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C16H17N2 [M + H]+: 237.1392, found: 237.1381. 
N,N-Dibenzyl-1-(pyridin-2-yl)but-3-yn-1-amine (252) 
 
To a solution of 2-pyridinecarboxaldehyde (53.6 mg, 47.6 µL, 0.5 mmol) in 
methanol (0.5 mL) was added dibenzylamine (98.6 mg, 99.0 µL, 0.5 mmol, 1.0 equiv.) 
and pinacol allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 equiv.) and stirred at 
room temperature for 3 days. The reaction mixture was evaporated and redissolved in 
CH2Cl2 (2 mL) and then washed with sat. aqueous NaHCO3 solution (2 x 2 mL). The 
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combined organic layer was dried (MgSO4), filtered and concentrated in vacuo. The 
crude product was purified by column chromatography on silica gel eluting with 7:93 
EtOAc/PS to afford the title compound 252 as a dark green oil (13.7 mg, 8%). 
Rf = 0.3 (EtOAc:PS = 7:93). 
IR (neat): νmax 3302, 3026, 2916, 2118, 1587, 1452, 1358, 1121, 908, 729, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.61 (d, J = 4.9 Hz, 1H, H-6′), 7.66 (td, J = 7.7, 1.9 Hz, 
1H, H-4′), 7.39 (d, J = 6.8 Hz, 4H, ArH), 7.30 (t, J = 7.5 Hz, 4H, ArH), 7.26 – 7.15 (m, 
4H, H-3′, H-5′ and ArH), 4.13 (dd, J = 8.0, 6.5 Hz, 1H, H-1), 3.85 (d, J = 14.0 Hz, 2H, 
PhCHAHBN), 3.44 (d, J = 14.0 Hz, 2H, PhCHAHBN), 3.05 (ddd, J = 16.7, 8.0, 2.7 Hz, 
1H, H-2A), 2.95 (ddd, J = 16.7, 6.5, 2.7 Hz, 1H, H-2B), 1.91 (t, J = 2.7 Hz, 1H, H-4). 
13C NMR (125 MHz, CDCl3): δ 158.9 (C-2′), 148.9 (C-6′), 140.0 (2 x ArC), 136.0 (C-
4′), 128.9 (4 x ArCH), 128.4 (4 x ArCH), 127.0 (2 x ArCH), 124.4 (C-5′), 122.3 (C-3′), 
83.2 (C-3), 69.7 (C-4), 61.7 (C-1), 54.0, 18.8 (C-2). 
ESIMS m/z 327 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C23H23N2 [M + H]+: 327.1861, found: 327.1871. 
6.3 Experimental for Chapter 3 
3-Benzyl-2-phenyl-4-(propa-1,2-dien-1-yl)oxazolidine (271) 
 
 Procedure A: To a solution of 2-(benzylamino)penta-3,4-dien-1-ol (210b) (12.0 
mg, 0.063 mmol) in toluene (0.1 mL) was added benzaldehyde (7.3 mg, 7.0 µL, 0.076 
mmol, 1.2 equiv.) and MgSO4 (0.1 g). The mixture was stirred at 60 oC for 24 h. The 
reaction was filtered and concentrated in vacuo. 1H NMR analysis of the crude reaction 
mixture indicated 100% conversion to the title compound 271. 
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Procedure B: To a solution of 273 (24.3 mg, 0.08 mmol) in anhydrous DCE 
(0.8 mL) was added benzaldehyde (10.2 mg, 9.8 µL, 0.096 mmol, 1.2 equiv.) and 
TMSCl (17.4 mg, 20.3 µL, 0.16 mmol) at room temperature. The mixture was stirred at 
60 oC for 16 h.The reaction was diluted with CH2Cl2 (2 mL) and washed with sat. 
aqueous NaHCO3 solution (2 x 2 mL). The combined organic layer was dried (MgSO4), 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 7:93 EtOAc/PS to afford the title compound 
271 as a colorless oil (3.1 mg, 14%). 
Rf = 0.4 (EtOAc:PS = 7:93). 
IR (neat): νmax 3058, 3026, 2940, 2856, 1956, 1453, 1080, 1059, 843, 755, 694 cm-1. 
1H NMR (500 MHz, CDCl3) (major diastereomer): δ 7.55 – 7.48 (m, 2H, ArH), 7.41 – 
7.14 (m, 8H, ArH), 5.03 (s, 1H, H-2), 4.98 (dt, J = 8.1, 6.6 Hz, 1H, H-1′), 4.71 (dd, J = 
6.6, 1.2 Hz, 2H, H-3′), 4.10 (t, J = 7.7 Hz, 1H, H-5A), 3.86 (d, J = 13.9 Hz, 1H, 
PhCHAHB), 3.82 (t, J = 7.7 Hz, 1H, H-5B), 3.66 (d, J = 13.9 Hz, 1H, PhCHAHB), 3.59 (q, 
J = 7.7 Hz, 1H, H-4). 
1H NMR (500 MHz, CDCl3) (minor diastereomer): δ 7.55 – 7.48 (m, 2H, ArH), 7.41 – 
7.14 (m, 8H, ArH), 5.29 (app. q, J = 7.0 Hz, 1H, H-1′), 5.25 (s, 1H, H-2), 4.74 (d, J = 
6.1 Hz, 2H, H-3′), 4.28 (dd, J = 7.7, 5.7 Hz, 1H, H-5A), 3.96 (dd, J = 7.7, 2.7 Hz, 1H, H-
5B), 3.91 – 3.87 (m, 1H, H-4), 3.65 (d, J = 13.6 Hz, 1H, PhCHAHB), 3.56 (d, J = 13.6 
Hz, 1H, PhCHAHB). 
13C NMR (125 MHz, CDCl3) (major diastereomer): δ 209.6 (C-2′), 139.6 (ArC), 137.2 
(ArC), 129.7 (2 x ArCH), 129.0 (ArCH), 128.4 (4 x ArCH), 128.1 (2 x ArCH), 127.1 
(ArCH), 96.6 (C-2), 90.7 (C-1′), 76.3 (C-3′), 71.2 (C-5), 62.3 (C-4), 54.0 (PhCH2N). 
13C NMR (125 MHz, CDCl3) (minor diastereomer): δ 209.1 (C-2′), 139.5 (ArC), 138.8 
(ArC), 129.0 (ArCH), 128.7 (2 x ArCH), 128.5 (3 x ArCH), 128.3 (3 x ArCH), 127.0 
(ArCH), 94.2 (C-2), 87.0 (C-1′), 76.3 (C-3′), 70.7 (C-5), 58.6 (C-4), 49.9 (PhCH2N). 
ESIMS m/z 278 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C19H20NO [M + H]+: 278.1545, found: 278.1559. 
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6.3.1 General method 9 for silylation of a primary alcohol 
N-Benzyl-1-((tert-butyldimethylsilyl)oxy)penta-3,4-dien-2-amine (273) 
 
To a solution of 2-(benzylamino)penta-3,4-dien-1-ol (210b) (0.1332 g, 0.70 
mmol) in DMF (1.5 mL) was added imidazole (0.1198 g, 1.75 mmol, 2.5 equiv.) 
followed by TBSCl (0.2121 g, 1.40 mmol, 2.0 equiv.) and the reaction mixture was 
stirred at room temperature for 3 h. After the reaction had completed, water (3 mL) was 
added and the mixture was extracted with EtOAc (2 x 5 mL). The organic layer was 
washed with water (20 mL), dried (MgSO4), and concentrated in vacuo. The crude 
product was purified by column chromatography on silica gel eluting with 7:93 
EtOAc/PS to afford the title compound 273 as a pale yellow oil (0.1977 g, 93%). 
Rf = 0.3 (EtOAc:PS = 10:90). 
IR (neat): νmax 3026, 2954, 2857, 1955, 1462, 1253, 1084, 775, 696 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.35 – 7.20 (m, 5H, ArH), 5.04 (app. q, J = 7.0 Hz, 1H, 
H-3), 4.83 – 4.74 (m, 2H, H-5), 3.93 (d, J = 13.4 Hz, 1H, PhCHAHB), 3.73 (d, J = 13.4 
Hz, 1H, PhCHAHB), 3.66 (dd, J = 9.9, 4.4 Hz, 1H, H-1A), 3.56 (dd, J = 9.9, 7.5 Hz, 1H, 
H-1B), 3.32 – 3.24 (m, 1H, H-2), 1.88 (brs, 1H, NH), 0.88 (s, 9H, (CH3)3CSi), 0.04 (s, 
3H, CH3Si), 0.03 (s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3): δ 208.9 (C-4), 140.7 (ArC), 128.5 (2 x ArCH), 128.3 (2 x 
ArCH), 126.9 (ArCH), 90.5 (C-3), 76.0 (C-5), 66.6 (C-1), 58.6 (C-2), 51.3 (PhCH2N), 
26.0 ((CH3)3C), 18.4 ((CH3)3CSi), -5.2 (CH3Si), -5.3 (CH3Si). 
ESIMS m/z 304 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C18H30NOSi [M + H]+: 304.2097, found: 304.2097. 
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N-Benzyl-1-((tert-butyldimethylsilyl)oxy)-N-(2-chloroethyl)penta-3,4-dien-2-amine 
(274) 
 
To a solution of 273 (24.3 mg, 0.08 mmol) in anhydrous DCE (0.8 mL) in a 10 
mL microwave tube was added benzaldehyde (10.2 mg, 9.8 µL, 0.096 mmol, 1.2 
equiv.) at room temperature, and the tube was sealed with a pressure cap. The solution 
was irradiated in a CEM Discover system microwave reactor for 10 min at 100 °C. 
After cooling to room temperature, the mixture was concentrated in vacuo. The crude 
product was purified by column chromatography on silica gel eluting with 2.5:97.5 
EtOAc/PS to afford the title compound 274 as a light brown oil (1.0 mg, 3%) and 
recovered amine 273 as a pale yellow oil (14.0 mg, 58%). 
Rf = 0.3 (EtOAc:PS = 10:90). 
1H NMR (500 MHz, CDCl3): δ 7.39 – 7.19 (m, 5H, ArH), 5.17 (q, J = 6.8 Hz, 1H, H-3), 
4.81 – 4.69 (m, 2H, H-5), 3.83 (d, J = 14.1 Hz, 1H, PhCHAHB), 3.79 – 3.65 (m, 3H, H-1′ 
and PhCHAHB), 3.39 (t, J = 7.5 Hz, 2H, H-2 and H-2′), 3.04 (dt, J = 14.6, 7.5 Hz, 1H, 
H-1A), 2.88 (dt, J = 14.6, 7.5 Hz, 1H, H-1B), 0.89 (s, 9H, (CH3)3CSi), 0.03 (s, 6H, 
CH3Si). 
13C NMR (125 MHz, CDCl3): δ 209.1 (C-4), 140.4 (ArC), 128.6 (2 x ArCH), 128.4 (2 x 
ArCH), 127.1 (ArCH), 87.2 (C-3), 75.5 (C-5), 65.0 (C-1), 61.5 (C-2), 56.6 (PhCH2N), 
53.5 (C-1′), 43.1 (C-2′), 26.0 ((CH3)3CSi), 18.3 ((CH3)3CSi), -5.27 (CH3Si), -5.3 
(CH3Si). 
ESIMS m/z 366 (75%) [M(35Cl) + H]+, 368 (25%) [M(37Cl) + H]+.  
HRMS: the sample decomposed before a HRMS could be measured. 
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1-Benzyl-2-(((tert-butyldimethylsilyl)oxy)methyl)-2,5-dihydro-1H-pyrrole (275) 
 
To a solution of 273 (24.3 mg, 0.08 mmol) in anhydrous DCE (0.8 mL) in a 
screw cap vial was then added benzaldehyde (9.3 mg, 9.8 µL, 0.096 mmol, 1.1 equiv.) 
at room temperature. The reaction was stirred and heated at 120 °C for 16 h. After 
cooling to room temperature, the solvent was evaporated. The crude product was 
purified by column chromatography on silica gel eluting with 3.5:96.5 EtOAc/PS to 
afford the title compound 275 as a light brown oil (2.5 mg, 10%). 
Rf = 0.4 (EtOAc:PS = 10:90). 
IR (neat): νmax 2955, 2856, 1495, 1472, 1453, 1361, 1253, 1099, 775, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.40 – 7.16 (m, 5H, ArH), 5.83 – 5.79 (m, 1H, H-4), 
5.79 – 5.75 (m, 1H, H-5), 4.12 (d, J = 13.3 Hz, 1H, PhCHAHB), 3.77 – 3.58 (m, 4H, H-
1′A, H-2, H-5A and PhCHAHB), 3.50 (dd, J = 9.6, 7.3 Hz, 1H, H-1′B), 3.30 – 3.22 (m, 
1H, H-5B), 0.94 – 0.81 (m, 9H, (CH3)3CSi), 0.04 (s, 3H, CH3Si), 0.03 (s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3): δ 140.3 (ArC), 129.8 (C-4), 128.8 (2 x ArCH), 128.4 (2 x 
ArCH), 127.8 (C-3), 126.9 (ArCH), 72.5 (C-2), 67.7 (C-1′), 60.9 (C-5), 60.1 (C-6), 26.1 
((CH3)3CSi), 18.5 ((CH3)3CSi), -5.1 (CH3Si), -5.2 (CH3Si). 
ESIMS m/z 304 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C18H30NOSi [M + H]+: 304.2097, found: 304.2087. 
N-Benzyl-1-((tert-butyldiphenylsilyl)oxy)penta-3,4-dien-2-amine (276) 
 
 The title compound was prepared following the general method for silylation of 
a primary alcohol using 2-(benzylamino)penta-3,4-dien-1-ol (210b) (0.0568 g, 0.3 
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mmol), imidazole (0.0511 g, 0.75 mmol, 2.5 equiv.) and TBDPSCl (0.1649 g, 156 µL, 
0.6 mmol, 2.0 equiv.). Purification by column chromatography on silica gel eluting with 
CH2Cl2 gave compound 276 as a colorless oil (0.0522 g, 41%). 
Rf = 0.4 (EtOAc:PS = 10:90). 
IR (neat): νmax 3068, 2959, 2930, 2858, 1954, 1427, 1106, 1084, 738, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.67 – 7.60 (m, 4H, ArH), 7.44 – 7.28 (m, 10H, ArH), 
7.28 – 7.21 (m, 1H, ArH), 5.04 (app. q, J = 6.9 Hz, 1H, H-3), 4.81 – 4.69 (m, 2H, H-5), 
3.93 (d, J = 13.4 Hz, 1H, PhCHAHB), 3.73 (d, J = 13.4 Hz, 1H, PhCHAHB), 3.71 – 3.63 
(m, 2H, H-1), 3.36 – 3.30 (m, 1H, H-2), 2.06 (brs, 1H, NH), 1.04 (s, 9H, (CH3)3CSi). 
13C NMR (125 MHz, CDCl3): δ 208.9 (C-4), 140.6 (ArC), 135.72 (2 x ArCH), 135.71 
(2 x ArCH), 133.55 (ArC), 133.51 (ArC), 129.81 (ArCH), 129.80 (ArCH), 128.5 (2 x 
ArCH), 128.3 (2 x ArCH), 127.82 (2 x ArCH), 127.81 (2 x ArCH), 126.9 (ArCH), 90.5 
(C-5), 76.1 (C-3), 67.2 (C-1), 58.4 (C-2), 51.3 (PhCH2), 27.0 ((CH3)3CSi), 19.4 
((CH3)3CSi). 
ESIMS m/z 428 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C28H34NOSi [M + H]+: 428.2410, found: 428.2392. 
(E)-2-(1-((2-Hydroxybenzylidene)amino)but-3-yn-1-yl)phenol (278) and 6-methoxy 
-12-(prop-2-yn-1-yl)-6H,12H-6λ4,13λ4-benzo[e]benzo[5,6][1,3,2]oxazaborinino [2,3-
b][1,3,2] oxazaborinine (279) 
                                           
 To a solution of salicylaldehyde (61.1 mg, 53 µL, 0.5 mmol) in methanol (0.5 
mL) was added ammonia solution 28-30% w/w (0.12 mL, 1.0 mmol, 2.0 equiv.) 
followed by pinacol allenylboronate (83.1 mg, 93.0 µL, 0.5 mmol, 1.0 equiv.). The 
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mixture was stirred at room temperature for 16 h, and then the solvent was evaporated. 
The crude product was purified by column chromatography on silica gel eluting with 
20:80 EtOAc/PS to afford the title compound 278 as a pale yellow oil (27.0 mg, 20%) 
and 279 as colorless crystals (12.8 mg, 8%), which were suitable for X-ray 
crystallographic analysis. 
278: Rf = 0.6 (EtOAc:PS = 40:60). 
IR (neat): νmax 3316, 3026, 2923, 2852, 2317, 2152, 1638, 1455, 1260, 1035, 753 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.47 (s, 1H, N=CH), 7.37 – 7.30 (m, 2H, H-3 and H-6′′), 
7.27 (d, J = 7.7 Hz, 1H, H-4′′), 7.16 (t, J = 7.7 Hz, 1H, H-5), 6.98 (d, J = 8.3 Hz, 1H, H-
3′′), 6.93 (t, J = 7.5 Hz, 1H, H-5′′), 6.87 (t, J = 7.4 Hz, 1H, H-4), 6.80 (d, J = 8.0 Hz, 
1H, H-6), 4.83 (dd, J = 8.0, 5.4 Hz, 1H, H-1′), 2.92 – 2.87 (m, 2H, H-2′), 2.02 (t, J = 2.6 
Hz, 1H, H-4′). 
13C NMR (125 MHz, CDCl3): δ 165.6 (N=CH), 161.9 (C-1′′), 153.1 (C-1), 133.1 (C-
6′′), 132.1 (C-4′′), 129.1 (C-5), 128.3 (C-3), 127.3 (C-2), 121.1 (C-5′′), 118.7 (C-4), 
118.5 (C-2′′), 117.5 (C-3′′), 116.2 (C-6), 81.3 (C-3′), 71.1 (C-4′), 67.5 (C-1′), 27.0 (C-
2′). 
ESIMS m/z 266 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C17H16NO2 [M + H]+:266.1181, found: 266.1188. 
279: Rf = 0.5 (EtOAc:PS = 40:60). 
Mp.: 184-185 °C. 
IR (neat): νmax 3286, 2967, 2827, 2161, 1640, 1555, 1487, 1282, 1087, 976, 749 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.45 (s, 1H, N=CH), 7.57 (t, J = 7.6 Hz, 1H, H-3), 7.41 
(dd, J = 7.8, 1.8 Hz, 1H, H-1), 7.19 (t, J = 7.7 Hz, 1H, H-9), 7.12 (d, J = 8.5 Hz, 1H, H-
4), 7.04 – 6.97 (m, 2H, H-8 and H-11), 6.93 (t, J = 7.5 Hz, 1H, H-2), 6.84 (t, J = 7.5 Hz, 
1H, H-10), 4.73 (dd, J = 11.3, 3.4 Hz, 1H, H-12), 3.43 (dd, J = 17.4, 11.3 Hz, 1H, H-
1′A), 3.25 (s, 3H, OCH3), 2.88 (dt, J = 17.4, 3.4 Hz, 1H, H-1′B), 2.25 (s, 1H, H-3′). 
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13C NMR (125 MHz, CDCl3): δ 163.0 (C-14), 160.6 (ArC), 153.6 (ArC), 138.6 (C-3), 
131.7 (C-1), 129.8 (C-9), 126.6 (C-11), 121.0 (ArC), 120.0 (C-8), 119.7 (C-4), 119.52 
(C-10), 119.50 (C-2), 115.5 (ArC), 80.9 (C-2′), 73.2 (C-3′), 66.6 (C-12), 49.6 (OCH3), 
29.7 (C-1′). 
ESIMS m/z 274 (100%) [M − OMe]+.  
HRMS (ESI): m/z calculated for C17H13BNO2 [M − OMe]+: 274.1039, found: 274.1049 
N-Benzylidene-4-methylbenzenesulfonamide (280)153 
 
To a solution of benzaldehyde (0.6367 g, 0.61 mL, 6.0 mmol, 1.1 equiv.) in 
anhydrous CH2Cl2 (20 mL) was added p-toluenesulfonamide (0.8561 g, 5.0 mmol, 1.0 
equiv.) and pyrrolidine (35.6 mg, 41.7 µL, 0.5 mmol, 0.1 equiv.) and the solution was 
stirred heated at 60 °C for 24 h. The reaction mixture was cooled to room temperature 
and then evaporated to afford the crude product. The crude product was dried under the 
high vacuum to remove an excess of benzaldehyde to afford the title compound 280 as a 
pale yellow solid (1.1363 g, 88%). The spectroscopic data of this compound matched 
with those in the literature.153 
Rf = 0.5 (EtOAc:PS = 15:85). 
1H NMR (500 MHz, CDCl3): δ 9.03 (s, 1H, N=CH), 7.96 – 7.86 (m, 4H, ArH), 7.61 (t, 
J = 7.2 Hz, 1H, ArH), 7.49 (t, J = 7.6 Hz, 2H, ArH), 7.35 (d, J = 7.9 Hz, 2H, ArH), 2.44 
(s, 3H, CH3). 
6.3.2 General method for activation of zinc powder154 
 Zinc powder (10 g) was placed in a 1 L Erlenmeyer flask and water (90 mL) was 
added and stirred vigorously followed by slow addition of conc. HCl (1 ml). After 
stirring for 15 min, the solvent was decanted and washed with water until neutral, 
acetone (3 x 25 mL) and Et2O (3 x 25 mL). The activated zinc powder was dried under 
vacuum and stored under N2 gas.  
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4-Methyl-N-(1-phenylbut-3-yn-1-yl)benzenesulfonamide (281)89 
 
To a solution of N-benzylidene-4-methylbenzenesulfonamide 280 (1.2966 g, 5.0 
mmol, 1.0 equiv.) and activated zinc powder (0.3922 g, 6.0 mmol, 1.2 equiv.) in 
anhydrous THF (5 mL) was added propargyl bromide (0.8922 g, 0.84 mL, 7.5 mmol, 
1.5 equiv.). The mixture was stirred at room temperature for 30 min and quenched with 
NH4Cl (sat.) and extracted with CH2Cl2 (2 x 2 mL). The combined organic layer was 
washed with brine, dried (MgSO4), filtered and concentrated in vacuo. The crude 
product was purified by recrystallization using absolute ethanol to afford the title 
compound 281 as colorless crystals (1.3770 g, 91%). The spectroscopic data of this 
compound matched with those in the literature.89 
Rf = 0.1 (EtOAc:PS = 12.5:87.5). 
1H NMR (300 MHz, CDCl3): δ 7.62 (d, J = 8.0 Hz, 2H, ArH), 7.24 – 7.10 (m, 7H, 
ArH), 5.32 (d, J = 7.3 Hz, 1H, NH), 4.50 (q, J = 6.5 Hz, 1H, H-1), 2.63 (dd, J = 6.5, 2.5 
Hz, 2H, H-2), 2.37 (s, 3H, CH3), 1.97 (t, J = 2.5 Hz, 1H, H-4). 
13C NMR (75 MHz, CDCl3): δ 143.4 (ArC), 139.3 (ArC), 137.4 (ArC), 129.6 (2 x 
ArCH), 128.5 (2 x ArCH), 128.0 (ArCH), 127.3 (2 x ArCH), 126.7 (2 x ArCH), 79.2 
(C-3), 72.3 (C-4), 55.9 (C-1), 27.4 (C-2), 21.6 (CH3). 
ESIMS m/z 322 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C17H17NO2NaS [M + Na]+: 322.0878, found: 322.0871. 
4-Methyl-N-(1-phenylbuta-2,3-dien-1-yl)benzenesulfonamide (282)49  
 
A solution of 280 (0.2593 g, 1.0 mmol) and pinacol allenylboronate (0.2492 g, 
0.28 mL, 1.5 mmol, 1.5 equiv.) in anhydrous toluene (5 mL) was cooled to 0 °C. Then 
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diethylzinc (1.0 M in hexane, 0.2 mL, 0.2 mmol, 0.2 equiv.) was added and stirring was 
continued at 0 °C for 16 h. The reaction mixture was warmed to room temperature and 
quenched with NH4Cl (sat.). The organic layer was washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 13:87 EtOAc/PS to afford the title compound 
282 as a light brown oil (59.2 mg, 20%) and 281 as a white power (99.7 mg, 33%). The 
spectroscopic data of this compound matched with those in the literature.49 
Rf = 0.1 (EtOAc:PS = 13:87). 
IR (neat): νmax 3263, 3060, 2928, 1955, 1598, 1496, 1453, 1159, 1093, 1046, 669 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.64 (d, J = 8.0 Hz, 2H, ArH), 7.25 – 7.16 (m, 7H, 
ArH), 5.30 (d, J = 7.7 Hz, 1H, NH), 5.23 (app. q, J = 6.3 Hz, 1H, H-2), 5.01 – 4.93 (m, 
1H, H-1), 4.77 (ddd, J = 11.0, 6.6, 3.0 Hz, 1H, H-4A), 4.71 (ddd, J = 11.0, 6.6, 3.0 Hz, 
1H, H-4B), 2.38 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 206.9 (C-3), 143.2 (ArC), 140.0 (ArC), 137.8 (ArC), 
129.4 (2 x ArCH), 128.6 (2 x ArCH), 127.8 (ArCH), 127.3 (2 x ArCH), 127.0 (2 x 
ArCH), 92.7 (C-2), 79.4 (C-4), 55.9 (C-1), 21.6 (CH3). 
ESIMS m/z 322 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C17H17NO2NaS [M + Na]+: 322.0878, found: 322.0886. 
(E)-4-Methyl-N-(1-phenyl-4-(triethylsilyl)but-3-en-1-yl)benzenesulfonamide (290) 
 
To a solution of (PPh3)3RhCl (9.2 mg, 0.01 mmol, 0.01 equiv.) in anhydrous 
toluene (1.5 mL) was added benzenesulfonamide 281 (299.4 mg, 1.0 mmol, 1.0 equiv.) 
and Et3SiH (174.4 mg, 0.24 mL, 1.5 mmol, 1.5 equiv.) and the solution was stirred at 40 
°C for 24 h. The reaction mixture was concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel eluting with 13:87 EtOAc/PS to afford 
the title compound 290 as a pale yellow oil (96.5 mg, 23%) 
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Rf = 0.3 (EtOAc:PS = 13:87). 
IR (neat): νmax 3272, 3030, 2951, 2873, 1599, 1495, 1455, 1323, 1157, 718, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.55 (d, J = 7.1 Hz, 2H, ArH), 7.20 – 7.10 (m, 5H, 
ArH), 7.10 – 7.02 (m, 2H, ArH), 5.71 (dt, J = 18.6, 6.6 Hz, 1H, H-3), 5.58 (d, J = 18.6 
Hz, 1H, H-4), 4.92 (d, J = 6.2 Hz, 1H, NH), 4.37 (q, J = 6.6 Hz, 1H, H-1), 2.58 – 2.44 
(m, 2H, H-2), 2.36 (s, 3H, CH3), 0.86 (t, J = 8.0 Hz, 9H, CH3CH2Si), 0.47 (q, J = 8.0 
Hz, 6H, CH3CH2Si). 
13C NMR (125 MHz, CDCl3): δ 143.2 (ArC), 142.1 (C-3), 140.6 (ArC), 137.6 (ArC), 
132.6 (C-4), 129.5 (2 x ArCH), 128.4 (2 x ArCH), 127.5 (ArCH), 127.2 (2 x ArCH), 
126.7 (2 x ArCH), 57.3 (C-1), 45.4 (C-2), 21.6 (CH3), 7.5 (3 x CH3CH2Si), 3.5 (3 x 
CH3CH2Si). 
ESIMS m/z 438 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C23H33NO2NaSiS [M + Na]+: 438.1899, found: 
438.1911. 
4-Methyl-N-(1-phenylbut-3-en-1-yl)benzenesulfonamide (291)93 
 
To a solution of 290 (17.0 mg, 0.04 mmol, 1 equiv.) in acetonitrile (0.8 mL) was 
added hexanal (8.1 mg, 9.7 µL, 0.08 mmol, 2.0 equiv.) and indium trichloride (13.3 mg, 
0.06 mmol, 1.5 equiv.) and the solution was stirred at reflux temperature for 24 h. After 
cooling to room temperature, the reaction mixture was concentrated in vacuo. The crude 
product was dissolved in CH2Cl2 (2 mL) and then washed with 0.5M NaOH. The 
aqueous layer was extracted with CH2Cl2. The combined organic layer was dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography (13:87 EtOAc/PS) to afford the title compound 291 as a white power 
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(2.5 mg, 21%). The spectroscopic data of this compound matched with those in the 
literature.93 
Rf = 0.1 (EtOAc:PS = 13:87). 
IR (neat): νmax 3256, 3065, 2926, 1601, 1458, 1318, 1159, 1096, 1058, 700, 667 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.55 (d, J = 8.0 Hz, 2H, ArH), 7.20 – 7.11 (m, 5H, 
ArH), 7.11 – 7.04 (m, 2H, ArH), 5.51 (ddt, J = 15.9, 11.0, 7.2 Hz, 1H, H-3), 5.09 – 5.02 
(m, 2H, H-4), 4.83 (d, J = 6.5 Hz, 1H, NH), 4.38 (q, J = 6.6 Hz, 1H, H-1), 2.52 – 2.40 
(m, 2H, H-2), 2.37 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 143.3 (ArC), 140.5 (ArC), 137.6 (ArC), 133.2 (C-3), 
129.5 (2 x ArCH), 128.5 (2 x ArCH), 127.5 (ArCH), 127.3 (2 x ArCH), 126.7 (2 x 
ArCH), 119.5 (C-4), 57.2 (C-1), 42.0 (C-2), 21.6 (CH3). 
ESIMS m/z 324 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C17H19NO2NaS [M + Na]+: 324.1034, found: 324.1037. 
N-Benzyl-1-phenylmethanimine (294)94 
 
To a solution of benzaldehyde (2.1224 g, 20.0 mmol, 1.0 equiv.) in anhydrous 
CH2Cl2 (20 mL) was added benzylamine (2.1432g, 2.18 mL, 20.0 mmol, 1.0 equiv.) and 
the solution was stirred at reflux temperature for 16 h. After cooling to room 
temperature, the solvent was evaporated to afford the title compound 294 as a yellow oil 
(2.9586 g, 76%). The spectroscopic data of this compound matched with those in the 
literature.94 
1H NMR (500 MHz, CDCl3): δ 8.39 (s, 1H, N=CH), 7.78 (dd, J = 6.9, 2.7 Hz, 2H, 
ArH), 7.44 – 7.38 (m, 2H, ArH), 7.37 – 7.31 (m, 3H, ArH), 7.25 (s, 3H, ArH), 4.83 (s, 
2H, PhCH2). 
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N-Benzyl-1-phenyl-3-butynylamine (295)95 
 
To a solution of N-benzylbenzaldimine (294) (0.5853 g, 3.0 mmol, 1.0 equiv.) 
and activated zinc powder (0.5882 g, 9.0 mmol, 3.0 equiv.) in anhydrous THF (12 mL) 
was added propargyl bromide (1 mL, 9 mmol, 3.0 equiv.). The reaction mixture was 
stirred at room temperature for 1 h and quenched with sat. aqueous NH4Cl solution and 
extracted with ethyl acetate. The combined organic layer was washed with brine, dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography (7:93 EtOAc/PS) to afford the title compound 295 as a brown oil 
(0.4188 g, 59%). The spectroscopic data of this compound matched with those in the 
literature.95 
Rf = 0.2 (EtOAc:PS = 7:93). 
IR (neat): νmax 3294, 3061, 3027, 2908, 2120, 1603, 1494, 1117, 1027, 733, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.43 – 7.21 (m, 10H, ArH), 3.87 (t, J = 6.7 Hz, 1H, H-
1), 3.71 (d, J = 13.3 Hz, 1H, PhCHAHBN), 3.58 (d, J = 13.3 Hz, 1H, PhCHAHBN), 2.57 
– 2.49 (m, 2H, H-2), 2.07 (brs, 1H, NH), 2.01 (t, J = 2.7 Hz, 1H, H-4). 
13C NMR (125 MHz, CDCl3): δ 142.6 (ArC), 140.5 (ArC), 128.6 (2 x ArCH), 128.5 (2 
x ArCH), 128.2 (2 x ArCH), 127.7 (ArCH), 127.3 (2 x ArCH), 127.1 (ArCH), 81.7 (C-
3), 70.6 (C-4), 60.9 (C-1), 51.6 (PhCH2N), 28.4 (C-2). 
ESIMS m/z 236 (100%) [M + H]+.  
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Ethyl 2-(benzylamino)penta-3,4-dienoate (296) and ethyl 2-(benzylamino)pent-4-
ynoate (297) 
            
To a solution of 295 (70.6 mg, 0.3 mmol, 1 equiv.) and ethyl glyoxylate (50% in 
toluene, 39.8 mg, 82.0 µL, 0.39 mmol, 1.3 equiv.) in acetonitrile (6 mL) was added 
indium trichloride (79.6 mg, 65.6 µL, 0.36 mmol, 1.2 equiv.) and the mixture was 
stirred at reflux temperature for 18 h. After cooling to room temperature, the solvent 
was evaporated. The crude product was dissolved in CH2Cl2 (4 mL) and then washed 
with 1M NaOH. The aqueous layer was extracted with CH2Cl2 (8 mL). The combined 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product 
was purified by column chromatography (15:85 EtOAc/PS) to afford a mixture (8.5:1) 
of compounds 296 and 297 as a yellow oil (12.0 mg, 17%). 
296: Rf = 0.2 (EtOAc:PS = 10:90). 
IR (neat): νmax 3282, 3029, 2981, 2849, 1957, 1732, 1453, 1182, 1026, 735, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.39 – 7.28 (m, 4H, ArH), 7.28 – 7.22 (m, 1H, ArH), 
5.26 (app. q, J = 6.7 Hz, 1H, H-3), 4.90 (app. d, J = 6.4 Hz, 2H, H-5), 4.20 (q, J = 7.0 
Hz, 2H, OCH2CH3) 3.88 (dd, J = 6.7, 3.2 Hz, 1H, H-2), 3.80 (s, 2H, PhCH2N), 1.28 (t, J 
= 7.0 Hz, 3H, OCH2CH3). 
13C NMR (125 MHz, CDCl3): δ 208.6 (C-4), 172.6 (C-1), 139.5 (ArC), 128.6 (2 x 
ArCH), 128.5 (2 x ArCH), 127.3 (ArCH), 89.6 (C-3), 78.0 (C-5), 61.3 (OCH2CH3), 
59.6 (C-2), 51.5 (PhCH2N), 14.4 (OCH2CH3). 
ESIMS m/z 232 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C14H18NO2 [M + H]+: 232.1338; found: 232.1345.  
297: Rf = 0.2 (EtOAc:PS = 10:90). 
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IR (neat): νmax 3292, 2982, 2316, 1733, 1730, 1182, 1027, 698 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 – 7.21 (m, 5H, ArH), 4.28 – 4.16 (m, 2H, 
OCH2CH3), 3.88 (d, J = 13.0 Hz, 1H, PhCHAHBN), 3.74 (d, J = 13.0 Hz, 1H, 
PhCHAHBN), 3.44 (t, J = 5.9 Hz, 1H, H-2), 2.62 (dd, J = 5.9, 2.7 Hz, 2H, H-3), 2.04 (t, 
J = 2.7 Hz, 1H, H-5), 1.28 (t, J = 7.1 Hz, 3H, OCH2CH3). 
13C NMR (125 MHz, CDCl3): δ 173.3 (C-1), 139.5 (ArC), 128.5 (2 x ArCH), 128.4 (2 x 
ArCH), 127.3 (ArCH), 79.7 (C-4), 71.2 (C-5), 61.2 (OCH2CH3), 58.8 (C-2), 51.9 
(PhCH2N), 23.4 (C-3), 14.4 (OCH2CH3). 
ESIMS m/z 232 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C14H18NO2 [M + H]+: 232.1338, found: 232.1345. 
(E)-N-Benzyl-1-phenyl-4-(triethylsilyl)but-3-en-1-amine (303) 
 
To N-benzyl-1-phenyl-3-butynylamine (295) (70.6 mg, 0.3 mmol) in a screw 
cap vial was added Et3SiH (69.8 mg, 9.8 µL, 0.6 mmol, 2.0 equiv.) and 10% H2PtCl6 (2 
drops) and the mixture stirred at 60 °C for 20 h. After cooling to room temperature, the 
reaction mixture was diluted with CH2Cl2 and MgSO4 was added. The mixture was 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 4:96 EtOAc/PS to afford the title compound 
303 as a light brown oil (53.0 mg, 50%). 
Rf = 0.2 (EtOAc:PS = 4:96). 
IR (neat): νmax 3026, 2951, 2873, 1605, 1494, 1453, 1028, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.38 – 7.20 (m, 10H, ArH), 5.92 (ddd, J = 18.7, 7.7, 5.6 
Hz, 1H, H-3), 5.62 (d, J = 18.7 Hz, 1H, H-4), 3.74 – 3.65 (m, 2H, H-1 and PhCHAHB), 
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3.50 (d, J = 13.3 Hz, 1H, PhCHAHB), 2.52 – 2.39 (m, 2H, H-2), 0.89 (t, J = 8.0 Hz, 9H, 
CH3CH2Si), 0.51 (q, J = 8.0 Hz, 6H, CH3CH2Si). 
13C NMR (125 MHz, CDCl3): δ 145.0 (C-3), 144.0 (ArC), 140.7 (ArC), 130.2 (C-4), 
128.5 (3 x ArCH), 128.3 (2 x ArCH), 127.5 (3 x ArCH), 127.1 (ArCH), 126.9 (ArCH), 
61.5 (C-1), 51.6 (PhCH2N), 46.6 (C-2), 7.5 (3 x CH3CH2Si), 3.6 (3 x CH3CH2Si). 
ESIMS m/z 352 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C23H34NSi [M + H]+: 352.2461, found: 352.2477. 
Ethyl (2S*,6S*)-1-benzyl-6-phenyl-1,2,5,6-tetrahydropyridine-2-carboxylate (304) 
 
Method A: To a solution of 303 (52.7 mg, 0.15 mmol) in acetonitrile (3 mL) 
was added ethyl glyoxylate (50% in toluene, 36.7 mg, 36.0 µL, 0.18 mmol, 1.2 equiv.) 
and indium trichloride (39.8 mg, 0.18 mmol, 1.2 equiv.) and the mixture was stirred at 
reflux temperature for 20 h. After cooling to room temperature, the solvent was 
evaporated. The crude product was dissolved in CH2Cl2 (4 mL) and then washed with 
1M NaOH. The aqueous layer was extracted with CH2Cl2 (8 mL). The combined 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product 
was purified by column chromatography (4:96 EtOAc/PS) to afford the title compound 
304 as a light brown oil (23.8 mg, 50%). 
Method B: To a solution of 303 (20.9 mg, 0.059 mmol) in xylene (0.5 mL) was 
added ethyl glyoxylate (50% in toluene, 9.0 mg, 17.6 µL, 0.089 mmol, 1.5 equiv.) and 
3Å molecular sieves. The reaction mixture was stirred at 80 °C for 36 h. After cooling 
to room temperature, the solvent was evaporated. The crude product was purified by 
column chromatography (6:94 EtOAc/PS) to afford the title compound 304 as a light 
brown oil (9.5 mg, 50%). 
Rf = 0.4 (EtOAc:PS = 7:93). 
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IR (neat): νmax 3030, 2907, 1732, 1494, 1454, 1204, 1174, 1029, 734, 697 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.53 (d, J = 7.6 Hz, 2H, ArH), 7.34 (t, J = 7.6 Hz, 2H, 
ArH), 7.31 – 7.16 (m, 6H, ArH), 6.09 – 6.03 (m, 1H, H-4), 5.85 – 5.77 (m, 1H, H-3), 
4.53 (dd, J = 10.0, 4.7 Hz, 1H, H-6), 4.18 (q, J = 7.2 Hz, 2H, CH3CH2O), 3.88 (s, 1H, 
H-2), 3.59 (d, J = 14.0 Hz, 1H, PhCHAHB), 3.41 (d, J = 14.0 Hz, 1H, PhCHAHB), 2.49 
(ddd, J = 17.8, 10.0, 2.6 Hz, 1H, H-5A), 2.37 (dt, J = 17.8, 4.7 Hz, 1H, H-5B), 1.28 (t, J 
= 7.2 Hz, 3H, CH3CH2O). 
13C NMR (125 MHz, CDCl3): δ 172.3 (C=O), 143.1 (ArC), 139.6 (ArC), 128.6 (2 x 
ArCH), 128.5 (2 x ArCH), 128.3 (2 x ArCH), 128.2 (C-4), 128.1 (2 x ArCH), 127.3 
(ArCH), 127.0 (ArCH), 123.4 (C-3), 60.6 (CH3CH2O), 60.2 (C-2), 57.4 (C-6), 52.5 
(PhCH2N), 30.4 (C-5), 14.5 (CH3CH2O). 
ESIMS m/z 322 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C21H24NO2 [M + H]+: 322.1807, found: 322.1805. 
 (2S*,6S*)-1-Benzyl-6-(hydroxymethyl)-2-phenyl-1,2,3,6-tetrahydropyridine (313) 
 
To a solution of 304 (21.6 mg, 0.067 mmol) in anhydrous diethyl ether (0.5 mL) 
was added LiBH4 (10 mg, 0.4 mmol, 6.0 equiv.) followed by addition of MeOH (20 µL) 
and the solution was stirred at room temperature for 6 h. The reaction mixture was 
quenched with sat. aqueous NH4Cl solution and stirred for 15 min and extracted with 
EtOAc (2 x 5 mL). The combined organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography 
(7:93 EtOAc/PS) to afford the title compound 313 as a pale yellow oil (7.1 mg, 38%). 
Rf = 0.4 (EtOAc:PS = 7:93). 
IR (neat): νmax 3447, 3026, 2918, 1602, 1495, 1449, 1122, 1028, 745, 696 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.51 (d, J = 7.7 Hz, 2H, ArH), 7.41 (t, J = 7.6 Hz, 2H, 
ArH), 7.29 (t, J = 7.5 Hz, 1H, ArH), 7.27 – 7.17 (m, 3H, ArH), 7.14 (d, J = 7.4 Hz, 2H, 
ArH), 6.16 – 6.07 (m, 1H, H-4), 5.65 (d, J = 10.2 Hz, 1H, H-5), 4.27 (dd, J = 11.4, 4.5 
Hz, 1H, H-2), 3.60 – 3.50 (m, 2H, H-1′A and PhCHAHBN), 3.47 (dd, J = 10.7, 4.5 Hz, 
1H, H-1′B), 3.33 (d, J = 12.9 Hz, 1H, PhCHAHBN), 3.31 – 3.25 (m, 1H, H-6), 2.74 – 
2.61 (m, 1H, H-3A), 2.34 (dt, J = 17.7, 4.4 Hz, 1H, H-3B). 
13C NMR (125 MHz, CDCl3): δ 141.5 (ArC), 139.5 (ArC), 129.1 (2 x ArCH), 128.6 (2 
x ArCH), 128.5 (2 x ArCH), 128.1 (2 x ArCH), 127.9 (C-4), 127.4 (ArCH), 127.3 
(ArCH), 125.0 (C-5), 62.0 (C-1′), 58.6 (C-6), 53.7 (C-2), 50.1 (PhCH2N), 23.7 (C-3). 
ESIMS m/z 280 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C19H22NO [M + H]+: 280.1701, found: 280.1711. 
6.4 Experimental for Chapter 4 
2-Bromo-4,5-dimethoxybenzaldehyde (352)119 
 
To a solution of 3,4-dimethoxybenzaldehyde (5.0 g, 30.1 mmol, 1.0 equiv.) in 
methanol (60 mL) was added bromine (5.0465 g, 1.63 mL, 31.6 mmol, 1.05 equiv.) 
dropwise and stirred at room temperature for 2 h. The solvent was evaporated and the 
precipitate was washed with water and filtered through a sintered glass Büchner funnel. 
The precipitate was washed again with cold methanol to afford the title compound 352 
as a white solid (6.7341 g, 91%). The spectroscopic data of this compound matched 
with those in the literature.119 
Rf = 0.2 (EtOAc:hexane = 7:93). 
Mp.: 146-148 °C. (lit.155 145-146 °C) 
IR (neat): νmax 3009, 2874, 1667, 1583, 1268, 1217, 1154, 1015, 737 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 10.18 (s, 1H, CHO), 7.41 (s, 1H, H-6), 7.05 (s, 1H, H-
3), 3.96 (s, 3H, OCH3), 3.92 (s, 3H, OCH3). 
13C NMR (125 MHz, CDCl3): δ 190.8 (C=O), 154.6 (C-4), 149.0 (C-5), 126.6 (C-1), 
120.5 (C-2), 115.5 (C-3), 110.5 (C-6), 56.6 (OCH3), 56.3 (OCH3). 
2-Iodo-4,5-dimethoxybenzaldehyde (356)156 
 
To a solution of 3,4-dimethoxybenzaldehyde (3.3236 g, 20.0 mmol, 1.0 equiv.) 
and silver trifluoroacetate (5.3011 g, 24.0 mmol, 1.2 equiv.) in anhydrous CH2Cl2 (120 
mL) was slowly added a solution of iodine (6.0912 g, 24.0 mmol, 1.2 equiv.) in 
anhydrous CH2Cl2 (120 mL). The mixture was stirred at room temperature for 18 h. The 
reaction mixture was then filtered and the filtrate was washed with sat. aqueous 
Na2S3O3 solution and sat. aqueous NaHCO3 solution. The organic layer was dried 
(MgSO4) and concentrated in vacuo. The crude product was purified by recrystallization 
from ethanol to afford the title compound 356 as white crystals (3.2568 g, 56%). The 
spectroscopic data of this compound matched with those in the literature.156 
Rf = 0.4 (EtOAc:hexane = 15:85). 
Mp.: 136-138 °C. (lit.156 137-139 °C) 
IR (neat): νmax 3074, 2851, 1671, 1580, 1499, 1432, 1376, 1260, 1151, 1018, 862 cm-1. 
1H NMR (500 MHz, CDCl3): δ 9.87 (s, 1H, CHO), 7.42 (s, 1H, H-6), 7.31 (s, 1H, H-3), 
3.96 (s, 3H, OCH3), 3.92 (s, 3H, OCH3). 
13C NMR (125 MHz, CDCl3): δ 195.0 (C=O), 154.7 (C-4), 150.0 (C-5), 128.6 (C-1), 
122.0 (C-3), 111.3 (C-6), 92.8 (C-2), 56.6 (OCH3), 56.2 (OCH3). 
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4-Hydroxy-3-iodobenzonitrile (357)109 
 
To a solution of potassium iodide (0.7968 g, 4.8 mmol, 1.2 equiv.) and iodine 
(1.2182 g, 4.8 mmol, 1.2 equiv.) in ammonia solution (28-30% w/w, 0.715 mL, 5.72 
mmol, 1.43 equiv.) and water (4.1 mL) was added 4-hydroxy-3-benzonitrile (0.5016 g, 
4.0 mmol, 1.0 equiv.) and the solution was stirred at room temperature for 20 h. Conc. 
HCl was then added to adjust the solution to pH1 and the mixture was extracted with 
EtOAc (2 x 10 mL). The combined organic layer was washed with water (20 mL), dried 
(MgSO4), and concentrated in vacuo. The crude product was purified by 
recrystallization from CH2Cl2 to afford the title compound 357 as white crystals (0.7576 
g, 91%). The spectroscopic data of this compound matched with those in the 
literature.109 
Rf = 0.4 (MeOH:CH2Cl2 = 2:98). 
Mp.: 136-138 °C. (lit.157 144 °C) 
IR (neat): νmax 3253, 3078, 2225, 1592, 1498, 1396, 1294, 1207, 822, 731 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.97 (s, 1H, H-2), 7.55 (d, J = 8.3 Hz, 1H, H-6), 7.05 (d, 
J = 8.3 Hz, 1H, H-5), 5.78 (br s, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 158.9 (C-4), 142.3 (C-2), 134.4 (C-6), 117.4 (C≡N), 
115.7 (C-5), 106.2 (C-1), 85.6 (C-3). 
3-Iodo-4-(methoxymethoxy)benzonitrile (358) 
 
A solution of benzonitrile 357 (1.2251 g, 5.0 mmol, 1.0 equiv.) in anhydrous 
CH2Cl2 (5.0 mL) was cooled to 0 °C. N,N-diisopropylethylamine (1.2944 g, 1.74 mL, 
10.0 mmol, 2.0 equiv.) and chloromethyl methyl ether (0.6038 g, 0.70 mL, 7.5 mmol, 
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1.5 equiv.) was respectively added and stirring was continued at 0 °C for 1 h. The 
mixture was warmed to room temperature and stirred continuously for 16 h. Water (10 
mL) was then added and the mixture was extracted with Et2O (4 x 15 mL). The 
combined organic layer was washed with brine (2 x 60 mL), dried (MgSO4) and 
concentrated in vacuo. The crude product was purified by recrystallization from CH2Cl2 
to afford the title compound 358 as white crystals (1.3008 g, 90%). 
Rf = 0.3 (EtOAc:hexane = 10:90). 
Mp.: 116-118 °C. 
IR (neat): νmax 3063, 2938, 2225, 1590, 1480, 1441, 1246, 1142, 1040, 980, 819 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.06 (d, J = 2.1 Hz, 1H, H-2), 7.59 (dd, J = 8.6, 2.1 Hz, 
1H, H-6), 7.12 (d, J = 8.6 Hz, 1H, H-5), 5.31 (s, 2H, OCH2OCH3), 3.51 (s, 3H, 
OCH2OCH3). 
13C NMR (125 MHz, CDCl3): δ 159.6 (C-4), 143.0 (C-2), 133.9 (C-6), 117.6 (C≡N), 
114.3 (C-5), 107.0 (C-1), 95.0 (OCH2OCH3), 86.9 (C-3), 56.9 (OCH2OCH3). 
ESIMS m/z 289 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C9H9NO2I [M + H]+: 289.9675, found: 289.9678. 
3-Bromo-4-(methoxymethoxy)benzonitrile (359)111 
 
To a solution of sodium hydride (60% dispersion in mineral oil, 0.1224 g, 3.06 
mmol, 1.02 equiv.) in anhydrous THF (6 mL) was cooled to 0 °C and a solution of 4-
hydroxy-3-bromobenzonitrile (0.5941 g, 3.0 mmol, 1.0 equiv.) in anhydrous THF (3.5 
mL) was added. The reaction mixture was stirred for 15 min, Chloromethyl methyl 
ether (0.2898 g, 0.28 mL, 3.6 mmol, 1.2 equiv.) was added and stirring was continued at 
0 °C for 45 min. The mixture was warmed to room temperature and stirred continuously 
for 2 h. After the reaction had completed, water (30 mL) was added and extracted with 
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EtOAc (2 x 30 mL). The combined organic layer was washed with water (60 mL) and 
brine (60 mL), dried (MgSO4), and concentrated in vacuo. The crude product was 
purified by recrystallization from CH2Cl2 to afford the title compound 359 as white 
solid (0.6748 g, 93%). The spectroscopic data of this compound matched with those in 
the literature.111 
Rf = 0.2 (EtOAc:hexane = 10:90). 
1H NMR (500 MHz, CDCl3): δ 7.85 (d, J = 2.1 Hz, 1H, H-2), 7.56 (dd, J = 8.6, 2.1 Hz, 
1H, H-6), 7.22 (d, J = 8.6 Hz, 1H, H-5), 5.32 (s, 2H, OCH2OCH3), 3.52 (s, 3H, 
OCH2OCH3). 
 (5-Cyano-2-(methoxymethoxy)phenyl)boronic acid (360)111 
 
A solution of benzonitrile 359 (0.2421 g, 1.0 mmol, 1.0 equiv.) in anhydrous 
THF (2.5 mL) was cooled to -78 °C. n-BuLi (1.6M in hexane, 0.75 mL, 1.2 mmol, 1.2 
equiv.) was then added dropwise and strring was continued at -78 °C for 2 h. Trimethyl 
borate (0.1559 g, 0.17 mL, 1.5 mmol, 1.5 equiv.) was added dropwise and the mixture 
was allowed to warm to room temperature. The reaction was quenched with 1M HCl 
(0.85mL) and extracted with EtOAc (2 x 5 mL). The combined organic layer was dried 
(MgSO4) and concentrated in vacuo. The crude product 360 was obtained as a yellow 
powder (35.0 mg, 17%) and used without further purification. The spectroscopic data of 
this compound matched with those in the literature.111 
IR (neat): νmax 3195, 2224, 1604, 1508, 1476, 1426, 1194, 669 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.18 (d, J = 2.2 Hz, 1H, H-6), 7.70 (dd, J = 8.7, 2.2 Hz, 
1H, H-4), 7.22 (d, J = 8.7 Hz, 1H, H-3), 5.58 (s, 2H, B-OH), 5.35 (s, 2H, OCH2OCH3), 
3.52 (s, 3H, OCH2OCH3). 
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13C NMR (125 MHz, CDCl3): δ 165.1 (C-2), 141.5 (C-6), 136.8 (C-4), 118.9 (C≡N), 
114.2 (C-3), 106.2 (C-5), 94.9 (OCH2OCH3), 57.0 (OCH2OCH3) (the quaternary carbon 
C-1 was not detected). 
2'-Formyl-4',5'-dimethoxy-6-(methoxymethoxy)-[1,1'-biphenyl]-3-carbonitrile 
(361) 
 
To a solution of aldehyde 352 (12.3 mg, 0.05 mmol, 1.0 equiv.), boronic acid 
360 (20.6 mg, 0.1 mmol, 2.0 equiv.) and potassium phosphate tribasic (21.2 mg, 0.1 
mmol, 2.0 equiv.) in 4:1 dimethoxyethane/water (0.63 mL) was added tetrakis 
(triphenylphosphine)palladium(0) (8.7 mg, 0.008 mmol, 0.15 equiv.). The reaction 
mixture was stirred and heated at reflux for 16 h. After cooling to room temperature, the 
mixture was filtered through a short pad of celite and extracted with EtOAc (2 x 5 mL). 
The combined organic layer was washed with brine (10 mL), dried (Na2SO4), and 
concentrated in vacuo. The crude product was purified by column chromatography 
(25:75 EtOAc/hexane) to afford the title compound 361 as a white solid (6.8 mg, 41%). 
Rf = 0.3 (EtOAc:hexane = 25:75). 
Mp.: 128-130 °C. 
IR (neat): νmax 3073, 2937, 2829, 2225, 1672, 1590, 1510, 1493, 1278, 1242, 1147, 968, 
879, 826, 745cm-1. 
1H NMR (500 MHz, CDCl3): δ 9.64 (s, 1H, CHO), 7.70 (dd, J = 8.7, 2.1 Hz, 1H, H-4), 
7.61 (d, J = 2.1 Hz, 1H, H-2), 7.52 (s, 1H, H-3′), 7.32 (d, J = 8.7 Hz, 1H, H-5), 6.74 (s, 
1H, H-6′), 5.16 (d, J = 11.8 Hz, 1H, OCHAHBOCH3) 5.15 (d, J = 11.8 Hz, 1H, 
OCHAHBOCH3), 4.00 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 3.37 (s, 3H, OCH2OCH3). 
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13C NMR (125 MHz, CDCl3): δ 190.3 (C=O), 158.2 (C-6), 153.9 (C-5′), 149.5 (C-4′), 
135.3 (C-2), 134.4 (C-1′), 134.2 (C-4), 129.1 (C-1), 127.4 (C-2′), 118.6 (C≡N), 115.0 
(C-5), 113.1 (C-6′), 108.9 (C-3′), 105.8 (C-3), 94.8 (OCH2OCH3), 56.9 (OCH3), 56.5 
(OCH3), 56.3 OCH2OCH3). 
ESIMS m/z 350 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C18H17NO5Na [M + Na]+: 350.1004, found: 350.1017. 
4-(Benzyloxy)-3-iodobenzonitrile (362) 
 
To a solution of benzonitrile 357 (0.2450 g, 1.0 mmol, 1.0 equiv.) in acetone (10 
mL) was added solid sodium carbonate (0.3879 g, 3.66 mmol, 3.66 equiv.) and benzyl 
bromide (0.1710 g, 1.0 mmol, 1.0 equiv.). The mixture was stirred and heated at reflux 
for 20 h. After cooling to room temperature, the solvent was filtered and evaporated and 
redissolved in CH2Cl2 followed by washing with water (2 x 10 mL). The combined 
organic layer was dried with MgSO4 and concentrated in vacuo. The crude product was 
purified by column chromatography (7:93 EtOAc/hexane) to afford the title compound 
362 as a white solid (0.2784 g, 94%). 
Rf = 0.3 (EtOAc:hexane = 10:90). 
Mp.: 94-96 °C. 
IR (neat): νmax 3065, 2923, 2222, 1590, 1488, 1449, 1291, 1046, 813, 729, 693 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.04 (d, J = 2.1 Hz, 1H, H-2), 7.56 (dd, J = 8.6, 2.1 Hz, 
1H, H-6), 7.45 (d, J = 7.5 Hz, 2H, ArH), 7.40 (t, J = 7.5 Hz, 2H, ArH), 7.36 – 7.31 (m, 
1H, ArH), 6.86 (d, J = 8.6 Hz, 1H, H-5), 5.20 (s, 2H, PhCH2O). 
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13C NMR (125 MHz, CDCl3): δ 160.9 (C-4), 143.1 (C-2), 135.5(ArC), 134.1 (C-6), 
129.0 (2 x ArCH), 128.6 (ArCH), 127.2 (2 x ArCH), 117.7 (C≡N), 112.5 (C-5), 106.4 
(C-1), 87.0 (C-3), 71.5 (PhCH2O). 
ESIMS m/z 358 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C14H11NOI [M + H]+: 335.9898, found: 335.9885. 
4-(Benzyloxy)-3-bromobenzonitrile (363)115 
 
To a solution of 4-hydroxy-3-bromobenzonitrile (2.4300 g, 12.3 mmol, 1.0 
equiv.) in acetone (25 mL) was added potassium carbonate (5.0875 g, 36.8 mmol, 3.0 
equiv.) and benzyl bromide (2.3090 g, 1.6 mL, 13.5 mmol, 1.07 equiv.) and the mixture 
was stirred at reflux for 20 h. After cooling to room temperature, the solvent was 
filtered and evaporated and redissolved in EtOAc (10 mL) followed by washing with 
water (2 x 10 mL). The combined organic layer was dried (MgSO4) and concentrated in 
vacuo. The crude product was purified by recrystallization from CH2Cl2 to afford the 
title compound 363 as pale yellow solid (3.3421 g, 95%). The spectroscopic data of this 
compound matched with those in the literature.115 
Rf = 0.3 (EtOAc:PS = 15:85). 
Mp.: 98-100 °C. 
IR (neat): νmax 3062, 2224, 1595, 1492, 1452, 1381, 1258, 998, 812, 737, 695 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.84 (d, J = 2.1 Hz, 1H, H-2), 7.54 (dd, J = 8.6, 2.1 Hz, 
1H, H-6), 7.47 – 7.32 (m, 5H, ArH), 6.97 (d, J = 8.6 Hz, 1H, H-5), 5.22 (s, 2H, 
PhCH2O). 
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13C NMR (125 MHz, CDCl3): δ 158.6 (C-4), 136.9 (C-2), 135.3 (ArC), 133.1 (C-6), 
128.9 (2 x ArCH), 128.5 ArCH), 127.1 (2 x ArCH), 117.8 (C≡N), 113.5 (C-5), 113.0 
(C-3), 105.6 (C-1), 71.1 (PhCH2O). 
ESIMS m/z 310 (48%) [M(79Br) + Na]+, 312 (52%) [M(81Br) + Na]+. 
6.4.1 General method 10 for the borylation reaction 
4,5-Dimethoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 
(366)113 
 
To a solution of bis(pinacolato)diboron (1.6760 g, 6.6 mmol, 1.1 equiv.) and          
[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloro- 
methane (0.4170 g, 0.18 mmol, 0.03 equiv.) in anhydrous THF (19 mL) was added 
potassium acetate (1.7714 g, 18.0 mmol, 3.0 equiv.) and aldehyde 352 (1.4705 g, 6.0 
mmol, 1.0 equiv.) and the mixture was stirred and heated at 55 °C for 18 h. After 
cooling to room temperature, the reaction mixture was poured into ice water and 
extracted with EtOAc (2 x 30 mL). The combined organic layer was washed with brine, 
dried (MgSO4) and concentrated in vacuo. The crude product was purified by column 
chromatography (20:80 EtOAc/hexane) to afford the title compound 366 as a white 
solid (1.6207 g, 93%). The spectroscopic data of this compound matched with those in 
the literature.113 
Rf = 0.5 (EtOAc:hexane = 30:70). 
Mp.: 98-100 °C. 
IR (neat): νmax 3015, 2980, 2933, 1680, 1583, 1517, 1454, 1358, 1322, 1299, 1216, 
1153, 1137, 1035, 877, 734 cm-1. 
1H NMR (500 MHz, CDCl3): δ 10.59 (s, 1H, CHO), 7.55 (s, 1H, H-6), 7.35 (s, 1H, H-
3), 4.01 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 1.38 (s, 12H, 4 x CH3). 
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13C NMR (125 MHz, CDCl3): δ 193.7 (C=O), 152.9 (C-4), 151.4 (C-4), 136.5 (C-1 and 
C-2), 117.4 (C-3), 108.8 (C-6), 84.4 (OC(CH3)2), 56.2 (OCH3), 56.1 (OCH3), 25.0 (4 x 
CH3). 
ESIMS m/z 315 (100%) [M + Na]+.  
4,4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2,2'-dicarbaldehyde (365)158 
 
Aldehyde dimer 365 was obtained as a by-product from the above borylation 
reaction of aldehyde 352 and bis(pinacolato)diboron as a white solid before optimizing 
the reaction conditions. The spectroscopic data of this compound matched with those in 
the literature.158 
Rf = 0.3 (MeOH:CH2Cl2 = 2:98). 
Mp.: 208-210 °C. (lit.158 213-215 °C) 
IR (neat): νmax 3011, 2930, 1671, 1594, 1499, 1448, 1386, 1260, 1150, 870, 752 cm-1. 
1H NMR (400 MHz, CDCl3): δ 9.67 (s, 2H, 2x CHO), 7.56 (s, 2H, H-3 and H-3′), 6.80 
(s, 2H, H-6 and H-6′), 4.01 (s, 6H, 2 x OCH3), 3.96 (s, 6H, 2 x OCH3). 
13C NMR (100 MHz, CDCl3): δ 189.9 (2 x C=O), 153.4 (C-5 and C-5′), 149.6 (C-4 and 
C-4′), 136.2 (C-1 and C-1′), 128.7 (C-2 and C-2′), 113.8 (C-6 and C-6′), 108.8 (C-3 and 
C-3′), 56.5 (2 x OCH3), 56.4 (2 x OCH3). 
ESIMS m/z 353 (100%) [M + Na]+. 
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6.4.2 General method 11 for the Suzuki coupling reaction 
6-(Benzyloxy)-2'-formyl-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (367) 
 
 Procedure A: To a solution of aldehyde 362 (0.5027 g, 1.5 mmol, 1.0 equiv.) in 
N2 purged anhydrous 1,2-dimethoxyethane (20 mL) was added boronate ester 366 
(0.6573 g, 2.25 mmol, 1.5 equiv.),  cesium fluoride  (0.6836 g, 4.5 mmol, 3.0 equiv.) 
and Pd(PPh3)4 (0.2600 g, 0.225 mmol, 0.15 equiv.) and the mixture was stirred and 
heated at reflux for 94 h. After cooling to room temperature, the reaction mixture was 
filtered through a short pad of celite and the residue was washed with EtOAc. The 
organic layer was dried (MgSO4) and concentrated in vacuo. The crude product was 
purified by column chromatography (10:20:70 EtOAc/CH2Cl2/hexane) to afford the title 
compound 367 as a white solid (0.4905 g, 88%). 
Procedure B: To a solution of aldehyde 363 (0.1441 g, 0.5 mmol, 1.0 equiv.) in 
degassed anhydrous 1,2-dimethoxyethane (5 mL) was added boronate ester 366 (0.2191 
g, 0.75 mmol, 1.5 equiv.),  cesium fluoride  (0.2279 g, 1.5 mmol, 3.0 equiv.) and 
Pd(PPh3)4 (0.0867 g, 0.075 mmol, 0.15 equiv.) and the mixture was stirred and heated at 
reflux for 48 h. After cooling to room temperature, the reaction mixture was filtered 
through a short pad of celite and the residue was washed with EtOAc. The organic layer 
was dried (MgSO4) and concentrated in vacuo. The crude product was purified by 
column chromatography (10:20:70 EtOAc/CH2Cl2/hexane) to afford the title compound 
367 as a white solid (0.1747 g, 94%). 
Rf = 0.2 (EtOAc:hexane = 20:80). 
Mp.: 132-134 °C. 
IR (neat): νmax 3008, 2936, 2225, 1677, 1595, 1511, 1491, 1454, 1346, 1276, 1251, 
1154, 1119, 989, 728, 696 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 9.66 (s, 1H, CHO), 7.68 (dd, J = 8.6, 2.1 Hz, 1H, H-4), 
7.58 (d, J = 2.1 Hz, 1H, H-2), 7.51 (s, 1H, H-3′), 7.35 – 7.24 (m, 3H, ArH), 7.19 (d, J = 
7.1 Hz, 2H, ArH), 7.10 (d, J = 8.6 Hz, 1H, H-5), 6.75 (s, 1H, H-6′), 5.16 – 5.06 (m, 2H, 
PhCH2O), 3.98 (s, 6H, OCH3), 3.94 (s, 6H, OCH3). 
13C NMR (125 MHz, CDCl3): δ 190.4 (C=O), 159.4 (C-6), 153.8 (C-5′), 149.3 (C-4′), 
135.4 (C-2), 135.4 (ArC), 134.4 (C-1′), 134.3 (C-4), 128.9 (C-1 and 2 x ArCH), 128.5 
(ArCH), 127.4 (C-2′), 127.1 (2 x ArCH), 118.7 (C≡N), 113.1 (C-6′), 113.1 (C-5), 108.8 
(C-3′), 104.8 (C-3), 70.9 (PhCH2O), 56.4 (OCH3), 56.3 (OCH3). 
ESIMS m/z 396 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C23H19NO4Na [M + Na]+: 396.1212, found: 396.1197. 
6.4.3 General method 12 for N-sulfinyl imine preparation 
(R)-N-((2'-(Benzyloxy)-5'-cyano-4,5-dimethoxy-[1,1'-biphenyl]-2-yl)methylene)-2-
methylpropane-2-sulfinamide (370) 
 
 To a solution of carbonitrile 367 (0.4712 g, 1.26 mmol) in CH2Cl2 (3 mL) was 
added potassium hydrogen sulfate (1.7224 g, 12.6 mmol, 10.0 equiv.) and (R)-(+)-2-
methyl-2-propanesulfinamide (0.2341 g, 1.89 mmol, 1.5 equiv.) and the mixture was 
stirred at room temperature for 24 h. The reaction mixture was filtered through a short 
pad of celite and concentrated in vacuo. The crude product was purified by column 
chromatography (25:75 EtOAc/Hexane) to afford the title compound 370 as a white 
powder (0.5366 g, 89%). 1H NMR analysis revealed the presence of two biphenyl axis 
rotamers in a 52:48 ratio. 
Rf = 0.4 (EtOAc:hexane = 30:70). 
    
    - 41.0 (c 0.25, CHCl3). 
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IR (neat): νmax 2962, 2222, 1601, 1582, 1510, 1453, 1212, 1156, 1126, 1075, 697 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the the minor rotamer, CDCl3): 
δ 8.27 (s, 1H, N=CH), 7.69 – 7.59 (m, 2H, H-3 and H-4′), 7.51 (s, 1H, H-6′), 7.33 – 7.23 
(m, 3H, ArH), 7.19 (d, J = 7.3 Hz, 1.04H, ArH), 7.15* (d, J = 7.1 Hz, 0.96H, ArH), 7.08 
(d, J = 8.6 Hz, 0.52H, H-3′), 7.04* (d, J = 8.7 Hz, 0.48H, H-3′), 6.75 (s, 1H, H-6), 5.16 
– 5.07 (m, 2H, PhCH2O), 4.00* (s, 1.44H, OCH3), 3.98 (s, 1.56H, OCH3), 3.94* (s, 
1.44H, OCH3), 3.92 (s, 1.56H, OCH3), 1.21 (s, 4.68H, CH3), 1.11* (s, 4.32H, CH3). 
13C NMR (125 MHz, the asterisk* denotes the signal of the the minor rotamer, CDCl3): 
δ 161.0 (N=CH), 159.31 (C-2′), 159.28* (C-2′), 152.3 (C-5), 149.2 (C-4), 149.1* (C-4), 
135.8* (ArC), 135.6 (C-6′), 135.5 (ArC), 135.2* (C-6′), 134.2 (C-4′), 134.1* (C-4′), 
132.8 (C-1), 130.0* (C-1′), 129.4 (C-1′), 128.8 (1 x ArCH), 128.7* (0.9 x ArCH), 128.3 
(0.6 x ArCH), 128.0* (0.4 x ArCH), 127.0 (1 x ArCH), 126.4* (0.9 x ArCH), 125.4 (C-
2), 118.9 (C≡N), 113.3 (C-3′), 113.19* (C-6), 113.16 (C-6), 109.9* (C-3), 109.2 (C-3), 
104.8 (C-5′), 104.7* (C-5′), 70.8 (PhCH2O), 70.5* (PhCH2O), 57.8 ((CH3)3C), 57.5* 
((CH3)3C), 56.3*(OCH3), 56.1 (OCH3), 22.7 ((CH3)33C), 22.5* ((CH3)3C). 
ESIMS m/z 499 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C27H28N2O4NaS [M+Na]+: 499.1667, found: 499.1674. 
6.4.4 General method 13 for allylation of a N-sulfinyl imine using an oragnozinc 
allyl reagent 
(R)-N-((S)-1-(2'-(Benzyloxy)-5'-cyano-4,5-dimethoxy-[1,1'-biphenyl]-2-yl)but-3-en-
1-yl)-2-methylpropane-2-sulfinamide (371) 
 
Procedure A: Zinc powder (0.2942 g, 4.5 mmol, 3.0 equiv.) was placed in a dry 
round bottom flask and anhydrous THF (4.5 mL) and allyl bromide (0.9074 g, 0.64 ml, 
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7.5 mmol, 5.0 equiv.) were added. The mixture was stirred and heated at reflux. After 
the disappearance of the zinc powder, the mixture was cooled to room temperature. 
Then a solution of the N-sulfinyl imine 367 (0.7148 g, 1.5 mmol, 1.0 equiv.) in 
anhydrous THF (5.5 mL) was added to the above prepared organozinc reagent dropwise 
at room temperature. After TLC analysis indicated the absence of sulfinamide 367, the 
reaction mixture was quenched with sat. aqueous NH4Cl solution and extracted with 
EtOAc (2 x10 ml). The organic layer was dried (MgSO4) and concentrated in vacuo. 
The crude product was purified by column chromatography (50:50 EtOAc/hexane) to 
afford the title compound 371 as a pale yellow crystalline solid (0.5758 g, 74%). 
Procedure B: Zinc powder (0.0981 g, 1.5 mmol, 3.0 equiv.) was placed in a dry 
round bottom flask and anhydrous THF (1.5 mL), zinc trifluoromethanesulfonate 
(0.5454 g, 1.5 mmol, 3.0 equiv.) and allyl bromide (0.1771 g, 0.13 ml, 1.5 mmol, 3.0 
equiv.) were added and the mixture was stirred and heated at reflux. After the 
disappearance of the zinc powder, the mixture was cooled to room temperature. Then a 
solution of the N-sulfinyl imine 367 (0.2383 g, 0.5 mmol, 1.0 equiv.) in anhydrous THF 
(3.5 mL) was added to the above prepared organozinc reagent dropwise at room 
temperature. After TLC analysis indicated the absence of sulfinamide 367, the reaction 
mixture was quenched with sat. aqueous NH4Cl solution and extracted with EtOAc (2 x 
5 ml). The organic layer was dried (MgSO4) and concentrated in vacuo. The crude 
product was purified by column chromatography (50:50 EtOAc/hexane) to afford the 
title compound 371 as a pale yellow crystalline solid (0.2129 g, 82%). 
Procedure C: To a solution of the N-sulfinyl imine 367 (0.7260 g, 1.52 mmol, 
1.0 equiv.) in anhydrous THF (5.0 mL) was added zinc powder (0.2987 g, 4.57 mmol, 
3.0 equiv.), zinc trifluoromethanesulfonate (1.6955 g, 4.57 mmol, 3.0 equiv.) and allyl 
bromide (0.5755 g, 0.42 ml, 4.87 mmol, 3.2 equiv.) and the mixture was stirred at room 
temperature for 8 h. After the reaction had completed, the mixture was quenched with 
sat. aqueous NH4Cl solution and extracted with EtOAc (2 x 10 ml). The organic layer 
was washed with brine, dried (MgSO4) and concentrated in vacuo. The crude product 
was purified by column chromatography (50:50 EtOAc/hexane) to afford the title 
compound 371 as a pale yellow crystalline solid (0.6842 g, 87%). 1H NMR analysis 
revealed the presence of two biphenyl axis rotamers in a 62:38 ratio. 
Chapter 6: Experimental Section | 272 
 
 
Rf = 0.2 (EtOAc:hexane = 60:40). 
Mp.: 156-158 °C. 
    
    - 88.5 (c 0.20, CHCl3). 
IR (neat): νmax 3271, 2936, 2855, 2225, 1662, 1512, 1495, 1461, 1267, 1155, 1120, 
1067, 1030, 747 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the the minor rotamer, CDCl3): 
δ 7.64 – 7.57 (m, 1.38H, H-4′ and H-6′ (minor)), 7.42 (s, 0.62H, H-6′), 7.31 – 7.15 (m, 
5H, ArH), 7.03 (s, 1H, H-3′), 7.01 (s, 0.62 H, H-3), 6.93* (s, 0.38 H, H-3), 6.66 (s, 
0.62H, H-6), 6.63* (s, 0.38H, H-6), 5.61 – 5.45 (m, 1H, H-3′′), 5.34 (d, J = 13.1 Hz, 
0.62H, PhCHAHBO), 5.19 (d, J = 13.0 Hz, 0.62H, PhCHAHBO), 5.15 – 4.96 (m, 2.76H, 
H-4′′ and PhCH2O (minor)), 4.23 (dd, J = 8.6, 5.3 Hz, 0.62H, H-1′′), 4.21* – 4.17* (m, 
0.38H, H-1′′), 3.90 (s, 3H, OCH3), 3.88 (s, 1.86H, OCH3), 3.85 (s, 1.14H, OCH3), 3.54* 
(s, 0.38H, NH), 3.48 (s, 0.62H, NH), 2.49* (m, 0.38H, H-2′′), 2.43 – 2.20 (m, 1.62H, H-
2′′), 1.17* (s, 3.42H, CH3), 1.07 (s, 5.58H, CH3). 
13C NMR (125 MHz, the asterisk* denotes the signal of the the minor rotamer, CDCl3): 
δ 159.5* (C-2′), 159.4 (C-2′), 149.1* (C-4), 149.0 (C-4), 148.0 (C-5), 147.97* (C-5), 
136.5 (ArC), 135.8* (ArC), 135.7* (C-6′), 135.4 (C-6′), 134.7* (C-3′′), 134.2 (C-3′′), 
133.8* (C-4′), 133.7 (C-4′), 132.9 (C-2), 132.1* (C-2), 131.1* (C-1′), 131.0 (C-1′), 
128.8 (0.76 x ArCH), 128.7* (C-1), 128.5 (1.24 x ArCH), 128.3 (C-1), 128.26* (0.38 x 
ArCH), 127.7 (0.62 x ArCH), 126.8* (0.76 x ArCH), 126.5 (1.24 x ArCH), 119.5 (C-
4′′), 119.2 (C≡N), 119.0* (C≡N), 118.8* (C-4′′), 113.3 (C-3′), 112.9*(C-6), 112.8* (C-
3′), 112.79 (C-6), 109.7 (C-3), 104.8* (C-5′), 103.7 (C-5′), 70.4* (PhCH2O), 70.3 
(PhCH2O), 56.1 (OCH3), 56.0* (OCH3), 55.99* (OCH3), 55.95 (OCH3), 55.7* 
(C(CH3)3), 55.4 (C(CH3)3), 53.6* (C-1′′), 53.0 (C-1′′), 43.5 (C-2′′), 42.6* (C-2′′), 22.7* 
(C(CH3)3), 22.8 (C(CH3)3). 
ESIMS m/z 541 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C30H34N2O4NaS [M+Na]+: 541.2137, found: 514.2135. 
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6.4.5 General method 14 for hydrolysis of a sulfinamide 
(S)-2'-(1-Aminobut-3-en-1-yl)-6-(benzyloxy)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (378) 
 
 To a solution of sulfinamide 371 (0.2200 g, 0.42 mmol, 1.0 equiv.) in MeOH 
(2.5 mL) was added TMSCl (0.0921 g, 0.85 mmol, 2.0 equiv.) and the solution was 
stirred at room temperature for 30 min. The solution was then evaporated to dryness in 
vacuo and the residue was washed with Et2O (5 mL) and redissolved in CH2Cl2 (2 mL). 
The solution was washed with sat. aqueous NaHCO3 solution. The organic layer was 
dried (MgSO4) and concentrated in vacuo to afford the title compound 378 as a pale 
yellow oil (0.1669 g, 95%) which was used I the next step without further purification. 
1H NMR analysis revealed the presence of two biphenyl axis rotamers in a 64:36 ratio. 
Rf = 0.2 (MeOH:CH2Cl2 = 5:95). 
    
    - 48.1 (c 0.09, CHCl3). 
IR (neat): νmax 3420, 3365, 3072, 2917, 2224, 1599, 1512, 1490, 1454, 1247, 1207, 
1181, 1154, 1118, 734, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.64 – 7.59 (m, 1H, H-4), 7.49* (s, 0.36H, H-2), 7.46 (s, 0.64H, H-2), 7.30 (d, J = 7.2 
Hz, 3H, ArH), 7.18 (d, J = 7.0 Hz, 2H, ArH), 7.12 – 7.02 (m, 2H, H-5 and H-3′), 6.62* 
(s, 0.36H, H-6′), 6.57 (s, 0.64H, H-6′), 5.61 – 5.42 (m, 1H, H-3′′), 5.17 – 5.07 (m, 2H, 
PhCH2O), 5.02 – 4.90 (m, 2H, H-4′′), 3.96 (s, 3H, OCH3), 3.87 (s, 1.92H, OCH3), 3.84 
(s, 1.08H, OCH3), 3.78 – 3.70 (m, 1H, H-1′′), 2.34* – 2.26* (m, 0.36H, H-2′′), 2.25 – 
2.16 (m, 1.64H, H-2′′), 1.45 (br s, 2H, NH2). 
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13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.7* (C-6), 159.2 (C-6), 149.3 (C-4′), 149.2* (C-4′), 147.6 (C-5′), 147.4* (C-5′), 
136.9 (C-2′), 136.5* (C-2′), 135.8* (C-2), 135.7 (ArC), 135.6 (C-2), 135.3 (C-3′′), 
135.2* (C-3′′), 133.5* (C-4), 133.3 (C-4), 132.3 (C-1), 131.9* (C-1), 128.9 (1.28 x 
ArCH), 128.8* (0.72 x ArCH), 128.5 (0.64 x ArCH), 128.2* (0.36 x ArCH), 127.1* (C-
1′), 127.0 (1.28 x ArCH), 126.9 (C-1′), 126.7* (0.72 x ArCH), 119.2 (C≡N), 117.6 (C-
4′′), 117.4* (C-4′′), 113.0* (C-5), 112.9 (C-5 and C-6′ (minor)), 112.6 (C-6′), 108.8* (C-
3′), 108.6 (C-3′), 104.5 (C-3), 104.2* (C-3), 70.6 (PhCH2O), 70.4* (PhCH2O), 56.2 
(OCH3), 56.1* (OCH3), 56.09* (OCH3), 56.07 (OCH3), 51.8 (C-1′′), 51.2* (C-1′′), 43.7 
(C-2′′), 43.2* (C-2′′). 
ESIMS m/z 415 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C26H27N2O3 [M + H]+: 415.2012, found: 415.2019. 
6.4.6 General method 15 for the O-PMB protection reaction 
1-Methoxy-4-((pent-4-en-1-yloxy)methyl)benzene (379)126 
 
To a solution of 4-penten-1-ol (1.0336 g, 12.0 mmol, 1.0 equiv.) was added 
DIPEA (2.0193 g, 2.7 mL, 15.6 mmol, 1.3 equiv.) and PMBCl (2.0516 g, 1.8 mL, 13.1 
mmol, 1.1 equiv.) and stirred at 150 °C for 2 h. After the reaction had completed, 
EtOAc (60 mL) was added and washed with 10% NaHSO4 (60 mL). The aqueous layer 
was washed with EtOAc (2 x 60 mL). The combined organic layer was dried and 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel eluting with 5:95 EtOAc/hexane to afford the title compound 379 as a 
colorless oil (2.3776 g, 96%). The spectroscopic data of this compound matched with 
those in the literature.126 
Rf = 0.4 (EtOAc:hexane = 5:95). 
IR (neat): νmax 3078, 2937, 2854, 1613, 1511, 1245, 1097, 1035, 819 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 7.26 (d, J = 8.5 Hz, 2H, ArH), 6.88 (d, J = 8.5 Hz, 2H, 
ArH), 5.81 (ddt, J = 17.0, 10.1, 6.7 Hz, 1H, H-4), 5.01 (dd, J = 17.0, 1.8 Hz, 1H, H-5A), 
4.95 (d, J = 10.1 Hz, 1H, H-5B), 4.43 (s, 2H, PMPCH2O), 3.80 (s, 3H, OCH3), 3.45 (t, J 
= 6.5 Hz, 2H, H-1), 2.18 – 2.09 (m, 2H, H-3), 1.75 – 1.65 (m, 2H, H-2). 
13C NMR (125 MHz, CDCl3): δ 159.2 (ArC), 138.4 (C-4), 130.8 (ArC), 129.3 (2 x 
ArCH), 114.8 (C-5), 113.8 (2 x ArCH), 72.6 (PMPCH2O), 69.5 (C-1), 55.3 (OCH3), 
30.5 (C-3), 29.1 (C-2). 
ESIMS m/z 229 (100%) [M + Na]+.  
6.4.7 General method 16 for olefin cross metathesis using Grubbs’ II ruthenium 
catalyst 
(E)-1-Methoxy-4-(((5-(phenylsulfonyl)pent-4-en-1-yl)oxy)methyl)benzene (380) 
 
To a solution of alkene 379 (0.5157 g, 2.5 mmol, 1.0 equiv.) in degassed 
anhydrous CH2Cl2 (9 mL) was added phenyl vinyl sulfone (1.2616 g, 7.5 mmol, 3.0 
equiv.) and Grubbs’ II ruthenium catalyst (0.1061 g, 0.125 mmol, 0.05 equiv.) and the 
mixture was stirred and heated at reflux for 18 h. The reaction mixture was cooled to 
room temperature and the solvent was evaporated. The crude product was purified by 
column chromatography on silica gel eluting with 10:25:65 Et2O/CH2Cl2/hexane to 
afford the title compound 380 as a colorless oil (0.6536 g, 76%). 
Rf = 0.6 (EtOAc:hexane = 40:60). 
IR (neat): νmax 3060, 2861, 1612, 1511, 1447, 1305, 1245, 1144, 1032, 816, 752 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 7.7 Hz, 2H, ArH), 7.61 (t, J = 7.5 Hz, 1H, 
ArH), 7.53 (t, J = 7.7 Hz, 2H, ArH), 7.22 (d, J = 8.6 Hz, 2H, ArH), 6.99 (dt, J = 15.0, 
6.8 Hz, 1H, H-4), 6.87 (d, J = 8.6 Hz, 2H, ArH), 6.30 (d, J = 15.0 Hz, 1H, H-5), 4.38 (s, 
2H, PMPCH2O), 3.80 (s, 3H, OCH3), 3.43 (t, J = 6.1 Hz, 2H, H-1), 2.39 – 2.27 (m, 2H, 
H-3), 1.75 (p, J = 6.6 Hz, 2H, H-2). 
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13C NMR (125 MHz, CDCl3): δ 159.4 (ArC), 146.7 (C-4), 140.9 (ArC), 133.3 (ArCH), 
130.9 (C-5), 130.4 (ArC), 129.4 (2 x ArCH), 129.3 (2 x ArCH), 127.7 (2 x ArCH), 
114.0 (2 x ArCH), 72.8 (PMPCH2O), 68.7 (C-1), 55.4 (OCH3), 28.5 (C-3), 28.0 (C-2). 
ESIMS m/z 369 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C19H22O4NaS [M + Na]+: 369.1131, found: 369.1135. 
6.4.8 General method 17 for Sharpless asymmetric dihydroxylation (ADH) using         
AD-mix 
3,6-Bis(3-((4-methoxybenzyl)oxy)propyl)-1,4-dioxane-2,5-diol or (R)-2-hydroxy-5-
((4-methoxybenzyl)oxy)pentanal dimer (381) 
 
To a solution of vinyl sulfone 380 (0.1732 g, 0.5 mmol, 1.0 equiv.) in 1:1          
t-BuOH/water (5 mL) was added methanesulfonamide (0.1047 g, 1.1 mmol, 2.2 equiv.) 
and AD-mix-β (3.5 g) and the mixture was stirred at room temperature for 24 h. The 
reaction mixture was quenched with sat. aqueous NaSO3 solution and extracted with 
EtOAc (2 x 10 mL). The combined organic layer was wash with brine, dried (MgSO4) 
and concentrated in vacuo to afford a crude Sharpless ADH product as a brown oil 
which was used without further purification. 
Rf = 0.4 (MeOH:CH2Cl2 = 4:96). 
ESIMS m/z 239 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C13H19O4 [M + H]+: 239.1283, found: 239.1286. 
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6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-4-hydroxy-7-((4-methoxybenzyl)oxy)-1-phenyl 
hept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile 
(382) and 6-(benzyloxy)-2'-((S)-1-(((3R,4R,E)-4-hydroxy-7-((4-methoxybenzyl)oxy)-
1-phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (383) 
                        
To a solution of the above crude Sharpless ADH product 381 in EtOH (0.5 mL) 
was added amine 378 (0.2152 g, 0.52 mmol, 1.0 equiv.) and (E)-2-phenylvinylboronic 
acid (0.1152 g, 0.78 mmol, 1.5 equiv.) and the mixture was stirred at room temperature 
for 72 h. The solution was evaporated and the residue was dissolved in EtOAc (5 mL) 
and then washed with sat. aqueous NaHCO3 solution (2 x 5 mL). The combined organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel eluting with 1:99 MeOH/CH2Cl2 to 
afford the title compound 382 as a pale yellow oil (0.1437 g, 37%) and 383 as a pale 
yellow oil (0.1335 g, 35%).  1H NMR analysis revealed the presence of two biphenyl 
axis rotamers in a 60:40 ratio for both products. 
382: Rf = 0.2 (MeOH:CH2Cl2 = 4:96). 
    
    + 43.3 (c 1.18, CHCl3). 
IR (neat): νmax 3427, 3064, 2935, 2224, 1600, 1512, 1490, 1453, 1247, 1179, 1115, 
1033, 817, 737, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.52 – 7.44 (m, 1H, H-4), 7.39 (d, J = 2.2 Hz, 0.6H, H-2), 7.36* (d, J = 2.2 Hz, 0.4H, H-
2), 7.32 – 7.11 (m, 10H, ArH), 7.09 – 7.03 (m, 1H, ArH), 7.02 (s, 0.6H, H-3′), 7.00* (s, 
0.4H, H-3′), 6.93* (d, J = 8.7 Hz, 0.4H, H-5), 6.84 – 6.77 (m, 2.6H, H-5 and ArH), 6.61 
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(s, 0.6H, H-6′), 6.55* (s, 0.4H, H-6′), 6.26* (d, J = 16.0 Hz, 0.4H, H-1′′′), 6.03 (d, J = 
16.0 Hz, 0.6H, H-1′′′), 5.93 – 5.81 (m, 1H, H-2′′′), 5.68 – 5.53 (m, 1H, H-3′′), 5.10 – 
4.90 (m, 2.6H, H-4′′ and PhCH2O (minor) and PhCHAHBO (major)), 4.87 (d, J = 12.4 
Hz, 0.4H, PhCHAHBO (major)), 4.42 – 4.35 (m, 2H, PMPCH2O), 3.91* (s, 1.2H, 
OCH3), 3.89 (s, 1.8H, OCH3), 3.83* (s, 1.2H, OCH3), 3.82 (s, 1.8H, OCH3), 3.77* (s, 
1.2H, OCH3), 3.75 (s, 1.8H, OCH3), 3.62 (t, J = 6.8 Hz, 0.6H, H-1′′), 3.55* (dd, J = 8.3, 
4.8 Hz, 0.4H, H-1′′), 3.48 – 3.28 (m, 2.4H, H-7′′ and H-4′′′ (minor)), 3.28 – 3.22 (m, 
0.6H, H-4′′′), 3.01* (dd, J = 8.8, 3.0 Hz, 0.4H, H-3′′′), 2.96 (dd, J = 9.4, 3.1 Hz, 0.6H, 
H-3′′′), 2.45 – 2.30 (m, 1.6H, H-2′′), 2.30* – 2.20* (m, 0.4H, H-2′′′), 1.77 – 1.56 (m, 
1.2H, H-6′′′), 1.51* – 1.42* (m, 0.8H, H-6′′′), 1.42* – 1.32* (m, 0.8H, H-5′′′), 1.16 – 
1.06 (m, 1.2H, H-5′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6* (C-6), 159.3 (ArC), 159.19* (ArC), 159.16 (C-6), 149.4 (C-4′), 149.2* (C-4′), 
147.58* (C-5′), 147.56 (C-5′), 136.8 (ArC), 136.7* (ArC), 135.9 (C-2′), 135.9* (C-2), 
135.7* (C-2′), 135.5 (C-2), 135.2* (C-3′′), 135.1 (ArC), 135.0 (C-3′′), 134.3* (ArC), 
133.42* (C-4), 133.40 (C-4), 133.0* (C-1′′′), 132.7 (C-1′′′), 132.0* (C-1), 131.5 (C-1), 
130.7* (ArC), 130.6 (ArC), 129.4 (1.2 x ArCH), 129.36* (0.8 x ArCH), 128.73* (0.8 x 
ArCH), 128.70 (1.2 x ArCH), 128.66* (0.8 x ArCH), 128.6 (1.2 x ArCH), 128.22* (0.4 
x ArCH), 128.16 (0.6 x ArCH), 128.15* (C-1′), 128.0 (0.6 x ArCH), 127.9 (C-1′), 127.7 
(C-2′′′), 127.69* (C-2′′′), 127.3 (0.6 x ArCH), 126.8* (0.8 x ArCH), 126.6 (1.2 x 
ArCH), 126.5 (ArCH), 119.0 (C≡N), 118.9* (C≡N), 117.8 (C-4′′), 117.2* (C-4′′), 113.9 
(1.2 x ArCH), 113.8* (0.8 x ArCH), 113.3 (C-5), 112.9* (C-5), 112.84* (C-6′), 112.80 
(C-6′), 109.2* (C-3′), 108.9 (C-3′), 104.3* (C-3), 104.1 (C-3), 72.7 (PMPCH2O), 72.6* 
(PMPCH2O), 71.7* (C-4′′′), 71.1 (C-4′′′), 71.1 (C-1′′′), 70.4 (PhCH2O), 70.2 (C-7′′′), 
70.15* (PhCH2O), 63.2* (C-3′′′), 62.0 (C-3′′′), 56.2 (OCH3), 56.1* (OCH3), 56.0* 
(OCH3), 55.4* (OCH3), 55.4 (OCH3 and C-1′′*), 54.9 (C-1′′), 41.3* (C-2′′), 41.2 (C-2′′), 
30.6* (C-5′′′), 30.5 (C-5′′′), 27.2 (C-6′′′), 26.8 (C-6′′′). 
ESIMS m/z 739 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C47H51N2O6 [M + H]+: 739.3747; found: 739.3749. 
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383: Rf = 0.3 (MeOH:CH2Cl2 = 4:96). 
    
    - 42.5 (c 2.40, CHCl3). 
IR (neat): νmax 3409, 2923, 2856, 2225, 1600, 1512, 1491, 1463, 1453, 1246, 1205, 
1178, 1032, 817, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.54 – 7.44 (m, 1.6H, H-4 and H-2), 7.40* (s, 0.4H, H-2), 7.35 – 7.00 (m, 13H, ArH and 
H-3′), 6.94* (d, J = 8.6 Hz, 0.4H, H-5), 6.91 (d, J = 8.6 Hz, 0.6H, H-5), 6.79 – 6.76 (m, 
2H, ArH), 6.63* (s, 0.4H, H-6′), 6.57 (s, 0.6H, H-6′), 5.88* (d, J = 16.0 Hz, 0.4H, H-
1′′′), 5.84 (d, J = 16.0 Hz, 0.6H, H-1′′′), 5.67 (dd, J = 16.0, 8.7 Hz, 0.6H, H-2′′′), 5.64* – 
5.55* (m, 0.4H, H-2′′′), 5.55 – 5.45 (m, 1H. , H-3′′), 5.14 – 4.97 (m, 4H, PhCH2O and 
H-4′′), 4.37 (s, 1.2H, PMPCH2O), 4.33* (s, 1.8H, PMPCH2O), 3.95 (s, 1.2H, OCH3), 
3.93 (s, 1.8H, OCH3), 3.87 (s, 1.8H, OCH3), 3.80 (s, 1.2H, OCH3), 3.76 (s, 3H, OCH3), 
3.63* (dd, J = 9.2, 4.1 Hz, 0.4H, H-1′′), 3.51 (d, J = 7.4 Hz, 0.8H, H-1′′), 3.43 – 3.20 
(m, 2.6H, H-4′′′ and H-7′′′), 3.21* – 3.13* (m, 0.4H, H-4′′′), 2.60* (t, J = 8.0 Hz, 0.4H, 
H-3′′′), 2.51 (t, J = 8.6 Hz, 0.6H, H-3′′′), 2.47 – 2.25 (m, 1.6H, H-2′′), 2.19* – 2.10* (m, 
0.4H, H-2′′), 1.79* – 1.68* (m, 0.4H, H-6′′′), 1.65 – 1.45 (m, 2H, H-6′′′ and H-5′′′A), 
1.42* – 1.33* (m, 0.4H, H-5′′′A), 1.31 – 1.21 (m, 0.6H, H-5′′′B), 1.09* – 1.00* (m, 0.4H, 
H-5′′′B). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.8 (C-6), 159.1 (ArC), 149.4 (C-4′), 149.37* (C-4′), 147.7 (C-5′), 147.4* (C-5′), 
136.8* (ArC), 136.4 (ArC), 135.9 (C-3′′), 135.7* (C-2′), 135.6* (C-3′′), 135.5 (C-2′), 
135.2 (C-2), 135.1* (C-2), 134.7 (ArC), 134.4* (ArC), 133.5 (C-4), 133.3* (C-4), 132.7 
(C-1′′′), 132.2 (C-1), 131.6* (C-1′′′), 131.4* (C-1), 130.7* (ArC), 130.6 (ArC), 129.4 
(C-2′′′), 129.3 (1.2 x ArCH), 129.26* (0.8x ArCH), 128.8* (0.8 x ArCH), 128.7 (2.4 x 
ArCH), 128.6* (0.8 x ArCH), 128.57* (C-2′′′), 128.3 (ArCH), 127.8 (C-2), 127.7 (0.6 x 
ArCH), 127.7* (0.4 x ArCH), 126.9 (1.2 x ArCH), 126.5* (0.8 x ArCH), 126.4 (1.2 x 
ArCH), 126.2* (0.8 x ArCH), 119.0 (C≡N), 118.7* (C-4′′), 118.0 (C-4′′), 113.8 (1.2 x 
ArCH), 113.77* (0.8 x ArCH), 113.0 (C-5), 112.9* (C-5), 112.9 (C-6′), 112.7* (C-6′), 
109.5 (C-3′), 109.4* (C-3′), 104.3 (C-3), 103.9* (C-3), 73.2* (C-4′′′), 73.15 (C-4′′′), 
72.5 (PMPCH2O), 72.4* (PMPCH2O), 70.5 (PhCH2O), 70.2* (PhCH2O), 70.0 (C-7′′′), 
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69.97* (C-7′′′), 63.3 (C-3′′′), 62.4* (C-3′′′), 56.1 (OCH3), 56.0* (OCH3), 55.4 (OCH3), 
54.0* (C-1′′), 53.8 (C-1′′), 43.4* (C-2′′), 42.1 (C-2′′), 30.4 (C-5′′′), 30.3* (C-5′′′), 26.1 
(C-6′′′), 26.0* (C-6′′′). 
ESIMS m/z 739 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C47H51N2O6 [M + H]+: 739.3747; found: 739.3741. 
6-(Benzyloxy)-4',5'-dimethoxy-2'-((S)-1-((4S,5R)-5-(3-((4-methoxybenzyl)oxy) 
propyl)-2-oxo-4-((E)-styryl)oxazolidin-3-yl)but-3-en-1-yl)-[1,1'-biphenyl]-3-
carbonitrile (384) 
 
The title compound was prepared following the General method 4 for synthesis 
of oxazolidinones, using 1,2-amino alcohol 382 (29.6 mg, 0.04 mmol, 1.0 equiv.), 
triethylamine (16.2 mg, 22.3 µL, 0.16 mmol, 4.0 equiv.), triphosgene (5.9 mg, 0.02 
mmol, 0.5 equiv.) and CH2Cl2 (0.7 mL). Purification by column chromatography on 
silica gel eluting with 30:70 EtOAc/hexane gave the title compound 384 as a pale 
yellow oil (10.2 mg, 33%). 1H NMR analysis revealed the presence of two biphenyl axis 
rotamers in a 63:37 ratio. 
Rf = 0.3 (EtOAc:hexane = 40:60). 
    
    + 71.4 (c 0.51, CHCl3). 
IR (neat): νmax 3067, 2932, 2223, 1738, 1600, 1512, 1493, 1401, 1249, 1209, 1180, 
1030, 816, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.55 (s, 0.63H, H-2), 7.49* (dd, J = 8.6, 2.1 Hz, 0.37H, H-4), 7.46 (s, 1H, H-3′), 7.41 
(dd, J = 8.6, 2.1 Hz, 0.63H , H-4), 7.38* (s, 0.37H , H-2), 7.36 – 7.04 (m, 11.26H, ArH), 
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7.01* (d, J = 8.7 Hz, 0.37H, H-5), 6.97* – 6.92* (m, 0.74H, ArH), 6.86 (d, J = 8.7 Hz, 
0.63H , H-5), 6.83 – 6.77 (m, 2H, ArH), 6.67* (s, 0.37H, H-6′), 6.56 (s, 0.63H, H-6′), 
5.99* (d, J = 15.8 Hz, 0.37H, H-2′′′′′), 5.83 (d, J = 15.8 Hz, 0.63H, H-2′′′′′), 5.77* – 
5.68* (m, 0.37H, H-3′′), 5.68 – 5.52 (m, 1.26H, H-3′′ and H-1′′′′′), 5.41* (dd, J = 15.8, 
8.3 Hz, 0.37H, H-1′′′′′), 5.19 – 4.96 (m, 4H, H-4′′ and PhCH2O), 4.49* – 4.44* (m, 
0.37H, H-1′′), 4.37 (s, 1H, PMPCH2O), 4.34* (s, 1H, PMPCH2O), 4.18 (dd, J = 11.1, 
4.5 Hz, 0.63H, H-1′′), 3.98 – 3.92 (m, 0.63H, H-5′′′), 3.86 (s, 1.89H OCH3), 3.82 (s, 
3.78H OCH3), 3.77 (s, 1.11H OCH3), 3.76 (s, 1.11H OCH3), 3.72* – 3.64* (m, 0.74H, 
H-4′′′ and H-5′′′), 3.52 (t, J = 8.2 Hz, 0.63H, H-4′′′), 3.45 – 3.28 (m, 2.63H, H-2′′A and 
H-3′′′′), 3.20* – 3.11* (m, 0.37H, H-2′′A), 2.68* (dt, J = 13.0, 6.0 Hz, 0.37H, H-2′′B), 
2.43 – 2.35 (m, 0.63H, H-2′′B), 1.74 – 1.46 (m, 2.74H, H-2′′′′ and H-1′′′′), 1.33 – 1.31 
(m, 1.26H, H-1′′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6* (C-6), 159.4 (C-6), 159.3* (ArC), 159.2 (ArC), 156.8* (C-2′′′), 156.6 (C-2′′′), 
149.1 (C-4′), 148.8* (C-4′), 148.3 (C-5′), 147.9* (C-5′′), 135.8* (ArC), 135.6 (C-3′′′), 
135.5 (ArC), 135.4 (C-2), 135.3* (C-2), 135.26 (ArC), 134.8* (C-3′′′), 134.6 (C-2′′′′′), 
133.8* (C-2′′′′′), 133.7* (C-4), 133.6 (C-4), 132.2 (C-2′), 131.8 (C-1), 131.1* (C-2′), 
130.7,* (C-1) 130.5 (ArC), 130.49* (ArC), 129.4 (1.26 x ArCH), 129.3* (0.74 x 
ArCH), 128.9* (0.74 x ArCH), 128.8 (1.26 x ArCH), 128.77* (0.74 x ArCH), 128.7 
(2.52x ArCH), 128.67* (0.74 x ArCH), 128.6* (0.37 x ArCH), 128.5 (0.63 x ArCH), 
128.3 (ArCH), 128.0 (C-1′), 127.1* (0.74 x ArCH), 126.9 (1.26 x ArCH), 126.8* (C-
1′′′′′), 126.6 (1.26 x ArCH), 126.5* (0.74 x ArCH), 125.9 (C-1′′′′′), 119.1 (C≡N), 118.9* 
(C≡N), 118.4* (C-7′′′), 117.6 (C-7′′′), 113.9 (2 x ArCH), 113.4 (C-5), 113.2* (C-5 and 
C-6′), 112.9* (C-6′), 111.4 (C-3′), 111.2* (C-3′), 104.5 (C-3), 104.4* (C-3), 79.0 (C-
5′′′), 78.8* (C-5′′′), 72.6 (PMPCH2O), 70.8 (PhCH2O), 70.4* (PhCH2O), 69.2* (C-3′′′′), 
69.1 (C-3′′′′), 65.1 (C-4′′′), 64.3* (C-4′′′), 56.1 (OCH3), 56.0 (OCH3), 55.4 (OCH3), 54.5 
(C-1′′), 53.8* (C-1′′), 36.3* (C-2′′),  35.5 (C-2′′), 30.6* (C-1′′′′), 29.8 (C-1′′′′), 25.4 (C-
2′′′′). 
ESIMS m/z 787 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C48H48N2O7Na [M + Na]+: 787.3359; found: 787.3380. 
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6-(Benzyloxy)-4',5'-dimethoxy-2'-((S)-1-((4R,5R)-5-(3-((4-methoxybenzyl)oxy) 
propyl)-2-oxo-4-((E)-styryl)oxazolidin-3-yl)but-3-en-1-yl)-[1,1'-biphenyl]-3-
carbonitrile (385) 
 
The title compound was prepared following the General Method 4 for synthesis 
of oxazolidinones, using 1,2-amino alcohol 383 (17.9 mg, 0.024 mmol, 1.0 equiv.), 
triethylamine (9.8 mg, 13.5 µL, 0.097 mmol, 4.0 equiv.), triphosgene (3.6 mg, 0.012 
mmol, 0.5 equiv.) and CH2Cl2 (1.2 mL). Purification by column chromatography on 
silica gel eluting with 30:70 EtOAc/hexane gave the title compound 385 as a pale 
yellow oil (7.3 mg, 40%). 1H NMR analysis revealed the presence of two biphenyl axis 
rotamers in a 53:47 ratio. 
Rf = 0.3 (EtOAc:hexane = 40:60). 
    
    + 39.6 (c 0.29, CHCl3). 
IR (neat): νmax 2924, 2225, 1740, 1600, 1513, 1491, 1248, 1179, 1031, 750, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.68* (dd, J = 8.6, 2.2 Hz, 0.47H, H-4), 7.63 (dd, J = 8.6, 2.2 Hz, 0.53H, H-4), 7.41 – 
7.20 (m, 8H, ArH), 7.19 – 7.03 (m, 3H, H-5 and ArH), 6.92* (s, 0.47H, H-3′), 6.90 (s, 
0.53H, H-3′), 6.81 – 6.75 (m, 2.53H, H-6′ and ArH), 6.69* (s, 0.47H, H-6′), 6.23* (d, J 
= 15.8 Hz, 0.47H, H-2′′′′′), 6.14 (d, J = 15.8 Hz, 0.53H, H-2′′′′′), 6.07* (dd, J = 15.8, 9.7 
Hz, 0.47H, H-1′′′′′), 6.00 (dd, J = 15.8, 9.7 Hz, 0.53H, H-1′′′′′), 5.68 – 5.53 (m, 1H, H-
3′′), 5.22 (d, J = 12.0 Hz, 0.53H, PhCHAHBO), 5.12 (d, J = 12.0 Hz, 0.53H, 
PhCHAHBO), 5.10 – 4.85 (m, 3.94H, H-1′′, H-4′′ and PhCH2O (minor)), 4.35* (s, 1H, 
PMPCH2O), 4.30 (s, 1H, PMPCH2O), 4.18* – 4.13* (m, 0.47H, H-5′′′), 3.91 (s, 3H, 
OCH3), 3.85 – 3.78 (m, 0.53H, H-4′′′), 3.77 (s, 4.59H, OCH3), 3.74 (s, 1.41H, OCH3), 
3.67* (t, J = 8.9 Hz, 0.47H, H-4′′′), 3.44 – 3.34 (m, 1.59H, H-3′′′′ and H-5′′′), 3.32* – 
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3.20* (m, 0.94H, H-3′′′′), 2.83 – 2.46 (m, 2H, H-2′′), 1.77* – 1.66* (m, 0.47H, H-2′′′′A), 
1.61 – 1.45 (m, 2H, H-1′′′′A, H-2′′′′B and H-2′′′′), 1.45* – 1.35* (m, 0.47H H-1′′′′B), 1.35 
– 1.21 (m, 1.06H, H-1′′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.8* (C-6), 159.2* (ArC), 159.15 (ArC), 159.0 (C-6), 156.6 (C-2′′′), 156.5* (C-2′′′), 
148.3 (C-4′), 148.2 (C-5′), 148.17* (C-4′), 148.1* (C-5′), 136.2* (ArC), 135.8 (ArC), 
135.5 (ArC), 135.4* (ArC), 135.0* (C-3′′), 134.8* (C-2), 134.7* (C-2′′′′′), 134.3 (C-3′′), 
134.29 (C-2), 134.2 (C-2′′′′′), 134.15* (C-4), 133.9 (C-4), 131.2 (C-1), 130.9* (C-1), 
130.7 (C-2′), 130.6 (ArC), 129.9* (C-2′), 129.3 (1.06 x ArCH), 129.2* (0.94 x ArCH), 
129.15 (1.06 x ArCH), 129.1* (0.94 x ArCH), 128.8* (0.47 x ArCH), 128.76 (0.53 x 
ArCH), 128.7* (0.94 x ArCH), 128.66 (1.06 x ArCH), 128.24* (0.47x ArCH), 128.2 
(0.53 x ArCH), 128.0 (C-1′), 127.2 (1.06 x ArCH), 126.7 (1.06 x ArCH), 126.6* (0.94 x 
ArCH), 126.3* (0.94 x ArCH), 125.8* (C-1′′′′′), 124.7 (C-1′′′′′), 119.2 (C≡N), 119.0* 
(C≡N), 118.2* (C-4′′), 117.5 (C-4′′), 113.8 (2 x ArCH), 113.76 (C-6′), 113.5* (C-5), 
113.1 (C-5), 111.1* (C-3′), 111.0 (C-3′), 104.5* (C-3), 104.3 (C-3), 77.5 (C-5′′′), 77.2* 
(C-2′′′), 72.4 (PMPCH2O), 70.7 (PhCH2O), 69.8* (PhCH2O), 69.2* (C-3′′′′), 68.8 (C-
3′′′′), 61.3* (C-4′′′), 60.1 (C-4′′′), 56.2* (OCH3), 56.1 (OCH3), 56.0* (OCH3), 55.95 
(OCH3), 55.4* (OCH3), 55.37 (OCH3), 54.1* (C-1′′), 53.8 (C-1′′), 38.3* (C-2′′), 37.3 
(C-2′′), 27.9* (C-1′′′′), 27.7 (C-1′′′′), 26.1* (C-2′′′′), 26.06 (C-2′′′′). 
ESIMS m/z 787 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C48H48N2O7Na [M + Na]+: 787.3359; found: 787.3398.  
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6-(Benzyloxy)-2'-((S)-1-(((3R,4S,E)-4-hydroxy-7-((4-methoxybenzyl)oxy)-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (387) 
 
To a solution of the crude Sharpless ADH product, for which AD-mix-α was 
used instead of AD-mix-β, in EtOH (0.2 mL) was added amine 378 (31.1 mg, 0.075 
mmol, 1.0 equiv.) and (E)-2-phenylvinylboronic acid (16.7 mg, 0.1125 mmol, 1.5 
equiv.) and the solution was stirred at room temperature for 3 d. The solution was 
evaporated and the residue was dissolved in CH2Cl2 (2 mL) and then washed with sat. 
aqueous NaHCO3 solution (2 x 2 mL). The combined organic layer was dried (MgSO4), 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 0.5:99.5 MeOH/CH2Cl2 to afford the title 
compound 387 as a pale yellow oil (37.6 mg, 68%). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 56:44 ratio. 
Rf = 0.3 (MeOH:CH2Cl2 = 4:96). 
    
    - 68.2 (c 0.06, CHCl3). 
IR (neat): νmax 3425, 3065, 2933, 2223, 1600, 1512, 1246, 1095, 816, 749, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.51 (s, 1H, H-4 and H-2), 7.47* (s, 0.44H, H-4), 7.45 (s, 0.56H, H-2), 7.39 – 7.09 (m, 
13H, ArH and H-3′ ), 6.93 (d, J = 8.7 Hz, 0.56H, H-5), 6.88* (d, J = 8.7 Hz, 0.44H, H-
5), 6.85 (d, J = 8.6 Hz, 2H, ArH), 6.67* (s, 0.44H, H-6′), 6.61 (s, 0.56H, H-6′), 6.03 (t, J 
= 16.0 Hz, 1H, H-1′′′), 5.91 (dd, J = 16.0, 8.3 Hz, 0.56H, H-2′′′), 5.76* (dd, J = 16.0, 7.5 
Hz, 1H, H-2′′′), 5.73 – 5.53 (m, 1H, H-3′′), 5.15* (d, J = 12.4 Hz, 0.88H, H-4′′), 5.12 – 
4.98 (m, 3.12H, H-4′′ and PhCH2O), 4.43 (s, 1.22H, PMPCH2O), 4.40* (s, 0.88H, 
PMPCH2O), 3.99* (s, 1.32H, OCH3), 3.98 (s, 1.68H, OCH3), 3.90 (s, 1.68H, OCH3), 
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3.84* (s, 1.32H, OCH3), 3.81 (s, 3H, OCH3), 3.66* (dd, J = 8.9, 4.4 Hz, 0.44H, H-1′′), 
3.56 (dd, J = 10.0, 3.0 Hz, 0.56H, H-1′′), 3.52* – 3.48* (m, 0.44H, H-4′′′), 3.48* – 
3.42* (m, 0.88H, H-7′′′), 3.41 – 3.35 (m, 1.68H, H-4′′′ and H-7′′′), 2.92* (dd, J = 7.7, 
4.0 Hz, 0.44H, H-3′′′), 2.87 (dd, J = 8.3, 4.0 Hz, 0.56H, H-3′′′), 2.48 – 2.28 (m, 1.56H, 
H-2′′), 2.25* – 2.15* (m, 0.44H, H-2′′), 1.83 – 1.47 (m, 2.44H, H-6′′′ and H-5′′′A 
(minor)), 1.39 – 1.27 (m, 1.12H, H-5′′′), 1.27 – 1.17 (m, 0.44H H-5′′′B (minor)). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.7 (C-6), 159.2* (C-6 and ArC), 159.1* (ArC), 149.3 (C-4′), 149.2* (C-4′), 147.5 
(C-5′), 147.3* (C-5′), 137.0* (ArC), 136.5 (ArC), 136.0 (C-3′′), 135.8* (C-2′), 135.6 (C-
2′), 135.5* (C-3′′), 135.3* (C-2), 135.2 (C-2), 135.0 (ArC), 134.8* (ArC), 133.4 (C-4), 
133.3* (C-4), 132.5 (C-1′′′), 132.1 (C-1), 131.5* (C-1′′′), 131.4* (C-1), 130.5* (ArC), 
129.4 (1.12 x ArCH), 129.3* (0.88 x ArCH), 128.9* (C-2′′′), 128.8* (0.88 x ArCH), 
128.7 (1.12 x ArCH), 128.66 (1.12 x ArCH), 128.6* (0.88 x ArCH), 128.2 (0.56 x 
ArCH), 128.15* (0.44x ArCH), 128.1 (C-2′′′), 127.9 (C-1′), 127.6 (0.56 x ArCH), 
127.58* (C-1), 127.5* (0.44 x ArCH), 126.8 (1.12 x ArCH), 126.42* (0.88 x ArCH), 
126.39 (1.12 x ArCH), 126.2* (0.88 x ArCH), 119.1* (C≡N), 118.9 (C≡N), 118.4* (C-
4′′), 117.8 (C-4′′), 113.83 (1.12 x ArCH), 113.81* (0.88 x ArCH), 113.0 (C-5), 112.97* 
(C-5), 112.8 (C-6′), 112.7* (C-6′), 109.6 (C-3′), 109.4* (C-3′), 104.2 (C-3), 103.8* (C-
3), 73.9 (C-4′′′), 72.6 (PMPCH2O), 70.4 (PhCH2O), 70.1* (PhCH2O), 70.0* (C-7′′′), 
69.99 (C-7′′′), 62.2 (C-3′′′), 61.6* (C-3′′′), 56.1 (OCH3), 56.05 (OCH3), 56.0 (OCH3), 
55.4 (OCH3), 54.8* (C-1′′), 54.5 (C-1′′), 43.4* (C-2′′), 42.2 (C-2′′), 30.3 (C-5′′′), 26.6 
(C-6′′′). 
ESIMS m/z 739 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C47H51N2O6 [M + H]+: 739.3747; found: 739.3777.   
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6-(Benzyloxy)-4',5'-dimethoxy-2'-((S)-1-((4R,5S)-5-(3-((4-methoxybenzyl)oxy) 
propyl)-2-oxo-4-((E)-styryl)oxazolidin-3-yl)but-3-en-1-yl)-[1,1'-biphenyl]-3-
carbonitrile (388) 
 
The title compound was prepared following the General method 4 for synthesis 
of oxazolidinones, using 1,2-amino alcohol 387 (31.4 mg, 0.088 mmol, 1.0 equiv.), 
triethylamine (33.5 mg, 46.2 µL, 0.332 mmol, 4.0 equiv.), triphosgene (12.3 mg, 0.041 
mmol, 0.5 equiv.) and CH2Cl2 (2.5 mL). Purification by column chromatography on 
silica gel eluting with 30:70 EtOAc/hexane gave the title compound 388 as a pale 
yellow oil (25.2 mg, 37%). 1H NMR analysis revealed the presence of two biphenyl axis 
rotamers in a 67:33 ratio. 
Rf = 0.2 (EtOAc:hexane = 40:60). 
    
    - 12.6 (c 0.21, CHCl3). 
IR (neat): νmax 2962, 2225, 1737, 1600, 1513, 1492, 1258, 1080, 1012, 793, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.52 (d, J = 2.2 Hz, 0.65H, H-2), 7.49 (dd, J = 8.6, 2.2 Hz, 1H, H-4), 7.44 (s, 0.65H, H-
3′), 7.42* (s, 0.35H, H-3′), 7.36* (s, 0.35H, H-2), 7.36 – 7.07 (m, 11.65H, ArH), 7.03* – 
6.98* (m, 0.7H, H-5 and ArH), 6.89 (d, J = 8.6 Hz, 0.65H, H-5), 6.78 (d, J = 8.6 Hz, 
2H, ArH), 6.62* (s, 0.35H, H-6′), 6.55 (s, 0.65H, H-6′), 5.87* (d, J = 15.9 Hz, 0.35H, 
H-2′′′′′), 5.76 (d, J = 15.9 Hz, 0.65H, H-2′′′′′), 5.69 (dd, J = 15.8, 9.2 Hz, 0.65H, H-1′′′′′), 
5.65 – 5.51 (m, 1.35H, H-3′′ and H-1′′′′′), 5.16 – 4.95 (m, 4H, H-4′′ and PhCH2O), 4.38 
– 4.31 (m, 2.65H, H-5′′′ and PMPCH2O), 4.22* (dd, J = 9.6, 6.2 Hz, 0.35H, H-1′′), 4.16 
– 4.11 (m, 1H, H-1′′ and H-5′′′), 3.98 – 3.88 (m, 2.05H, H-4′′′ and OCH3), 3.85 (s, 
1.95H, OCH3), 3.84 (s, 1.95H, OCH3), 3.81* (s, 1.05H, OCH3), 3.78* (s, 1.05H, 
OCH3), 3.76 (s, 1.95H, OCH3), 3.46 – 3.29 (m, 2.65H, H-2′′A and H-3′′′′), 3.26* – 3.18* 
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(m, 0.35H, H-2′′A), 2.71* – 2.61* (m, 0.35H, H-2′′B), 2.41 – 2.34 (m, 0.65H, H-2′′B), 
1.81 – 1.37 (m, 4H, H-1′′′′ and H-2′′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.5 (C-6), 159.3* (ArC), 159.2 (ArC), 157.0* (C-2′′′), 156.7 (C-2′′′), 149.2 (C-4′), 
148.3 (C-5′), 147.9* (C-5′), 135.6* (C-3′′), 135.58 (C-3′′), 135.5* (ArC), 135.48 (ArC), 
135.44 (ArC), 135.4 (C-2), 135.0 (C-2′′′′′), 134.9* (C-2′′′′′), 133.6 (C-4), 132.2 (C-1), 
132.17 (C-2′), 131.4* (C-2′), 131.3* (C-1), 130.6 (ArC), 130.5* (ArC), 129.3 (2 x 
ArCH), 128.9* (0.7 x ArCH), 128.89 (1.3 x ArCH), 128.8* (0.7 x ArCH), 128.7 (1.3 x 
ArCH), 128.6 (ArCH), 128.3 (ArCH), 127.8 (C-1′), 127.2* (0.7 x ArCH), 126.8 (1.3 x 
ArCH), 126.6 (1.3 x ArCH), 126.5* (0.7 x ArCH), 124.1* (C-1′′′′′), 123.6 (C-1′′′′′), 
119.1 (C≡N), 118.8* (C≡N), 118.3* (C-4′′), 117.7 (C-4′′), 113.8 (2 x ArCH), 113.4* (C-
5), 113.37 (C-5), 112.9* (C-6′), 112.8 (C-6′), 111.2 (C-3′), 111.1* (C-3′), 104.4 (C-3), 
77.4 (C-5′′′), 72.6* (PMPCH2O), 72.5 (PMPCH2O), 70.8 (PhCH2O), 70.7* (PhCH2O), 
69.2* (C-3′′′), 69.15 (C-3′′′), 62.4 (C-4′′′), 62.1* (C-4′′′), 56.1 (OCH3), 56.06 (OCH3), 
56.0* (OCH3), 55.98* (OCH3), 55.4 (OCH3), 54.6, (C-1′′) 54.57* (C-1′′), 37.2* (C-2′′), 
35.8 (C-2′′), 28.0 (C-1′′′′), 27.8* (C-1′′′′), 26.2* (C-2′′′′), 26.1 (C-2′′′′). 
ESIMS m/z 787 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C48H48N2O7Na [M + Na]+: 787.3359; found: 787.3398. 
(R)-N-(2-Bromo-4,5-dimethoxybenzylidene)-2-methylpropane-2-sulfinamide (389) 
 
The title compound was prepared following the General method 12 for N-
sulfinyl imine preparation using aldehyde 352 (0.2588 g, 1.06 mmol, 1.0 equiv.), 
potassium hydrogen sulfate (1.4436 g, 10.6 mmol, 10.0 equiv.), (R)-(+)-2-methyl-2-
propanesulfinamide (0.1919 g, 1.58 mmol, 1.5 equiv.) and CH2Cl2 (2 mL). Purification 
by column chromatography on silica gel eluting with 15:85 EtOAc/hexane gave the title 
compound 389 as a white solid (7.3 mg, 40%). 
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Rf = 0.5 (EtOAc:hexane = 50:50). 
Mp.: 156-158 °C. 
    
    - 64.5 (c 0.35, CHCl3). 
IR (neat): νmax 2958, 2841, 1577, 1507, 1440, 1390, 1255, 1213, 1166, 1024, 759 cm-1. 
1H NMR (500 MHz, CDCl3): δ 8.86 (s, 1H, N=CH), 7.55 (s, 1H, H-6), 7.07 (s, 1H , H-
3), 3.95 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 1.28 (s, 9H, C(CH3)3). 
13C NMR (125 MHz, CDCl3): δ 161.5 (N=CH), 153.0 (C-4), 148.7 (C-5), 125.4 (C-1), 
119.0 (C-2), 115.4 (C-3), 110.5 (C-6), 57.8 (C(CH3)3, 56.4 (OCH3), 56.1 (OCH3), 22.7 
(C(CH3)3. 
ESIMS m/z 370 (49%) [M(79Br) + Na]+, 372 (51%) [M(81Br) + Na]+. 
HRMS (ESI): m/z calculated for C13H18NO3NaSBr [M + Na]+: 370.0088; found: 
370.0093. 
6.4.9 General method 18 for allylation of N-sulfinyl imine using a Grignard 
reagent 
(R)-N-((S)-1-(2-Bromo-4,5-dimethoxyphenyl)but-3-en-1-yl)-2-methylpropane-2-
sulfinamide (390) 
 
 To a solution of N-sulfinyl imine 389 (102.4 mg, 0.293 mmol) in anhydrous 
CH2Cl2 (1.5 mL) at -78 °C was added drowise allylmagnesium bromide (1.0 M in Et2O, 
0.33 mL, 0.323 mmol, 1.1 equiv.). After stirring at -78 °C for 4 h, the reaction was 
quenched at -78 °C with sat. aqueous NaHCO3 solution. The aqueous layer was 
extracted with EtOAc (2 x 5 mL). The combined organic layers were dried (MgSO4), 
filtered and the solvent was concentrated in vacuo. The crude product was purified by 
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column chromatography on silica gel eluting with 50:50 EtOAc/hexane to afford the 
title compound 391 as a pale yellow oil (93.2 mg, 82%). 
Rf = 0.2 (EtOAc:hexane = 50:50). 
    
    - 75.7 (c 0.18, CHCl3). 
IR (neat): νmax 3224, 2957, 2929, 1603, 1505, 1459, 1384, 1254, 1202, 1158, 1051, 
1026, 925, 869, 795 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.01 (s, 1H, H-3), 6.93 (s, 1H, H-6), 5.87 – 5.70 (m, 1H, 
H-3′), 5.25 – 5.16 (m, 2H, H-4′), 4.94 – 4.84 (m, 1H, H-1′), 3.87 (s, 3H, OCH3), 3.84 (s, 
3H, OCH3), 3.69 (s, 1H, NH), 2.70 – 2.58 (m, 1H, H-2′A), 2.44 – 2.34 (m, 1H, H-2′B), 
1.23 (s, 9H, C(CH3)3). 
13C NMR (125 MHz, CDCl3): δ 148.8 (C-4), 148.5 (C-5), 134.1 (C-3′), 132.6 (C-1), 
119.5 (C-4′), 115.5 (C-3), 113.6 (C-2), 111.1 (C-6), 56.2 (OCH3), 56.0 (OCH3), 55.8 
(C(CH3)3, 55.5 (C-1′), 41.9 (C-2′), 22.7 (C(CH3)3. 
ESIMS m/z 390 (45%) [M(79Br) + H]+, 392 (55%) [M(81Br) + H]+. 
HRMS (ESI): m/z calculated for C16H25NO3SBr [M + H]+: 390.0739; found: 390.0737. 
(S)-1-(2-Bromo-4,5-dimethoxyphenyl)but-3-en-1-amine (391)159 
 
The title compound was prepared following the General method 14 for 
hydrolysis of sulfinamide using sulfinamide 390 (83.3 mg, 0.213 mmol, 1.0 equiv.), 
TMSCl (46.4 mg, 54.2 µL, 0.426 mmol, 2.0 equiv.) and MeOH (2 mL). The title 
compound 391 was obtained as a light brown oil (53.7 mg, 88%) without purification. 
The spectroscopic data of this compound matched with those in the literature for the 
racemate.159 
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Rf = 0.3 (MeOH:CH2Cl2 = 5:95). 
    
    - 26.0 (c 0.21, CHCl3). 
IR (neat): νmax 3363, 2932, 1602, 1498, 1438, 1380, 1255, 1209, 1152, 1028, 791 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.11 (s, 1H, H-6), 6.99 (s, 1H, H-3), 5.86 – 5.74 (m, 1H, 
H-3′), 5.16 (d, J = 17.2 Hz, 1H, H-4′A), 5.12 (d, J = 10.2 Hz, 1H, H-4′B), 4.38 (dd, J = 
8.6, 4.5 Hz, 1H, H-1′), 3.89 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 2.54 – 2.47 (m, 1H, H-
2′A), 2.28 – 2.19 (m, 1H, H-2′B), 1.77 (s, 2H, NH2). 
13C NMR (125 MHz, CDCl3): δ 148.7 (C-4), 148.3 (C-5), 136.2 (C-1), 135.2 (C-3′), 
118.0 (C-4′), 115.4 (C-3), 112.8 (C-2), 110.1 (C-6), 56.2 (OCH3), 56.1 (OCH3), 53.3 
(C-1′), 42.5 (C-2′). 
ESIMS m/z 269 (49%) [M(79Br) - NH2]+, 271 (51%) [M(81Br) - NH2]+. 
 (3S,4R,E)-3-(((S)-1-(2-Bromo-4,5-dimethoxyphenyl)but-3-en-1-yl)amino)-7-((4-
methoxybenzyl)oxy)-1-phenylhept-1-en-4-ol (392) 
 
To a solution of the crude Sharpless ADH product 381 in EtOH (0.4 mL) was 
added amine 391 (48.7 mg, 0.170 mmol, 1.0 equiv.) and (E)-2-phenylvinylboronic acid 
(37.8 mg, 0.255 mmol, 1.5 equiv.) and the solution was stirred at room temperature for 
2 d. The reaction mixture was evaporated and dissolved in EtOAc (5 mL) and then 
washed with sat. aqueous NaHCO3 solution (2 x 5 mL). The combined organic layer 
was dried (MgSO4), filtered and concentrated in vacuo. The crude product was    
purified by column chromatography on silica gel eluting with 2:10:30:58 
MeOH/EtOAc/CH2Cl2/hexane to afford the title compound 392 as a pale yellow oil 
(45.6 mg, 44%). 
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Rf = 0.2 (EtOAc:hexane = 50:50). 
    
    + 18.0 (c 0.35, CHCl3). 
IR (neat): νmax 3406, 2932, 1612, 1511, 1438, 1381, 1247, 1030, 970, 820, 751 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.27 – 7.19 (m, 7H, ArH), 6.93 (s, 1H, H-6), 6.90 (s, 
1H, H-3), 6.82 (d, J = 8.1 Hz, 2H, ArH), 6.37 (d, J = 16.0 Hz, 1H, H-1′′), 6.06 (dd, J = 
16.0, 8.8 Hz, 1H, H-2′′), 5.82 – 5.73 (m, 1H, H-3′), 5.14 – 5.04 (m, 2H, H-4′), 4.40 (s, 
2H, PMPCH2O), 4.26 (t, J = 6.7 Hz, 1H, H-1′), 3.87 (s, 1H, OH), 3.81 (s, 3H, OCH3), 
3.80 – 3.78 (m, 1H, H-4′′), 3.77 (s, 3H, OCH3), 3.47 – 3.40 (m, 2H, H-7′′), 3.08 (d, J = 
8.8 Hz, 1H, H-3′′), 2.48 – 2.39 (m, 1H, H-2′A), 2.38 – 2.29 (m, 1H, H-2′B), 1.76 (dt, J = 
14.0, 6.9 Hz, 1H, H-5′′A), 1.65 (dt, J = 14.0, 7.1 Hz, 1H, H-5′′B), 1.43 (q, J = 7.1 Hz, 
2H, H-6′′). 
13C NMR (125 MHz, CDCl3): δ 159.2 (ArC), 148.7 (C-4), 148.4 (C-5), 136.8 (ArC), 
134.9 (C-3′), 134.6 (C-1), 132.8 (C-1′′), 130.5 (ArC), 129.4 (2 x ArCH), 128.5 (2 x 
ArCH), 127.6 (ArCH), 127.6 (C-2′′), 126.4 (2 x ArCH), 118.0 (C-4′), 115.4 (C-3), 113.9 
(C-2), 113.8 (2 x ArCH), 110.5 (C-6), 72.6 (PMPCH2O), 71.1 (C-4′′), 70.1 (C-7′′), 63.2 
(C-3′′), 58.0 (C-1′), 56.2 (2 x OCH3), 55.4 (OCH3), 41.5 (C-2′), 30.5 (C-6′′), 26.6 (C-
5′′). 
ESIMS m/z 610 (48%) [M(79Br) + H]+, 610 (52%) [M(81Br) + H]+.  
HRMS (ESI): m/z calculated for C33H41NO5Br [M + H]+: 610.2168; found: 610.2192. 
6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-4,7-dihydroxy-1-phenylhept-1-en-3-
yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (393) 
 
To a solution of 1,2-amino alcohol 382 (20.0 mg, 0.027 mmol, 1.0 equiv.) in 
20:1 CH2Cl2/water (0.28 mL) was added DDQ (12.3 mg, 0.054 mmol, 2.0 equiv.) and 
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the mixture was stirred at room temperature for 6 h. The reaction mixture was quenched 
with sat. aqueous NaHCO3 solution. The aqueous layer was extracted with DCM (2 x 3 
mL). The combined organic layer was washed with brine, dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel eluting with 2:98 MeOH/CH2Cl2 to afford the title compound 393 as a light 
brown oil (7.6 mg, 46%). 
Rf = 0.2 (MeOH:CH2Cl2 = 5:95). 
    
    + 45.3 (c 0.58, CHCl3). 
IR (neat): νmax 3333, 2926, 2224, 1600, 1515, 1491, 1453, 1253, 1120, 733, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.57 (dd, J = 8.6, 2.2 Hz, 0.51H, H-4), 7.51* (dd, J = 8.6, 2.2 Hz, 0.49H, H-4), 7.41 (d, 
J = 2.2 Hz, 0.51H, H-2), 7.40* (d, J = 2.2 Hz, 0.49H, H-2), 7.34 – 7.07 (m, 10H, ArH), 
7.02* (s, 0.49H, H-3′), 7.00* (d, J = 8.7 Hz, 0.49H, H-5), 6.94 (s, 0.51H, H-3′), 6.91 (d, 
J = 8.6 Hz, 0.51H, H-5), 6.63* (s, 0.49H, H-6′), 6.59 (s, 0.51H, H-6′), 6.26 (d, J = 15.9 
Hz, 0.51H, H-1′′′), 6.13* (s, 0.49H, H-1′′′), 5.97* (dd, J = 16.0, 8.7 Hz, 0.49H, H-2′′′), 
5.86 (dd, J = 15.9, 9.2 Hz, 0.51H, H-2′′′), 5.70 – 5.51 (m, 1H, H-3′′), 5.15 – 4.89 (m, 
4H, H-4′′ and PhCH2O), 3.90 (s, 3H, OCH3), 3.86* (s, 1.47H, OCH3), 3.85 (s, 1.53H, 
OCH3), 3.66 – 3.46 (m, 3H, H-1′′ and H-7′′′), 3.35* (s, 0.49H, H-4′′′), 3.24 (d, J = 9.2 
Hz, 0.51H, H-4′′′), 3.06* (s, 0.49H, H-3′′′), 2.96 (dd, J = 8.7, 3.0 Hz, 0.51H, H-3′′′), 
2.44 – 2.19* (m, 2H, H-2′′), 1.68* – 1.59* (m, 0.98H, H-6′′′), 1.58 – 1.47 (m, 1.02H, H-
6′′′), 1.42 – 1.29 (m, 1.02H, H-5′′′), 1.15 – 0.97* (m, 0.98H, H-5′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.7* (C-6), 159.0 (C-6), 149.33 (C-4′), 149.3* (C-4′), 147.7* (C-5′), 147.69 (C-5′), 
136.4 (ArC), 135.7 (ArC), 135.65 (C-3′′), 135.5 (C-2′), 135.4* (C-2), 135.1 (C-2), 
134.5* (C-3′′), 133.5 (C-4 and C-1′′′), 133.2* (C-1′′′), 131.8* (C-1), 131.5 (C-1), 128.7 
(2.04 x ArCH), 128.6* (1.96 x ArCH), 128.2 (ArCH), 128.19* (C-1′), 128.1 (C-1′), 
128.0* (0.49 x ArCH), 127.8 (0.51 x ArCH), 126.8* (C-2′′′ and 1.96 x ArCH), 126.5 
(2.04 x ArCH), 126.4 (C-2′′′), 119.1* (C≡N), 118.9 (C≡N), 118.0* (C-4′′), 117.2 (C-4′′), 
113.4* (C-5), 113.0 (C-5), 112.7 (C-6′), 112.6* (C-6′), 108.8* (C-3′), 108.5 (C-3′), 
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104.4* (C-3), 104.1 (C-3), 70.9* (C-4′′′), 70.8 (C-4′′′), 70.4 (PhCH2O), 70.3 (PhCH2O), 
62.9 (C-7′′′), 62.8* (C-7′′′ and C-3′′′), 62.3 (C-3′′′), 56.1* (OCH3), 56.0 (OCH3), 55.1* 
(C-1′′), 55.0 (C-1′′), 41.0 (C-2′′), 30.7* (C-5′′′), 30.6 (C-5′′′), 30.3* (C-6′′′), 30.2 (C-6′′′). 
ESIMS m/z 619 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C39H43N2O5 [M + H]+: 619.3172; found: 619.3174. 
6.4.10 General method 19 for mesylation-cyclization 
6-(Benzyloxy)-2'-((S)-1-((2S,3R)-3-hydroxy-2-((E)-styryl)piperidin-1-yl)but-3-en-1-
yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (394) 
 
To a solution of diol 393 (45.3 mg, 0.073 mmol, 1.0 equiv.) in anhydrous 
CH2Cl2 (0.73 mL) at 0 °C was added triethylamine (7.4 mg, 10.2 µL, 0.073 mmol, 1.0 
equiv.) and then dropwise methanesulfonyl chloride (7.4 mg, 10.2 µL, 0.073 mmol, 1.0 
equiv.). The reaction mixture was stirred for 5 min then warmed up to 45 °C and stirred 
for 18 h. After the reaction had completed, the mixture was concentrated in vacuo. The 
crude product was purified by column chromatography on silica gel eluting with 2:98 
MeOH/CH2Cl2 to afford the title compound 394 as a light green oil (23.8 mg, 54%) and 
recovered diol 393 as a pale yellow oil (13.8 mg, 31%). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 67:33 ratio. 
Rf = 0.3 (MeOH:CH2Cl2 = 3:97). 
    
    + 18.1 (c 0.14, CHCl3). 
IR (neat): νmax 3351, 2930, 2224, 1600, 1514, 1493, 1258, 1122, 1024, 746, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.65 (dd, J = 8.6, 2.2 Hz, 1H, H-4), 7.54 (d, J = 2.2 Hz, 1H, H-2), 7.45 – 7.10 (m, 8H, 
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ArH), 7.04* (d, J = 8.5 Hz, 0.33H, H-5), 6.96* (s, 0.33H, H-3′′), 6.91 – 6.88 (m, 2H, 
ArH), 6.87 (s, 0.67H, H-3′′), 6.81 (d, J = 8.6 Hz, 0.67H, H-5), 6.65* (s, 0.33H, H-6′), 
6.61 (s, 0.67H, H-6′), 6.58 (d, J = 15.8 Hz, 1H, H-2′′′′), 5.65* – 5.50* (m, 0.33H, H-3′′), 
5.30 (ddt, J = 16.9, 10.0, 6.8 Hz, 0.67H, H-3′′), 5.13* (d, J = 12.4 Hz, 0.33H, 
PhCHAHBO (minor)), 5.07* (d, J = 12.4 Hz, 0.33H, PhCHAHBO (minor)), 5.00* – 4.92* 
(m, 0.33H, H-4′′A), 4.85 (dd, J = 17.1, 2.0 Hz, 1H, H-4′′B (minor) and H-4′′A), 4.75 (dd, 
J = 15.8, 9.3 Hz, 1H, H-1′′′′), 4.69 (d, J = 12.5 Hz, 0.67H, PhCHAHBO), 4.59 (d, J = 
11.6 Hz, 1.34H, H-4′′B and PhCHAHBO), 3.93* (s, 0.99H, OCH3), 3.93 (s, 2.01H, 
OCH3), 3.89 – 3.85* (m, 0.33H, H-1′′), 3.84 (s, 2.01H, OCH3), 3.82* (s, 0.99H, OCH3), 
3.75 (dd, J = 11.0, 3.9 Hz, 0.67H, H-1′′), 3.17 – 3.10 (m, 1H, H-3′′′), 3.08* – 2.98* (m, 
0.33H, H-2′′′), 2.84 (t, J = 8.4 Hz, 0.67H, H-2′′′), 2.64 (d, J = 11.3 Hz, 0.67H, H-6′′′A), 
2.58* – 2.49* (m, 0.66H, H-2′′), 2.48 – 2.40 (m, 1.34H, H-2′′), 2.40* – 2.33* (m, 0.33H, 
H-6′′′A), 2.13 (t, J = 9.6 Hz, 0.67H, H-6′′′B), 2.08* – 1.96* (m, 0.99H, H-4′′′ and H-
6′′′B), 1.63* – 1.53* (m, 0.66H, H-5′′′), 1.32 – 1.16 (m, 2.68H, H-4′′′ and H-5′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
160.2* (C-6), 159.1 (C-6), 147.9* (C-4′), 147.6 (C-4′), 147.4 (C-5′), 147.2* (C-5′), 
137.3 (C-2), 136.5 (ArC), 136.1* (ArC), 136.0 (C-3′′), 135.8 (ArC), 135.6* (C-3′′), 
135.0* (C-2′′′′), 134.8 (C-2′′′′), 133.2* (C-4), 132.8 (C-4), 132.7* (C-1), 132.4 (C-1), 
131.5* (C-2′), 131.2 (C-2′), 130.9 (C-1′), 130.1* (C-1′), 129.0* (0.66 x ArCH), 128.7* 
(0.66 x ArCH), 128.6 (1.34 x ArCH), 128.5 (1.34 x ArCH), 128.2* (0.33 x ArCH), 
128.1* (0.33 x ArCH), 128.07 (0.67 x ArCH), 127.9 (0.67 x ArCH), 126.8 (1.34 x 
ArCH), 126.6* (0.66 x ArCH), 126.5* (0.66 x ArCH), 126.47 (1.34 x ArCH), 119.3 
(C≡N), 119.1* (C≡N), 117.3* (C-4′′), 116.3 (C-4′′), 113.9* (C-6′), 113.8 (C-6′), 113.0 
(C-5), 112.8* (C-5), 111.9 (C-3′), 111.8* (C-3′), 103.8* (C-3), 103.5 (C-3), 70.9 (C-
3′′′), 70.5* (C-2′′′), 70.4 (C-2′′′), 70.1* (PhCH2O), 70.0 (PhCH2O), 60.2* (C-1′′), 60.1 
(C-1′′), 56.2 (OCH3), 56.0* (OCH3), 44.5* (C-6′′′), 44.1 (C-6′′′), 31.6 (C-4′′′), 30.4* (C-
4′′′), 27.5 (C-2′′), 23.4 (C-5′′′), 22.3* (C-5′′′). 
ESIMS m/z 601 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C39H41N2O4 [M + H]+: 601.3066; found: 601.3086. 
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6.4.11 General method 20 for ring-closing metathesis using Grubbs’ II ruthenium 
catalyst using Ti(OiPr)4 
6-(Benzyloxy)-2'-((1R,6S,9aS)-1-hydroxy-1,3,4,6,7,9a-hexahydro-2H-quinolizin-6-
yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (397) 
 
To a solution of carbonitrile 394 (15.8 mg, 0.026 mmol, 1.0 equiv.) in N2 purged 
anhydrous CH2Cl2 (0.26 mL) was added Ti(OiPr)4 (7.5 mg, 7.7 , 0.26 mmol, 1.0 equiv.) 
and Grubbs’ II ruthenium catalyst (4.1 mg, 0.0053 mmol, 0.18 equiv.) and the mixture 
was stirred and heated at 50 °C for 8 h. The reaction mixture was then cooled to room 
temperature and the solvent was evaporated. The crude product was purified by column 
chromatography on silica gel eluting with 3:97 MeOH/CH2Cl2 to afford the title 
compound 397 as a light brown oil (5.2 mg, 40%). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 75:25 ratio. 
Rf = 0.2 (MeOH:CH2Cl2 = 5:95). 
    
    - 71.1 (c 0.27, CHCl3). 
IR (neat): νmax 3351, 2928, 2224, 1600, 1514, 1490, 1253, 1035, 731, 696 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.59 (d, J = 9.0 Hz, 1H, H-4), 7.54 (d, J = 2.2 Hz, 1H, H-2), 7.35 – 7.13 (m, 5H, ArH), 
7.13 – 7.07 (m, 1.25H, H-5 and H-3′), 6.98 (d, J = 8.6 Hz, 0.75H, H-5), 6.69* (s, 0.25H, 
H-6′), 6.58 (s, 0.75H, H-6′), 6.20 – 6.11 (m, 1H, H-9′′), 6.02* (d, J = 9.1 Hz, 0.25H, H-
8′′), 5.92 (d, J = 10.1 Hz, 0.75H, H-8′′), 5.18* (d, J = 12.4 Hz, 0.25H, PhCHAHBO 
(minor)), 5.13 – 5.01 (m, 1.75H PhCHAHBO (minor) and PhCH2O), 4.02* (d, J = 6.1 
Hz, 0.25H, H-6′′), 3.88 (s, 2.25H, OCH3), 3.86* (s, 0.75H, OCH3), 3.84 (s, 2.25H, 
OCH3), 3.82 – 3.79 (m, 0.75H, H-6′′), 3.79* (s, 0.75H, OCH3), 3.29 (br s, 1H, H-1′′), 
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2.76 – 2.58 (m, 2H, H-7′′A (minor), H-7′′A and H-9a′′), 2.32* – 2.25* (m, 0.25H, H-7′′B 
(minor),), 2.22 – 1.77 (m, 4.75H, H-2′′, H-3′′A, H-2′′ and H-7′′B), 1.53 – 1.09 (m, 2H, H-
3′′B, H-2′′ (minor)). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6* (C-6), 159.4 (C-6), 149.0 (C-4′), 147.6 (C-5′), 135.8 (ArC), 135.7 (C-2), 133.3 
(C-4), 133.1 (C-1), 132.54* (C-1), 132.5 (C-1′), 131.9* (C-1′), 128.8 (2 x ArCH), 128.6 
(C-2′), 128.3 (ArCH), 127.0 (2 x ArCH), 126.4 (C-9′′), 126.2* (C-8′′), 125.8 (C-8′′), 
119.3 (C≡N), 113.2* (C-5 and C-6), 112.9 (C-5), 112.8 (C-6), 110.4* (C-3′), 110.2 (C-
3′), 104.5 (C-3), 71.7 (C-1′′), 71.2* (C-1′′), 70.8 (PhCH2O), 70.3* (PhCH2O), 61.2 (C-
9a′′), 56.1 (C-6′′), 56.0 (2 x OCH3), 54.6* (C-6′′), 51.1 (C-4′′), 50.3* (C-4′′), 34.5 (C-
2′′), 31.9 (C-7′′), 23.6 (C-3′′), 22.8 (C-3′′). 
ESIMS m/z 497 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C31H33N2O4 [M + H]+: 497.2440; found: 497.2454. 
6.4.12 General method 21 for the silylation of a secondary alcohol with TBSCl 
6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-4-((tert-butyldimethylsilyl)oxy)-7-((4-methoxy 
benzyl)oxy)-1-phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-
biphenyl]-3-carbonitrile (398) 
 
To a solution of 1,2-amino alcohol 382 (10.2 mg, 0.013 mmol, 1.0 equiv.) in 
anhydrous CH2Cl2 (0.05 mL) was added imidazole (4.7 mg, 0.069 mmol, 5.0 equiv.) 
followed by TBSCl (8.3 mg, 0.055 mmol, 4.0 equiv.) and the reaction mixture was 
stirred at 50 °C for 20 h. The reaction was quenched with sat. aqueous NH4Cl solution 
and extracted with CH2Cl2 (2 x 2 mL). The organic layer was washed with water, brine, 
dried (MgSO4), and concentrated in vacuo. The crude product was purified by column 
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chromatography on silica gel eluting with 20:80 EtOAc/hexane to afford the title 
compound 398 as a pale yellow oil (7.3 mg, 65%). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 58:42 ratio. 
Rf = 0.1 (EtOAc:hexane = 20:80). 
    
    + 4.2 (c 1.24, CHCl3). 
IR (neat): νmax 2929, 224, 1600, 1512, 1491, 1247, 1097, 1034, 815, 775, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.39* (d, J = 8.3 Hz, 0.41H, H-4), 7.36* (s, 0.41H, H-2), 7.33 – 6.99 (m, 13H, H-3′ and 
ArH), 6.84 (d, J = 8.9 Hz, 0.51H, H-5), 6.81 (d, J = 7.7 Hz, 2H, ArH), 6.52* (s, 0.41H, 
H-6′), 6.44 (s, 0.59H, H-6′), 6.42* (d, J = 8.7 Hz, 0.41H, H-5), 6.18 (d, J = 16.0 Hz, 
0.59H, H-1′′′), 6.04* (d, J = 16.0 Hz, 0.41H, H-1′′′), 5.77* (dd, J = 16.0, 9.1 Hz, 0.41H, 
H-2′′′), 5.61 (dd, J = 16.0, 8.7 Hz, 0.51H, H-2′′′), 5.58 – 5.49 (m, 1H, H-3′′), 5.08 – 4.99 
(m, 1.18H, PhCH2O), 4.99 – 4.80 (m, 2.41H, H-4′′ and PhCHAHBO (minor)), 4.76 (d, J 
= 12.8 Hz, 0.41H, PhCHAHBO (minor)), 4.38 (s, 1.18H, PMPCH2O), 4.37* (s, 0.82H, 
PMPCH2O), 3.94 (s, 1.77H, OCH3), 3.89* (s, 1.23H, OCH3), 3.79* (s, 1.23H, OCH3), 
3.78 (s, 3H, OCH3), 3.75 (s, 1.77H, OCH3), 3.68 – 3.59 (m, 1H, H-4′′′), 3.55* (dd, J = 
7.6, 5.1 Hz, 0.41H, H-1′′), 3.44 – 3.31 (m, 2.59H, H-1′′ and H-7′′′), 3.18 (dd, J = 8.7, 3.2 
Hz, 0.59H, H-3′′′), 3.05* (dd, J = 9.1, 3.2 Hz, 0.41H, H-3′′′), 2.41 – 2.21 (m, 2H, H-2′′), 
1.72 – 1.38 (m, 4H, H-5′′′ and H-6′′′), 0.86 (s, 5.31H, (CH3)3CSi), 0.79* (s, 3.69H, 
(CH3)3CSi), 0.03 (s, 1.77H, CH3Si), 0.00 (s, 1.77H, CH3Si), -0.01* (s, 1.23H, CH3Si), -
0.03* (s, 1.23H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.5* (C-6), 159.1* (ArC), 159.1 (ArC), 158.9 (C-6), 148.8* (C-4′), 148.7 (C-4′), 
147.2 (C-5′), 147.1* (C-5′), 137.4* (ArC), 136.9 (ArC), 136.1* (C-2′), 135.9* (C-3′′), 
135.8 (C-2′), 135.6* (C-2), 135.2 (C-3′′), 135.18 (C-2), 135.16 (ArC), 133.0 (C-4), 
132.8* (C-4), 131.9 (C-1), 131.8* (C-1′′′), 131.7* (C-1), 131.0 (C-1′′′), 130.7 (ArC), 
130.6* (ArC), 130.5 (C-2′′′), 129.2 (1.18 x ArCH), 129.19* (0.82 x ArCH), 128.8* (C-
2′′′), 128.6 (1.18 x ArCH), 128.57* (0.82 x ArCH), 128.5 (1.18 x ArCH), 128.4* (0.82 x 
ArCH), 128.0 (0.59 x ArCH), 127.9* (0.41 x ArCH), 127.3 (ArCH), 127.26 (C-1′), 
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126.6 (1.18 x ArCH), 126.4* (0.82 x ArCH), 126.36* (0.82 x ArCH), 126.3 (1.18 x 
ArCH), 119.1* (C≡N), 119.0 (C≡N), 117.3* (C-4′′), 117.2 (C-4′′), 113.7 (2 x ArCH), 
113.1* (C-5), 112.6 (C-5), 112.5 (C-6′), 112.2* (C-6′), 110.3 (C-3′), 110.0* (C-3′), 
103.8 (C-3), 103.4* (C-3), 76.0 (C-4′′′), 75.6* (C-4′′′), 72.5 (PMPCH2O), 70.2 
(PhCH2O), 70.15 (C-7′′′), 69.9* (PhCH2O), 64.9 (C-3′′′), 61.6* (C-3′′′), 56.6 (C-1′′), 
56.0 (OCH3), 55.9 (OCH3), 55.87* (OCH3), 55.8* (OCH3), 55.3 (OCH3), 55.1* (C-1′′), 
41.3 (C-2′′), 41.1* (C-2′′), 31.2* (C-5′′′), 29.3 (C-5′′′), 26.3 (C-6′′′), 26.0 ((CH3)3CSi), 
25.9* ((CH3)3CSi), 25.7* (C-3′′′), 18.12* ((CH3)3CSi), 18.1 ((CH3)3CSi), -4.0 (CH3Si), -
4.2 (CH3Si), -4.4 (CH3Si). 
ESIMS m/z 853 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C53H65N2O6Si [M + H]+: 853.4612; found: 853.4653. 
tert-Butyldimethyl(pent-4-en-1-yloxy)silane (399)160 
 
The title compound was prepared following the General method 9 for the 
silylation of a primary alcohol, using 4-penten-1-ol (2.1533 g, 25.0 mmol, 1.0 equiv.), 
imidazole (2.0424 g, 30.0 mmol, 1.2 equiv.), TBSCl (4.5219 g, 30.0 mmol, 1.2 equiv.) 
and CH2Cl2 (25 mL). Purification by column chromatography on silica gel eluting with 
1:99 Et2O/hexane gave the title compound 399 as a colorless oil (4.9099 g, 98%).. The 
spectroscopic data of this compound matched with those in the literature.160 
Rf = 0.7 (Et2O:CH2Cl2:hexane = 10:10:80). 
IR (neat): νmax 2928, 2856, 1630, 1446, 1319, 1252, 1146, 1086, 834, 775, 688 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.82 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H, H-4), 5.02 (d, J = 
17.0 Hz, 1H, H-5A), 4.95 (d, J = 10.2 Hz, 1H, H-5B), 3.62 (t, J = 6.5 Hz, 2H, H-1), 2.10 
(q, J = 7.3 Hz, 2H, H-3), 1.61 (p, J = 6.9 Hz, 2H, H-2), 0.90 (s, 9H, (CH3)3CSi), 0.05 (s, 
6H, 2 x CH3Si). 
13C NMR (125 MHz, CDCl3): δ 138.7 (C-4), 114.6 (C-5), 62.7 (C-1), 32.2 (C-2), 30.2 
(C-3), 26.1 ((CH3)3CSi), 18.5 ((CH3)3CSi), -5.1 (2 x CH3Si). 
Chapter 6: Experimental Section | 299 
 
 
(E)-tert-Butyldimethyl((5-(phenylsulfonyl)pent-4-en-1-yl)oxy)silane (400) 
 
The title compound was prepared following the General method 16 for olefin 
cross metathesis using alkene 399 (0.4008 g, 2.0 mmol, 1.0 equiv.), phenyl vinyl 
sulfone (1.0093 g, 6.0 mmol, 3.0 equiv.), Grubbs’ II ruthenium catalyst (0.0849 g, 0.01 
mmol, 0.05 equiv.) and CH2Cl2 (40 mL). Purification by column chromatography on 
silica gel eluting with 10:10:80 Et2O/CH2Cl2/hexane gave the title compound 400 as a 
colorless oil (0.4316 g, 63%). 
Rf = 0.2 (Et2O:CH2Cl2:hexane = 10:10:80). 
IR (neat): νmax 2929, 2858, 1643, 1473, 1256, 1099, 911 833, 774 cm-1. 
1H NMR (500 MHz, CDCl3): δ δ 7.88 (d, J = 7.1 Hz, 2H, ArH), 7.61 (t, J = 7.6 Hz, 1H, 
ArH), 7.53 (t, J = 7.8 Hz, 2H, ArH), 7.01 (dt, J = 15.0, 6.9 Hz, 1H, H-4), 6.33 (d, J = 
15.0 Hz, 1H, H-5), 3.60 (t, J = 6.0 Hz, 2H, H-1), 2.33 (q, J = 8.3, 7.7 Hz, 2H, H-3), 1.71 
– 1.62 (m, 2H, H-2), 0.87 (s, 9H, (CH3)3CSi), 0.01 (s, 6H, 2 x CH3Si). 
13C NMR (125 MHz, CDCl3): δ 147.0 (C-4), 140.9 (ArC), 133.3 (ArCH), 130.8 (C-5), 
129.4 (2 x ArCH), 127.7 (2 x ArCH), 61.9 (C-1), 30.8 (C-2), 28.2 (C-3), 26.0 
((CH3)3CSi), 18.4 ((CH3)3CSi), -5.2 (2 x CH3Si). 
ESIMS m/z 363 (100%) [M+Na]+. 
HRMS (ESI): m/z calculated for C17H29O3SSi [M + H]+: 341.1607; found: 341.1622. 
3,6-Bis(3-((tert-butyldimethylsilyl)oxy)propyl)-1,4-dioxane-2,5-diol or (R)-5-((tert-
butyl dimethylsilyl)oxy)-2-hydroxypentanal dimer (401) 
 
The title compound was prepared following the General method 17 for Sharpless 
asymmetric dihydroxylation (ADH) using, alkene 400 (0.7662 g, 2.25 mmol, 1.0 
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equiv.), methanesulfonamide (0.4701 g, 4.95 mmol, 2.2 equiv.), AD-mix-β (13.5 g) and 
1:1 t-BuOH/water (22 mL). The crude Sharpless ADH product 401 was used without 
further purification. 
Rf = 0.2 (MeOH:CH2Cl2 = 3:97). 
IR (neat): νmax 3267, 2929, 1725, 1620, 1464, 1254, 1150, 1093, 980, 833, 775 cm-1. 
ESIMS m/z 487 (100%) [M + Na]+.  
HRMS (ESI): m/z calculated for C22H48O6Si2Na [M + Na]+: 487.2887; found: 487.2906. 
6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-7-((tert-butyldimethyl silyl)oxy)-4-hydroxy-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (402) and 6-(benzyloxy)-2'-((S)-1-(((3R,4R,E)-7-((tert-butyldimethyl 
silyl)oxy)-4-hydroxy-1-phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-
[1,1'-biphenyl]-3-carbonitrile (403)  
                                    
To a solution of the Sharpless ADH product 401 in EtOH (2.5 mL) was added 
amine 378 (1.0350 g, 2.5 mmol, 1.0 equiv.) and (E)-2-phenylvinylboronic acid (0.7400 
g, 5.0 mmol, 2.0 equiv.) and stirred at room temperature for 3 d. The reaction mixture 
was evaporated to dryness and the residue was dissolved in EtOAc (5 mL) and the 
solution was washed with 1.0 M NaOH solution (4 x 5 mL). The combined organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel eluting with 0:100 to 2:98 
MeOH/CH2Cl2 to afford the title compound 402 (0.7813 g, 43%), as a pale yellow oil 
and compound 403 (0.6328 g, 35%), as a pale yellow oil. 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 57:43 ratio for compound 402 and in a 
59:41 ratio for compound 403. 
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402: Rf = 0.2 (EtOAc:hexane = 30:70). 
    
    - 74.4 (c 2.26, CHCl3). 
IR (neat): νmax 3491, 3023, 2926, 22 26, 1600, 1515, 1490, 1463, 1248, 1205, 1034, 
967, 834, 749, 693 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.50* (d, J = 8.7 Hz, 0.43H, H-4), 7.44 (d, J = 8.7 Hz, 0.57H, H-4), 7.40 (s, 0.57H, H-
2), 7.37* (s, 0.43H, H-2), 7.34 – 7.03 (m, 11H, H-3′ and ArH), 6.94 (d, J = 8.7 Hz, 
0.57H, H-5), 6.83* (d, J = 8.7 Hz, 0.43H, H-5), 6.61 (s, 0.57H, H-6′), 6.56* (s, 0.43H, 
H-6′), 6.28* (d, J = 16.0 Hz, 0.43H, H-1′′′), 6.12 (d, J = 15.9 Hz, 0.57H, H-1′′′), 5.93 – 
5.81 (m, 1H, H-2′′′), 5.70 – 5.48 (m, 1H, H-3′′), 5.12 – 4.89 (m, 4H, H-4′′ and PhCH2O), 
3.92* (s, 1.29H, OCH3), 3.90* (s, 1.29H, OCH3), 3.84 (s, 3.42H, OCH3), 3.65* (t, J = 
5.8 Hz, 0.86H, H-7′′′), 3.62 – 3.56 (m, 1H, H-1′′), 3.53 (t, J = 6.3 Hz, 1.14H, H-7′′′), 
3.45 – 3.37 (m, 1H, H-4′′′), 3.08 – 3.00 (m, 1H, H-3′′′), 2.42 – 2.33 (m, 1.57H, H-2′′ and 
H-2′′A (minor)), 2.32* – 2.23* (m, 0.43H, H-2′′B (minor)), 1.67 – 1.51 (m, 1.14H, H-
6′′′), 1.50 – 1.35 (m, 2H, H-5′′′ and H-6′′′), 1.23* – 1.10* (m, 0.86H, H-5′′′), 0.85 (s, 9H, 
(CH3)3CSi), 0.02* (s, 2.58H, CH3Si), 0.02 (s, 3.42H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6 (C-6), 159.0* (C-6), 149.3* (C-4′), 149.2 (C-4′), 147.6* (C-5′), 147.5 (C-5′), 
136.8* (ArC), 136.7 (ArC), 135.8 (C-3′′ and ArC), 135.7* (ArC), 135.5* (C-2), 135.2 
(C-2), 134.9* (C-3′′), 134.2 (C-2′), 133.4* (C-4), 133.3 (C-4), 133.0* (C-1′′′), 132.5 (C-
1′′′), 131.9* (C-1), 131.7 (C-1), 128.7 (1.14 x ArCH), 128.7* (0.86 x ArCH), 128.6 
(1.14 x ArCH), 128.6* (0.86 x ArCH), 128.2 (1.14 x ArCH), 128.2* (0.86 x ArCH), 
128.0* (C-1′), 127.9 (C-1′), 127.7* (C-2′′′), 127.6 (C-2′′′), 126.8* (0.86 x ArCH), 
126.5* (0.86 x ArCH), 126.5 (2.28 x ArCH), 118.9* (C≡N), 118.9 (C≡N), 117.8* (C-
4′′), 117.2 (C-4′′), 113.3 (C-5), 112.9 (C-5), 112.8 (C-6′), 112.7* (C-6′), 109.3* (C-3′), 
109.2 (C-3′), 104.2 (C-3), 71.8 (C-4′′′), 71.4* (C-4′′′), 70.4 (PhCH2O), 70.3* (PhCH2O), 
63.5* (C-7′′′), 63.4 (C-7′′′), 63.3 (C-3′′′), 62.2* (C-3′′′), 56.1 (OCH3), 56.1* (OCH3), 
56.0* (OCH3), 55.4 (C-1′′), 55.1* (C-1′′), 41.2* (C-2′′), 41.0 (C-2′′), 30.6 (C-5′′′), 30.5* 
(C-5′′′), 29.9 (C-6′′′), 29.7* (C-6′′′), 26.0 ((CH3)3CSi), 18.4 ((CH3)3CSi), 18.4* 
((CH3)3CSi), -5.2 (CH3Si), -5.2* (CH3Si). 
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ESIMS m/z 733 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H57N2O5Si [M + H]+: 733.4037; found: 733.4058. 
403: Rf = 0.4 (MeOH:CH2Cl2 = 5:95). 
    
    + 19.5 (c 0.18, CHCl3). 
IR (neat): νmax 3510, 2930, 2225, 1600, 1510, 1489, 1251, 1095, 834, 775, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.50 (d, J = 2.0 Hz, 0.59H, H-2), 7.49* (dd, J = 8.6, 1.9 Hz, 0.41H, H-4), 7.46 (dd, J = 
8.6, 2.1 Hz, 0.59H, H-4), 7.40* (d, J = 2.1 Hz, 0.41H, H-2), 7.34 – 7.19 (m, 8.36H, 
ArH), 7.17* (d, J = 7.4 Hz, 0.82H, ArH), 7.13 – 7.09 (m, 1.82H, H-3′ and ArH), 7.04* 
(d, J = 7.5 Hz, 0.82H, ArH), 6.92 (t, J = 8.6 Hz, 1H, H-5), 6.63* (s, 0.41H, H-6′), 6.57 
(s, 0.59H, H-6′), 5.91* (d, J = 16.0 Hz, 0.41H, H-1′′′), 5.86 (d, J = 15.9 Hz, 0.59H, H-
1′′′), 5.67 (dd, J = 15.9, 8.6 Hz, 059H, H-2′′′), 5.59* (dd, J = 16.0, 7.7 Hz, 0.41H, H-
2′′′), 5.63 – 5.45 (m, 1H, H-3′′), 5.16* – 5.08* (m, 0.41H, H-4′′), 5.08 – 4.96 (m, 2.59H, 
H-4′′ and PhCH2O), 3.96* (s, 1.23H, OCH3), 3.94 (s, 1.77H, OCH3), 3.87 (s, 1.77H, 
OCH3), 3.80* (s, 1.23H, OCH3), 3.63* (dd, J = 9.3, 4.3 Hz, 0.41H, H-1′′), 3.60 – 3.39 
(m, 2.59H, H-1′′ and H-7′′′), 3.24 (td, J = 8.5, 2.4 Hz, 0.59H, H-4′′′), 3.17* (td, J = 8.0, 
2.5 Hz, 0.41H, H-4′′′), 2.61* (t, J = 8.0 Hz, 0.41H, H-3′′′), 2.53 (t, J = 8.5 Hz, 0.59H, H-
3′′′), 2.46 – 2.23 (m, 1.41H, H-2′′ (minor) and H-2′′A), 2.14 (dt, J = 14.5, 9.6 Hz, 0.59H, 
H-2′′B), 1.71 – 1.33 (m, 2H, H-6′′′), 1.24 – 0.98 (m, 2H, H-5′′′), 0.81 (s, 9H, (CH3)3CSi), 
-0.02* (s, 1.23H, CH3Si), -0.02 (s, 1.77H, CH3Si), -0.03 (s, 1.77H, CH3Si), -0.03* (s, 
1.23H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.8 (C-6), 159.2* (C-6), 149.5 (C-4′), 149.4* (C-4′), 147.7 (C-5′), 147.4* (C-5′), 
136.9 (ArC), 136.4 (ArC), 136.0* (C-3′′), 135.7* (C-2′), 135.6* (C-2), 135.6 (C-2′), 
135.3 (C-3′′), 135.2 (C-2), 134.8 (ArC), 134.5* (ArC), 133.4 (C-4), 133.3* (C-4), 132.7 
(C-1′′′), 132.3 (C-1), 131.6* (C-1′′′), 131.5 (C-1), 129.6* (C-2′′′), 128.8* (0.82 x ArCH), 
128.76 (C-2′′′), 128.7 (1.18 x ArCH), 128.68 (1.18 x ArCH), 128.6* (0.82 x ArCH), 
128.3 (ArCH), 127.9 (C-2), 127.7 (0.59 x ArCH), 127.68* (C-2), 127.6* (0.41 x 
ArCH), 126.9 (1.18 x ArCH), 126.5* (0.82 x ArCH), 126.4 (1.18 x ArCH), 126.2* 
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(0.82 x ArCH), 119.0* (C≡N), 118.9 (C≡N), 118.6* (C-4′′), 117.9 (C-4′′), 113.1 (C-5), 
113.0* (C-5), 112.9 (C-6′), 112.7* (C-6′), 109.6 (C-3′), 109.5* (C-3′), 104.4 (C-3), 
103.9 (C-3), 73.5* (C-4′′′), 73.4 (C-4′′′), 70.5 (PhCH2O), 70.2 (PhCH2O), 63.4 (C-3′′′), 
63.3 (C-7′′′), 63.2* (C-7′′′), 62.5* (C-3′′′), 56.1 (OCH3), 56.08 (OCH3), 54.1* (C-1′′), 
53.9 (C-1′′), 43.5* (C-2′′), 42.2 (C-2′′), 30.2 (C-5′′′), 30.1* (C-5′′′), 29.2 (C-6′′′), 29.1* 
(C-6′′′), 26.0 ((CH3)3CSi), 18.4 ((CH3)3CSi), -5.2 (2 x CH3Si). 
ESIMS m/z 733 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H57N2O5Si [M + H]+: 733.4037; found: 733.4042. 
6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-4,7-bis((tert-butyldimethylsilyl)oxy)-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (404) 
 
The title compound was prepared following the General method 21 for the 
silylation of a secondary alcohol using 1,2-amino alcohol 402 (0.4459 g, 0.608 mmol, 
1.0 equiv.), imidazole (0.3313 g, 4.866 mmol, 8.0 equiv.), TBSCl (0.5501 g, 3.649 
mmol, 6.0 equiv.) and CH2Cl2 (1.5 mL). Purification by column chromatography on 
silica gel eluting with 15:85 EtOAc/hexane gave the title compound 404 as a pale 
yellow oil (0.4533 g, 88%). 1H NMR analysis revealed the presence of two biphenyl 
axis rotamers in a 58:42 ratio. 
Rf = 0.3 (EtOAc:hexane = 20:80). 
    
    + 11.3 (c 1.68, CHCl3). 
IR (neat): νmax 2928, 2225, 1600, 1514, 1491, 1463, 1250, 1037, 834, 746, 693 cm-1. 
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1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.38* (dd, J = 8.7, 2.1 Hz, 0.42H, H-4), 7.36* (d, J = 2.1 Hz, 0.42H, H-2), 7.34 – 7.00 
(m, 12.16H, H-2, H-4, H-3′ and ArH), 6.84 (d, J = 8.6 Hz, 0.58H, H-5), 6.53* (s, 0.42H, 
H-6′), 6.45 (s, 0.58H, H-6′), 6.43* (d, J = 8.7 Hz, 0.42H, H-5), 6.18 (d, J = 16.0 Hz, 
0.58H, H-1′′′), 6.06* (d, J = 16.0 Hz, 0.42H, H-1′′′), 5.76* (dd, J = 16.0, 9.1 Hz, 0.42H, 
H-2′′′), 5.62 (dd, J = 16.0, 8.7 Hz, 0.58H, H-2′′′), 5.60 – 5.50 (m, 1H, H-3′′), 5.08 – 4.90 
(m, 2.32H, H-4′′ and PhCH2O), 4.89* – 4.76* (m, 1.68H, H-4′′ and PhCH2O), 3.95 (s, 
1.74H, OCH3), 3.91* (s, 1.26H, OCH3), 3.79* (s, 1.26H, OCH3), 3.75 (s, 1.74H, 
OCH3), 3.70* – 3.66* (m, 0.42H, H-4′′′), 3.66 – 3.61 (m, 0.58H, H-4′′′), 3.59 – 3.47 (m, 
2.58H, H-1′′ and H-7′′′), 3.43* (dd, J = 7.7, 5.2 Hz, 0.42H, H-1′′), 3.18 (dd, J = 8.7, 3.3 
Hz, 0.58H, H-3′′′), 3.07* (dd, J = 9.2, 3.4 Hz, 0.42H, H-3′′′), 2.42 – 2.23 (m, 2H, H-2′′), 
1.77 (br s, 1H, NH), 1.68 – 1.32 (m, 4H, H-5′′′ and H-6′′′), 0.87 (s, 5.22H, (CH3)3CSi), 
0.85* (s, 3.78H, (CH3)3CSi), 0.85 (s, 5.22H, (CH3)3CSi), 0.79* (s, 3.78H, (CH3)3CSi), 
0.05* (s, 2.52H, CH3Si), 0.04 (s, 3.48H, CH3Si), 0.00* (s, 3.48H, CH3Si), -0.01* (s, 
2.52H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6 (C-6), 159.0* (C-6), 148.9* (C-4′), 148.8 (C-4′), 147.3 (C-5′), 147.2* (C-5′), 
137.5* (ArC), 137.0 (ArC), 136.2 (ArC), 136.1* (ArC), 136.1 (C-3′′), 135.9 (C-2′), 
135.7* (C-2), 135.4* (C-3′′), 135.37* (C-2′), 135.2 (C-2), 133.1 (C-4), 132.9* (C-4), 
132.0 (C-1), 131.9* (C-1′′′), 131.1 (C-1′′′), 130.6 (C-2′′′), 129.0* (C-2′′′), 128.7 (1.16 x 
ArCH), 128.66 (1.16 x ArCH), 128.5 * (0.84 x ArCH), 128.45 * (0.84 x ArCH), 128.1 
(0.58 x ArCH), 128.0 * (0.42 x ArCH), 127.4 (C-1), 127.3 (ArCH), 126.7 (1.16 x 
ArCH), 126.5* (0.84 x ArCH), 126.45 (1.16 x ArCH), 126.4* (0.84x ArCH), 119.2* 
(C≡N), 119.0 (C≡N), 117.3* (C-4′′), 117.2 (C-4′′), 113.2* (C-5), 112.8 (C-5), 112.7 (C-
6′), 112.4* (C-64′), 110.5 (C-3′), 110.2* (C-3′), 104.0 (C-3), 103.6* (C-3), 76.2 (C-4′′′), 
75.8* (C-4′′′), 70.3 (PhCH2O), 70.0* (PhCH2O), 65.0 (C-3′′), 63.3 (C-7′′′), 63.28* (C-
7′′′), 61.6* (C-3′′), 56.7 (C-1′′), 56.1 (OCH3), 56.0 (OCH3), 55.97* (OCH3), 55.9* 
(OCH3), 55.2* (C-1′′), 41.4 (C-2′′), 41.2* (C-2′′), 31.1* (C-6′′′), 29.5 (C-6′′′), 29.3 (C-
5′′′), 28.8* (C-5′′′), 26.1 ((CH3)3CSi), 26.0 ((CH3)3CSi), 18.4 ((CH3)3CSi), 18.2 
((CH3)3CSi), -3.9* (CH3Si), -4.08 (CH3Si), -4.1 (CH3Si), -4.3* (CH3Si), -5.16 (CH3Si), 
-5.2* (CH3Si). 
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ESIMS m/z 847 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C51H71N2O5Si [M + H]+: 847.4902; found: 847.4904. 
6-(Benzyloxy)-2'-((S)-1-(((3R,4R,E)-4,7-bis((tert-butyldimethylsilyl)oxy)-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (405) 
 
The title compound was prepared following the General method 21 for the 
silylation of a secondary alcohol using 1,2-amino alcohol 403 (105.0 mg, 0.143 mmol, 
1.0 equiv.), imidazole (48.8 mg, 0.716 mmol, 5.0 equiv.), TBSCl (64.8 mg, 0.429 
mmol, 3.0 equiv.) and CH2Cl2 (1.43 mL). Purification by column chromatography on 
silica gel eluting with 10:90 EtOAc/hexane gave the title compound 405 as a pale 
yellow oil (89.4 mg, 85%). 1H NMR analysis revealed the presence of two biphenyl axis 
rotamers in a 55:45 ratio. 
Rf = 0.6 (EtOAc:hexane = 30:70). 
    
    - 35.9 (c 0.18, CHCl3). 
IR (neat): νmax 2926, 2856, 2225, 1600, 1513, 1490, 1462, 1361, 1246, 1205, 1155, 
1035, 834, 744, 693 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.43 – 7.09 (m, 11.1H, H-2, H-4 and ArH), 7.00* (d, J = 7.5 Hz, 0.9H, ArH), 6.84 (d, J 
= 8.5 Hz, 0.55H, H-5), 6.66* (d, J = 8.7 Hz, 0.45H, H-5), 6.63* (s, 0.45H, H-6′), 6.55 
(s, 0.55H, H-6′), 5.96 (d, J = 16.1 Hz, 0.55H, H-1′′′), 5.93 – 5.85 (m, 1H, H-1′′′ and H-
2′′′), 5.71* (dd, J = 16.0, 7.1 Hz, 0.45H, H-2′′′), 5.72* – 5.64* (m, 0.45H, H-3′′), 5.63 – 
5.50 (m, 0.55H, H-3′′), 5.13* (d, J = 16.1 Hz, 0.9H, H-4′′), 5.10 – 4.95 (m, 2.2H, H-4′′ 
and PhCH2O), 4.87* (s, 0.90H, PhCH2O), 3.96* (s, 1.35H, OCH3), 3.95 (s, 2.65H 
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OCH3), 3.85 (s, 2.65H OCH3), 3.77* (s, 1.35H OCH3), 3.61* (dd, J = 9.5, 3.7 Hz, 
0.45H, H-1′′), 3.58 – 3.42 (m, 3.55H, H-1′′, H-4′′′ and H-7′′′), 2.86 – 2.77 (m, 1H, H-
3′′′), 2.43 – 2.22 (m, 1.45H, H-2′′ (minor) and H-2′′A), 2.12 (dt, J = 13.9, 9.2 Hz, 0.55H, 
H-2′′B), 1.84 (br s, 1H, NH), 1.76 – 1.67 (m, 1.1H, H-5′′′), 1.53* – 1.45* (m, 0.9H, H-
5′′′), 1.43 – 1.27 (m, 2H, H-6′′′), 0.89 – 0.85 (m, 13.95H, (CH3)3CSi)), 0.82* (s, 4.05H, 
(CH3)3CSi)), 0.01 (s, 6.3H, CH3Si), -0.01 (s, 1.65H, CH3Si), -0.05* (s, 1.35H, CH3Si), -
0.08* (s, 1.35H, CH3Si), -0.16* (s, 1.35H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.7 (C-6), 159.1* (C-6), 149.2* (C-4′), 149.1 (C-4′), 147.3 (C-5′), 147.1* (C-5′), 
137.5* (ArC), 136.9 (ArC), 136.3 (C-3′′), 136.1* (C-2), 135.8 (C-2), 135.7 (ArC), 
135.7* (C-3′′), 135.4* (C-2′), 135.2 (C-2′), 133.2 (C-4), 133.0* (C-4), 132.7* (C-2′′′), 
132.1 (C-1), 131.4* (C-1), 131.3 (C-2′′′), 130.9 (C-1′′′), 130.2* (C-1′′′), 128.7* (0.9 x 
ArCH), 128.7 (1.1 x ArCH), 128.7 (1.1 x ArCH), 128.5* (0.9 x ArCH), 128.1 (0.55 x 
ArCH), 128.0* (0.45 x ArCH), 127.9 (C-1′), 127.4* (C-1′), 127.3 (0.55 x ArCH), 
127.1* (0.45 x ArCH), 126.8 (1.1 x ArCH), 126.2 (2 x ArCH), 126.0* (0.9 x ArCH), 
119.2* (C≡N), 118.9 (C≡N), 118.1* (C-4′′), 117.4 (C-4′′), 113.1* (C-6′), 112.9* (C-5), 
112.8 (C-6′), 112.7 (C-5), 109.8 (C-3′), 109.6* (C-3′), 104.2 (C-3), 103.5* (C-3), 76.4* 
(C-4′′′), 76.2 (C-4′′′), 70.4 (PhCH2O), 69.9* (PhCH2O), 63.3 (C-7′′′), 63.2* (C-7′′′), 60.0 
(C-3′′′), 59.2* (C-3′′′), 56.1* (OCH3), 56.0 (OCH3), 54.1 (C-1′′), 54.0* (C-1′′), 44.0* (C-
2′′), 42.4 (C-2′′), 30.2* (C-5′′′), 30.2 (C-5′′′), 29.0* (C-6′′′), 28.9 (C-6′′′), 26.1 
((CH3)3CSi), 26.1* ((CH3)3CSi), 26.0* ((CH3)3CSi), 18.4 ((CH3)3CSi), 18.2* 
((CH3)3CSi), 18.2* ((CH3)3CSi), -4.1* (CH3Si), -4.1* (CH3Si), -4.5 (CH3Si), -5.2 
(CH3Si). 
ESIMS m/z 848 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C51H71N2O5Si2 [M + H]+: 847.4902; found: 847.4935. 
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6.4.13 General method 22 for the selective deprotection of a primary TBS ether 
6-(Benzyloxy)-2'-((S)-1-(((3R,4R,E)-4-((tert-butyldimethylsilyl)oxy)-7-hydroxy-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (406) 
 
A solution of bis-silyl ether 405 (55.9 mg, 0.066 mmol, 1.0 equiv.) in anhydrous 
THF (0.65 mL) in a plastic vial was cooled at 0 °C. HF·py solution, which was prepared 
from 2.0 g of 70% HF·pyridine, 4 mL of pyridine and 16 mL of THF, (0.99 mL, 0.99 
mmol, 15 equiv.) was added in one portion and the mixture was stirred at 0 °C for 4 h 
and then quenched by careful addition of sat. aqueous NaHCO3 solution. The aqueous 
layer was extracted with EtOAc (3 x 5 mL). The combined organic layer was dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 0:100 to 1:99 MeOH/CH2Cl2 to afford the 
title compound 406 as a pale yellow oil (37.1 mg, 77%). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 54:46 ratio. 
Rf = 0.4 (MeOH:CH2Cl2 = 3:97). 
    
    - 64.1 (c 0.51, CHCl3). 
IR (neat): νmax 3519, 2930, 2224, 1599, 1513, 1490, 1248, 1234, 1153, 1109, 1035, 814, 
734, 745, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.42 – 7.38 (m, 1.46H, H-2 and H-4), 7.36 (dd, J = 8.6, 2.1 Hz, 0.54H, H-4), 7.34 – 7.19 
(m, 8.16H, ArH), 7.18 – 7.11 (m, 1.92H, H-3′ and ArH), 7.02* (d, J = 6.9 Hz, 0.92H, 
ArH), 6.86 (d, J = 8.6 Hz, 0.54H, H-5), 6.71* (d, J = 9.2 Hz, 0.46H, H-5), 6.65* (s, 
0.46H, H-6′), 6.57 (s, 0.54H, H-6′), 5.95 (d, J = 16.1 Hz, 0.54H, H-1′′′), 5.92 – 5.85 (m, 
Chapter 6: Experimental Section | 308 
 
 
1H, H-1′′′ and H-2′′′), 5.72* (dd, J = 16.0, 7.1 Hz, 0.46H, H-2′′′), 5.72 – 5.49 (m, 1H, H-
3′′), 5.18* – 5.09* (m, 0.92H, H-4′′), 5.08 – 5.02 (m, 1.08H, PhCH2O), 5.02 – 4.96 (m, 
1.08H, H-4′′), 4.95* – 4.86* (m, 0.92H, PhCH2O), 3.98* (s, 1.38H, OCH3), 3.97 (s, 
1.62H, OCH3), 3.86 (s, 1.62H, OCH3), 3.79* (s, 1.38H, OCH3), 3.62 – 3.54 (m, 2H, H-
1′′ (minor), H-4′′′ (minor) and H-7′′′), 3.53 – 3.42 (m, 2H, H-1′′, H-4′′′ and H-7′′′ 
(minor)), 2.84 (dd, J = 7.3, 3.8 Hz, 0.54H, H-3′′′), 2.81* (dd, J = 6.9, 2.9 Hz, 0.46H, H-
3′′′), 2.45 – 2.25 (m, 1.54H, H-2′′ and H-2′′A), 2.17* (dt, J = 14.0, 9.3 Hz, 0.46H, H-
2′′B), 1.55 – 1.18 (m, 4H, H-5′′′ and H-6′′′), 0.87 (s, 4.86H, (CH3)3CSi), 0.83* (s, 4.14H, 
(CH3)3CSi), -0.00 (s, 1.62H, CH3Si), -0.04* (s, 1.38H, CH3Si), -0.08 (s, 1.62H, CH3Si), 
-0.16* (s, 1.38H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.7 (C-6), 159.1* (C-6), 149.2 (C-4′), 149.15* (C-4′), 147.5 (C-5′), 147.2* (C-5′), 
137.4* (ArC), 136.9 (ArC), 136.3 (C-3′′), 136.1* (C-2′), 135.8 (C-2′), 135.7 (ArC), 
135.67* (ArC), 135.6 (C-3′′), 135.4* (C-2), 135.3 (C-2), 133.3 (C-5), 133.1* (C-5), 
132.4* (C-2′′′), 132.2 (C-1), 131.3* (C-1), 131.1 (C-4′′′), 131.0* (C-4′′′), 130.2 (C-2′′′), 
128.8* (0.92 x ArCH), 128.7 (1.08 x ArCH), 128.69 (1.08 x ArCH), 128.5* (0.92 x 
ArCH), 128.2 (0.54 x ArCH), 128.1* (0.46 x ArCH), 128.0 (C-1′), 127.8* (C-1′), 127.4 
(0.54 x ArCH), 127.2* (0.46 x ArCH), 126.8 (1.08 x ArCH), 126.4* (0.92 x ArCH), 
126.3 (1.08 x ArCH), 126.1* (0.92 x ArCH), 119.2* (C≡N), 119.0 (C≡N), 118.2* (C-
4′′), 117.5 (C-4′′), 113.1* (C-6′), 112.8 (C-6′), 112.79 (C-5), 110.2* (C-3′), 110.1 (C-3′), 
104.2 (C-3), 103.6* (C-3), 76.2* (C-4′′′), 75.9 (C-4′′′), 70.4 (PhCH2O), 69.9* 
(PhCH2O), 63.2 (C-7′′′), 63.1* (C-7′′′), 60.3 (C-3′′′), 59.1* (C-3′′′), 56.3* (OCH3), 56.2 
(OCH3), 56.1 (OCH3), 56.05* (OCH3), 54.4 (C-1′′), 54.1* (C-1′′), 43.8* (C-2′′), 42.3 
(C-2′′), 30.4* (C-6′′′), 30.2 (C-6′′′), 28.9* (C-5′′′), 28.8 (C-5′′′), 26.03 ((CH3)3CSi), 
26.0* ((CH3)3CSi), 18.2 ((CH3)3CSi), 18.16* ((CH3)3CSi), -4.08 (CH3Si), -4.1* 
(CH3Si), -4.48* (CH3Si), -4.5 (CH3Si). 
ESIMS m/z 733 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H57N2O5Si [M + H]+: 733.4037; found: 733.4037. 
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6-(Benzyloxy)-2'-((S)-1-(((3R,4R,E)-4,7-dihydroxy-1-phenylhept-1-en-3-
yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (407) 
 
Diol 407 was obtained as a by-product from the above selective deprotection of 
a primary silyl ether of bis-silyl ether 405 as a white solid (4.1 mg, 10%).1H NMR 
analysis revealed the presence of two biphenyl axis rotamers in a 58:42 ratio. 
Rf = 0.3 (MeOH:CH2Cl2 = 4:96). 
    
    - 68.2 (c 0.06, CHCl3). 
IR (neat): νmax 3370, 3005, 2933, 2224, 1599, 1513, 1491, 1248, 1033, 745, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.54 (d, J = 2.2 Hz, 0.58H, H-2), 7.52* (d, J = 2.2 Hz, 0.42H, H-4), 7.49 (dd, J = 8.6, 
2.2 Hz, 0.58H, H-4), 7.40* (d, J = 2.2 Hz, 0.42H, H-2), 7.35 – 7.02 (m, 11H, H-3′ and 
ArH), 6.98* (d, J = 8.6 Hz, 0.42H, H-5), 6.92 (d, J = 8.6 Hz, 0.58H, H-5), 6.64* (s, 
0.48H, H-6′), 6.58 (s, 0.58H, H-6′), 5.88* (d, J = 16.0 Hz, 0.42H, H-1′′′), 5.83 (d, J = 
16.0 Hz, 0.58H, H-1′′′), 5.64 (dd, J = 16.0, 8.7 Hz, 0.58H, H-2′′′), 5.61 – 5.43* (m, 
1.42H, H-3′′ and H-2′′′), 5.16 – 4.95 (m, 4H, H-4′′ and PhCH2O), 3.96* (s, 1.26H, 
OCH3), 3.94 (s, 1.74H, OCH3), 3.88 (s, 1.74H, OCH3), 3.81* (s, 1.26H, OCH3), 3.67 – 
3.39 (m, 3H, H-1′′ and H-7′′′), 3.23 (t, J = 8.8 Hz, 0.58H , H-4′′′), 3.15* (t, J = 8.2 Hz, 
0.42H, H-4′′′), 2.58* (t, J = 8.2 Hz, 0.42H, H-3′′′), 2.50 (t, J = 8.8 Hz, 0.58H, H-3′′′), 
2.47 – 2.23 (m, 1.42H, H-2′′ (minor) and H-2′′A), 2.15 (dt, J = 14.5, 9.5 Hz, 0.58H, H-
2′′B), 1.66 – 1.36 (m, 2H, H-6′′′), 1.31 – 1.20 (m, 1.16H, H-5′′′), 1.00 – 0.90 (m, 0.84H, 
H-5′′′). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.9, 159.2, 149.5, 149.5, 147.9, 147.5, 136.7, 136.2, 135.8, 135.7, 135.6, 135.5, 
135.3, 135.0, 134.5, 134.1, 133.5, 133.4, 133.1, 132.3, 132.0, 131.5, 129.0* (C-2′′′), 
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128.9* (0.84 x ArCH), 128.7 (1.16 x ArCH), 128.7 (1.16 x ArCH), 128.7* (0.84 x 
ArCH), 128.3 (ArCH), 128.1 (C-2′′′), 127.9 (C-1′), 127.9 (0.58 x ArCH), 127.8* (0.42 x 
ArCH), 127.8* (C-1′), 126.9 (1.16 x ArCH), 126.5* (0.84 x ArCH), 126.4 (1.16 x 
ArCH), 126.2* (0.84 x ArCH), 119.0 (C≡N), 118.9* (C≡N), 118.9* (C-4′′), 118.2 (C-
4′′), 113.1* (C-5), 113.0* (C-6′), 112.9 (C-5), 112.7 (C-6′), 109.6 (C-3′), 109.5* (C-3′), 
104.3 (C-3), 104.0* (C-3), 73.4* (C-4′′′), 73.3 (C-4′′′), 70.6 (PhCH2O), 70.3* 
(PhCH2O), 63.3 (C-3′′′), 63.0 (C-7′′′), 62.9* (C-7′′′), 62.4 (C-3′′′), 56.1 (OCH3), 56.1* 
(OCH3), 54.0* (C-1′′), 53.8 (C-1′′), 43.3* (C-2′′), 42.1 (C-2′′), 30.8 (C-5′′′), 30.6* (C-
5′′′), 29.6 (C-6′′′), 29.6* (C-6′′′). 
ESIMS m/z 619 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C39H43N2O5 [M + H]+: 619.3172; found: 619.3165.   
6-(Benzyloxy)-2'-((S)-1-(((3S,4R,E)-4-((tert-butyldimethylsilyl)oxy)-7-hydroxy-1-
phenylhept-1-en-3-yl)amino)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
carbonitrile (408) 
 
The title compound was prepared following the General method 22 for selective 
deprotection of a primary TBS ether using bis-silyl ether 404 (72.4 g, 0.085 mmol, 1.0 
equiv.), HF·py solution (1.46 mL, 1.025 mmol, 12.0 equiv.) and THF (0.85 mL). 
Purification by column chromatography on silica gel eluting with 0:100 to 4:96 
MeOH/CH2Cl2 gave the title compound 408 as a pale yellow oil (49.4 mg, 79%) and 
diol 393 as a by-product (6.4 mg, 12%). 1H NMR analysis of 408 revealed the presence 
of two biphenyl axis rotamers in a 60:40 ratio. 
Rf = 0.2 (MeOH:CH2Cl2 = 3:97). 
    
    + 36.0 (c 0.74, CHCl3). 
IR (neat): νmax 3519, 2929, 2224, 1600, 1515, 1463, 1250, 1035, 835, 749, 694 cm-1. 
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1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.44* (dd, J = 8.6, 2.1 Hz, 0.4H, H-4), 7.38* (d, J = 2.1 Hz, 0.4H, H-2), 7.35 (d, J = 2.1 
Hz, 0.6H, H-2), 7.34 – 7.03 (m, 11.6H, H-4, H-3′ and ArH), 6.89 (d, J = 8.6 Hz, 0.6H, 
H-5), 6.55* (s, 0.4H, H-6′), 6.51* (d, J = 9.1 Hz, 0.4H, H-5), 6.49 (s, 0.6H, H-6′), 6.22 
(d, J = 16.0 Hz, 0.6H, H-1′′′), 6.09* (d, J = 16.0 Hz, 0.4H, H-1′′′), 5.71* (dd, J = 16.0, 
9.1 Hz, 0.4H, H-2′′′), 5.64 (dd, J = 16.0, 8.6 Hz, 0.6H, H-2′′′), 5.60 – 5.48 (m, 1H, H-
3′′), 5.09 – 5.00 (m, 1.2H, PhCH2O), 5.00 – 4.79 (m, 2.8H, H-4′′ and PhCH2O), 3.95 (s, 
1.8H, OCH3), 3.92* (s, 1.2H, OCH3), 3.81* (s, 1.2H, OCH3), 3.77 (s, 1.8H, OCH3), 
3.65 – 3.52 (m, 3.4H, H-1′′, H-4′′′ and H-7′′′), 3.45 (t, J = 6.5 Hz, 0.6H, H-1′′), 3.22 (dd, 
J = 8.8, 3.4 Hz, 0.6H, H-3′′′), 3.11* (dd, J = 9.1, 4.2 Hz, 0.4H, H-3′′′), 2.46 – 2.25 (m, 
2H, H-2′′), 1.83 (s, 2H, OH and NH), 1.71 – 1.39 (m, 4H, H-5′′′ and H-6′′′), 0.88 (s, 
5.4H, (CH3)3CSi), 0.80* (s, 3.6H, (CH3)3CSi), 0.06 (s, 1.8H, CH3Si), 0.04* (s, 1.2H, 
CH3Si), 0.01 (s, 1.8H, CH3Si), -0.01* (s, 1.2H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.6 (C-6), 159.0* (C-6), 149.0* (C-4′), 148.9 (C-4′), 147.3 (C-5′), 137.3* (ArC), 
136.9 (ArC), 136.1* (ArC), 136.0 (C-3′′), 135.8 (ArC), 135.7* (C-3′′), 135.67 (C-2′), 
135.5 (C-2), 135.2* (C-2), 135.1* (C-2′), 133.1 (C-4), 132.9* (C-4), 132.1* (C-1′′′), 
132.0 (C-1), 131.9* (C-1), 131.3 (C-1′′′), 130.4 (C-2′′′), 129.3 (C-2′′′), 128.7* (0.8 x 
ArCH), 128.69 (1.2 x ArCH), 128.6 (1.2 x ArCH), 128.5* (0.8 x ArCH), 128.1 (0.6 x 
ArCH), 128.09* (0.4 x ArCH), 127.6 (C-1′), 127.5* (C-1′), 127.4 (ArCH), 126.7 (1.2 x 
ArCH), 126.5* (1.6 x ArCH), 126.4 (1.2 x ArCH), 119.2 (C≡N), 119.16* (C≡N), 
117.4* (C-4′′), 117.3 (C-4′′), 113.2* (C-5), 112.9 (C-5), 112.7* (C-6′), 112.4 (C-6′), 
110.4 (C-3′), 110.3* (C-3′), 103.8 (C-3), 103.7* (C-3), 75.9 (C-4′′′), 75.4* (C-4′′′), 70.3 
(PhCH2O), 70.1* (PhCH2O), 64.7 (C-3′′′), 63.1 (C-7′′′), 62.9* (C-7′′′), 61.9* (C-3′′′), 
56.6 (C-1′′), 56.1 (OCH3), 56.03 (OCH3), 56.0* (OCH3), 55.96* (OCH3), 55.4* (C-1′′), 
41.1 (C-2′′), 40.8* (C-2′′), 30.8* (C-6′′′), 29.4 (C-6′′′), 29.2 (C-5′′′), 28.4* (C-5′′′), 26.1 
((CH3)3CSi), 26.0* ((CH3)3CSi), 18.2 ((CH3)3CSi), 18.18* ((CH3)3CSi), -4.0* (CH3Si), 
-4.1 (CH3Si), -4.2* (CH3Si). 
ESIMS m/z 733 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H57N2O5Si [M + H]+: 733.4037; found: 733.4057. 
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6-(Benzyloxy)-2'-((S)-1-((2R,3R)-3-((tert-butyldimethylsilyl)oxy)-2-((E)-styryl) 
piperidin-1-yl)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (409) 
 
The title compound was prepared following the General method 19 for 
mesylation-cyclization using alcohol 406 (0.4890 g, 0.667 mmol, 1.0 equiv.), 
triethylamine (0.1350 g, 185.9 µL, 1.334 mmol, 2.0 equiv.), methanesulfonyl chloride 
(0.1375 g, 93.0 µL, 1.20 mmol, 1.8 equiv.) and CH2Cl2 (6.7 mL). The reaction mixture 
stirred at 0 °C for 5 min and then an additional portion of triethylamine (0.1350 g, 185.9 
µL, 1.334 mmol, 2.0 equiv.) was added and the mixture was stirred and heated 45 °C 
for 18 h. Purification by column chromatography on silica gel eluting with 10:90 
EtOAc/hexane gave the title compound 409 as a pale yellow oil (0.4100 g, 86%). 1H 
NMR analysis revealed the presence of two biphenyl axis rotamers in a 51:49 ratio. 
Rf = 0.5 (EtOAc:hexane = 30:70). 
    
    - 45.9 (c 0.23, CHCl3). 
IR (neat): νmax 2925, 2857, 2218, 1599, 1508, 1489, 1251, 1109, 1023, 834, 773 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.54 – 7.41 (m, 2H, H-2 and H-4), 7.35 – 7.09 (m, 9.51H, H-3′ and ArH), 7.02 (s, 
0.51H, H-3′), 6.97* (d, J = 7.2 Hz, 0.98H, ArH), 6.92* (d, J = 8.5 Hz, 0.49H, H-5), 
6.70* (s, 0.49H, H-6′), 6.64 (d, J = 8.5 Hz, 0.51H, H-5), 6.56 (s, 0.51H, H-6′), 6.29* 
(dd, J = 16.0, 8.4 Hz, 0.49H, H-1′′′), 6.19 – 6.03 (m, 1.51H, H-1′′′ and H-2′′′), 5.82 – 
5.70 (m, 0.51H, H-3′′), 5.70* – 5.60* (m, 0.49H, H-3′′), 5.13 – 4.94 (m, 2H, H-4′′ and 
PhCH2O), 4.82* (d, J = 12.2 Hz, 0.49H, PhCHAHBO), 4.79 – 4.62 (m, 1.51H, H-4′′and 
PhCHAHBO), 3.93* (s, 1.47H, OCH3), 3.84 (s, 3.06H, OCH3), 3.81* – 3.76* (m, 0.49H, 
H-1′′), 3.72* (s, 1.47H, OCH3), 3.72 – 3.67 (m, 0.51H, H-1′′), 3.67 – 3.60 (m, 1H, H-
3′′′), 3.20 – 3.17 (m, 0.51H, H-2′′′), 3.17* – 3.11* (m, 0.49H, H-2′′′), 2.81* – 2.73* (m, 
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0.49H, H-6′′′A), 2.62 – 2.36 (m, 3.51H, H-2′′, H-6′′′ (major) and H-6′′′B), 1.74 – 1.31 (m, 
4H, H-5′′′ and H-6′′′), 0.80 (s, 4.59H, (CH3)3CSi), 0.75* (s, 4.41H, (CH3)3CSi), -0.03* 
(s, 1.47H, CH3Si), -0.08 (s, 1.53H, CH3Si), -0.11 (s, 1.53H, CH3Si), -0.18* (s, 1.47H, 
CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.3* (C-6), 159.2 (C-6), 148.7* (C-4′), 148.0 (C-4′), 147.1* (C-5′), 146.8 (C-5′), 
138.2 (ArC), 137.6* (ArC), 136.4* (C-3′′), 136.1 (ArC), 136.0 (C-3′′), 135.7 (C-2), 
134.2* (C-2′), 134.0 (C-2′′′), 133.7 (C-2′), 133.3* (C-2′′′), 133.0* (C-4), 132.8 (C-4), 
132.6 (C-1), 130.9* (C-1), 128.7*  (0.98 x ArCH), 128.68 (2.04 x ArCH), 128.3* (0.98 
x ArCH), 128.1 (0.51 x ArCH), 128.0* (0.49 x ArCH), 127.3 (C-1′), 127.2 (0.51 x 
ArCH), 127.0* (0.49 x ArCH), 126.8* (0.98 x ArCH), 126.7 (C-1′′′′), 126.3* (0.98 x 
ArCH), 126.26 (1.02 x ArCH), 126.2 (1.02 x ArCH), 124.8 (C-1′′′′), 119.3* (C≡N), 
118.9 (C≡N), 117.3* (C-4′′), 116.0 (C-4′′), 113.8 (C-6′), 113.6* (C-6′), 113.0* (C-5), 
112.8 (C-5), 111.3 (C-3′), 110.8* (C-3′), 104.2 (C-3), 103.2* (C-3), 71.8 (C-3′′′), 71.6* 
(C-3′′′), 70.4 (PhCH2O), 69.8* (PhCH2O), 65.3 (C-2′′′), 62.9* (C-2′′′), 61.4 (C-1′′), 
59.9* (C-1′′), 56.1* (OCH3), 56.0* (OCH3), 55.9 (OCH3), 43.3* (C-6′′′), 42.2 (C-6′′′), 
39.7 (C-2′′), 36.4* (C-2′′), 30.4* (C-4′′′), 29.7 (C-4′′′), 26.0 ((CH3)3CSi), 24.5 (C-5′′′), 
23.9* (C-5′′′), 18.2 ((CH3)3CSi), -4.4* (CH3Si), -4.48 (CH3Si), -4.5 (CH3Si), -4.7* 
(CH3Si). 
ESIMS m/z 715 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H55N2O4Si [M + H]+: 715.3944; found: 715.3940. 
6-(Benzyloxy)-2'-((S)-1-((2S,3R)-3-((tert-butyldimethylsilyl)oxy)-2-((E)-styryl) 
piperidin-1-yl)but-3-en-1-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (410) 
 
The title compound was prepared following the General method 19 for 
mesylation-cyclization using alcohol 408 (0.6550 g, 0.89 mmol, 1.0 equiv.), 
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triethylamine (0.1808 g, 0.25 mL, 1.78 mmol, 2.0 equiv.), methanesulfonyl chloride 
(0.1842 g, 124.5 µL, 1.61 mmol, 1.8 equiv.) and CH2Cl2 (0.7 mL). The reaction mixture 
stirred at 0 °C for 5 min and then an additional portion of triethylamine (0.1808 g, 0.25 
mL, 1.78 mmol, 2.0 equiv.) was added and the mixture was stirred and heated at 45 °C 
for 18 h.  Purification by column chromatography on silica gel eluting with 15:85 
EtOAc/hexane gave the title compound 410 as a pale yellow oil (0.5727 g, 90%). 1H 
NMR analysis revealed the presence of two biphenyl axis rotamers in a 88:12 ratio. 
Rf = 0.3 (EtOAc:hexane = 20:80). 
    
    - 28.8 (c 2.44, CHCl3). 
IR (neat): νmax 2925, 2852, 2223, 1599, 1516, 1491, 1257, 1094, 835, 747, 694 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.68 (dd, J = 8.5, 2.2 Hz, 1H, H-4), 7.55 (d, J = 2.2 Hz, 1H, H-2), 7.43 – 7.10 (m, 8H, 
ArH), 7.09* (s, 0.12H, H-5), 6.96* (s, 0.12H, H-3′), 6.85 (s, 0.88H, H-3′), 6.83 – 6.78 
(m, 2H, ArH), 6.81 (d, J = 8.7 Hz, 0.88H, H-5), 6.66* (s, 0.12H , H-6′), 6.61 (s, 0.88H, 
H-6′), 6.44 (d, J = 15.9 Hz, 1H, H-2′′′′), 5.66* – 5.53* (m, 0.12H, H-3′′), 5.32 – 5.21 (m, 
0.88H, H-3′′), 5.16* (d, J = 12.4 Hz, 0.12H, PhCHAHBO), 5.08* (d, J = 12.4 Hz, 0.12H, 
PhCHAHBO), 4.92* (t, J = 17.0, 13.6 Hz, 0.12H, H-4′′A), 4.85 (d, J = 17.0 Hz, 0.88H, 
H-4′′A), 4.73* (dd, J = 15.9, 9.4 Hz, 0.12H, H-4′′B), 4.57 (d, J = 12.4 Hz, 0.88H, 
PhCH2O), 4.53 (d, J = 10.2 Hz, 0.88H, H-4′′B), 4.45 (d, J = 12.4 Hz, 0.88H, PhCH2O), 
4.48 – 4.41 (m, 1H, H-1′′′), 3.92* (s, 0.36H, OCH3), 3.91 (s, 2.64H, OCH3), 3.84 (s, 
2.64H, OCH3), 3.80* (s, 0.36H, OCH3), 3.78 (dd, J = 11.5, 3.4 Hz, 1H, H-1′′), 3.15 – 
3.06 (m, 1.76H, H-3′′′), 2.95* – 2.88* (m, 0.24H, H-3′′′), 2.77 (t, J = 8.7 Hz, 1H, H-2′′′), 
2.63 – 2.56 (m, 1H, H-6′′′A), 2.56 – 2.49 (m, 1H, H-2′′A), 2.48 – 2.38 (m, 1H, H-2′′B), 
2.06 – 2.00 (m, 1H, H-6′′′B), 1.95 – 1.90 (m, 1H, H-4′′′A), 1.54 – 1.49 (m, 1H, H-5′′′A), 
1.27 – 1.19 (m, 2H, H-4′′′B and H-5′′′B), 0.75 (s, 9H, (CH3)3CSi), 0.01 (s, 2.64H, 
CH3Si), -0.09* (s, 0.36H, CH3Si), -0.10 (s, 2.64H, CH3Si), -0.20* (s, 0.36H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
160.6* (C-6), 159.1 (C-6), 147.6* (C-4′), 147.4 (C-4′), 147.3 (C-5′), 147.1* (C-5′), 
137.8 (C-2), 137.4 (ArC), 136.8* (ArC), 136.2 (C-3′′), 136.1* (ArC), 135.9 (ArC), 
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133.5 9 (C-2′′′′), 133.3* 9 (C-2′′′′), 132.5 (C-1), 132.4 (C-4), 131.7* (C-1′), 131.4 (C-
1′), 131.3 (C-2′), 130.9 (C-1′′′′), 130.4* (C-2′), 128.9* (0.24 x ArCH), 128.7* (0.24 x 
ArCH), 128.4 (3.52 x ArCH), 128.1* (0.12 x ArCH), 127.8 (0.88 x ArCH), 127.5* 
(0.12 x ArCH), 127.4 (0.88 x ArCH), 126.8 (1.76 x ArCH), 126.5 (2 x ArCH), 126.3* 
(0.24 x ArCH), 119.4 (C≡N), 119.1* (C≡N), 116.8* (C-4′′), 116.1 (C-4′′), 114.2* (C-
6′), 113.8 (C-6′), 113.1 (C-5), 112.6* (C-5), 112.5* (C-3′), 112.2 (C-3′), 104.0* (C-3), 
103.5 (C-3), 72.4 (C-3′′′), 72.3* (C-3′′′), 71.3* (C-2′′′), 71.1 (C-2′′′), 70.1* (PhCH2O), 
69.9 (PhCH2O), 59.6 (C-1′′), 56.2 (OCH3), 56.0 (OCH3), 44.6* (C-6′′′), 44.3* (C-6′′′), 
34.8 (C-4′′′), 34.4* (C-4′′′), 27.0* (C-2′′), 26.1 (C-2′′), 25.9 ((CH3)3CSi), 24.1 (C-5′′′), 
23.4* (C-5′′′), 18.1* ((CH3)3CSi), 18.0 ((CH3)3CSi), -4.3 (CH3Si), -4.4 (CH3Si). 
ESIMS m/z 715 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C45H55N2O4Si [M + H]+: 715.3931; found: 715.3958. 
6.4.14 General method 23 for ring-closing metathesis using Grubbs’ II ruthenium 
catalyst 
6-(Benzyloxy)-2'-((1R,6S,9aR)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexa 
hydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (411) 
 
To a solution of carbonitrile 409 (190.2mg, 0.2660 mmol, 1.0 equiv.) in N2 
purged anhydrous CH2Cl2 (3.7 mL) was added Grubbs’ II ruthenium catalyst (33.9 mg, 
0.0399 mmol, 0.15 equiv.) and stirred at 50 °C for 6 h. After the reaction had 
completed, the reaction mixture was cooled to room temperature and the solvent was 
evaporated. The crude product was purified by column chromatography on silica gel 
eluting with 2:98 MeOH/CH2Cl2 to afford the title compound 411 as a light brown oil 
(109.2 mg, 67%). 1H NMR analysis revealed the presence of two biphenyl axis rotamers 
in a 56:44 ratio. 
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Rf = 0.3 (EtOAc:hexane = 20:80). 
    
    + 32.7 (c 0.17, CHCl3). 
IR (neat): νmax 2925, 2853, 2224, 1601, 1516, 1490, 1462, 1252, 1209, 1120, 1034, 834, 
772, 735, 695 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.59* (d, J = 8.6 Hz, 0.44H, H-4), 7.56 (d, J = 8.6 Hz, 0.56H, H-4), 7.42* (s, 0.44H, H-
2), 7.38 (s, 0.56H, H-2), 7.32 – 7.15 (m, 6H and ArH), 7.02* (d, J = 8.6 Hz, 0.44H, H-
5), 6.99 (d, J = 8.6 Hz, 0.56H, H-5), 6.57 (s, 0.56H, H-6′), 6.55 (s, 0.44H, H-6′), 5.69 – 
5.59 (m, 1H, H-8′′), 5.39 (d, J = 10.2 Hz, 0.56H, H-9′′), 5.35* (d, J = 10.3 Hz, 0.44H, 
H-9′′), 5.18 – 5.05 (m, 2H, PhCH2O), 3.91 (s, 1.68H, OCH3), 3.90* (s, 1.32H, OCH3), 
3.84 (s, 1.68H, OCH3), 3.83* (s, 1.32H, OCH3), 3.79 – 3.71 (m, 1H, H-1′′), 3.18 (s, 
0.56H, H-6′′), 3.04* (s, 0.44H, H-6′′), 2.74 – 2.57 (m, 3H, H-4′′ and H-9a′′ ), 2.35* – 
2.16* (m, 0.88H, H-7′′), 2.04 – 1.89 (m, 1.12H, H-7′′), 1.85 – 1.58 (m, 2H, H-2′′ and H-
3′′), 1.49* – 1.36* (m, 0.88H, H-2′′), 1.35 – 1.21 (m, 1.22H, H-3′′), 0.91 (s, 9H, 
(CH3)3CSi)), 0.03* (s, 1.32H, CH3Si), 0.02 (s, 1.68H, CH3Si), 0.01 (s, 3H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.8* (C-6), 159.3 (C-6), 149.5* (C-4′), 149.4 (C-4′), 147.3* (C-5′), 147.1 (C-5′), 
136.0* (ArC), 135.96 (ArC), 135.9 (C-2), 135.2* (C-2), 133.3* (C-4), 133.1 (C-4), 
132.4 (C-2′), 132.2 (C-1), 128.8 (C-9′′ and 1.12 x ArCH), 128.7* (0.88 x ArCH), 128.2 
(0.56 x ArCH), 128.1* (0.44 x ArCH), 127.6 (C-1′), 126.8* (0.88 x ArCH), 126.7 (1.12 
x ArCH), 125.3 (C-8′′), 124.9* (C-8′′), 119.4 (C≡N), 119.3* (C≡N), 113.0 (C-5), 112.8* 
(C-5), 112.3 (C-6′), 110.1 (C-3′), 109.7* (C-3′), 104.0* (C-3), 103.9 (C-3), 70.4 
(PhCH2O), 70.3* (PhCH2O), 69.8 (C-1′′), 69.76* (C-1′′), 65.9 (C-9a′′), 59.7 (C-6′′), 
59.4* (C-6′′), 56.1 (OCH3), 56.0 (OCH3), 55.9* (OCH3), 55.8* (OCH3), 52.2 (C-4′′), 
35.9 (C-7′′), 33.4* (C-2′′), 33.0 (C-2′′), 25.94 ((CH3)3CSi), 25.9* ((CH3)3CSi), 21.8 (C-
3′′), 21.5* (C-3′′), 18.32 ((CH3)3CSi), 18.3 ((CH3)3CSi), -4.2* (CH3Si), -4.5 (CH3Si). 
ESIMS m/z 611 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C37H47N2O4Si [M + H]+: 611.3305; found: 611.3311. 
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6-(Benzyloxy)-2'-((1R,6S,9aS)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexa 
hydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbonitrile (412) 
 
The title compound was prepared following the General method 23 for ring-
closing metathesis using Grubbs’ II ruthenium catalyst using, carbonitrile 410 (71.5 mg, 
0.1 mmol, 1.0 equiv.), Grubbs’ II ruthenium catalyst (8.5 mg, 0.001 mmol, 0.1 equiv.) 
and CH2Cl2 (1.4 mL). The reaction mixture stirred and heated  at 80 °C for 4 h. 
Purification by column chromatography on silica gel eluting with 20:80 EtOAc/hexane 
gave the title compound 412 as a light brown oil (43.0 mg, 70%). 1H NMR analysis 
revealed the presence of two biphenyl axis rotamers in a 76:24 ratio. 
Rf = 0.2 (EtOAc:hexane = 30:70). 
    
    + 7.7 (c 2.15, CHCl3). 
IR (neat): νmax 2923, 2853, 2229, 1600, 1515, 1463, 1252, 1113, 836, 775, 696 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.61* (d, J = 8.9 Hz, 0.24H, H-4), 7.58 (dd, J = 8.5, 2.2 Hz, 0.76H, H-4), 7.53 (d, J = 
2.2 Hz, 0.76H, H-2), 7.34 – 7.25 (m, 4.24H, H-2 and ArH), 7.22* (d, J = 7.3 Hz, 0.48H, 
ArH), 7.17 (d, J = 6.1 Hz, 1.52H, ArH), 7.14* (s, 0.24H, H-3′), 7.11 (s, 0.76H, H-3′), 
7.08* (d, J = 8.6 Hz, 0.24H, H-5), 6.97 (d, J = 8.6 Hz, 0.76H, H-5), 6.70* (s, 0.24H, H-
6′), 6.57 (s, 0.76H, H-6′), 6.11 (d, J = 10.0 Hz, 1H, H-9′′), 5.96* (d, J = 9.7 Hz, 0.24H, 
H-8′′), 5.86 (d, J = 10.0 Hz, 0.76H, H-8′′), 5.17* (d, J = 12.2 Hz, 0.24H, PhCHAHBO 
(minor)), 5.12 – 5.01 (m, 1.76H, PhCHAHBO (minor) and PhCH2O), 4.03* (d, J = 6.1 
Hz, 0.24H, H-6′′), 3.88 (s, 2.28H, OCH3), 3.85* (s, 0.72H, OCH3), 3.83 (s, 2.28H, 
OCH3), 3.82 – 3.78 (m, 0.76H, H-6′′), 3.78* (s, 0.72H, OCH3), 3.34 – 3.20 (m, 1H, H-
1′′), 2.80 – 2.55 (m, 2H, H-7′′A (minor), H-7′′A and H-9a′′), 2.27* (d, J = 17.1 Hz, 
0.24H, H-7′′B (minor)), 2.10 – 1.91 (m, 1.76H), H-4′′A and H-7′′B), 1.85 (dd, J = 12.8, 
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3.8 Hz, 1H, H-2′′A), 1.78 (td, J = 11.8, 3.0 Hz, 1H, H-4′′B), 1.50 – 1.29 (m, 2H, H-3′′), 
1.20 – 1.08 (m, 1H, H-2′′B), 0.88 (s, 9H, (CH3)3CSi), 0.05 (s, 2.28H, CH3Si), 0.03 (s, 
2.28H, CH3Si), 0.01* (s, 0.72H, CH3Si), 0.00* (s, 0.72H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
159.5* (C-6), 159.4 (C-6), 148.9 (C-4′), 147.5 (C-5′), 146.9* (C-5′), 135.9* (C-2), 
135.89* (ArC), 135.8 (ArC), 135.7 (C-2), 133.2 (C-4), 133.17 (C-1), 132.6 (C-2′), 
132.3* (C-1), 131.8* (C-2′), 128.8* (0.48 x ArCH), 128.77 (1.52 x ArCH), 128.6 (C-1′), 
128.5* (C-1′), 128.3 (0.76 x ArCH), 128.2* (0.24 x ArCH), 127.6* (C-9′′), 127.4 (C-
9′′), 127.0 (1.52 x ArCH), 126.6* (0.48 x ArCH), 125.3 (C-8′′), 124.8* (C-8′′), 119.2 
(C≡N), 119.1* (C≡N), 113.2* (C-5), 113.1* (C-6′), 112.9 (C-5), 112.7 (C-6′), 110.6* 
(C-3′), 110.4 (C-3′), 104.5 (C-3), 104.0* (C-3), 72.6 (C-1′′), 72.4* (C-1′′), 70.8 
(PhCH2O), 70.3* (PhCH2O), 61.7* (C-9a′′), 61.3 (C-9a′′), 56.3 (C-6′′), 56.0 (OCH3), 
55.95* (OCH3), 55.9 (OCH3), 54.8* (C-6′′), 51.4 (C-4′′), 50.7* (C-4′′), 35.1* (C-2′′), 
34.9 (C-2′′), 32.7* (C-7′′), 32.0 (C-7′′), 26.0 ((CH3)3CSi), 23.7 (C-3′′), 23.3* (C-3′′), 
18.2 ((CH3)3CSi), -3.8 (CH3Si), -3.9* (CH3Si), -4.5* (CH3Si), -4.6 (CH3Si). 
ESIMS m/z 611 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C37H47N2O4Si [M + H]+: 611.3305; found: 611.3324. 
6.4.15 General method 24 for reduction of a nitrile using DIBAL-H 
6-(Benzyloxy)-2'-((1R,6S,9aR)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexa 
hydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbaldehyde (413) 
 
To a solution of carbonitrile 411 (46.0 mg, 0.075 mmol, 1.0 equiv.) in toluene 
(0.27 mL) at -78 °C was added DIBAL-H (0.15 mL, 0.15 mmol, 1.0 M in toluene, 2.0 
equiv.). After stirring for 1 h, the reaction was quenched with water at -78 °C and 
allowed to reach room temperature and stirred for another 30 min. The reaction mixture 
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was extracted with EtOAc (3 x 2 mL). The combined organic layer was dried (MgSO4), 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 15:85 EtOAc/CH2Cl2 to afford the title 
compound 413 as a pale yellow oil (24.8 mg, 54 %). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 53:47 ratio. 
Rf = 0.3 (EtOAc:hexane = 30:70). 
    
    + 9.4 (c 0.55, CHCl3). 
IR (neat): νmax 2927, 2854, 1691, 1597, 1514, 1462, 1251, 1116, 835, 773 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
9.94 (s, 0.53H, CHO), 9.93* (s, 0.47H, CHO), 7.87 (dd, J = 8.7, 2.1 Hz, 0.53H, H-4), 
7.85* (dd, J = 8.6, 2.1 Hz, 0.47H, H-4), 7.71* (d, J = 2.1 Hz, 0.47H, H-2), 7.68 (d, J = 
2.1 Hz, 0.53H, H-2), 7.35 – 7.21 (m, 6H, H-3′ and ArH), 7.12* (d, J = 8.6 Hz, 0.47H, 
H-5), 7.09 (d, J = 8.7 Hz, 0.53H, H-5), 6.66 (s, 0.53H, H-6′), 6.63* (s, 0.47H, H-6′), 
5.66 (br s, 1H, H-8′′), 5.40* (d, J = 10.5 Hz, 0.47H, H-9′′), 5.36 (d, J = 10.5 Hz, 0.53H, 
H-9′′), 5.26 – 5.12 (m, 2H, PhCH2O), 3.95 (s, 1.59H, OCH3), 3.94* (s, 1.41H, OCH3), 
3.87 (s, 3H, OCH3), 3.77 (br s, 1H, H-1′′), 3.25 (br s, 0.53H, H-6′′), 3.12* (br s, 0.47H, 
H-6′′), 2.77 – 2.67 (m, 2.53H, H-4′′ and H-9a′′), 2.64 (br s, 0.47H, H-9a′′), 2.36* – 2.16* 
(m, 0.94H, H-7′′), 2.06 – 1.96 (m, 1.06H, H-7′′), 1.94 – 1.40 (m, 4H, H-2′′ and H-3′′), 
0.94 (s, 9H, (CH3)3CSi), 0.05 (s, 2.82H, CH3Si), 0.04 (s, 3.18H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
191.05 (C=O), 191.0* (C=O), 161.4 (C-6), 161.0* (C-6), 149.3* (C-4′), 149.3 (C-4′), 
147.2* (C-5′), 147.0 (C-5′), 136.6* (C-2′), 136.3 (ArC), 136.2* (ArC), 135.5 (C-2′), 
133.8 (C-2), 133.2* (C-2), 131.8 (C-1), 131.6* (C-1), 131.5* (C-4), 131.2 (C-4), 129.7* 
(C-3), 129.7 (C-3), 129.1* (C-1′), 128.7 (1.06 x ArCH), 128.6* (0.94 x ArCH), 128.5 
(C-1′), 128.1 (0.53 x ArCH), 128.0* (0.47 x ArCH), 126.8* (0.94 x ArCH), 126.7 (1.06 
x ArCH), 125.4 (C-8′′), 125.0* (C-8′′), 112.5* (C-5), 112.5 (C-6′), 112.3 (C-5), 110.0 
(C-3′), 109.6* (C-3′), 70.3 (PhCH2O), 70.3* (PhCH2O), 69.8 (C-1′′), 69.8* (C-1′′), 66.0 
(C-9a′′), 65.9* (C-9a′′), 59.7 (C-6′′), 59.4* (C-6′′), 56.0 (OCH3), 56.0 (OCH3), 55.9* 
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(OCH3), 55.8* (OCH3), 52.3 (C-4′′), 35.8 (C-7′′), 33.4* (C-2′′), 33.1 (C-2′′), 25.9 
((CH3)3CSi), 21.8 (C-3′′), 21.5* (C-3′′), 18.3 ((CH3)3CSi), -4.2 (CH3Si), -4.5 (CH3Si). 
ESIMS m/z 614 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C37H48NO5Si [M + H]+: 614.3302; found: 614.3306. 
6-(Benzyloxy)-2'-((1R,6S,9aS)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexa 
hydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-carbaldehyde (414) 
 
The title compound was prepared following the General method 24 for a nitrile 
reduction using carbonitrile 412 (91.6 mg, 0.15 mmol, 1.0 equiv.), DIBAL-H (0.3 mL, 
0.30 mmol, 1.0 M in toluene, 2.0 equiv.) and toluene (0.54 mL). Purification by column 
chromatography on silica gel eluting with 25:75 EtOAc/hexane gave the title compound 
414 as a pale yellow oil (77.9 mg, 83%). 1H NMR analysis revealed the presence of two 
biphenyl axis rotamers in a 77:23 ratio. 
Rf = 0.4 (EtOAc:hexane = 40:60). 
    
    + 8.6 (c 0.34, CHCl3). 
IR (neat): νmax 2933, 2852, 1692, 1599, 1515, 1464, 1251, 1115, 835, 773 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
9.93 (s, 0.77H, CHO), 9.90* (s, 0.23H, CHO), 7.86* (dd, J = 8.5, 2.2 Hz, 0.23H, H-4), 
7.82 (dd, J = 8.5, 2.2 Hz, 0.77H, H-4), 7.79 (d, J = 2.2 Hz, 0.77H, H-2), 7.57* (d, J = 
2.2 Hz, 0.23H, H-2), 7.36 – 7.16 (m, 5.23H, H-5 and ArH), 7.15* (s, 0.23H, H-3′), 7.11 
(s, 0.77H, H-3′), 7.04 (d, J = 8.5 Hz, 0.77H, H-5), 6.75* (s, 0.23H, H-6′), 6.64 (s, 
0.77H, H-6′), 6.10 (d, J = 9.8 Hz, 1H, H-9′′), 5.98 – 5.93* (m, 0.23H, H-8′′), 5.89 – 5.84 
(m, 0.77H, H-8′′), 5.22* (d, J = 12.3 Hz, 0.23H, PhCHAHBO (minor)), 5.17 – 5.03 (m, 
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1.77H, PhCH2O and PhCHAHBO (minor)), 4.12* – 4.07* (m, 0.23H, H-6′′), 3.88 (s, 
2.31H, OCH3), 3.86* (s, 0.69H, OCH3), 3.83 (s, 3.08H, H-6′′ and OCH3), 3.78* (s, 
0.69H, OCH3), 3.31 – 3.18 (m, 1H, H-1′′), 2.78 – 2.55 (m, 2H, H-7′′A (minor), H-7′′A, 
H-9a′′), 2.35* – 2.24* (m, 0.23H, H-7′′B (minor)), 2.16 – 1.91 (m, 1.77H, H-4′′A and H-
7′′B), 1.88 – 1.72 (m, 2H, H-2′′A and H-4′′B), 1.42 – 1.29 (m, 2H, H-3′′), 1.21 – 1.07 (m, 
1H, H-2′′B), 0.88 (s, 6.93H, (CH3)3CSi), 0.87* (s, 2.07H, (CH3)3CSi), 0.05 (s, 2.31H, 
CH3Si), 0.03* (s, 0.69H, CH3Si), 0.02 (s, 2.31H, CH3Si), -0.00* (s, 0.69H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
191.0 (C=O), 190.8* (C=O), 161.1* (C-6), 161.06 (C-6), 148.7 (C-4′), 147.5 (C-5′), 
146.9* (C-5′), 136.2* (ArC), 136.1 (ArC), 134.0* (C-2), 133.3 (C-2), 132.6 (C-1), 132.5 
(C-2′), 132.3* (C-1), 131.7 (C-4), 131.3* (C-4), 130.1 (C-3), 129.6 (C-1′), 129.5* (C-
1′), 128.8 (1.54 x ArCH), 128.7* (0.46 x ArCH), 128.2 (C-1), 127.6* (C-9′′), 127.4 (C-
9′′), 126.9 (1.54 x ArCH), 126.6* (0.46 x ArCH), 125.4 (C-8′′), 124.9* (C-8′′), 113.3* 
(C-6′), 112.9 (C-6′), 112.6* (C-5), 112.3 (C-5), 110.6* (C-3′), 110.3 (C-3′), 72.6 (C-1′′), 
72.4* (C-1′′), 70.8 (PhCH2O), 70.3 (PhCH2O), 61.7* (C-9a′′), 61.4 (C-9a′′), 56.2 (C-6′′), 
56.0 (OCH3), 55.9 (OCH3), 54.7* (C-6′′), 51.3 (C-4′′), 50.7* (C-4′′), 35.1* (C-2′′), 34.9 
(C-2′′), 32.8* (C-7′′), 32.1 (C-7′′), 26.0 ((CH3)3CSi), 23.7 (C-3′′), 23.3* (C-3′′), 18.2 
((CH3)3CSi), -3.8 (CH3Si), -3.9* (CH3Si), -4.5 (CH3Si). 
ESIMS m/z 614 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C37H48NO5Si [M + H]+: 614.3302; found: 614.3313. 
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6.4.16 General method 25 for the Still–Gennari modified Horner-Wadsworth-
Emmons reaction 
Methyl (Z)-3-(6-(benzyloxy)-2'-((1R,6S,9aR)-1-((tert-butyldimethylsilyl)oxy)-
1,3,4,6,7, 9a-hexahydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-
yl)acrylate (415) 
 
To a solution of 18-crown-6 (52.5 mg, 0.1987 mmol, 5.0 equiv.) in anhydrous 
THF (0.69 mL) at -78 °C was added KHMDS (63.5 µL, 0.0556 mmol, 0.5 M in toluene, 
1.6 equiv.) and the mixture was stirred for 10 min. Bis(2,2,2-trifluoro-
ethyl)(methoxycarbonylmethyl) phosphonate (20.2 mg, 0.0635 mmol, 1.6 equiv.) was 
added and the reaction mixture was strried for 10 min. A solution of aldehyde 413 (24.4 
mg, 0.0397 mmol, 1.0 equiv.) in THF (0.11 mL) was added slowly and stirring was 
continued for 2 h. The reaction was quenched with sat. aqueous NH4Cl solution and 
extracted with EtOAc (3 x 5 mL). The combined organic layer was brine, dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 20:80 EtOAc/hexane to afford the title 
compound 415 as a pale yellow oil (14.7 mg, 56 %). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 48:52 ratio. 
Rf = 0.2 (EtOAc:hexane = 20:80). 
    
    + 13.8 (c 0.92, CHCl3). 
IR (neat): νmax 2933, 2852, 1721, 1599, 1514, 1498, 1250, 1172, 1152, 831, 773 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.83 (td, J = 8.3, 2.3 Hz, 1H, H-4′), 7.38 (d, J = 2.4 Hz, 
0.52H, H-2′), 7.35* (d, J = 2.4 Hz, 0.48H, H-2′), 7.32 – 7.16 (m, 6H, ArH and H-3′′), 
6.94 (d, J = 8.7 Hz, 0.52H, H-5′), 6.92* (d, J = 8.7 Hz, 0.48H, H-5′), 6.84* (d, J = 12.8 
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Hz, 0.48H, H-3), 6.83 (d, J = 12.8 Hz, 0.52H, H-3), 6.65* (s, 0.48H, H-6′′), 6.62 (s, 
0.52H, H-6′′), 5.84* (d, J = 12.8 Hz, 0.48H, H-2), 5.84 (d, J = 12.8 Hz, 0.52H, H-2), 
5.65 – 5.57 (m, 1H, H-8′′), 5.33 (t, J = 12.0 Hz, 1H, H-9′′), 5.16 – 5.02 (m, 2H, 
PhCH2O), 3.90* (s, 1.44H, OCH3), 3.89* (s, 1.44H, OCH3), 3.84 (s, 1.56H, OCH3), 
3.83 (s, 1.56H, OCH3), 3.74 (s, 1H, H-1′′′), 3.71 (s, 3H, OCH3), 3.32* – 3.28* (m, 
0.48H, H-6′′′), 3.20 – 3.15 (s, 0.52H, H-6′′′), 2.74 – 2.61 (m, 3H, H-4′′′ and H-9a′′′), 
2.26 – 1.95 (m, 2H, H-7′′′), 1.88 – 1.55 (m, 2H, H-2′′′A (major), H-3′′′A (major) and H-
3′′′A (minor)), 1.50 – 1.36 (m, 0.96H, H-2′′′ (minor)), 1.36 – 1.20 (m, 1H, H-2′′′B 
(major), H-3′′′B (minor)), 0.91 (s, 9.52H, H-3′′′B (major) and (CH3)3CSi)), 0.01 (s, 6H 
CH3Si). 
13C NMR (125 MHz, CDCl3): δ 166.7 (C-1), 157.3* (C-6′), 156.7 (C-6′), 148.9 (C-4′′), 
148.8* (C-4′′), 146.8 (C-5), 146.7* (C-5), 143.5 (C-3), 143.46* (C-3), 136.9* (ArC), 
136.87 (ArC), 136.5 (C-2′′), 135.5* (C-2′′), 134.9 (C-2′), 134.4* (C-2′), 130.9 (C-4′), 
130.6* (C-4′), 130.4 (C-1′), 130.2* (C-1′), 129.8* (C-1′′), 129.3 (C-1′′), 128.8 (C-9′′′), 
128.6* (C-9′′′), 128.5* (0.96 x ArCH), 128.3 (1.04 x ArCH), 127.6* (0.48 x ArCH), 
127.57 (0.52 x ArCH), 127.0* (C-3′), 126.9 (C-3′), 126.7* (0.96 x ArCH), 126.6 (1.04 x 
ArCH), 125.4* (C-8′′′), 124.9 (C-8′′′), 116.9 (C-2), 116.8* (C-2), 112.53* (C-6′′), 112.5 
(C-6′′), 112.0 (C-5′), 111.8* (C-5′), 109.7 (C-3′′), 109.4 (C-3′′), 70.0 (PhCH2O), 69.9* 
(PhCH2O), 69.7* (C-1′′′), 69.69 (C-1′′′), 65.9* (C-9a′′′), 65.7 (C-9a′′′), 59.4 (C-6′′′), 
59.1* (C-6′′′), 55.83 (OCH3), 55.8* (OCH3), 55.7* (OCH3), 55.6 (OCH3), 52.2 (C-4′′′), 
51.3 (OCH3), 35.7 (C-7′′′), 34.5* (C-7′′′), 33.3 (C-2′′′), 33.1* (C-2′′′), 25.8 ((CH3)3CSi), 
25.78* ((CH3)3CSi), 21.6* (C-3′′′), 21.3 (C-3′′′), 18.2* ((CH3)3CSi), 18.2 ((CH3)3CSi),    
-4.3 (CH3Si), -4.7 (CH3Si). 
ESIMS m/z 670 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C40H52NO6Si [M + H]+: 670.3564; found: 670.3595. 
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Methyl (Z)-3-(6-(benzyloxy)-2'-((1R,6S,9aS)-1-((tert-butyldimethylsilyl)oxy)-1,3,4, 
6,7,9a-hexahydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-yl)acrylate 
(416) 
 
The title compound was prepared following the General method 25 for the Still–
Gennari modified Horner-Wadsworth-Emmons reaction using 18-crown-6 (66.5 mg, 
0.2515 mmol, 5.0 equiv.), KHMDS (0.15 mL, 0.0755 mmol, 0.5 M in toluene, 1.5 
equiv.), bis(2,2,2-trifluoroethyl)(methoxycarbonylmethyl) phosphonate (24.0 mg, 
0.0755 mmol, 1.5 equiv.) and aldehyde 414 (30.9 mg, 0.0503 mmol, 1.0 equiv.) in THF 
(1.0 mL). Purification by column chromatography on silica gel eluting with 30:70 
EtOAc/hexane gave the title compound416 as a pale yellow oil (20.9 mg, 60%). 1H 
NMR analysis revealed the presence of two biphenyl axis rotamers in a 71:29 ratio. 
Rf = 0.3 (EtOAc:hexane = 30:70). 
    
    + 29.6 (c 0.19, CHCl3). 
IR (neat): νmax 2927, 1723, 1626, 1598, 1515, 1495, 1462, 1250, 1192, 1169, 1114, 
1042, 835, 773, 696 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.78* (dd, J = 8.7, 2.3 Hz, 0.29H, H-4′), 7.72 (dd, J = 8.5, 2.3 Hz, 0.71H, H-4′), 7.54 (d, 
J = 2.3 Hz, 0.71H, H-2′), 7.42* (d, J = 2.3 Hz, 0.29H, H-2′), 7.34 – 7.16 (m, 5H, ArH), 
7.15* (s, 0.29H, H-3′′), 7.10 (s, 0.71H, H-3′′), 7.01* (d, J = 8.7 Hz, 0.29H, H-5′), 6.93 – 
6.81 (m, 1.71H, H-3 and H-5′), 6.79* (s, 0.29H, H-6′′), 6.68 (s, 0.71H, H-6′′), 6.10 (d, J 
= 9.8 Hz, 1H, H-9′′′), 5.96* (d, J = 10.1 Hz, 0.29H, H-8′′′), 5.89 – 5.82 (m, 0.71H, H-
8′′′), 5.86 (d, J = 12.6 Hz, 1H, H-2), 5.15* (d, J = 12.3 Hz, 0.29H, PhCHAHBO (minor)), 
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5.03 (dd, J = 13.7, 7.1 Hz, 1.71H, PhCHAHBO (minor) and PhCH2O), 4.26* (d, J = 6.8 
Hz, 0.29H, H-6′′′), 3.96 (d, J = 7.1 Hz, 0.71H, H-6′′′), 3.88 (s, 2.73H, OCH3), 3.85* (s, 
0.87H, OCH3), 3.83 (s, 2.73H, OCH3), 3.77* (s, 0.87H, OCH3), 3.71 (s, 3H, OCH3), 
3.32 – 3.22 (m, 1H, H-1′′′), 2.78* (d, J = 18.3 Hz, 0.29H, H-7′′′A (minor)), 2.74 – 2.60 
(m, 1.71H, H-7′′′A and H-9a′′′), 2.31* (d, J = 17.4 Hz, 0.29H, H-7′′′B (minor)), 2.18 – 
1.93 (m, 1.71H, H-4′′′A and H-7′′′B), 1.87 – 1.72 (m, 2H, H-2′′′A and H-4′′′B), 1.47 – 
1.30 (m, 2H, H-3′′′), 1.19 – 1.11 (m, 1H, H-2′′′B), 0.88 (s, 6.39H, (CH3)3CSi), 0.87* (s, 
2.61H, (CH3)3CSi), 0.05 (s, 2.13H, CH3Si), 0.03* (s, 0.87H, CH3Si), 0.02 (s, 2.13H, 
CH3Si), 0.00* (s, 0.87H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
166.7 (C-1), 166.6* (C-1), 157.0* (C-6′), 156.9 (C-6′), 148.3 (C-4′′), 147.3 (C-5′′), 
146.7* (C-5′′), 143.5* (C-3), 143.4 (C-3), 137.0* (ArC), 136.95 (ArC), 135.0* (C-2′), 
134.7 (C-2′), 132.5 (C-2′′), 132.1* (C-2′′), 131.2 (C-1′), 131.2* (C-4′), 131.0 (C-4′), 
130.7 (C-1′′), 130.6* (C-1′), 130.0* (C-1′′), 128.7* (0.58 x ArCH), 128.6 (1.42 x 
ArCH), 127.9 (0.71 x ArCH), 127.8* (0.29 x ArCH), 127.7* (C-9′′′), 127.6 (C-3′), 
127.4 (C-9′′′), 127.1* (C-3′), 126.9 (1.42x ArCH), 126.5* (0.58 x ArCH), 125.7 (C-8′′′), 
125.2* (C-8′′′), 117.3 (C-2), 113.7* (C-5′), 113.2 (C-5′), 112.0* (C-6′′), 112.0 (C-6′′), 
110.6* (C-3′′), 110.3 (C-3′′), 72.7 (C-1′′′), 72.5* (C-1′′′), 70.6 (PhCH2O), 69.9* 
(PhCH2O), 61.7* (C-9a′′′), 61.4 (C-9a′′′), 56.1 (C-6′′′), 55.9 (OCH3), 55.89* (OCH3), 
54.5* (C-6′′′), 51.4 (OCH3), 51.3 (C-4′′′), 50.6* (C-4′′′), 35.1* (C-2′′′), 35.0 (C-2′′′), 
32.8* (C-7′′′), 32.1 (C-7′′′), 26.0 ((CH3)3CSi), 23.7 (C-3′′′), 23.3 (C-3′′′), 18.2 
((CH3)3CSi), -3.8 (CH3Si), -3.9* (CH3Si), -4.5 (CH3Si). 
ESIMS m/z 670 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C40H52NO6Si [M + H]+: 670.3564; found: 670.3581. 
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6.4.17 General method 26 for hydrolysis of methyl ester derivative using 
LiOH·H2O 
(Z)-3-(6-(Benzyloxy)-2'-((1R,6S,9aR)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-
hexa hydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-yl)acrylic acid 
(417) 
 
To a solution of methyl ester 415 (15.0 mg, 0.0224 mmol, 1.0 equiv.) in 4:1:1 
THF:MeOH:H2O (0.28 mL) was added LiOH·H2O (17.4 mg, 0.4478 mmol, 20.0 
equiv.) and stirred at 50 °C for 9 h. The mixture was dilute with water (1 mL) and 
acidified to pH 3-4 with 1M citric acid. The aqueous layer was extracted with EtOAc    
(3 x 3 mL). The combined organic layer was brine, dried (MgSO4), filtered and 
concentrated in vacuo. The crude acid 417 was used without further purification. 
ESIMS m/z 656 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C39H50NO6Si [M + H]+: 656.3407; found: 656.3402. 
(Z)-3-(6-(Benzyloxy)-2'-((1R,6S,9aS)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-
hexahydro-2H-quinolizin-6-yl)-4',5'-dimethoxy-[1,1'-biphenyl]-3-yl)acrylic acid 
(418) 
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The title compound was prepared following the General method 26 for 
hydrolysis of methyl ester derivative using methyl ester 416 (13.7 mg, 0.0198 mmol, 
1.0 equiv.), LiOH•H2O (12.3 mg, 0.2936 mmol, 15.0 equiv.) and 4:1:1 
THF:MeOH:H2O (0.1 mL). The crude acid 418 was used without further purification. 
ESIMS m/z 656 (100%) [M + H]+.  
HRMS (ESI): m/z calculated for C39H50NO6Si [M + H]+: 656.3407; found: 656.3437. 
(1R,6S,9aR)-6-(2'-(benzyloxy)-5'-((Z)-2-bromovinyl)-4,5-dimethoxy-[1,1'-biphenyl]-
2-yl)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexahydro-2H-quinolizine (419) 
 
To a solution of the crude acid 417 (5.0 mg, 7.6 µmol, 1.0 equiv.) in MeCN (38 
µL) was added diphenyl diselenide (0.1 mg, 0.38 µmol, 0.05 equiv.) and the mixture 
was cooled to at -30 °C. Next, N-bromosuccinimide (1.5 mg, 8.36 µmol, 1.1 equiv.) was 
added and the reaction mixture was stirred for 5 h. The mixture was dilute with EtOAc 
(2 mL) and washed with water (2 x 5 mL). The organic layer was brine, dried (MgSO4), 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel eluting with 10:90 EtOAc/hexane to afford the title 
compound 419 as a pale yellow oil (1.0 mg, 14 %). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 48:52 ratio. 
Rf = 0.3 (EtOAc:hexane = 15:75). 
    
    + 18.6 (c 0.05, CHCl3). 
IR (neat): νmax 3029, 2925, 2852, 1645, 1600, 1515, 1493, 1460, 1251, 1119, 1022, 871, 
736, 696 cm-1. 
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1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.66 (d, J = 8.5 Hz, 1H, H-4′′), 7.49 (s, 1H, H-6′′), 7.32 – 7.16 (m, 6H, , H-3′ and ArH), 
7.00* (d, J = 8.1 Hz, 0.48H, H-1′′′), 6.99 (d, J = 8.1 Hz, 0.52H, H-1′′′), 6.96 (d, J = 8.7 
Hz, 0.52H, H-3′′), 6.94* (d, J = 8.7 Hz, 0.48H, H-3′′), 6.64* (s, 0.48H, H-6′), 6.63 (s, 
0.52H, H-6′), 6.31 (d, J = 8.1 Hz, 1H, H-2′′′), 5.62 (d, J = 8.5 Hz, 1H, H-8), 5.34 (t, J = 
11.5 Hz, 1H, H-9), 5.12 – 5.01 (m, 2H, PhCH2O), 3.91* (s, 1.44H, OCH3), 3.89* (s, 
1.44H, OCH3), 3.83 (s, 3.12H, OCH3), 3.77 – 3.72 (m, 1H, H-1), 3.35 – 3.30 (m, 0.52H, 
H-6), 3.24* – 3.18* (m, 0.48H, H-6), 2.77 – 2.60 (m, 3H, H-4 and H-9a), 2.31 – 1.98 
(m, 2H, H-7), 1.88 – 1.28 (m, 4H, H-2 and H-3), 0.91 (s, 9H, (CH3)3CSi)), 0.01 (s, 6H, 
CH3Si)). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
156.3* (C-2′′), 155.7 (C-2′′), 148.9 (C-4′), 148.8* (C-4′), 146.8* (C-5′), 146.7 (C-5′), 
137.0 (ArC), 136.97* (ArC), 136.4* (C-2′), 135.5 (C-2′), 132.9 (C-6′′), 132.6* (C-6′′), 
131.6 (C-3′′′), 131.59* (C-3′′′), 130.7 (C-1′′), 130.5* (C-1′′), 129.9* (C-1′), 129.5 (C-1′), 
129.3 (C-4′′), 129.1* (C-4′′), 128.8 (C-9), 128.5 (1.04 x ArCH), 128.3* (0.96 x ArCH), 
127.6* (0.48 x ArCH), 127.56 (0.52 x ArCH), 127.3 (C-5′′), 127.28* (C-5′′), 126.6* 
(0.96 x ArCH), 126.58 (1.04 x ArCH), 125.4* (C-8), 124.9 (C-8), 112.5(C-6′), 112.2 
(C-3′′), 112.1* (C-3′′), 109.7* (C-3′), 109.4 (C-3′), 104.5 (C-2′′′), 104.4* (C-2′′′), 70.0 
(PhCH2O), 69.96* (PhCH2O), 69.7 (C-1), 65.9 (C-9a), 65.8* (C-9a), 59.3 (C-6), 59.1* 
(C-6), 55.9 (OCH3), 55.8 (OCH3), 55.7* (OCH3), 55.65* (OCH3), 33.3* (C-2), 33.1 (C-
2), 25.8 ((CH3)3CSi), 21.6* (C-3), 21.3 (C-3), 18.2 ((CH3)3CSi), -4.3 (CH3Si), -4.7* 
(CH3Si) (The methylene carbons C-4 and C-7 were not detected.). 
ESIMS m/z 690 (47%) [M(79Br) + H]+, 692 (55%) [M(81Br) + H]+. 
HRMS (ESI): m/z calculated for C38H49NO4SiBr [M + H]+: 690.2614; found: 690.2642. 
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(1R,6S,9aS)-6-(2'-(benzyloxy)-5'-((Z)-2-bromovinyl)-4,5-dimethoxy-[1,1'-biphenyl]-
2-yl)-1-((tert-butyldimethylsilyl)oxy)-1,3,4,6,7,9a-hexahydro-2H-quinolizine (420) 
 
To a solution of the crude acid 418(10.6 mg, 16.1 µmol, 1.0 equiv.) in MeCN 
(81 µL) was added diphenyl diselenide (0.3 mg, 0.81 µmol, 0.05 equiv.) and the 
mixture was cooled to at -30 °C. Next, N-bromosuccinimide (3.5 mg, 19.4 µmol, 1.2 
equiv.) was added and the reaction mixture was stirred for 2 h. The mixture was dilute 
with EtOAc (0.8 mL) and washed with water (2 x 2 mL). The organic layer was brine, 
dried (MgSO4), filtered and concentrated in vacuo. The crude product was purified by 
column chromatography on silica gel eluting with 20:80 EtOAc/hexane to afford the 
title compound 420 as a pale yellow oil (2.0 mg, 18 %). 1H NMR analysis revealed the 
presence of two biphenyl axis rotamers in a 39:61 ratio. 
Rf = 0.4 (EtOAc:hexane = 30:70). 
    
    - 12.3 (c 0.10, CHCl3). 
IR (neat): νmax 3037, 2927, 2854, 1660, 1513, 1492, 1462, 1250, 1113, 1092, 1016, 834, 
774, 734, 696 cm-1. 
1H NMR (500 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
7.64 (d, J = 2.4 Hz, 0.69H, H-6′′), 7.57 (dd, J = 8.6, 2.4 Hz, 0.69H, H-4′′), 7.55* (dd, J 
= 8.6, 2.4 Hz, 0.31H, H-4′′), 7.52* (d, J = 2.3 Hz, 0.31H, H-6′′), 7.33 – 7.16 (m, 5H, 
ArH), 7.15* (s, 0.31H, H-3′), 7.11 (s, 0.69H, H-3′), 7.04* (d, J = 8.6 Hz, 0.31H, H-3′′), 
7.02 (d, J = 8.0 Hz, 0.69H, H-1′′′), 6.99* (d, J = 8.0 Hz, 0.31H, H-1′′′), 6.91* (d, J = 8.6 
Hz, 0.31H, H-3′′), 6.81* (s, 0.31H, H-6′), 6.66 (s, 0.69H, H-6′), 6.34 (d, J = 8.0 Hz, 
0.69H, H-2′′′), 6.32* (d, J = 8.0 Hz, 0.31H, H-2′′′), 6.14 – 6.07 (m, 1H, H-9), 5.99* – 
5.93* (m, 0.31H, H-8), 5.90 – 5.86 (m, 0.69H, H-8), 5.15* (d, J = 12.4 Hz, 0.31H 
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PhCHAHBO (minor)), 5.08 – 4.98 (m, 1.69H, PhCHAHBO (minor) and PhCH2O), 4.32* 
(dd, J = 6.9, 2.7 Hz, 0.31H, H-6), 3.97 (d, J = 6.9 Hz, 0.69H, H-6), 3.87 (s, 2.07H, 
OCH3), 3.85* (s, 0.93H, OCH3), 3.83 (s, 2.07H, OCH3), 3.78* (s, 0.93H, OCH3), 3.31 – 
3.24 (m, 1H, H-1), 2.81 – 2.68 (m, 1H, H-7A and H-7A (minor)), 2.65 (d, J = 7.8 Hz, 
1H, H-9a), 2.37* – 2.30* (m, 0.31H, H-7B (minor)), 2.19 – 2.12 (m, 1H, H-4A), 2.11 – 
2.04 (m, 0.69H, H-7B), 1.86 – 1.79 (m, 2H, H-2A and H-4B), 1.40 – 1.35 (m, 2H, H-3), 
1.18 – 1.12 (m, 1H, H-2B), 0.88 (d, J = 1.2 Hz, 6.21H, (CH3)3CSi), 0.87* (s, 2.79H, 
(CH3)3CSi), 0.05 (s, 2.07H, CH3Si), 0.03* (s, 0.93H, CH3Si), 0.02 (s, 3H, CH3Si). 
13C NMR (125 MHz, the asterisk* denotes the signal of the minor rotamer, CDCl3): δ 
155.9* (C-2′′), 155.8 (C-2′′), 148.3* (C-4′), 148.2 (C-4′), 147.2 (C-5′), 136.9 (ArC), 
136.5* (ArC), 132.9* (C-6′′), 132.7 (C-6′′), 132.4 (C-2′), 131.9* (C-2′), 131.6 (C-1′′′), 
131.4* (C-1′′′), 130.6 (C-1′ and C-1′′), 129.6* (C-4′′), 129.5 (C-4′′), 128.5* (C-5′′ and 
0.62 x ArCH), 128.45 (1.38 x ArCH), 127.8* (0.31 x ArCH), 127.7 (0.69 x ArCH), 
127.3 (C-9), 126.8 (1.38x ArCH), 126.4* (0.62 x ArCH), 125.5 (C-8), 125.0* (C-8), 
113.5* (C-6′), 112.8 (C-6′), 112.2* (C-3′′), 112.1 (C-3′′), 110.4* (C-3′), 110.1 (C-3′), 
104.8 (C-2′′′), 72.6 (C-1), 72.2* (C-1), 70.5 (PhCH2O), 69.7* (PhCH2O), 61.6* (C-9a), 
61.3 (C-9a), 56.0 (C-6), 55.8 (OCH3), 54.3* (C-6), 51.3 (C-4), 50.4* (C-4), 35.0* (C-2), 
34.8 (C-2), 32.8* (C-7), 32.0 (C-7), 25.9 ((CH3)3CSi), 23.6 (C-3), 18.1 ((CH3)3CSi),       
-4.0 (CH3Si), -4.7 (CH3Si). 
ESIMS m/z ESIMS m/z 690 (47%) [M(79Br) + H]+, 692 (55%) [M(81Br) + H]+. 
HRMS (ESI): m/z calculated for C38H49NO4SiBr [M + H]+: 690.2614; found: 690.2648. 
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